Journal Menu
► ▼ Journal Menu-
- JPM Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
28 October 2024
Meet Us at Pharmacology 2024, 10–12 December 2024, Harrogate, UK
Conference: Pharmacology 2024
Date: 10–12 December 2024
Location: Harrogate, UK
MDPI will be attending Pharmacology 2024 as an exhibitor. We welcome researchers from different backgrounds to visit and share their latest ideas with us.
The British Pharmacological Society is a charity and global membership community whose mission is to promote and advance the whole spectrum of pharmacology. It leads the way in pharmacology research and application around the world, with around 4,000 members from more than 60 countries. Each year, the British Pharmacological Society hosts its annual Pharmacology conference, gathering individuals from academia, healthcare, industry, and the regulatory sector to share and celebrate the latest research and developments in this field and other related areas. This conference is a great opportunity for those studying and working in this field to attend lectures from experts and emerging researchers, network, socialize, and showcase their own work.
The following MDPI journals will be represented:
- Pharmaceuticals;
- Pharmacoepidemiology;
- Pharmacy;
- Antioxidants;
- Neurology International;
- Future Pharmacology;
- BioTech;
- Cancers;
- Sci. Pharm.;
- Sclerosis;
- Medicines;
- JPM;
- DDC.
28 October 2024
Journal of Personalized Medicine | Selected Popular Special Issues in 2023–2024
Explore the 2023–2024 popular Special Issues from the Journal of Personalized Medicine (JPM, ISSN: 2075-4426), encompassing advanced topics in surgery, genomics, and personalized prevention and treatment strategies. We warmly invite scholars to delve into these issues and contribute to the ongoing dialogue in personalized medicine.
“Computer Assisted Maxillo-Facial Surgery” Guest Editors: Dr. Giovanni Gerbino and Dr. Emanuele Zavattero Cited by 41+ | Viewed by 29500+ |
“Precision Medicine Genomics: Pharmacogenomics” Guest Editors: Dr. Luis Andrés López-Fernández, Dr. Sara Salvador-Martín and Dr. Matea Zajc Petranović Cited by 28+ | Viewed by 20300+ |
“Personalized Medicine for Coronary Artery Disease: Diagnosis, Prevention, and Treatment” Guest Editor: Dr. Jacek Bil Cited by 27+ | Viewed by 17900+ |
“Innovations in Knee and Hip Arthroplasty” Guest Editor: Prof. Dr. Günther Maderbacher Cited by 12+ | Viewed by 14300+ |
You are welcome to view all the Special Issues, submit relevant papers to Journal of Personalized Medicine, and subscribe to JPM at https://www.mdpi.com/journal/jpm/toc-alert.
JPM Editorial Office
28 October 2024
Journal of Personalized Medicine | Highly Cited Papers on Oral Health in 2022–2023
Discover the highly cited oral health research from 2022–2023 in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426). Explore groundbreaking studies and insights that are shaping personalized dental care. Please feel free to read the selected articles below.
1. “Dental and Skeletal Side Effects of Oral Appliances Used for the Treatment of Obstructive Sleep Apnea and Snoring in Adult Patients—A Systematic Review and Meta-Analysis”
by Ioannis A. Tsolakis, Juan Martin Palomo, Stefanos Matthaios and Apostolos I. Tsolakis
J. Pers. Med. 2022, 12(3), 483; https://doi.org/10.3390/jpm12030483
Available online: https://www.mdpi.com/2075-4426/12/3/483
Cited by 16+ | Viewed by 4870+
2. “Effectiveness of Virtual Reality-Based Training on Oral Healthcare for Disabled Elderly Persons: A Randomized Controlled Trial”
by Ai-Hua Chang, Pei-Chen Lin, Pei-Chao Lin, Yi-Ching Lin, Yuji Kabasawa, Cheng-Yu Lin and Hsiao-Ling Huang
J. Pers. Med. 2022, 12(2), 218; https://doi.org/10.3390/jpm12020218
Available online: https://www.mdpi.com/2075-4426/12/2/218
Cited by 16+ | Viewed by 3680+
3. “The Predictive Value of Systemic Immune-Inflammation Index and Symptom Severity Score for Sepsis and Systemic Inflammatory Response Syndrome in Odontogenic Infections”
by Marius Pricop, Oana Ancusa, Serban Talpos, Horatiu Urechescu and Bogdan Andrei Bumbu
J. Pers. Med. 2022, 12(12), 2026; https://doi.org/10.3390/jpm12122026
Available online: https://www.mdpi.com/2075-4426/12/12/2026
Cited by 16+ | Viewed by 2110+
4. “Three-Dimensional Accuracy and Stability of Personalized Implants in Orthognathic Surgery: A Systematic Review and a Meta-Analysis”
by Alexandru Diaconu, Michael Boelstoft Holte, Gabriele Berg-Beckhoff and Else Marie Pinholt
J. Pers. Med. 2023, 13(1), 125; https://doi.org/10.3390/jpm13010125
Available online: https://www.mdpi.com/2075-4426/13/1/125
Cited by 12+ | Viewed by 2950+
5. “Blood Cell Count Inflammatory Markers as Prognostic Indicators of Periodontitis: A Systematic Review and Meta-Analysis”
by Oana Almășan, Daniel-Corneliu Leucuța and Mihaela Hedeșiu
J. Pers. Med. 2022, 12(6), 992; https://doi.org/10.3390/jpm12060992
Available online: https://www.mdpi.com/2075-4426/12/6/992
Cited by 10+ | Viewed by 1600+
6. “A New Detection Method of Oral and Oropharyngeal Squamous Cell Carcinoma Based on Multivariate Analysis of Surface Enhanced Raman Spectra of Salivary Exosomes”
by Cosmin Ioan Faur, Cristian Dinu, Valentin Toma, Anca Jurj, Radu Mărginean, Anca Onaciu, Rareș Călin Roman, Carina Culic, Magdalena Chirilă, Horațiu Rotar et al.
J. Pers. Med. 2023, 13(5), 762; https://doi.org/10.3390/jpm13050762
Available online: https://www.mdpi.com/2075-4426/13/5/762
Cited by 9+ | Viewed by 2280+
7. “Three-Dimensional Guided Zygomatic Implant Placement after Maxillectomy”
by Nathalie Vosselman, Haye H. Glas, Bram J. Merema, Joep Kraeima, Harry Reintsema, Gerry M. Raghoebar, Max J. H. Witjes and Sebastiaan A. H. J. de Visscher
J. Pers. Med. 2022, 12(4), 588; https://doi.org/10.3390/jpm12040588
Available online: https://www.mdpi.com/2075-4426/12/4/588
Cited by 9+ | Viewed by 2970+
8. “Simultaneous PSI-Based Orthognathic and PEEK Bone Augmentation Surgery Leads to Improved Symmetric Facial Appearance in Craniofacial Malformations”
by Valentin Kerkfeld, Lara Schorn, Rita Depprich, Julian Lommen, Max Wilkat, Norbert Kübler, Majeed Rana and Ulrich Meyer
J. Pers. Med. 2022, 12(10), 1653; https://doi.org/10.3390/jpm12101653
Available online: https://www.mdpi.com/2075-4426/12/10/1653
Cited by 8+ | Viewed by 2430+
9. “Association between Periodontitis Extent, Severity, and Progression Rate with Systemic Diseases and Smoking: A Retrospective Study”
by Georgios S. Chatzopoulos, Ziou Jiang, Nicholas Marka and Larry F. Wolff
J. Pers. Med. 2023, 13(5), 814; https://doi.org/10.3390/jpm13050814
Available online: https://www.mdpi.com/2075-4426/13/5/814
Cited by 7+ | Viewed by 2350+
10. “Radiation Exposure and Frequency of Dental, Bitewing and Occlusal Radiographs in Children and Adolescents”
by Ina Manuela Schüler, Christoph-Ludwig Hennig, Rika Buschek, Rebecca Scherbaum, Collin Jacobs, Marcel Scheithauer and Hans-Joachim Mentzel
J. Pers. Med. 2023, 13(4), 692; https://doi.org/10.3390/jpm13040692
Available online: https://www.mdpi.com/2075-4426/13/4/692
Cited by 6+ | Viewed by 4830+
To read more relevant papers, subscribe to JPM at https://www.mdpi.com/journal/jpm/toc-alert.
JPM Editorial Office
16 October 2024
MDPI's Newly Launched Journals in September 2024
Five new journals covering a diverse range of subjects launched their inaugural issue in September 2024. Like other journals in MDPI’s portfolio, these journals are dedicated to sharing the latest research through open access, reflecting our commitment to making knowledge accessible to all.
We extend our sincere gratitude to the Editorial Board Members for their dedication to the launch and development of our new journals. Each journal will ensure its high-quality output via excellent editorial and rigorous peer-review processes so that the published articles achieve significant impact and broad visibility.
We invite you to explore and learn more about these new journals below.
Journal | Founding Editor-in-Chief | Journal Topics (Selected) |
Prof. Dr. Nejat Düzgüneş, University of the Pacific, USA | Editorial | view inaugural issue | biological therapy and stem-cell therapy; drug therapy; chemotherapy; radiation and other nonsurgical therapeutic strategies | view journal scope | submit an article | |
Prof. Dr. Magda Tsolaki, Greek Federation of Alzheimer’s Disease, Greece; Aristotle University of Thessaloniki, Greece | Editorial | view inaugural issue | surgical/procedural complications; complications; perioperative adverse events; postoperative adverse events | view journal scope | submit an article | |
Prof. Dr. Steven R. Fassnacht, Colorado State University, USA; Cooperative Institute for Research in the Atmosphere, USA | Editorial | view inaugural issue | ice as a mineral; atmospheric ice; sea ice; freshwater ice; ice sheets; ice caps and ice shelves | view journal scope | submit an article | |
Dr. Francisco Epelde, Hospital Universitari Parc Tauli, Spain; University Autonoma of Barcelona, Spain | Editorial | view inaugural issue | hospital management; hospital facilities; hospital services; hospital risk management; health law | view journal scope | submit an article | |
Prof. Dr. Nicola Ferri, University of Padova, Italy | Editorial | view inaugural issue | lipids in cells and whole organisms; lipid structure and function; lipid products and processes; dietary lipids and nutrition | view journal scope | submit an article |
We wish to thank everyone who has supported the development of open access publishing. You are welcome to send an application here or contact the New Journal Committee ([email protected]) if you would like to create more new journals.
29 September 2024
MDPI New Journal Proposal—Invitation to Shape the Future of Open Science Together
As a leader in open access publishing, MDPI is eager to explore new collaboration opportunities, including the launch of new journals and the transfer of existing ones. At present, MDPI publishes over 400 journals, more than 160 of which have established partnerships with academic organizations. Additionally, we publish 19 association journals.
In order to enhance exchange and cooperation with scientific researchers and share the results of open science, MDPI invites experts and scholars from various fields to submit proposals for new journal collaboration opportunities. If your proposal is approved, you could take on the role of Editor-in-Chief, Deputy Editor-in-Chief, or Editorial Board Member of the journal. This position allows you to manage the manuscript review process alongside our editorial department, participate in calls for papers, strengthen your network with scholars in the field, expand scientific research cooperation, enhance your personal and academic influence internationally, and play a leading role in academia.
Once the new journal is online, MDPI will provide a variety of promotional channels to market the journal internationally.
MDPI will offer various promotional channels to enhance its visibility and promote it internationally.
How can you determine the theme of a new journal?
- Assess research hotspots/academic frontiers;
- Assess pioneers in the field/key research directions of universities;
- Determine whether MDPI has already established a journal in the field.
You can browse MDPI’s existing journals at the following link: https://www.mdpi.com/about/journals.
Advantages of collaborating with MDPI:
- MDPI is a global leader in open-access publishing with extensive academic resources.
- MDPI offers a professional publishing team that provides comprehensive support throughout the publishing process.
- MDPI’s diverse promotional platforms and channels help journals quickly increase their international visibility and influence.
We invite you to submit new journal proposal here, and contribute to academic development! In addition, if your institution (university, institute, college, national key laboratory, society, etc.) intends to establish a journal, you can also submit a draft to MDPI on its behalf.
27 September 2024
MDPI’s 2023 Travel Awards—Winners Announced
MDPI journals frequently grant travel awards to empower junior researchers to showcase their latest research at academic conferences, thereby amplifying their impact within their research fields.
We extend our heartfelt congratulations to the 103 recipients of MDPI's 2023 Travel Awards from different countries and territories for their exceptional presentations. These outstanding individuals were selected by the journal editors based on the strength of their research proposals and the anticipated impact of their presentations at academic conferences. We commend their exceptional contributions and wish them continued success in their academic endeavors.
MDPI will continue to provide support and recognition to the academic community. To learn more about the list of awardees, please visit the following pages:
- Biology and Life Sciences;
- Chemistry and Materials Sciences;
- Engineering;
- Environmental and Earth Sciences;
- Medicine and Pharmacology;
- Public Health and Healthcare;
- Others.
About MDPI Awards:
To reward the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.
To explore more MDPI awards, please click here.
20 September 2024
Journal of Personalized Medicine | Most Viewed Papers in 2022–2023 in the Section “Disease Biomarker”
We are pleased to invite you to read the most viewed papers in 2022 and 2023 in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) in the Section “Disease Biomarker”. The list of papers is as follows.
1. “BMI at Discharge from Treatment Predicts Relapse in Anorexia Nervosa: A Systematic Scoping Review”
by Stein Frostad, Natalia Rozakou-Soumalia, Ştefana Dârvariu, Bahareh Foruzesh, Helia Azkia, Malina Ploug Larsen, Ehsan Rowshandel and Jan Magnus Sjögren
J. Pers. Med. 2022, 12(5), 836; https://doi.org/10.3390/jpm12050836
Available online: https://www.mdpi.com/2075-4426/12/5/836
Cited by 17+ | Viewed by 5920+
2. “Skin Cancer Research Goes Digital: Looking for Biomarkers within the Droplets”
by Elena-Georgiana Dobre, Carolina Constantin and Monica Neagu
J. Pers. Med. 2022, 12(7), 1136; https://doi.org/10.3390/jpm12071136
Available online: https://www.mdpi.com/2075-4426/12/7/1136
Cited by 7+ | Viewed by 4590+
3. “Langerhans Cells—Revising Their Role in Skin Pathologies”
by Monica Neagu, Carolina Constantin, Gheorghita Jugulete, Victor Cauni, Sandrine Dubrac, Attila Gábor Szöllősi and Sabina Zurac
J. Pers. Med. 2022, 12(12), 2072; https://doi.org/10.3390/jpm12122072
Available online: https://www.mdpi.com/2075-4426/12/12/2072
Cited by 5+ | Viewed by 3780+
4. “Machine Learning-Assisted FTIR Analysis of Circulating Extracellular Vesicles for Cancer Liquid Biopsy”
by Riccardo Di Santo, Maria Vaccaro, Sabrina Romanò, Flavio Di Giacinto, Massimiliano Papi, Gian Ludovico Rapaccini, Marco De Spirito, Luca Miele, Umberto Basile and Gabriele Ciasca
J. Pers. Med. 2022, 12(6), 949; https://doi.org/10.3390/jpm12060949
Available online: https://www.mdpi.com/2075-4426/12/6/949
Cited by 20+ | Viewed by 3590+
5. “Relaxin-2 as a Potential Biomarker in Cardiovascular Diseases”
by Alana Aragón-Herrera, Sandra Feijóo-Bandín, Laura Anido-Varela, Sandra Moraña-Fernández, Esther Roselló-Lletí, Manuel Portolés, Estefanía Tarazón, Oreste Gualillo, José Ramón González-Juanatey and Francisca Lago
J. Pers. Med. 2022, 12(7), 1021; https://doi.org/10.3390/jpm12071021
Available online: https://www.mdpi.com/2075-4426/12/7/1021
Cited by 10+ | Viewed by 3340+
6. “Immune Biomarkers in Triple-Negative Breast Cancer: Improving the Predictivity of Current Testing Methods”
by Francesca Maria Porta, Elham Sajjadi, Konstantinos Venetis, Chiara Frascarelli, Giulia Cursano, Elena Guerini-Rocco, Nicola Fusco and Mariia Ivanova
J. Pers. Med. 2023, 13(7), 1176; https://doi.org/10.3390/jpm13071176
Available online: https://www.mdpi.com/2075-4426/13/7/1176
Cited by 9+ | Viewed by 3180+
7. “Associations of BDNF/BDNF-AS SNPs with Depression, Schizophrenia, and Bipolar Disorder”
by Anton Shkundin and Angelos Halaris
J. Pers. Med. 2023, 13(9), 1395; https://doi.org/10.3390/jpm13091395
Available online: https://www.mdpi.com/2075-4426/13/9/1395
Cited by 10+ | Viewed by 2860+
8. “Evaluation of Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Systemic Immune–Inflammation Index (SII) as Potential Biomarkers in Patients with Sporadic Medullary Thyroid Cancer (MTC)”
by Roberta Modica, Roberto Minotta, Alessia Liccardi, Giuseppe Cannavale, Elio Benevento and Annamaria Colao
J. Pers. Med. 2023, 13(6), 953; https://doi.org/10.3390/jpm13060953
Available online: https://www.mdpi.com/2075-4426/13/6/953
Cited by 14+ | Viewed by 2280+
9. “PD-L1, CD4+, and CD8+ Tumor-Infiltrating Lymphocytes (TILs) Expression Profiles in Melanoma Tumor Microenvironment Cells”
by Bogdan Marian Caraban, Elena Matei, Georgeta Camelia Cozaru, Mariana Aşchie, Mariana Deacu, Manuela Enciu, Gabriela Izabela Bălţătescu, Anca Chisoi, Nicolae Dobrin, Lucian Petcu et al.
J. Pers. Med. 2023, 13(2), 221; https://doi.org/10.3390/jpm13020221
Available online: https://www.mdpi.com/2075-4426/13/2/221
Cited by 8+ | Viewed by 2240+
10. “Mid-Regional Pro-Adrenomedullin and N-Terminal Pro-B-Type Natriuretic Peptide Measurement: A Multimarker Approach to Diagnosis and Prognosis in Acute Heart Failure”
by Silvia Spoto, Josepmaria Argemi, Roberta Di Costanzo, Juan Josè Gavira Gomez, Nahikari Salterain Gonzales, Stefania Basili, Roberto Cangemi, Antonio Abbate, Luciana Locorriere, Francesco Masini et al.
J. Pers. Med. 2023, 13(7), 1155; https://doi.org/10.3390/jpm13071155
Available online: https://www.mdpi.com/2075-4426/13/7/1155
Cited by 6+ | Viewed by 1810+
To read more relevant papers, subscribe to JPM at https://www.mdpi.com/journal/jpm/toc-alert.
JPM Editorial Office
20 September 2024
Journal of Personalized Medicine | Highly Cited Papers in 2022–2023 in the Section “Methodology, Drug and Device Discovery”
We are pleased to invite you to read the highly cited papers in 2022 and 2023 in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) in the Section “Methodology, Drug and Device Discovery”. The list of papers is as follows.
1. “Artificial Intelligence-Driven Prediction Modeling and Decision Making in Spine Surgery Using Hybrid Machine Learning Models”
by Babak Saravi, Frank Hassel, Sara Ülkümen, Alisia Zink, Veronika Shavlokhova, Sebastien Couillard-Despres, Martin Boeker, Peter Obid and Gernot Michael Lang
J. Pers. Med. 2022, 12(4), 509; https://doi.org/10.3390/jpm12040509
Available online: https://www.mdpi.com/2075-4426/12/4/509
Cited by 62+ | Viewed by 8300+
2. “Atlas of PD-L1 for Pathologists: Indications, Scores, Diagnostic Platforms and Reporting Systems”
by Stefano Marletta, Nicola Fusco, Enrico Munari, Claudio Luchini, Alessia Cimadamore, Matteo Brunelli, Giulia Querzoli, Maurizio Martini, Elena Vigliar, Romano Colombari et al.
J. Pers. Med. 2022, 12(7), 1073; https://doi.org/10.3390/jpm12071073
Available online: https://www.mdpi.com/2075-4426/12/7/1073
Cited by 46+ | Viewed by 6300+
3. “Predicting the Onset of Diabetes with Machine Learning Methods”
by Chun-Yang Chou, Ding-Yang Hsu and Chun-Hung Chou
J. Pers. Med. 2023, 13(3), 406; https://doi.org/10.3390/jpm13030406
Available online: https://www.mdpi.com/2075-4426/13/3/406
Cited by 37+ | Viewed by 6090+
4. “Pathophysiology, Classification and Comorbidities after Traumatic Spinal Cord Injury”
by James Guest, Nilanjana Datta, George Jimsheleishvili and David R. Gater
J. Pers. Med. 2022, 12(7), 1126; https://doi.org/10.3390/jpm12071126
Available online: https://www.mdpi.com/2075-4426/12/7/1126
Cited by 34+ | Viewed by 7200+
5. “CRIDECO Anticholinergic Load Scale: An Updated Anticholinergic Burden Scale. Comparison with the ACB Scale in Spanish Individuals with Subjective Memory Complaints”
by Hernán Ramos, Lucrecia Moreno, Jordi Pérez-Tur, Consuelo Cháfer-Pericás, Gemma García-Lluch and Juan Pardo
J. Pers. Med. 2022, 12(2), 207; https://doi.org/10.3390/jpm12020207
Available online: https://www.mdpi.com/2075-4426/12/2/207
Cited by 33+ | Viewed by 8680+
6. “The Contribution of “Individual Participant Data” Meta-Analyses of Psychotherapies for Depression to the Development of Personalized Treatments: A Systematic Review”
by Pim Cuijpers, Marketa Ciharova, Soledad Quero, Clara Miguel, Ellen Driessen, Mathias Harrer, Marianna Purgato, David Ebert and Eirini Karyotaki
J. Pers. Med. 2022, 12(1), 93; https://doi.org/10.3390/jpm12010093
Available online: https://www.mdpi.com/2075-4426/12/1/93
Cited by 31+ | Viewed by 4650+
7. “Potential and Pitfalls of Mobile Mental Health Apps in Traditional Treatment: An Umbrella Review”
by Jerica Koh, Germaine Y. Q. Tng and Andree Hartanto
J. Pers. Med. 2022, 12(9), 1376; https://doi.org/10.3390/jpm12091376
Available online: https://www.mdpi.com/2075-4426/12/9/1376
Cited by 30+ | Viewed by 7240+
8. “Sex-Related Differences in Pharmacological Response to CNS Drugs: A Narrative Review”
by Mirabela Romanescu, Valentina Buda, Adelina Lombrea, Minodora Andor, Ionut Ledeti, Maria Suciu, Corina Danciu, Cristina Adriana Dehelean and Liana Dehelean
J. Pers. Med. 2022, 12(6), 907; https://doi.org/10.3390/jpm12060907
Available online: https://www.mdpi.com/2075-4426/12/6/907
Cited by 24+ | Viewed by 5680+
9. “FFPE-Based NGS Approaches into Clinical Practice: The Limits of Glory from a Pathologist Viewpoint”
by Filippo Cappello, Valentina Angerilli, Giada Munari, Carlotta Ceccon, Marianna Sabbadin, Fabio Pagni, Nicola Fusco, Umberto Malapelle and Matteo Fassan
J. Pers. Med. 2022, 12(5), 750; https://doi.org/10.3390/jpm12050750
Available online: https://www.mdpi.com/2075-4426/12/5/750
Cited by 19+ | Viewed by 5380+
10. “Challenging ChatGPT 3.5 in Senology—An Assessment of Concordance with Breast Cancer Tumor Board Decision Making”
by Sebastian Griewing, Niklas Gremke, Uwe Wagner, Michael Lingenfelder, Sebastian Kuhn and Jelena Boekhoff
J. Pers. Med. 2023, 13(10), 1502; https://doi.org/10.3390/jpm13101502
Available online: https://www.mdpi.com/2075-4426/13/10/1502
Cited by 16+ | Viewed by 2360+
To read more relevant papers, subscribe to JPM at https://www.mdpi.com/journal/jpm/toc-alert.
JPM Editorial Office
11 September 2024
MDPI’s 2023 Best PhD Thesis Awards—Winners Announced
MDPI’s Best PhD Thesis Awards are granted to promising young scholars whose PhD theses are deemed exceptional within their respective research fields. These awards aim to encourage young scholars to continue their outstanding accomplishments and further contribute to their field.
We extend our heartfelt congratulations to the 54 winners of the 2023 Best PhD Thesis Awards and wish them success with their future research endeavors.
MDPI will continue to provide support and recognition to the academic community. To learn more about all the awardees and their research projects in your field of study, please visit the following pages:
About MDPI Awards:
To reward the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.
To explore more MDPI awards, please click here.
10 September 2024
Meet Us at the GSA 2024 Annual Scientific Meeting (GSA 2024), 13–16 November 2024, Seattle, USA
MDPI will be attending the GSA 2024 Annual Scientific Meeting (GSA 2024), which will be held from 13 to 16 of November 2024, in Seattle, USA.
The Gerontological Society of America (GSA) Annual Scientific Meeting draws professionals in the field of aging on a global scale, representing specialties including geriatrics, biological sciences, nursing, nutrition, medicine, social work, economics, policy, and psychology. The GSA is the largest and most established international, interdisciplinary scientific organization devoted to the advancement of gerontological research.
GSA 2024 offers numerous opportunities for career development and networking. Nearly 4,000 researchers, clinicians, educators, and other professionals will gather in Seattle to learn about and discuss the latest trends, research, and key issues in aging.
The following MDPI journals will be represented at the conference:
- Healthcare;
- Geriatrics;
- Nursing Report;
- Epidemiologia;
- Journal of Clinical Medicine (JCM);
- International Journal of Environmental Research and Public Health (IJERPH);
- European Journal of Investigation in Health, Psychology and Education (EJIHPE);
- Journal of Personalized Medicine (JPM);
- Nutrients;
- Journal of Ageing and Longevity (JAL);
- International Journal of Molecular Sciences (IJMS);
- Societies;
- Behavioral Sciences.
If you are planning to attend the conference, we encourage you to visit our booth and speak to our representatives. We are eager to meet you in person and assist you with any queries you may have. For more information about the conference, please visit the official website at https://www.gsa2024.org/.
23 August 2024
Journal of Personalized Medicine | Highly Cited Papers in 2022–2023 in the Section “Omics/Informatics”
We are pleased to invite you to read the highly cited papers from 2022 and 2023 in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) in the Section “Omics/Informatics”. The list of papers is as follows:
1. “Global Challenges to Public Health Care Systems during the COVID-19 Pandemic: A Review of Pandemic Measures and Problems”
by Roxana Filip, Roxana Gheorghita Puscaselu, Liliana Anchidin-Norocel, Mihai Dimian and Wesley K. Savage
J. Pers. Med. 2022, 12(8), 1295; https://doi.org/10.3390/jpm12081295
Available online: https://www.mdpi.com/2075-4426/12/8/1295
Cited by 135+ | Viewed by 11730+
2. “Computational Models for Clinical Applications in Personalized Medicine—Guidelines and Recommendations for Data Integration and Model Validation”
by Catherine Bjerre Collin, Tom Gebhardt, Martin Golebiewski, Tugce Karaderi, Maximilian Hillemanns, Faiz Muhammad Khan, Ali Salehzadeh-Yazdi, Marc Kirschner, Sylvia Krobitsch, EU-STANDS4PM consortium et al.
J. Pers. Med. 2022, 12(2), 166; https://doi.org/10.3390/jpm12020166
Available online: https://www.mdpi.com/2075-4426/12/2/166
Cited by 30+ | Viewed by 10270+
3. “Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases”
by Giulia Gentile, Giovanna Morello, Valentina La Cognata, Maria Guarnaccia, Francesca Luisa Conforti and Sebastiano Cavallaro
J. Pers. Med. 2022, 12(5), 770; https://doi.org/10.3390/jpm12050770
Available online: https://www.mdpi.com/2075-4426/12/5/770
Cited by 30+ | Viewed by 5820+
4. “The Evolution of a Large Biobank at Mass General Brigham”
by Natalie T. Boutin, Samantha B. Schecter, Emma F. Perez, Natasha S. Tchamitchian, Xander R. Cerretani, Vivian S. Gainer, Matthew S. Lebo, Lisa M. Mahanta, Elizabeth W. Karlson and Jordan W. Smoller
J. Pers. Med. 2022, 12(8), 1323; https://doi.org/10.3390/jpm12081323
Available online: https://www.mdpi.com/2075-4426/12/8/1323
Cited by 20+ | Viewed by 2410+
5. “Image Analysis in Digital Pathology Utilizing Machine Learning and Deep Neural Networks”
by Paris Amerikanos and Ilias Maglogiannis
J. Pers. Med. 2022, 12(9), 1444; https://doi.org/10.3390/jpm12091444
Available online: https://www.mdpi.com/2075-4426/12/9/1444
Cited by 15+ | Viewed by 3130+
6. “Personalized Immunotherapies for Type 1 Diabetes: Who, What, When, and How?”
by Claire Deligne, Sylvaine You and Roberto Mallone
J. Pers. Med. 2022, 12(4), 542; https://doi.org/10.3390/jpm12040542
Available online: https://www.mdpi.com/2075-4426/12/4/542
Cited by 10+ | Viewed by 5350+
7. “Pharmacogenetics in the Treatment of Huntington’s Disease: Review and Future Perspectives”
by Xandra García-González, Esther Cubo, Lucía Simón-Vicente, Natividad Mariscal, Raquel Alcaraz, Laura Aguado, Jéssica Rivadeneyra-Posadas, Antonio Sanz-Solas and Miriam Saiz-Rodríguez
J. Pers. Med. 2023, 13(3), 385; https://doi.org/10.3390/jpm13030385
Available online: https://www.mdpi.com/2075-4426/13/3/385
Cited by 9+ | Viewed by 3740+
8. “Metabolic Profiling in Rheumatoid Arthritis, Psoriatic Arthritis, and Psoriasis: Elucidating Pathogenesis, Improving Diagnosis, and Monitoring Disease Activity”
by Erika Dorochow, Michaela Köhm, Lisa Hahnefeld and Robert Gurke
J. Pers. Med. 2022, 12(6), 924; https://doi.org/10.3390/jpm12060924
Available online: https://www.mdpi.com/2075-4426/12/6/924
Cited by 9+ | Viewed by 3540+
9. “Probiotics and Probiotic-like Agents against Chemotherapy-Induced Intestinal Mucositis: A Narrative Review”
by Laura López-Gómez, Alexandra Alcorta and Raquel Abalo
J. Pers. Med. 2023, 13(10), 1487; https://doi.org/10.3390/jpm13101487
Available online: https://www.mdpi.com/2075-4426/13/10/1487
Cited by 7+ | Viewed by 2870+
10. “Identification of Transporter Polymorphisms Influencing Metformin Pharmacokinetics in Healthy Volunteers”
by Miriam Saiz-Rodríguez, Dolores Ochoa, Pablo Zubiaur, Marcos Navares-Gómez, Manuel Román, Paola Camargo-Mamani, Sergio Luquero-Bueno, Gonzalo Villapalos-García, Raquel Alcaraz, Gina Mejía-Abril et al.
J. Pers. Med. 2023, 13(3), 489; https://doi.org/10.3390/jpm13030489
Available online: https://www.mdpi.com/2075-4426/13/3/489
Cited by 7+ | Viewed by 2077+
To read more relevant papers, subscribe to JPM at https://www.mdpi.com/journal/jpm/toc-alert.
JPM Editorial Office
23 August 2024
Journal of Personalized Medicine | Highly Cited Papers in 2022–2023 in the Section “Mechanisms of Diseases”
We are pleased to invite you to read the highly cited papers from 2022 and 2023 in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) in the Section “Mechanisms of Diseases”. The list of papers is as follows:
1. “Emerging Biomarkers for Early Detection of Chronic Kidney Disease”
by Maja Mizdrak, Marko Kumrić, Tina Tičinović Kurir and Joško Božić
J. Pers. Med. 2022, 12(4), 548; https://doi.org/10.3390/jpm12040548
Available online: https://www.mdpi.com/2075-4426/12/4/548
Cited by 40+ | Viewed by 8990+
2. “Multi-Omics Profiling Approach to Asthma: An Evolving Paradigm”
by Yadu Gautam, Elisabet Johansson and Tesfaye B. Mersha
J. Pers. Med. 2022, 12(1), 66; https://doi.org/10.3390/jpm12010066
Available online: https://www.mdpi.com/2075-4426/12/1/66
Cited by 30+ | Viewed by 5470+
3. “Endotypes of Prematurity and Phenotypes of Bronchopulmonary Dysplasia: Toward Personalized Neonatology”
by Maria Pierro, Karen Van Mechelen, Elke van Westering-Kroon, Eduardo Villamor-Martínez and Eduardo Villamor
J. Pers. Med. 2022, 12(5), 687; https://doi.org/10.3390/jpm12050687
Available online: https://www.mdpi.com/2075-4426/12/5/687
Cited by 20+ | Viewed by 7800+
4. “Towards Machine Learning-Aided Lung Cancer Clinical Routines: Approaches and Open Challenges”
by Francisco Silva, Tania Pereira, Inês Neves, Joana Morgado, Cláudia Freitas, Mafalda Malafaia, Joana Sousa, João Fonseca, Eduardo Negrão, Beatriz Flor de Lima et al.
J. Pers. Med. 2022, 12(3), 480; https://doi.org/10.3390/jpm12030480
Available online: https://www.mdpi.com/2075-4426/12/3/480
Cited by 20+ | Viewed by 5110+
5. “The Paris System for Reporting Urinary Cytology: A Meta-Analysis”
by Ilias P. Nikas, Svenja Seide, Tanja Proctor, Zoi Kleinaki, Maria Kleinaki and Jordan P. Reynolds
J. Pers. Med. 2022, 12(2), 170; https://doi.org/10.3390/jpm12020170
Available online: https://www.mdpi.com/2075-4426/12/2/170
Cited by 17+ | Viewed by 9560+
6. “Precision Medicine in Head and Neck Cancers: Genomic and Preclinical Approaches”
by Giacomo Miserocchi, Chiara Spadazzi, Sebastiano Calpona, Francesco De Rosa, Alice Usai, Alessandro De Vita, Chiara Liverani, Claudia Cocchi, Silvia Vanni, Chiara Calabrese et al.
J. Pers. Med. 2022, 12(6), 854; https://doi.org/10.3390/jpm12060854
Available online: https://www.mdpi.com/2075-4426/12/6/854
Cited by 16+ | Viewed by 3550+
7. “Effectiveness of Platelet-Rich Plasma Therapy in Androgenic Alopecia—A Meta-Analysis”
by Simona Roxana Georgescu, Andreea Amuzescu, Cristina Iulia Mitran, Madalina Irina Mitran, Clara Matei, Carolina Constantin, Mircea Tampa and Monica Neagu
J. Pers. Med. 2022, 12(3), 342; https://doi.org/10.3390/jpm12030342
Available online: https://www.mdpi.com/2075-4426/12/3/342
Cited by 14+ | Viewed by 8770+
8. “Is Ozone a Valid Adjuvant Therapy for Periodontitis and Peri-Implantitis? A Systematic Review”
by Francesco D’Ambrosio, Mario Caggiano, Alfonso Acerra, Massimo Pisano and Francesco Giordano
J. Pers. Med. 2023, 13(4), 646; https://doi.org/10.3390/jpm13040646
Available online: https://www.mdpi.com/2075-4426/13/4/646
Cited by 13+ | Viewed by 2660+
9. “Updated Views in Targeted Therapy in the Patient with Non-Small Cell Lung Cancer”
by Miguel A. Ortega, Leonel Pekarek, Fátima Navarro, Oscar Fraile-Martínez, Cielo García-Montero, Miguel Ángel Álvarez-Mon, Raúl Diez-Pedrero, María del Carmen Boyano-Adánez, Luis G. Guijarro, Silvestra Barrena-Blázquez et al.
J. Pers. Med. 2023, 13(2), 167; https://doi.org/10.3390/jpm13020167
Available online: https://www.mdpi.com/2075-4426/13/2/167
Cited by 9+ | Viewed by 3010+
10. “Prognostic Value of Malondialdehyde (MDA) in the Temporal Progression of Chronic Spinal Cord Injury”
by Sergio Haro Girón, Jorge Monserrat Sanz, Miguel A. Ortega, Cielo Garcia-Montero, Oscar Fraile-Martínez, Ana M. Gómez-Lahoz, Diego Liviu Boaru, Diego de Leon-Oliva, Luis G. Guijarro, Mar Atienza-Perez et al.
J. Pers. Med. 2023, 13(4), 626; https://doi.org/10.3390/jpm13040626
Available online: https://www.mdpi.com/2075-4426/13/4/626
Cited by 9+ | Viewed by 2254+
To read more relevant papers, subscribe to JPM at https://www.mdpi.com/journal/jpm/toc-alert.
JPM Editorial Office
19 August 2024
MDPI’s 2023 Young Investigator Awards—Winners Announced
MDPI’s Young Investigator Awards recognize promising early career scientists, acknowledge their contributions, and foster collaboration within the scientific community. We are proud to announce the recipients for 2023, who were carefully selected by the journals’ esteemed Award Evaluation Committee.
We extend our heartfelt congratulations to the 79 winners of MDPI’s 2023 Young Investigator Awards for their excellent contributions in their research field. We look forward to seeing these rising stars continue to contribute to the advancement of science.
MDPI will continue to support and recognize the academic community. To explore details about the awardees by field, please visit the individual pages listed below:
Congratulations to all the winners for their exceptional contributions and dedication to advancing scientific research.
About MDPI Awards:
To support the academic community, particularly young researchers, and to enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help to elevate the profiles of talented individuals who have made outstanding achievements and are making significant contributions to advancements in their respective fields.
To find out more about MDPI awards, please click here.
2 August 2024
MDPI Romania Author Training Sessions in May
In May, MDPI Romania held three author training sessions – one endorsing an external event and two stand-alone sessions.
The National Session of Scientific Student Communications took place at Technical University Cluj on 17 and 18 May 2024. MDPI Romania sponsored this event and contributed an author training session on the production of research papers and case study analyses. JRS Norbert Kiss gave a presentation called The World of Open Access to explain different open access publishing models and the benefits of open access publishing. His presentation highlighted the impact of open access publishing on scientific progress and innovation.
On 29 May 2024, MDPI Romania hosted an author training session for Ph.D. students, early career researchers, and professors at the Carol Davila University of Medicine and Pharmacy. In collaboration with Prof. Andreea Arsene, JRS Ioana Paunescu prepared two presentations: The Steps of the Publishing Process and Elaboration of a Peer Review Report. In her first presentation, she delved into MDPI’s history and mission, MDPI’s editorial process, and MDPI journals of various scopes that are accepting submissions. Her second presentation outlined the types of peer review, the contents of a peer review report by an MDPI reviewer, and the responsibilities of an MDPI reviewer.
MDPI Romania also hosted an author training session at the Iasi University of Life Sciences on 29 May 2024. JRSs Laurentiu Preda and Cosmin Artan gave four presentations: Efficient Writing of an ISI-Indexed Scientific Article, Benefits of Publishing in the Open Access Model, Various Methods of Open Access Publishing, and MDPI Guide for the Article Review Process. The first three presentations offered guidance on how to improve academic writing, the fourth focused on how to write peer review reports. A highly interactive discussion followed the presentations, during which the JRSs provided extensive answers to attendees’ questions.
MDPI is grateful for all the attendees, speakers, and organizers involved in these events. Through their enthusiasm and dedication, these events were great successes.
1 August 2024
Meet Us at the 2024 CAMO Annual Scientific Meeting, 24–26 October 2024, Ottawa, ON, Canada
Conference: 2024 CAMO Annual Scientific Meeting
Date: 24–26 October 2024
Location: Ottawa, ON, Canada
The Canadian Association of Medical Oncologists (CAMO) is a national specialty society of the Royal College of Physicians and Surgeons of Canada. Their mission is to contribute to cancer control, through research, education, and clinical practice in prevention, screening, diagnosis, treatment, supportive care, palliative care, and rehabilitation. The Association is committed to achieving and maintaining, among its members, excellence in clinical and scholarly activity, within a culture of compassion and respect for human dignity. CAMO Annual Scientific Meetings have been held since 2014.
The following MDPI journals will be represented at the 2024 CAMO Annual Scientific Meeting:
- Current Oncology;
- Cancers;
- Life;
- Onco;
- Women;
- Journal of Personalized Medicine;
- Journal of Molecular Pathology.
Our delegates look forward to meeting you in person at the booth at the conference and answering any questions you may have. For more information regarding the conference, please visit the following link: https://camo-acom.ca/page-1549450.
26 July 2024
Meet Us at the 22nd Congress of the International Society for Burn Injuries (ISBI) and the 55th Annual Meeting of the British Burn Association (BBA), 18–22 August 2024, Birmingham, UK
MDPI will be attending the 22nd Congress of the International Society for Burn Injuries (ISBI) and the 55th Annual Meeting of the British Burn Association (BBA) in Birmingham, UK, from 18 to 22 August 2024. The 2024 ISBI/BBA Congress is organized to continue to promote the concept of “one world and one standard of burn care” for people suffering as a result of a thermal injury.
The following MDPI journals will be represented:
If you are planning to attend the conference, please do visit our booth. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://worldburn.org/events/7/2024_isbibba_congress.
24 July 2024
Journal of Personalized Medicine | Top 10 Cited Papers on Liver Disease in 2022–2023
28 July 2024 marks the 14th World Hepatitis Awareness Day, with various global events taking place to promote this important date. The aim of this day is to make more people aware of the dangers of hepatitis and draw their attention to this condition.
We would like to take this opportunity to extend our appreciation to all researchers who have contributed to the fight against hepatitis. In particular, we would like to share some of the high-quality and innovative research findings in the field of personalized therapy for hepatitis and liver disease, published in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426).
We hope that this announcement will provide useful information on research in this evolving field.
The list of relevant papers can be seen below:
1. “Gender and Autoimmune Liver Diseases: Relevant Aspects in Clinical Practice”
by Federica Invernizzi, Marta Cilla, Silvia Trapani, Maria Guarino, Valentina Cossiga, Martina Gambato, Maria Cristina Morelli, Filomena Morisco, Patrizia Burra and Annarosa Floreani
J. Pers. Med. 2022, 12(6), 925; https://doi.org/10.3390/jpm12060925
Available online: https://www.mdpi.com/2075-4426/12/6/925
Cited by 14+ | Viewed by 2830+
2. “Reappraisal of the Role of Alkaline Phosphatase in Hepatocellular Carcinoma”
by Chun-Wei Huang, Tsung-Han Wu, Heng-Yuan Hsu, Kuang-Tse Pan, Chao-Wei Lee, Sio-Wai Chong, Song-Fong Huang, Sey-En Lin, Ming-Chin Yu and Shen-Ming Chen
J. Pers. Med. 2022, 12(4), 518; https://doi.org/10.3390/jpm12040518
Available online: https://www.mdpi.com/2075-4426/12/4/518
Cited by 12+ | Viewed by 3675+
3. “Efficacy and Safety of Distal Radial Access for Transcatheter Arterial Chemoembolization (TACE) of the Liver”
by Roberto Minici, Raffaele Serra, Marco Giurdanella, Marisa Talarico, Maria Anna Siciliano, Gianpaolo Carrafiello and Domenico Laganà
J. Pers. Med. 2023, 13(4), 640; https://doi.org/10.3390/jpm13040640
Available online: https://www.mdpi.com/2075-4426/13/4/640
Cited by 12+ | Viewed by 3130+
4. “Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease”
by Laura Valenzuela-Vallejo, Despina Sanoudou and Christos S. Mantzoros
J. Pers. Med. 2023, 13(5), 830; https://doi.org/10.3390/jpm13050830
Available online: https://www.mdpi.com/2075-4426/13/5/830
Cited by 10+ | Viewed by 2625+
5. “Direct-Acting Antivirals for HCV Treatment in Decompensated Liver Cirrhosis Patients: A Systematic Review and Meta-Analysis”
by JiHyun An, Dong Ah Park, Min Jung Ko, Sang Bong Ahn, Jeong-Ju Yoo, Dae Won Jun and Sun Young Yim
J. Pers. Med. 2022, 12(9), 1517; https://doi.org/10.3390/jpm12091517
Available online: https://www.mdpi.com/2075-4426/12/9/1517
Cited by 9+ | Viewed by 1875+
6. “Long-Term Outcome of HBV-Infected Patients with Clinically Significant Portal Hypertension Achieving Viral Suppression”
by Mathias Jachs, Lukas Hartl, David Bauer, Benedikt Simbrunner, Albert Friedrich Stättermayer, Robert Strassl, Michael Trauner, Mattias Mandorfer and Thomas Reiberger
J. Pers. Med. 2022, 12(2), 239; https://doi.org/10.3390/jpm12020239
Available online: https://www.mdpi.com/2075-4426/12/2/239
Cited by 7+ | Viewed by 2130+
7. “Cytokines and Hepatocellular Carcinoma: Biomarkers of a Deadly Embrace”
by Krizia Pocino, Annunziata Stefanile, Valerio Basile, Cecilia Napodano, Francesca D’Ambrosio, Riccardo Di Santo, Cinzia Anna Maria Callà, Francesca Gulli, Raffaele Saporito, Gabriele Ciasca et al.
J. Pers. Med. 2023, 13(1), 5; https://doi.org/10.3390/jpm13010005
Available online: https://www.mdpi.com/2075-4426/13/1/5
Cited by 7+ | Viewed by 2290+
8. “Nonalcoholic Fatty Liver Disease and Altered Neuropsychological Functions in Patients with Subcortical Vascular Dementia”
by Rita Moretti, Mauro Giuffré, Lory Saveria Crocè, Silvia Gazzin and Claudio Tiribelli
J. Pers. Med. 2022, 12(7), 1106; https://doi.org/10.3390/jpm12071106
Available online: https://www.mdpi.com/2075-4426/12/7/1106
Cited by 7+ | Viewed by 2060+
9. “Clinical and Genetic Risk Factors for Drug-Induced Liver Injury Associated with Anti-Tuberculosis Treatment—A Study from Patients of Portuguese Health Centers”
by Maria João Cavaco, Celeste Alcobia, Bárbara Oliveiros, Luís Alcides Mesquita, Aurora Carvalho, Fernando Matos, José Miguel Carvalho, Miguel Villar, Raquel Duarte, João Mendes et al.
J. Pers. Med. 2022, 12(5), 790; https://doi.org/10.3390/jpm12050790
Available online: https://www.mdpi.com/2075-4426/12/5/790
Cited by 7+ | Viewed by 3720+
10. “Impact of l-Carnitine Supplementation on Liver Enzyme Normalization in Patients with Chronic Liver Disease: A Meta-Analysis of Randomized Trials”
by Hyunwoo Oh, Chan Hyuk Park and Dae Won Jun
J. Pers. Med. 2022, 12(7), 1053; https://doi.org/10.3390/jpm12071053
Available online: https://www.mdpi.com/2075-4426/12/7/1053
Cited by 7+ | Viewed by 2200+
To read more relevant papers, subscribe to JPM at https://www.mdpi.com/journal/jpm/toc-alert.
JPM Editorial Office
24 July 2024
Journal of Personalized Medicine | Highly Cited Papers in 2022–2023 in the Section “Clinical Medicine, Cell, and Organism Physiology”
We are pleased to invite you to read the highly cited papers in 2022 and 2023 in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) in the Section “Clinical Medicine, Cell, and Organism Physiology”. The list of papers is as follows:
1. “CD24: A Novel Target for Cancer Immunotherapy”
by Emmanouil Panagiotou, Nikolaos K. Syrigos, Andriani Charpidou, Elias Kotteas and Ioannis A. Vathiotis
J. Pers. Med. 2022, 12(8), 1235; https://doi.org/10.3390/jpm12081235
Available online: https://www.mdpi.com/2075-4426/12/8/1235
Cited by 34+ | Viewed by 6195+
2. “Pericapsular Nerve Group (PENG) Block versus Supra-Inguinal Fascia Iliaca Compartment Block for Total Hip Arthroplasty: A Randomized Clinical Trial”
by Yong Seon Choi, Kwan Kyu Park, Bora Lee, Won Seok Nam and Do-Hyeong Kim
J. Pers. Med. 2022, 12(3), 408; https://doi.org/10.3390/jpm12030408
Available online: https://www.mdpi.com/2075-4426/12/3/408
Cited by 33+ | Viewed by 9925+
3. “Combination Therapies for Nonalcoholic Fatty Liver Disease”
by Evangelia S. Makri, Eleftheria Makri and Stergios A. Polyzos
J. Pers. Med. 2022, 12(7), 1166; https://doi.org/10.3390/jpm12071166
Available online: https://www.mdpi.com/2075-4426/12/7/1166
Cited by 22+ | Viewed by 3375+
4. “Adipose-Derived Stem Cells for Facial Rejuvenation”
by Agnieszka Surowiecka and Jerzy Strużyna
J. Pers. Med. 2022, 12(1), 117; https://doi.org/10.3390/jpm12010117
Available online: https://www.mdpi.com/2075-4426/12/1/117
Cited by 21+ | Viewed by 7365+
5. “Mepolizumab Improves Outcomes of Chronic Rhinosinusitis with Nasal Polyps in Severe Asthmatic Patients: A Multicentric Real-Life Study”
by Stefania Gallo, Paolo Castelnuovo, Luca Spirito, Marta Feduzi, Veronica Seccia, Dina Visca, Antonio Spanevello, Erica Statuti, Manuela Latorre, Claudio Montuori et al.
J. Pers. Med. 2022, 12(8), 1304; https://doi.org/10.3390/jpm12081304
Available online: https://www.mdpi.com/2075-4426/12/8/1304
Cited by 19+ | Viewed by 3060+
6. “A Revised Stem Cell Theory for the Pathogenesis of Endometriosis”
by Tetsuo Maruyama
J. Pers. Med. 2022, 12(2), 216; https://doi.org/10.3390/jpm12020216
Available online: https://www.mdpi.com/2075-4426/12/2/216
Cited by 18+ | Viewed by 5895+
7. “Personalized Management of Patients with Chronic Rhinosinusitis with Nasal Polyps in Clinical Practice: A Multidisciplinary Consensus Statement”
by Eugenio De Corso, Maria Beatrice Bilò, Andrea Matucci, Veronica Seccia, Fulvio Braido, Matteo Gelardi, Enrico Heffler, Manuela Latorre, Luca Malvezzi, Girolamo Pelaia et al.
J. Pers. Med. 2022, 12(5), 846; https://doi.org/10.3390/jpm12050846
Available online: https://www.mdpi.com/2075-4426/12/5/846
Cited by 16+ | Viewed by 4375+
8. “Management of Patients with Severe Asthma and Chronic Rhinosinusitis with Nasal Polyps: A Multidisciplinary Shared Approach”
by Veronica Seccia, Maria D’Amato, Giulia Scioscia, Diego Bagnasco, Fabiano Di Marco, Gianluca Fadda, Francesco Menzella, Ernesto Pasquini, Girolamo Pelaia, Eugenio Tremante et al.
J. Pers. Med. 2022, 12(7), 1096; https://doi.org/10.3390/jpm12071096
Available online: https://www.mdpi.com/2075-4426/12/7/1096
Cited by 15+ | Viewed by 3870+
9. “Use of High-Frequency Transducers in Breast Sonography”
by Antonio Corvino, Carlo Varelli, Fabio Catalano, Giulio Cocco, Andrea Delli Pizzi, Andrea Boccatonda, Fabio Corvino, Luigi Basile and Orlando Catalano
J. Pers. Med. 2022, 12(12), 1960; https://doi.org/10.3390/jpm12121960
Available online: https://www.mdpi.com/2075-4426/12/12/1960
Cited by 15+ | Viewed by 2930+
10. “Personalized Self-Monitoring of Energy Balance through Integration in a Web-Application of Dietary, Anthropometric, and Physical Activity Data”
by Giada Bianchetti, Alessio Abeltino, Cassandra Serantoni, Federico Ardito, Daniele Malta, Marco De Spirito and Giuseppe Maulucci
J. Pers. Med. 2022, 12(4), 568; https://doi.org/10.3390/jpm12040568
Available online: https://www.mdpi.com/2075-4426/12/4/568
Cited by 13+ | Viewed by 2635+
11. “Prevention of Post-Transplant Diabetes Mellitus: Towards a Personalized Approach”
by Didier Ducloux and Cécile Courivaud
J. Pers. Med. 2022, 12(1), 116; https://doi.org/10.3390/jpm12010116
Available online: https://www.mdpi.com/2075-4426/12/1/116
Cited by 12+ | Viewed by 2670+
12. “Epidemiology and Risk Factors of UTIs in Children—A Single-Center Observation”
by Maria Daniel, Hanna Szymanik-Grzelak, Janusz Sierdziński, Edyta Podsiadły, Magdalena Kowalewska-Młot and Małgorzata Pańczyk-Tomaszewska
J. Pers. Med. 2023, 13(1), 138; https://doi.org/10.3390/jpm13010138
Available online: https://www.mdpi.com/2075-4426/13/1/138
Cited by 12+ | Viewed by 3770+
13. “The Role of BDNF as a Biomarker in Cognitive and Sensory Neurodegeneration”
by Anna Pisani, Fabiola Paciello, Valeria Del Vecchio, Rita Malesci, Eugenio De Corso, Elena Cantone and Anna Rita Fetoni
J. Pers. Med. 2023, 13(4), 652; https://doi.org/10.3390/jpm13040652
Available online: https://www.mdpi.com/2075-4426/13/4/652
Cited by 12+ | Viewed by 3395+
14. “Sinonasal Biomarkers Defining Type 2-High and Type 2-Low Inflammation in Chronic Rhinosinusitis with Nasal Polyps”
by Eugenio De Corso, Silvia Baroni, Stefano Settimi, Maria Elisabetta Onori, Rodolfo Francesco Mastrapasqua, Eliana Troiani, Giacomo Moretti, Donatella Lucchetti, Marco Corbò, Claudio Montuori et al.
J. Pers. Med. 2022, 12(8), 1251; https://doi.org/10.3390/jpm12081251
Available online: https://www.mdpi.com/2075-4426/12/8/1251
Cited by 11+ | Viewed by 2265+
15. “Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease”
by Laura Valenzuela-Vallejo, Despina Sanoudou and Christos S. Mantzoros
J. Pers. Med. 2023, 13(5), 830; https://doi.org/10.3390/jpm13050830
Available online: https://www.mdpi.com/2075-4426/13/5/830
Cited by 10+ | Viewed by 2625+
To read more relevant papers, subscribe to JPM at https://www.mdpi.com/journal/jpm/toc-alert.
JPM Editorial Office
15 July 2024
Journal of Personalized Medicine | Big Reviews Project 2024
We invite you to participate in the Big Reviews Project 2024 of the Journal of Personalized Medicine (JPM, ISSN: 2075-4426).
The Big Review Project aims to commission comprehensive review papers co-authored by at least 3 recognized experts with multiple affiliation units (at least 3 units) to increase our portfolio of influential reviews.
Requirements for Big Reviews:
- Author Requirements
- Leading authors should be senior Editorial Board Members and the first author to complete the Big Review. You may have a PostDoc or Ph.D. student in their final year assisting you (Ph.D. obtained or at least 3 publications);
- The authors should be from two continents, with at least three affiliations, and at least two authors should be as senior as the journal's Editorial Board Members.
- Scope of Big Reviews
Authors can submit their Big Review to the corresponding Section based on their research focus. For detailed information on each Section, please click https://www.mdpi.com/journal/jpm/sections. If you are interested, please contact the Editorial Office for consultation as soon as possible.
In addition, we have some recommended hot topics for your reference:
- Multi-omics analysis in cancer;
- Pharmacogenomics in human disease;
- Macrophage polarization in inflammatory diseases;
- Vaccinomics;
- Cancer, autophagy and apoptosis;
- Tumor microenvironment;
- Radiomics and radiogenomics;
- Artificial intelligence in diagnostics and/or therapeutics in personalized medicine;
- The tumor ecosystem: cellular interactions and therapeutic opportunities;
- Bioinformatics for clinical applications in precision medicine;
- Reconstructive microsurgery;
- Sex hormones and gender in disease mechanisms;
- lncRNAs in cancer;
- Outcomes after critical illness.
- Word Count
Big Reviews are expected to be a minimum of 6000 words.
- Benefits for authors
4.1 The lead (invited) author will receive a travel grant of CHF 500. The travel grant will be granted to the lead author when attending a conference and promoting MDPI and the published Big Review to your colleagues.
4.2 Other collaborators will receive a waiver for one submission to JPM. The other authors of Big Reviews, including non-leading authors, can enjoy one waiver for their other full research article or comprehensive review.
4.3 Authors will receive a PDF booklet containing a selection of comprehensive reviews, which are published in the Journal of Personalized Medicine.
4.4 All collaborators will be invited to join the journal’s physical meeting and online meeting. We will invite all Big Review authors to participate in journal-related theme meetings to provide you with a communication platform for interaction with outstanding Editorial Board Members.
Submission Guidelines:
- Manuscripts should be submitted online through the Journal of Personalized Medicine portal (https://www.mdpi.com/journal/jpm);
- Authors are encouraged to follow the journal's guidelines for formatting and referencing;
- All submissions will undergo a rigorous peer review process to ensure the highest quality and relevance to the Special Issue.
Submission Deadline: 31 December 2024.
For more details or inquiries, please contact the Editorial Office.
JPM Editorial Office
12 July 2024
MDPI Webinar | World Hepatitis Day 2024, 29 July 2024
MDPI invites all experts recognized in their fields to attend the MDPI World Hepatitis Day Webinar 2024. Inspired by the collaborative spirit of World Hepatitis Day, this webinar aims to raise awareness about hepatitis and promote the development of innovative strategies to combat it. By engaging experts and the public, the webinar seeks to drive advancements and highlight the importance of collective efforts in scientific research and innovation.
We are looking forward to seeing you at the MDPI World Hepatitis Day Webinar 2024.
Title: MDPI World Hepatitis Day Webinar 2024
Date: 29 July 2024
Time: 15:00–17:00 (CEST) | 21:00–23:00 (CST Asia)
More Information: https://sciforum.net/event/WHD2024
This is a free webinar. After registration, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.
Unable to attend? Register anyway and we will let you know when the recording is available for viewing.
Register for free:
Program:
Speaker/Presentation |
Time in CEST |
Time in CST Asia |
Host |
15:00–15:10 |
21:00–21:10 |
Assoc. Prof. Yee-Joo Tan |
15:10–15:40 |
21:10–21:40 |
Dr. Giuseppe Colucci |
15:40–16:10 |
21:40–22:10 |
Prof. Dr. Chia-Yen Dai |
16:10–16:40 |
22:10-22:40 |
Q&A Session |
16:40–16:50 |
22:40–22:50 |
Host |
16:50–17:00 |
22:50–23:00 |
Relevant Special Issues:
Animals
“Diseases of the Small and Large Intestine, Liver and Pancreas in Small Animals: Second Edition”
Edited by Dr. Alessio Pierini and Dr. Eleonora Gori
Deadline for submission: 20 December 2024
“Metabolic Disorders of Poultry”
Edited by Dr. Victoria Anthony Uyanga and Dr. Felix Kwame Amevor
Deadline for submission: 28 February 2025
Cancers
“Hepatitis Viruses and Cancer”
Edited by Prof. Dr. John Koskinas and Dr. Urania Georgopoulou
Deadline for submission: 1 November 2024
Cells
“Interdisciplinary Approaches to Studying Human Liver Biology and Promoting Organ Regeneration: Understanding the Curse of Prometheus”
Edited by Prof. Dr. David C. Hay, Dr. Matthew Sinton and Alvile Kasarinaite
Deadline for submission: N.A.
Children
“Old and New Therapeutic Strategies in Children with Liver Disease”
Edited by Dr. Raffaele Iorio and Dr. Fabiola Di Dato
Deadline for submission: 30 September 2024
Diagnostics
“Diagnosis, Management, and Prognosis of Liver Disease and Its Syndromes”
Edited by Prof. Dr. Chien Hao Huang
Deadline for submission: 31 August 2024
“Diagnostic and Prognostic Markers in Liver Diseases”
Edited by Dr. Dávid Tornai
Deadline for submission: 31 October 2024
“Diagnosis of Liver Disease”
Edited by Dr. Sung-Eun Kim
Deadline for submission: 31 December 2024
Gastroenterology Insights
“Novelties in Diagnostics and Therapeutics in Hepatology: 2nd Edition”
Edited by Dr. Giovanni Marasco and Dr. Matteo Renzulli
Deadline for submission: 31 December 2024
Journal of Personalized Medicine
“Chronic Liver Disease: New Targets and New Mechanisms”
Edited by Dr. Theodoros Androutsakos
Deadline for submission: 20 February 2025
Livers
“Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment”
Edited by Prof. Dr. Ralf Weiskirchen and Prof. Dr. Tilman Sauerbruch
Deadline for submission: 20 December 2024
Medicina
“Editorial Board Members’ Collection Series: Gastrointestinal and Hepatic Diseases”
Edited by Prof. Dr. Ludovico Abenavoli and Dr. Marcello Candelli
Deadline for submission: 24 December 2024
“Advances in Liver Surgery”
Edited by Prof. Dr. Jai Young Cho
Deadline for submission: 24 December 2024
“Novelties in Chronic Liver Diseases”
Edited by Prof. Dr. Ludovico Abenavoli
Deadline for submission: 30 September 2024
Metabolites
“Research on Pharmacotherapy of Metabolic-Associated Fatty Liver Disease”
Edited by Dr. Aleksandra Bołdys
Deadline for submission: 30 September 2024
“Metabolic Syndrome and Non-alcoholic Liver Disease”
Edited by Prof. Dr. Mircea-Catalin Fortofoiu, and Dr. Luigi Boccuto
Deadline for submission: 20 October 2024
“Liver Injury and Regeneration—Metabolic Research”
Edited by Dr. Miguel Suárez Matías
Deadline for submission: 31 December 2024
Microorganisms
“Hepatitis B Virus Infection and Vaccine”
Edited by Dr. Nishi N. Prabdial-Sing
Deadline for submission: 15 December 2024
Nutrients
“Metabolic-Dysfunction-Associated Steatotic Liver Disease at the Forefront: Confronting Nutritional Obstacles in Advanced Chronic Liver Disease and Portal Hypertension”
Edited by Dr. Angelo Armandi and Dr. Federico Ravaioli
Deadline for submission: 15 October 2024
“Prevention and Treatment of Liver Diseases by Dietary Habits and Lifestyle”
Dr. Marica Cariello and Dr. Raffaella Maria Gadaleta
Deadline for submission: 15 December 2024
“Managing Nonalcoholic Fatty Liver Disease with Nutrition”
Edited by Dr. Nobuyuki Toshikuni
Deadline for submission: 25 December 2024
Pathogens
“Zoonotic Hepatitis E Virus: A Focus on Animals, Food and Environment”
Edited by Prof. Dr. Barbara Di Martino, Dr. Federica Di Profio and Dr. Andrea Palombieri
Deadline for submission: 10 October 2024
Vaccines
“Vaccines and Vaccination: HIV, Hepatitis Viruses, and HPV”
Edited by Dr. Ivan Schietroma and Dr. Sonia Moretti
Deadline for submission: 28 February 2025
“Vaccination and Treatments against Viral Hepatitis: Achievements, Challenges and Perspectives”
Edited by Dr. Bárbara Vieira Do Lago and Dr. Vinicius M. Mello
Deadline for submission: 15 March 2025
10 July 2024
MDPI's Newly Launched Journals in June 2024
Five new journals covering multiple subjects have launched their inaugural issue in June 2024. We are excited to be able to share with you the newest research rooted in the value of open access.
We would like to express our deepest appreciation to all the Editorial Board Members and each journal will ensure its high-quality output using excellent editorial and rigorous peer review processes, to ensure that the articles achieve high impact and visibility.
Please feel free to browse and discover more about the new journals below.
Journal |
Founding Editor-in-Chief |
Journal Topics (Selected) |
Prof. Dr. Marco Ranucci, IRCCS Policlinico San Donato, Italy |
anaesthetic medications; blood and fluid management; pain management; critical care; critical illness | view journal scope | submit an article |
|
Dr. Giovanni E. Cacciamani, University of Southern California, USA |
surgical/procedural complications; complications; perioperative adverse events; postoperative adverse events | view journal scope | submit an article |
|
Prof. Dr. Gassan Hodaifa, Universidad Pablo de Olavide, Spain |
laboratory management; laboratory safety; protective equipment; laboratory problems and challenges; laboratory Innovation | view journal scope | submit an article |
|
Prof. Dr. Jan S. Suchodolski, Texas A&M University, USA |
companion animals health and disease; veterinary care and nutrition; genetics and genomics; behavior and welfare; human-animal relations | view journal scope | submit an article |
|
Prof. Dr. Pierfrancesco De Paola, University of Naples Federico II, Italy |
real estate appraisal; economic and financial valuation of real estate projects; sustainable real estate; housing and urban economics | view journal scope | submit an article |
We wish to thank everyone who has supported the development of open access publishing. You are welcome to send an application here, or contact the New Journal Committee ([email protected]) if you would like to create more new journals.
30 June 2024
Journal of Personalized Medicine | Top 10 Cited Papers in 2022–2023 in the Section “Personalized Therapy and Drug Delivery”
We are pleased to invite you to read the top 10 cited papers in 2022 and 2023 in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) in the Section “Personalized Therapy and Drug Delivery”. The list of papers is as follows.
1. “Diffuse Intrinsic Pontine Glioma: Molecular Landscape, Evolving Treatment Strategies and Emerging Clinical Trials”
by Sudarshawn Damodharan, Montserrat Lara-Velazquez, Brooke Carmen Williamsen, Jeffrey Helgager and Mahua Dey
J. Pers. Med. 2022, 12(5), 840; https://doi.org/10.3390/jpm12050840
Available online: https://www.mdpi.com/2075-4426/12/5/840
2. “Should Neurosurgeons Try to Preserve Non-Traditional Brain Networks? A Systematic Review of the Neuroscientific Evidence”
by Nicholas B. Dadario and Michael E. Sughrue
J. Pers. Med. 2022, 12(4), 587; https://doi.org/10.3390/jpm12040587
Available online: https://www.mdpi.com/2075-4426/12/4/587
3. “Enhanced Permeability and Retention Effect as a Ubiquitous and Epoch-Making Phenomenon for the Selective Drug Targeting of Solid Tumors”
by Waliul Islam, Takuro Niidome and Tomohiro Sawa
J. Pers. Med. 2022, 12(12), 1964; https://doi.org/10.3390/jpm12121964
Available online: https://www.mdpi.com/2075-4426/12/12/1964
4. “Thyroid Diseases and Breast Cancer”
by Enke Baldini, Augusto Lauro, Domenico Tripodi, Daniele Pironi, Maria Ida Amabile, Iulia Catalina Ferent, Eleonora Lori, Federica Gagliardi, Maria Irene Bellini, Flavio Forte et al.
J. Pers. Med. 2022, 12(2), 156; https://doi.org/10.3390/jpm12020156
Available online: https://www.mdpi.com/2075-4426/12/2/156
5. “Long COVID: Clinical Framing, Biomarkers, and Therapeutic Approaches”
by Valeria Conti, Graziamaria Corbi, Francesco Sabbatino, Domenico De Pascale, Carmine Sellitto, Berenice Stefanelli, Nicola Bertini, Matteo De Simone, Luigi Liguori, Ilenia Di Paola et al.
J. Pers. Med. 2023, 13(2), 334; https://doi.org/10.3390/jpm13020334
Available online: https://www.mdpi.com/2075-4426/13/2/334
6. “Advancing Patient Care: How Artificial Intelligence Is Transforming Healthcare”
by Diana Gina Poalelungi, Carmina Liana Musat, Ana Fulga, Marius Neagu, Anca Iulia Neagu, Alin Ionut Piraianu and Iuliu Fulga
J. Pers. Med. 2023, 13(8), 1214; https://doi.org/10.3390/jpm13081214
Available online: https://www.mdpi.com/2075-4426/13/8/1214
7. “The Effect of Meditation, Mindfulness, and Yoga in Patients with Rheumatoid Arthritis”
by Laura Slagter, Koen Demyttenaere, Patrick Verschueren and Diederik De Cock
J. Pers. Med. 2022, 12(11), 1905; https://doi.org/10.3390/jpm12111905
Available online: https://www.mdpi.com/2075-4426/12/11/1905
8. “Diagnostic Challenge of Invasive Lobular Carcinoma of the Breast: What Is the News? Breast Magnetic Resonance Imaging and Emerging Role of Contrast-Enhanced Spectral Mammography”
by Melania Costantini, Rino Aldo Montella, Maria Paola Fadda, Vincenzo Tondolo, Gianluca Franceschini, Sonia Bove, Giorgia Garganese and Pierluigi Maria Rinaldi
J. Pers. Med. 2022, 12(6), 867; https://doi.org/10.3390/jpm12060867
Available online: https://www.mdpi.com/2075-4426/12/6/867
9. “Application of Artificial Intelligence Techniques to Predict Risk of Recurrence of Breast Cancer: A Systematic Review”
by Claudia Mazo, Claudia Aura, Arman Rahman, William M. Gallagher and Catherine Mooney
J. Pers. Med. 2022, 12(9), 1496; https://doi.org/10.3390/jpm12091496
Available online: https://www.mdpi.com/2075-4426/12/9/1496
10. “Breast Reconstruction by Exclusive Lipofilling after Total Mastectomy for Breast Cancer: Description of the Technique and Evaluation of Quality of Life”
by Alexandre Piffer, Gabrielle Aubry, Claudio Cannistra, Nathalie Popescu, Maryam Nikpayam, Martin Koskas, Catherine Uzan, Jean-Christophe Bichet and Geoffroy Canlorbe
J. Pers. Med. 2022, 12(2), 153; https://doi.org/10.3390/jpm12020153
Available online: https://www.mdpi.com/2075-4426/12/2/153
30 June 2024
Journal of Personalized Medicine | Most Viewed Papers in 2022–2023 in the Section “Sex, Gender and Hormone Based Medicine”
We are pleased to invite you to read the most viewed papers in 2022 and 2023 in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) in the Section “Sex, Gender and Hormone Based Medicine”. The list of papers is as follows.
1. “Focus on Sex and Gender: What We Need to Know in the Management of Rheumatoid Arthritis”
by Beatrice Maranini, Alessandra Bortoluzzi, Ettore Silvagni and Marcello Govoni
J. Pers. Med. 2022, 12(3), 499; https://doi.org/10.3390/jpm12030499
Available online: https://www.mdpi.com/2075-4426/12/3/499
2. “Digital Anthropometry for Body Circumference Measurements: European Phenotypic Variations throughout the Decades”
by Marco Alessandro Minetto, Angelo Pietrobelli, Chiara Busso, Jonathan P. Bennett, Andrea Ferraris, John A. Shepherd and Steven B. Heymsfield
J. Pers. Med. 2022, 12(6), 906; https://doi.org/10.3390/jpm12060906
Available online: https://www.mdpi.com/2075-4426/12/6/906
3. “Review of Endometrial Receptivity Array: A Personalized Approach to Embryo Transfer and Its Clinical Applications”
by Sarah C. Rubin, Mawerdi Abdulkadir, Joshua Lewis, Aleksandr Harutyunyan, Rahim Hirani and Cara L. Grimes
J. Pers. Med. 2023, 13(5), 749; https://doi.org/10.3390/jpm13050749
Available online: https://www.mdpi.com/2075-4426/13/5/749
4. “Serological Response and Relationship with Gender-Sensitive Variables among Healthcare Workers after SARS-CoV-2 Vaccination”
by Roberto Cangemi, Manuela Di Franco, Antonio Angeloni, Alessandra Zicari, Vincenzo Cardinale, Marcella Visentini, Guido Antonelli, Anna Napoli, Emanuela Anastasi, Giulio Francesco Romiti et al.
J. Pers. Med. 2022, 12(6), 994; https://doi.org/10.3390/jpm12060994
Available online: https://www.mdpi.com/2075-4426/12/6/994
5. “Gender and Autoimmune Liver Diseases: Relevant Aspects in Clinical Practice”
by Federica Invernizzi, Marta Cilla, Silvia Trapani, Maria Guarino, Valentina Cossiga, Martina Gambato, Maria Cristina Morelli, Filomena Morisco, Patrizia Burra and Annarosa Floreani
J. Pers. Med. 2022, 12(6), 925; https://doi.org/10.3390/jpm12060925
Available online: https://www.mdpi.com/2075-4426/12/6/925
6. “Sex-Related Differences of Matrix Metalloproteinases (MMPs): New Perspectives for These Biomarkers in Cardiovascular and Neurological Diseases”
by Alessandro Trentini, Maria Cristina Manfrinato, Massimiliano Castellazzi and Tiziana Bellini
J. Pers. Med. 2022, 12(8), 1196; https://doi.org/10.3390/jpm12081196
Available online: https://www.mdpi.com/2075-4426/12/8/1196
7. “Sex-Based Difference in the Effect of Metoprolol on Heart Rate and Bradycardia in a Population-Based Setting”
by Linda C. Hendriksen, Grace Omes-Smit, Birgit C. P. Koch, M. Arfan Ikram, Bruno H. Stricker and Loes E. Visser
J. Pers. Med. 2022, 12(6), 870; https://doi.org/10.3390/jpm12060870
Available online: https://www.mdpi.com/2075-4426/12/6/870
8. “Gender Differences in Acute Aortic Dissection”
by Eduardo Bossone, Andreina Carbone and Kim A. Eagle
J. Pers. Med. 2022, 12(7), 1148; https://doi.org/10.3390/jpm12071148
Available online: https://www.mdpi.com/2075-4426/12/7/1148
9. “Factors Associated with Postpartum Sexual Dysfunction in Spanish Women: A Cross-Sectional Study”
by Pedro Hidalgo-Lopezosa, Sandra Pérez-Marín, Andrea Jiménez-Ruz, Juan de la Cruz López-Carrasco, Ana María Cubero-Luna, Rubén García-Fernández, María Aurora Rodríguez-Borrego, Cristina Liébana-Presa and Pablo Jesús López-Soto
J. Pers. Med. 2022, 12(6), 926; https://doi.org/10.3390/jpm12060926
Available online: https://www.mdpi.com/2075-4426/12/6/926
10. “Gender and Psychosocial Differences in Psychological Resilience among a Community of Older Adults during the COVID-19 Pandemic”
by Alberto Sardella, Vittorio Lenzo, Giorgio Basile, Alessandro Musetti, Christian Franceschini and Maria C. Quattropani
J. Pers. Med. 2022, 12(9), 1414; https://doi.org/10.3390/jpm12091414
Available online: https://www.mdpi.com/2075-4426/12/9/1414
24 June 2024
Journal of Personalized Medicine Receives an Updated Impact Factor of 3.0
We are pleased to share that Journal of Personalized Medicine (JPM, ISSN: 2075-4426) was awarded an updated Impact Factor of 3.0 in the 2023 Journal Citation Reports™ released by Clarivate in June 2024. Journal of Personalized Medicine ranks Q1 (58 among 325 titles) in the “Medicine, General & Internal” category and Q2 (51 among 174 titles) in the “Health Care Sciences & Services” category.
3.02023 Impact Factor |
58/325 (Q1)Medicine, General & Internal 51/174 (Q2)Health Care Sciences & Services |
12,728Citations in 2023 |
4.12023 CiteScore |
137/398 (Q2)Medicine (miscellaneous) |
0.742SNIP |
For further statistics, please visit https://www.mdpi.com/journal/jpm/stats. For more information about MDPI flagship journals' citation metrics, please see here.
At MDPI, our mission is simple yet powerful, and we strive every day to make scientific research freely accessible to everyone, everywhere. With over 3.5 million authors choosing MDPI, we have established ourselves as a key player driving the open access initiative.
Our journals have received over 12,728 citations in the Web of Science, making us the most cited open access publisher. With over 800 institutional partners, MDPI continues to demonstrate its dedication to providing reliable and collaborative publishing services.
JPM Editorial Office
20 June 2024
2023 Impact Factors for MDPI Journals Released
MDPI is pleased to announce the inclusion of 237 journals in the 2024 release of the Journal Citation Reports (JCR) and share the key results (see above).
This year, journals covered in the Emerging Sources Citation Index (ESCI) received category ranks together with journals in the Science Citation Index Expanded (SCIE) and Social Sciences Citation Index (SSCI). Overall, 139 MDPI journals indexed in ESCI are included in the new unified rankings for the first time.
Enhanced Comparability of Data
According to Clarivate, "the creation of unified category rankings [provides] a simpler and more complete category view for the evaluation of journal performance. [...] The category-first approach simplifies journal performance assessment with a holistic view of all journals in each subject category."
We are thrilled to announce that 72% of our ranked MDPI journals (171 of 237) are above average, in Q1 or Q2. Twenty-nine of our journals received their first Impact Factor this year, accounting for more than 5% of the journals accepted into the Web of Science last year.
MDPI Journals Ranked in JCR
The following data includes all MDPI journals indexed in SCIE, SSCI, ESCI and AHCI.
Journal |
Impact Factor |
Rank Quartile |
Category |
Q3 |
Acoustics |
||
Q2 |
Engineering, Mechanical |
||
Q2 |
Instruments & Instrumentation |
||
Q2 |
Management |
||
Q3 |
Respiratory System |
||
Q2 |
Engineering, Aerospace |
||
Q1 |
Agronomy |
||
Q2 |
Agricultural Engineering |
||
Q1 |
Agronomy |
||
Q1 |
Plant Sciences |
||
Q2 |
Computer Science, Artificial Intelligence |
||
Q2 |
Computer Science, Interdisciplinary Applications |
||
Q3 |
Computer Science, Artificial Intelligence |
||
Q2 |
Computer Science, Theory & Methods |
||
Q1 |
Agriculture, Dairy & Animal Science |
||
Q1 |
Veterinary Sciences |
||
Q1 |
Infectious Diseases |
||
Q1 |
Pharmacology & Pharmacy |
||
Q3 |
Immunology |
||
Q1 |
Biochemistry & Molecular Biology |
||
Q1 |
Chemistry, Medicinal |
||
Q1 |
Food Science & Technology |
||
Q2 |
Chemistry, Multidisciplinary |
||
Q1 |
Engineering, Multidisciplinary |
||
Q3 |
Materials Science, Multidisciplinary |
||
Q2 |
Physics, Applied |
||
Q2 |
Computer Science, Information Systems |
||
Q2 |
Engineering, Electrical & Electronic |
||
Q2 |
Telecommunications |
||
N/A |
Humanities, Multidisciplinary |
||
Q3 |
Environmental Sciences |
||
Q3 |
Meteorology & Atmospheric Sciences |
||
Q3 |
Physics, Atomic, Molecular & Chemical |
||
Q1 |
Audiology & Speech-language Pathology |
||
Q1 |
Mathematics, Applied |
||
Q2 |
Electrochemistry |
||
Q2 |
Energy & Fuels |
||
Q2 |
Materials Science, Multidisciplinary |
||
Q2 |
Psychology, Multidisciplinary |
||
Q2 |
Food Science & Technology |
||
Q2 |
Computer Science, Artificial Intelligence |
||
Q2 |
Computer Science, Information Systems |
||
Q1 |
Computer Science, Theory & Methods |
||
Q2 |
Engineering, Biomedical |
||
Q1 |
Biology |
||
Q2 |
Biochemistry & Molecular Biology |
||
Q2 |
Medicine, Research & Experimental |
||
Q1 |
Pharmacology & Pharmacy |
||
Q1 |
Engineering, Multidisciplinary |
||
Q3 |
Materials Science, Biomaterials |
||
Q1 |
Biochemistry & Molecular Biology |
||
Q1 |
Chemistry, Analytical |
||
Q1 |
Instruments & Instrumentation |
||
Q2 |
Nanoscience & Nanotechnology |
||
Q3 |
Biotechnology & Applied Microbiology |
||
Q1 |
Ornithology |
||
Q3 |
Neurosciences |
||
Q2 |
Construction & Building Technology |
||
Q2 |
Engineering, Civil |
||
Q2 |
Materials Science, Multidisciplinary |
||
Q1 |
Oncology |
||
Q4 |
Cardiac & Cardiovascular Systems |
||
Q2 |
Chemistry, Physical |
||
Q2 |
Cell Biology |
||
Q1 |
Materials Science, Ceramics |
||
Q3 |
Materials Science, Multidisciplinary |
||
Q2 |
Engineering, Chemical |
||
Q3 |
Chemistry, Multidisciplinary |
||
Q2 |
Chemistry, Analytical |
||
Q2 |
Electrochemistry |
||
Q1 |
Instruments & Instrumentation |
||
Q2 |
Pediatrics |
||
Q2 |
Engineering, Environmental |
||
Q2 |
Environmental Sciences |
||
Q3 |
Green & Sustainable Science & Technology |
||
Q2 |
Meteorology & Atmospheric Sciences |
||
Q2 |
Medicine, General & Internal |
||
Q3 |
Clinical Neurology |
||
Q3 |
Neurosciences |
||
Q2 |
Materials Science, Coatings & Films |
||
Q3 |
Materials Science, Multidisciplinary |
||
Q2 |
Physics, Applied |
||
Q3 |
Chemistry, Physical |
||
Q2 |
Mathematics, Interdisciplinary Applications |
||
Q2 |
Computer Science, Interdisciplinary Applications |
||
Q3 |
Physics, Condensed Matter |
||
Q2 |
Biochemistry & Molecular Biology |
||
Q2 |
Dermatology |
||
Q3 |
Computer Science, Information Systems |
||
Q2 |
Computer Science, Theory & Methods |
||
Q2 |
Crystallography |
||
Q3 |
Materials Science, Multidisciplinary |
||
Q3 |
Biochemistry & Molecular Biology |
||
Q2 |
Oncology |
||
Q3 |
Computer Science, Information Systems |
||
Q2 |
Multidisciplinary Sciences |
||
Q2 |
Dentistry, Oral Surgery & Medicine |
||
Q3 |
Dermatology |
||
Q3 |
Endocrinology & Metabolism |
||
Q1 |
Medicine, General & Internal |
||
Q2 |
Medicine, Research & Experimental |
||
Q2 |
Biodiversity Conservation |
||
Q3 |
Ecology |
||
Q1 |
Remote Sensing |
||
Q3 |
Environmental Sciences |
||
Q3 |
Geosciences, Multidisciplinary |
||
Q3 |
Ecology |
||
Q3 |
Economics |
||
Q2 |
Economics |
||
Q1 |
Education & Educational Research |
||
Q2 |
Computer Science, Information Systems |
||
Q2 |
Engineering, Electrical & Electronic |
||
Q2 |
Physics, Applied |
||
Q3 |
Energy & Fuels |
||
Q2 |
Physics, Multidisciplinary |
||
Q2 |
Environmental Sciences |
||
Q3 |
Genetics & Heredity |
||
Q4 |
Critical Care Medicine |
||
Q4 |
Dermatology |
||
European Journal of Investigation in Health Psychology and Education |
Q1 |
Psychology, Clinical |
|
Q2 |
Biotechnology & Applied Microbiology |
||
Q2 |
Materials Science, Multidisciplinary |
||
Q2 |
Ecology |
||
Q1 |
Forestry |
||
Q2 |
Fisheries |
||
Q2 |
Marine & Freshwater Biology |
||
Q3 |
Mechanics |
||
Q3 |
Physics, Fluids & Plasmas |
||
Q1 |
Food Science & Technology |
||
Q2 |
Multidisciplinary Sciences |
||
Q1 |
Forestry |
||
Q1 |
Mathematics, Interdisciplinary Applications |
||
Q3 |
Energy & Fuels |
||
Q3 |
Engineering, Chemical |
||
Q2 |
Computer Science, Information Systems |
||
Q2 |
Astronomy & Astrophysics |
||
Q4 |
Economics |
||
Q4 |
Mathematics, Interdisciplinary Applications |
||
Q4 |
Social Sciences, Mathematical Methods |
||
Q3 |
Gastroenterology & Hepatology |
||
Q4 |
Gastroenterology & Hepatology |
||
Q1 |
Polymer Science |
||
Q3 |
Ethnic Studies |
||
Q4 |
Family Studies |
||
Q3 |
Sociology |
||
Q2 |
Genetics & Heredity |
||
Q2 |
Geosciences, Multidisciplinary |
||
Q3 |
Geriatrics & Gerontology |
||
Q2 |
Health Care Sciences & Services |
||
Q2 |
Health Policy & Services |
||
Q4 |
Hematology |
||
Q4 |
Hematology |
||
N/A |
Humanities, Multidisciplinary |
||
Q2 |
Multidisciplinary Sciences |
||
Q1 |
Horticulture |
||
N/A |
Humanities, Multidisciplinary |
||
Q2 |
Water Resources |
||
Q4 |
Immunology |
||
Q2 |
Infectious Diseases |
||
Q2 |
Computer Science, Interdisciplinary Applications |
||
Q3 |
Computer Science, Information Systems |
||
Q2 |
Construction & Building Technology |
||
Q2 |
Engineering, Civil |
||
Q2 |
Transportation Science & Technology |
||
Q2 |
Chemistry, Inorganic & Nuclear |
||
Q1 |
Entomology |
||
Q2 |
Business, Finance |
||
Q1 |
Biochemistry & Molecular Biology |
||
Q2 |
Chemistry, Multidisciplinary |
||
Q1 |
Genetics & Heredity |
||
Q1 |
Pediatrics |
||
International Journal of Turbomachinery Propulsion and Power |
Q2 |
Engineering, Aerospace |
|
Q3 |
Engineering, Mechanical |
||
Q2 |
Engineering, Multidisciplinary |
||
Q2 |
Computer Science, Information Systems |
||
Q2 |
Geography, Physical |
||
Q2 |
Remote Sensing |
||
Q2 |
Cardiac & Cardiovascular Systems |
||
Q1 |
Medicine, General & Internal |
||
Q2 |
Materials Science, Composites |
||
Q3 |
Developmental Biology |
||
Q1 |
Engineering, Biomedical |
||
Q2 |
Materials Science, Biomaterials |
||
Q1 |
Sport Sciences |
||
Q2 |
Microbiology |
||
Q1 |
Mycology |
||
Q3 |
Imaging Science & Photographic Technology |
||
Q1 |
Psychology, Multidisciplinary |
||
Q3 |
Engineering, Electrical & Electronic |
||
Q2 |
Engineering, Manufacturing |
||
Q1 |
Engineering, Mechanical |
||
Q2 |
Materials Science, Multidisciplinary |
||
Q1 |
Engineering, Marine |
||
Q2 |
Engineering, Ocean |
||
Q2 |
Oceanography |
||
Q2 |
Health Care Sciences & Services |
||
Q1 |
Medicine, General & Internal |
||
Q2 |
Computer Science, Information Systems |
||
Q2 |
Telecommunications |
||
Journal of Theoretical and Applied Electronic Commerce Research |
Q1 |
Business |
|
Q1 |
Toxicology |
||
Q2 |
Biodiversity Conservation |
||
Q2 |
Communication |
||
Q2 |
Environmental Studies |
||
N/A |
Language & Linguistics |
||
Q2 |
Linguistics |
||
Q1 |
Law |
||
Q1 |
Biology |
||
Q2 |
Management |
||
Q2 |
Operations Research & Management Science |
||
Q2 |
Engineering, Mechanical |
||
Q2 |
Computer Science, Artificial Intelligence |
||
Q2 |
Computer Science, Interdisciplinary Applications |
||
Q2 |
Engineering, Electrical & Electronic |
||
Q3 |
Engineering, Electrical & Electronic |
||
Q2 |
Engineering, Mechanical |
||
Q2 |
Chemistry, Inorganic & Nuclear |
||
Q3 |
Chemistry, Physical |
||
Q3 |
Materials Science, Multidisciplinary |
||
Q1 |
Chemistry, Medicinal |
||
Q1 |
Pharmacology & Pharmacy |
||
Q3 |
Chemistry, Physical |
||
Q2 |
Materials Science, Multidisciplinary |
||
Q1 |
Metallurgy & Metallurgical Engineering |
||
Q2 |
Physics, Applied |
||
Q2 |
Physics, Condensed Matter |
||
Q2 |
Mathematics, Interdisciplinary Applications |
||
Q1 |
Mathematics |
||
Q1 |
Medicine, General & Internal |
||
Q2 |
Chemistry, Physical |
||
Q2 |
Engineering, Chemical |
||
Q2 |
Materials Science, Multidisciplinary |
||
Q2 |
Polymer Science |
||
Q2 |
Biochemistry & Molecular Biology |
||
Q3 |
Materials Science, Multidisciplinary |
||
Q2 |
Metallurgy & Metallurgical Engineering |
||
Q3 |
Biochemical Research Methods |
||
Q3 |
Microbiology |
||
Q2 |
Chemistry, Analytical |
||
Q2 |
Instruments & Instrumentation |
||
Q3 |
Nanoscience & Nanotechnology |
||
Q2 |
Physics, Applied |
||
Q2 |
Microbiology |
||
Q2 |
Geochemistry & Geophysics |
||
Q2 |
Mineralogy |
||
Q2 |
Mining & Mineral Processing |
||
Q3 |
Engineering, Multidisciplinary |
||
Q4 |
Chemistry, Organic |
||
Q2 |
Biochemistry & Molecular Biology |
||
Q2 |
Chemistry, Multidisciplinary |
||
Q3 |
Computer Science, Artificial Intelligence |
||
Q2 |
Computer Science, Cybernetics |
||
Q3 |
Computer Science, Information Systems |
||
Q2 |
Chemistry, Multidisciplinary |
||
Q2 |
Materials Science, Multidisciplinary |
||
Q2 |
Nanoscience & Nanotechnology |
||
Q2 |
Physics, Applied |
||
Q2 |
Clinical Neurology |
||
Q3 |
Clinical Neurology |
||
Q4 |
Neurosciences |
||
Q4 |
Environmental Sciences |
||
Q2 |
Biochemistry & Molecular Biology |
||
Q2 |
Genetics & Heredity |
||
Q1 |
Nursing |
||
Q1 |
Nutrition & Dietetics |
||
Q3 |
Marine & Freshwater Biology |
||
Q3 |
Oceanography |
||
Q4 |
Optics |
||
Q3 |
Chemistry, Organic |
||
Q3 |
Astronomy & Astrophysics |
||
Q2 |
Physics, Nuclear |
||
Q3 |
Physics, Particles & Fields |
||
Q2 |
Microbiology |
||
Q2 |
Pathology |
||
Q3 |
Pediatrics |
||
Q2 |
Chemistry, Medicinal |
||
Q1 |
Pharmacology & Pharmacy |
||
Q1 |
Pharmacology & Pharmacy |
||
Q3 |
Pharmacology & Pharmacy |
||
Q2 |
History & Philosophy of Science |
||
N/A |
Philosophy |
||
Q2 |
Optics |
||
Q2 |
Physics, Multidisciplinary |
||
Q1 |
Plant Sciences |
||
Q3 |
Physics, Fluids & Plasmas |
||
Q1 |
Polymer Science |
||
Q1 |
Polymer Science |
||
Q2 |
Engineering, Chemical |
||
Q4 |
Materials Science, Biomaterials |
||
Q2 |
Biochemistry & Molecular Biology |
||
Q4 |
Psychiatry |
||
Q1 |
Information Science & Library Science |
||
Q3 |
Instruments & Instrumentation |
||
Q3 |
Materials Science, Characterization & Testing |
||
Q4 |
Quantum Science & Technology |
||
Q2 |
Geosciences, Multidisciplinary |
||
Q3 |
Chemistry, Multidisciplinary |
||
Q2 |
Green & Sustainable Science & Technology |
||
N/A |
Religion |
||
Q2 |
Environmental Sciences |
||
Q1 |
Geosciences, Multidisciplinary |
||
Q2 |
Imaging Science & Photographic Technology |
||
Q2 |
Remote Sensing |
||
Q3 |
Medicine, General & Internal |
||
Q4 |
Obstetrics & Gynecology |
||
Q4 |
Reproductive Biology |
||
Q2 |
Environmental Sciences |
||
Q3 |
Green & Sustainable Science & Technology |
||
Q2 |
Business, Finance |
||
Q2 |
Robotics |
||
Q3 |
Public, Environmental & Occupational Health |
||
Q3 |
Pharmacology & Pharmacy |
||
Q2 |
Chemistry, Analytical |
||
Q2 |
Engineering, Electrical & Electronic |
||
Q2 |
Instruments & Instrumentation |
||
Q3 |
Chemistry, Analytical |
||
Q2 |
Medicine, General & Internal |
||
Q3 |
Psychology, Multidisciplinary |
||
Q2 |
Social Sciences, Interdisciplinary |
||
Q2 |
Womens Studies |
||
Q1 |
Engineering, Electrical & Electronic |
||
Q1 |
Urban Studies |
||
Q2 |
Social Sciences, Interdisciplinary |
||
Q2 |
Sociology |
||
Q2 |
Soil Science |
||
Q3 |
Chemistry, Physical |
||
Q3 |
Materials Science, Multidisciplinary |
||
Q2 |
Sport Sciences |
||
Q4 |
Mathematics, Interdisciplinary Applications |
||
Q3 |
Statistics & Probability |
||
Q3 |
Chemistry, Physical |
||
Q3 |
Materials Science, Multidisciplinary |
||
Q4 |
Surgery |
||
Q2 |
Environmental Sciences |
||
Q2 |
Environmental Studies |
||
Q3 |
Green & Sustainable Science & Technology |
||
Q2 |
Multidisciplinary Sciences |
||
Q1 |
Social Sciences, Interdisciplinary |
||
Q1 |
Engineering, Multidisciplinary |
||
Q3 |
Telecommunications |
||
Q4 |
Hematology |
||
Q2 |
Radiology, Nuclear Medicine & Medical Imaging |
||
Q2 |
Environmental Sciences |
||
Q1 |
Toxicology |
||
Q2 |
Food Science & Technology |
||
Q1 |
Toxicology |
||
Q2 |
Infectious Diseases |
||
Q2 |
Parasitology |
||
Q1 |
Tropical Medicine |
||
Q2 |
Astronomy & Astrophysics |
||
Q2 |
Physics, Particles & Fields |
||
Q3 |
Environmental Sciences |
||
Q3 |
Environmental Studies |
||
Q2 |
Geography |
||
Q3 |
Regional & Urban Planning |
||
Q2 |
Urban Studies |
||
Q1 |
Immunology |
||
Q1 |
Medicine, Research & Experimental |
||
Q2 |
Engineering, Mechanical |
||
Q2 |
Transportation Science & Technology |
||
Q2 |
Veterinary Sciences |
||
Q3 |
Engineering, Mechanical |
||
Q3 |
Mechanics |
||
Q2 |
Virology |
||
Q2 |
Environmental Sciences |
||
Q2 |
Water Resources |
||
Q2 |
Economics |
||
Q2 |
Political Science |
||
Q1 |
Social Sciences, Interdisciplinary |
||
Q2 |
Engineering, Electrical & Electronic |
||
Q2 |
Transportation Science & Technology |
Source: 2023 Journal Impact Factors, Journal Citation Reports TM (Clarivate, 2024)
About MDPI
A pioneer in scholarly, open access publishing, MDPI has supported academic communities since 1996. MDPI is leading the transition to open science by making more research free and accessible to everyone. Over 3.5 million researchers have entrusted MDPI with publishing their scientific discoveries. MDPI’s editorial process is bolstered by a network of dedicated reviewers, a team of 6000 professional, well-trained staff members, and an in-house article submission platform that was designed to ensure efficient processes within its 440 fully open access titles.
17 June 2024
Meet Us at the 5th Belt & Road Initiative Global Health International Congress & 2024 University Alliance of the Silk Road Global Health Forum, 21–23 June 2024, Xi’an, China
MDPI will be attending the 5th Belt & Road Initiative Global Health International Congress & 2024 University Alliance of the Silk Road Global Health Forum, which will be held from 21 to 23 June 2024, in Xi’an, China.
The symposium will focus on major global health issues, including approximately 20 keynote forums and thematic forums, as well as research result poster exchange and youth forums. Government officials, experts, scholars, clinicians and public health practitioners from medical and health-related fields will attend the conference.
The following topics will be covered:
- Elderly populations;
- Smart healthcare;
- Integration of medical and preventive measures;
- Healthy China Action—Proactive Health;
- Eliminating health imbalances;
- Obesity prevention and control;
- Diabetes prevention and control;
- Prevention and control of chronic diseases;
- Infectious disease prevention and control;
- Environment and prevention and control of endemic diseases;
- Nutrition and health;
- Health media and health promotion.
The following MDPI journals will be represented:
- Nutrients;
- Obesities;
- Antioxidants;
- Healthcare;
- Diabetology;
- Children;
- JPM;
- Epidemiologia;
- Endocrines.
If you are considering attending this conference, we encourage you to visit our booth and speak to our representatives. We are eager to meet you in person and assist you with any queries you may have.
For more information about the conference, please visit the official website at https://ghi.xjtu.edu.cn/info/1016/1872.htm.
17 June 2024
Journal of Personalized Medicine Receives an Increased CiteScore of 4.1
We are pleased to inform you that Journal of Personalized Medicine (JPM, ISSN: 2075-4426) has received an increased CiteScore of 4.1.
CiteScore provides transparent metrics that enable well-informed publishing strategy, library collection development, and the benchmarking of journal performance. It is now a standard citation metric alongside SNIP and SJR that gives an up-to-date view of a journal’s impact.
The 2023 CiteScore provides an assessment of the scientific influence of journals in the 2020 to 2023 period.
This is a reflection of the excellent performance, support, and dedication of all journal editors, reviewers, authors, and readers.
JPM’s CiteScore ranks as follows:
- Q2 (137 out of 398) in the “ Medicine (miscellaneous)” category.
For more journal statistics, please visit https://www.mdpi.com/journal/jpm/stats.
Thank you to everyone who has contributed to the journal.
JPM Editorial Office
7 June 2024
MDPI Calls for Greater Open Access to Science for Ocean Protection
On UNESCO’s 2024 Oceans Day, MDPI encourages the scientific community to increase the accessibility of ocean research to accelerate ocean conservation.
Basel, Switzerland, June 7, 2024: MDPI, a leading open access (OA) publisher, is proud to announce its active support for World Oceans Day 2024, celebrated under UNESCO’s Ocean Decade framework. MDPI’s CEO, Stefan Tochev hopes that “the latest ocean research can be made freely accessible to help empower scientists and communities at large to save our oceans,” under UNESCO’s Ocean Decade until 2030.
Open Access: A Catalyst for Ocean Action
MDPI’s presence at the UNESCO Ocean Decade Conference 2024 highlights our unwavering commitment to using OA to advance ocean science, support research communities, and promote sustainable ocean management.
"Our involvement in the UNESCO Ocean Decade Conference underscores MDPI's commitment to the underfunded Ocean SDG. By promoting OA to scientific articles and books on SDGs, we aim to inspire critical actions," said Tochev. "Our initiatives, like the World Sustainability Award and Emerging Sustainability Award, further demonstrate our dedication to advancing sustainability.”
Showcasing MDPI’s Contributions to Ocean Research
Over the past three years, MDPI has published 30,000 papers focused on ocean research and related topics. Key MDPI journals contributing to this body of work include:
- Journal of Marine Science and Engineering (4.9k papers)
- Remote Sensing (2.6k papers)
- Sustainability (2k papers)
- International Journal of Molecular Sciences (IJMS) (1.7k papers)
- Marine Drugs (1.5k papers)
- Water (1.5k papers)
These publications highlight MDPI’s contributions to ocean science, reinforcing our role in the broader sustainability agenda by promoting blue innovation and economy.
Additionally, MDPI has launched Oceans, an international, peer-reviewed forum specifically aimed at publishing studies related to all branches of oceanography with an emphasis on the functioning of the ocean and the sustainable use of its resources and ecosystem services.
Affirming MDPI’s Commitment to Ocean Science
MDPI’s commitment to OA is pivotal in addressing critical global challenges, from climate change to ocean sustainability. Our efforts resonate with Outcome 4 of the UNESCO Ocean Decade action roadmap: an accessible ocean with open and equitable access to data, information, technology, and innovation. By aligning with UNESCO’s goals, MDPI continues to contribute to shaping a sustainable future for our oceans, reinforcing our position as a forward-thinking publisher dedicated to environmental stewardship and scientific excellence.
For more information, contact Rui Duarte at [email protected] or +41764313242.
About MDPI
A pioneer in scholarly, open access publishing, MDPI has supported academic communities since 1996. MDPI is leading the transition to open science by making more research free and accessible to everyone. Over 3.5 million researchers have entrusted MDPI with publishing their scientific discoveries. MDPI’s editorial process is bolstered by a network of dedicated reviewers, a team of over 6000 professional, well-trained staff members, and an in-house article submission platform that was designed to ensure efficient processes within its 430 fully open access titles.
5 June 2024
MDPI Sets a New Benchmark for Publishing Excellence
95% of authors rate MDPI’s publication process as excellent or good, setting a new benchmark in scientific publishing – reveals 2023 Annual Report.
Basel, Switzerland, June 4, 2024: MDPI, the leading open access (OA) publisher, proudly announces the release of its 2023 Annual Report, detailing remarkable achievements and reaffirming its leadership in advancing OA publishing. In 2023, MDPI received 655,065 submissions, of which 285,244 articles were published. The company now commands a 17% market share in gold open access articles, with a median publication time of six weeks.
Stefan Tochev, MDPI's CEO, stated, "As a pioneer in open access publishing, MDPI has long been a game-changer in the scholarly community, serving millions of authors around the world to ensure the latest research is freely available. Reflecting on our incredible journey at MDPI, 2023 has been marked by growth in paper submissions, ambitious projects and initiatives aimed at improving our internal processes and delivering top-notch services to our scientists."
MDPI's 2023 Annual Report highlights several key achievements:
- 17% market share in gold open access articles across all disciplines.
- Record satisfaction rates: 95% of authors, 82% of reviewers, and 85% of guest editors.
- Enhanced editorial standards and feedback processes.
- Increased reach and impact with 54 new MDPI journal inclusions in Scopus, 29 in Web of Science, and 77 in DOAJ.
MDPI’s unwavering commitment to advancing OA has transformed the landscape of scholarly publishing, making high-quality research freely accessible to the global scientific community. The continuous improvement in our editorial standards and feedback processes underscores MDPI’s dedication to ensuring academic integrity and excellence.
Global Reach and Collaboration
MDPI’s global footprint continues to expand, with authors from diverse regions: 37% from Asia/Pacific, 36% from Europe, 15% from the Americas, and 12% from other parts of the world. The company’s fully OA platform attracted nearly 14 million monthly visitors in 2023, reflecting its widespread influence in the scientific community.
Commitment to Partnerships
With over 800 institutional partners, MDPI continues to demonstrate its dedication to providing reliable and collaborative publishing services. The introduction of a transparent flat-fee model highlights MDPI's ongoing efforts to enhance affordability and support to the academic community. For more details read our 2023 Annual Report.
For more information, contact Rui Duarte at [email protected] or +41764313242.
About MDPI
A pioneer in scholarly, open access publishing, MDPI has supported academic communities since 1996. MDPI is leading the transition to open science by making more research free and accessible to everyone. Over 3.5 million researchers have entrusted MDPI with publishing their scientific discoveries. MDPI’s editorial process is bolstered by a network of dedicated reviewers, a team of over 6000 professional, well-trained staff members, and an in-house article submission platform that was designed to ensure efficient processes within its 430 fully open access titles.
4 June 2024
MDPI Insights: The CEO's Letter #12 - First Term as CEO, Tu Youyou Award, Books Report
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Renewed Term as CEO of MDPI
I released the first CEO Letter at the end of June 2023, reflecting on my first month as CEO. Looking back at the first release, I’m pleased to see a marked consistency of content – from talking about open access (OA) and highlighting the great work being done at MDPI, to bringing together the science community with our conferences and building relations with our editorial board members and our industry as a whole.
For example, in the first letter, I highlighted our meeting with Dr. Eric O. Freed, the founding and current Editor-in-Chief (EiC) of our journal Viruses. Meeting with Eric is a pleasure, as he has a strong commitment and clear vision for the journal.
On 21 May, 2024 we met with EiC Prof. Dr. Antonino Carbone, and Section EiC Prof. Dr. Alberto Signore (pictured on the left), of our journal Hemato (tracked for Impact Factor, and indexed in Scopus), showing our continued and active collaboration with our chief editors to develop the visions for the journal. Over the course of the day, we gathered feedback and gained an understanding of the journal's expectations and focus on strategic growth.
Reflections on my first year as CEO: achievements and initiatives
During my first year as CEO, there have been many remarkable moments, including a strong focus on bringing people together, focusing on company communications and performance.
According to a recent study of 3,400 people across 10 countries, “Managers impact employees’ mental health (69%) more than doctors (51%) or therapists (41%) — and even the same as a partner (69%).” This is an important topic for me, and perhaps that’s why I place a high value on management culture due to its tangible impact on people’s lives.
When I joined MDPI, I created a weekly meet-up for the Corporate Marketing department and their team leads. On the final Thursday of every month, we hold a Global Marketing meet-up to present projects, share knowledge, and conduct training. For years, I’ve maintained the tradition of ending each of our monthly global calls with a group photo to boost morale, motivation, and productivity, and to finish on a positive note.
In keeping with this, when I stepped into the role of CEO, I launched a bi-weekly management meeting, chairing over 20 MDPI Management Team meetings in my first year. These sessions provide an opportunity for managers to present their team’s work, focusing on their achievements and the challenges they face, while at the same time creating space for sharing knowledge.
“I firmly believe that OA is the future of publishing”
I co-organized and co-led the 2023 MDPI Strategy Management meeting this past October, from which we established an Executive Task Force that meets monthly to prioritize projects aimed at building MDPI into the world’s most trusted publisher. To achieve our goals, we as managers need to maintain collaborative communication and connect to the bigger picture.
As CEO, I focused on leadership communication by publishing 12 CEO Letters, one for each month of my tenure, to share more about MDPI news and achievements. I also produced ten videos to help further communicate our message.
I was happy to attend eight publishing and conference events, including STM in Frankfurt and Washington, APE, and R2R, and facilitate critical company meetings with Elsevier, Web of Science, ResearchGate, DOAJ, and others. It was a pleasure to meet and have discussions with key organizations and governing bodies such as CAS in China and ANVUR in Italy.
The best part was the opportunity to visit seven MDPI offices across Europe and Asia-Pacific, meeting with local managers and colleagues and supporting them in person. As part of this, I conducted training sessions while continuing to lead the Corporate Marketing department.
Looking ahead
My goal for my second year as CEO is to continue building on the initiatives from the past, including leadership communications, public relations, educational marketing, and company culture, while representing MDPI to the best of my ability. Additionally, I have a few new projects I hope to launch that I believe will be valuable to MDPI and the industry at large.
I firmly believe that OA is the future of publishing, and I am grateful to be in a position to advocate for this belief as part of MDPI, the world's leading open access publisher.
Thank you to our staff and industry friends for your genuine support in this role.
Impactful Research
Nominations Open for the Prestigious Tu Youyou Award 2024
I am pleased to share that MDPI has opened nominations for the 2024 Tu Youyou Award, a prestigious recognition established in honour of Professor Tu Youyou, Nobel Laureate, whose work has significantly transformed the global fight against malaria.
The Tu Youyou Award offers CHF 100,000
In 2015, Professor Tu Youyou was awarded the Nobel Prize in Physiology or Medicine for her discovery of artemisinin, significantly reducing mortality rates from malaria and shaping global health policies. Artemisinin-based combination therapies (ACTs) are now the standard treatment endorsed by the World Health Organization (WHO), saving countless lives, especially in regions heavily burdened by malaria.
MDPI Special Issue
To mark Professor Tu’s 80th birthday in 2009, MDPI’s journal Molecules issued a Special Issue focusing on her contributions to medical research. Recognizing her continuous contribution, MDPI created the Tu Youyou Award in 2016 to honour outstanding achievements in natural products and medicinal chemistry.
The deadline for nominations is 31 December 2024
Nominations are open to scientists excelling in natural products and medicinal chemistry. Eligible nominators include academic institutes, universities, and societies. The deadline for nominations is 31 December 2024, with the winners to be announced on 30 April 2025. The Tu Youyou Award offers CHF 100,000, split equally among the winners.
MDPI encourages the academic community to nominate individuals who have demonstrated excellence and innovation in line with Professor Tu’s legacy. This award not only honours individual achievement but also encourages further scientific exploration and discovery in critical areas of medicine.
This award embodies our deep commitment to groundbreaking research that drives societal progress and celebrates the legacy of one of the greatest medical innovators of our time.
Inside MDPI
2023 MDPI Books Report
In past CEO letters, I have highlighted our publishing process and the impactful peer-reviewed articles that represent the core output of scholarly publishing. However, scholarly books are another pillar of publishing that MDPI also services, which our core audience may not be fully aware of. In this section, I highlight the 2023 MDPI Books report, released by our MDPI Books team in May 2024.
Download the 2023 MDPI Books Report
In the report, you will find a summary of MDPI Books’ 10th anniversary, the books indexed in the Web of Science Book Citation Index, our market outreach, and our outlook for 2024.
MDPI Books celebrated its 10th anniversary in 2023
MDPI Books published its first OA Reprint, “From the Renaissance to the Modern World,” in 2013. Over the past ten years, MDPI Books has seen a significant increase in both the volume and nature of published Reprints. As of December 2023, our catalogue includes a total of 7,369 Reprints, with 1,811 of them added in 2023 alone. MDPI Books includes monographs, book series, edited books and reprints of special issues and topical collections, among other book types.
We’re also celebrating the 10-year MDPI anniversary of Laura Wagner, Head of MDPI Books.
Laura Wagner (Head of Books Division)
Laura holds a Bachelor’s degree in Art History and History from the University of Basel. After her studies, she started her career at an art gallery in Basel.
Since joining MDPI in 2014, Laura has held several roles within the company. This included editorial work, development of reprint and book services, and the temporary management of the journal Arts.
Currently Laura holds the role of Head of Books Division and is in charge of the development and strategic direction of MDPI Books.
MDPI Books indexed in Web of Science Book Citation Index
Another milestone in 2023 was the indexing of four book titles in the Web of Science Book Citation Index. The indexing of our open access books is crucial for their reach and accessibility, ensuring higher visibility within the open science community.
- Self-Representation in an Expanded Field: From Self-Portraiture to Selfie, Contemporary Art in the Social Media Age by editor Ace Lehner
- Towards Socially Integrative Cities: Perspectives on Urban Sustainability in Europe and China by editors Bernhard Müller, Jian Liu, Jianming Cai, Paulina Schiappacasse, Hans-Martin Neumann, and Baojun Yang
- Transitioning to Gender Equality by editors Christa Binswanger and Andrea Zimmermann
- Under Construction: Performing Critical Identity by editor Marie-Anne Kohl
If you would like to learn more about MDPI Books, please visit: www.mdpi.com/books
If you are thinking of writing or editing a book, you can submit your proposal at www.mdpi.com/books/publish-with-us, or email us at [email protected].
Coming Together for Science
Polymers 2024 – Polymers for a Safe and Sustainable Future
Our conference team successfully managed the Polymers 2024 – Polymers for a Safe and Sustainable Future international conference which took place from 28–31 May 2024 in Athens, Greece. The conference was chaired by Prof. Dr. Dimitrios Bikiaris and Prof. Dr. Konstantinos Triantafyllidis from the Aristotle University of Thessaloniki, Greece, and Dr. Ioanna Deligkiozi from AXIA Innovation, Germany. In total, the conference had 259 accepted abstracts and over 300 attendees from 22 different countries.
The conference featured three keynote speakers and 12 invited speakers, including esteemed scholars from Europe, Asia, Africa, and Canada. It included 60 selected talks and 189 posters, chosen by the 24 members of the Scientific Committee along with the three Conference Chairs. The event explored the latest scientific advancements and innovations in polymer science, focusing on creating safe, sustainable, and environmentally friendly materials. Emphasizing green polymer chemistry and the use of bioresources, the conference promoted the synthesis of biobased and biodegradable polymers.
The conference featured esteemed scholars from Europe, Asia, Africa, and Canada
Conference awards
The conference also presented three awards: two sponsored by the journal Polymers – The Best Poster Award (€500) and the Best Oral Presentation Award (€600) – and one sponsored by Ossila, the Best Student Poster Award (€500).
Thank you to our 16 sponsors, three partnering societies (Hellenic Polymer Society, European Polymer Federation, and North American Thermal Analysis Society [NATAS]) and eight media partners.
Upcoming in-person event
1–4 August, 2024
The 1st International Conference on AI Sensors & The 10th International Symposium on Sensor Science
Location: Singapore
The AI Sensors 2024 Conference will unite innovators and experts in the realms of sensors, sensing technology, and artificial intelligence.
Find more upcoming MDPI events here.
Closing Thoughts
3rd World Forum Principles of Scientific Publications
I’m pleased to share that MDPI sponsored and attended the 3rd World Forum on Principles of Scientific Publications, which took place from 22–24 May in Malaga, Spain. The event brought together academic professionals and leading researchers to discuss critical topics in the realm of publishing and research. Presentation topics included Open Science, AI in Publishing, Predatory Journals, Fake Publications, Challenges for Non-native English Speakers, and more.
“It was great to see strong support from MDPI authors in the audience”
MDPI presentations
Stefan Tochev (CEO, MDPI) presenting at the 3rd World Forum Principles of Scientific Publications
I had the privilege of attending and presenting at the event, along with my colleague Dr. Enric Sayas (Business Analyst, MDPI) from our Barcelona office, who explored the ethical concerns and opportunities brought by AI in publishing.
I took the opportunity to present on Open Science, the benefits of Open Access, and MDPI’s performance, operations, and investment in ethics. Special thanks to Evan Escamilla (Project Manager, MDPI Books) and Facundo Santomé (Sr. Marketing Manager, MDPI) who also joined the conference.
It was great to see strong support from MDPI authors in the audience who shared their positive experiences publishing with us. Their story reflects the experience of the vast majority of authors who choose to work with MDPI.
We also encountered some conservative views on OA, which created an opportunity for open discussion aimed at addressing concerns about OA and MDPI. Engaging in such discussions is important, as scepticism sometimes arises from misinformation or from a misunderstanding of who we are and how we operate. When we engage in open and honest discussion, we tend to see people getting a better understanding of MDPI, which helps address any misconceptions they may have had.
Left to right: Dr. Enric Sayas (Business Analyst, MDPI), Stefan Tochev (CEO, MDPI), Facundo Santomé (Sr. Marketing Manager, MDPI), and Evan Escamilla (Project Manager, MDPI Books) at 3rd World Forum Principles of Scientific Publications
Chief Executive Officer
MDPI AG
30 May 2024
Journal of Personalized Medicine | Most Viewed Special Issues in 2022–2023 in Section “Methodology, Drug and Device Discovery”
We are pleased to invite you to read the most viewed Special Issues from 2022 and 2023 in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) in Section “Methodology, Drug and Device Discovery”. We hope this announcement will provide useful information for those working in this field.
The Special Issue list is as follows:
“Personalized and Precision Medicine 2022” |
“Personalized Radiotherapy” |
“Computer Assisted Maxillo-Facial Surgery” |
“Cutting-Edge in Arthroplasty: Before, While and after Surgery” |
You are welcome to view all of the Special Issues and submit relevant papers to the Journal of Personalized Medicine. If you have any questions, you can contact the Editorial Office at [email protected].
Journal of Personalized Medicine Editorial Office
30 May 2024
Journal of Personalized Medicine | Most Viewed Papers in 2022–2023 in Section “Regenerative Medicine and Therapeutics”
We are pleased to invite you to read the most viewed papers in 2022–2023 in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) in the Section “Regenerative Medicine and Therapeutics”. The list of papers is as follows:
1. “Personalized Treatment Decisions for Traumatic Proximal Finger Amputations: A Retrospective Cohort Study”
by Nadjib Dastagir, Doha Obed, Khaled Dastagir and Peter M. Vogt
J. Pers. Med. 2023, 13(2), 215; https://doi.org/10.3390/jpm13020215
Available online: https://www.mdpi.com/2075-4426/13/2/215
2. “Lipedema Research—Quo Vadis?”
by Anna M. Ernst, Hannelore Bauer, Hans-Christian Bauer, Marianne Steiner, Anna Malfertheiner and Anna-Theresa Lipp
J. Pers. Med. 2023, 13(1), 98; https://doi.org/10.3390/jpm13010098
Available online: https://www.mdpi.com/2075-4426/13/1/98
3. “Modified Keystone Perforator Island Flap Techniques for Small- to Moderate-Sized Scalp and Forehead Defect Coverage: A Retrospective Observational Study”
by Byung-Woo Yoo, Kap-Sung Oh, Junekyu Kim, Hyun-Woo Shin and Kyu-Nam Kim
J. Pers. Med. 2023, 13(2), 329; https://doi.org/10.3390/jpm13020329
Available online: https://www.mdpi.com/2075-4426/13/2/329
4. “Treatment of Complex Wounds with NovoSorb® Biodegradable Temporising Matrix (BTM)—A Retrospective Analysis of Clinical Outcomes”
by Frederik Schlottmann, Doha Obed, Alperen S. Bingöl, Vincent März, Peter M. Vogt and Nicco Krezdorn
J. Pers. Med. 2022, 12(12), 2002; https://doi.org/10.3390/jpm12122002
Available online: https://www.mdpi.com/2075-4426/12/12/2002
5. “Efficacy and Safety of Distal Radial Access for Transcatheter Arterial Chemoembolization (TACE) of the Liver”
by Roberto Minici, Raffaele Serra, Marco Giurdanella, Marisa Talarico, Maria Anna Siciliano, Gianpaolo Carrafiello and Domenico Laganà
J. Pers. Med. 2023, 13(4), 640; https://doi.org/10.3390/jpm13040640
Available online: https://www.mdpi.com/2075-4426/13/4/640
6. “A Randomized Controlled Trial of Three Advanced Wound Dressings in Split-Thickness Skin Grafting Donor Sites—A Personalized Approach?”
by Andrzej Hecker, David Benjamin Lumenta, Petra Brinskelle, Isabelle Sawetz, Andreas Steiner, Birgit Michelitsch, Herwig Friedl, Daniel Gmainer, Lars-Peter Kamolz and Raimund Winter
J. Pers. Med. 2022, 12(9), 1395; https://doi.org/10.3390/jpm12091395
Available online: https://www.mdpi.com/2075-4426/12/9/1395
7. “Efficacy and Safety of Axiostat® Hemostatic Dressing in Aiding Manual Compression Closure of the Femoral Arterial Access Site in Patients Undergoing Endovascular Treatments: A Preliminary Clinical Experience in Two Centers”
by Roberto Minici, Raffaele Serra, Claudio Maglia, Giuseppe Guzzardi, Marco Spinetta, Federico Fontana, Massimo Venturini and Domenico Laganà
J. Pers. Med. 2023, 13(5), 812; https://doi.org/10.3390/jpm13050812
Available online: https://www.mdpi.com/2075-4426/13/5/812
8. “Risk Stratification of Local Flaps and Skin Grafting in Skin Cancer-Related Facial Reconstruction: A Retrospective Single-Center Study of 607 Patients”
by Frederik Penzien Wainer Mamsen, Claes Hannibal Kiilerich, Jørgen Hesselfeldt-Nielsen, Iselin Saltvig, Celine Lund-Nielsen Remvig, Hannah Trøstrup and Volker-Jürgen Schmidt
J. Pers. Med. 2022, 12(12), 2067; https://doi.org/10.3390/jpm12122067
Available online: https://www.mdpi.com/2075-4426/12/12/2067
9. “Comparative Evaluation of Tissue Adhesives and Sutures in the Management of Facial Laceration Wounds in Children”
by Yu-Chi Tsai, Dun-Wei Huang, Yu-Yu Chou, Yu-Chin An, Yung-Sheng Cheng, Po-Huang Chen and Yuan-Sheng Tzeng
J. Pers. Med. 2023, 13(9), 1350; https://doi.org/10.3390/jpm13091350
Available online: https://www.mdpi.com/2075-4426/13/9/1350
10. “Does Electrical Stimulation through Nerve Conduits Improve Peripheral Nerve Regeneration?—A Systematic Review”
by Sophie Hasiba-Pappas, Lars-P. Kamolz, Hanna Luze, Sebastian P. Nischwitz, Judith C. J. Holzer-Geissler, Alexandru Cristian Tuca, Theresa Rienmüller, Mathias Polz, Daniel Ziesel and Raimund Winter
J. Pers. Med. 2023, 13(3), 414; https://doi.org/10.3390/jpm13030414
Available online: https://www.mdpi.com/2075-4426/13/3/414
23 May 2024
Transfer Service in MDPI
We are pleased to announce MDPI’s Transfer Service.
This service provides a convenient method of transferring your manuscript file, along with any reviewer comments, to another journal within our publishing portfolio.
We are committed to helping authors find the right home for their research, and we will provide authors with guidance and technical support through all stages of the transfer process. Authors will be able to choose to transfer in the following two situations:
1. Select alternative journals on submission.
2. Authors are encouraged to transfer manuscripts to other MDPI journals.
More details about the Transfer Service can be found at the following link:
17 May 2024
Tu Youyou Award—Open for Nominations
In acknowledgment of the groundbreaking achievements of Professor Tu Youyou, the Nobel laureate credited with the discovery of artemisinin, MDPI is proud to announce the Tu Youyou Award. This award, inaugurated in 2016, seeks to honor scholars who excel in the fields of natural products chemistry and medicinal chemistry.
Prize:
- CHF 100,000 in total (If there is more than one winner, the prize will be divided equally amongst the winners);
- An award medal for each winner.
Who should be nominated?
- Scientists with outstanding achievements and contributions in the fields of natural products chemistry and medicinal chemistry.
Who can submit a nomination?
- Academic research institutes
- Universities
- Academic societies
Any personal nominations are not accepted.
How do I submit a nomination?
Candidates’ institutional affiliations need to submit their nominations for final candidates to the Tu Youyou Award Team directly by email after internal screening, and each institution can only nominate a maximum of two candidates for each edition of the Tu Youyou Award. Please note that the nominations cannot be modified once they are submitted and confirmed by the Tu Youyou Award Team.
Required nomination materials:
Nomination Form (Download)
Schedule:
Nomination deadline: 31 December 2024;
Winner announcement: 30 April 2025.
Contact:
Tu Youyou Award Team ([email protected])
More information can be found on the Tu Youyou Award official website. For any inquiries, do not hesitate to contact the Tu Youyou Award Team.
16 May 2024
MDPI Romania Author Training Academic Events in April
MDPI Romania sponsored four events over the month of April, contributing author training sessions to each event.
The NutriSciLabs 2024 conference was held at the Carol Davila University of Medicine and Pharmacy on 12 April 2024. Organized by the Association of Students from the Faculty of Pharmacy Studies, the conference aimed to enhance students’ academic writing and research skills, and bolster their confidence in participating in the academic world. Ioana Paunescu, journal relations specialist for MDPI Romania, led the training session. Paunescu first outlined MDPI’s history and core values, then explained academic writing techniques, ethics, and similarity percentages. The presentation covered the entire editorial process, highlighting the amount of attention paid to details throughout manuscript processing. Paunescu also discussed common errors that authors make while writing, and how to avoid such errors.
On 13 April 2024, the NextGEN 2.0 Student Conference took place at the Babes-Bolyai University of Cluj-Napoca. NextGen Healthcare organized this event with the university’s European Students’ Society to discuss European and international current affairs. MDPI Romania contributed an author training session called Steps of the Publication Process. Irina Codruta Zaharia, journal relations specialist, began the session with a general introduction of MDPI before diving into different article types, different layout formats, possible journals to submit to, the MDPI submission checklist, and the MDPI editorial process. By explaining the fundamentals of writing and publishing academic papers, Zaharia imparted valuable industry knowledge to the curious minds present. Participants were eager to engage with Zaharia in the subsequent Q&A session.
Celebrating its 20th anniversary this year, the International Conference “Students for Students” has long been a gathering place for undergraduate and postgraduate students of all nationalities to present their work and exchange ideas with each other. This year’s conference was held on 18 April 2024, with MDPI Romania contributing an author training session called The World of Open Access. Key speakers included Dr. Norbert Kiss from MDPI Romania and Prof. Dragos Horvath from Strasbourg University. Dr. Kiss discussed the history of open access, differences between open access publishing and traditional publishing, and implications for open access in the future. Attendees expressed keen interest in the subject, approaching Dr. Kiss with questions about academic publishing as well as his career trajectory.
Most recently, on 26 April 2024, MDPI Romania sponsored the National Symposium of Students from Geology and Geophysics Faculties. The AAPG Students Chapter at the Babes-Bolyai University organized this event as an opportunity for geology students from all Romanian universities to present their work and confer with other researchers. Dr. Kiss gave his lecture The World of Open Access at this event as well.
MDPI is thankful to all the participants, speakers, and organizers who attended these events. Through their enthusiasm and dedication, these events were great successes.
8 May 2024
Meet Us at the 61st ERA Congress, 23–26 May 2024, Stockholm, Sweden
MDPI will be attending the 61st ERA Congress, which will be held from 23 to 26 May 2024 in Stockholm, Sweden.
The ERA Annual Congress remains committed to advancing the understanding and treatment of kidney disease to improve the well-being of patients. Our aim is to disseminate knowledge with a focus on clinical assessment and treatment, with the overarching theme for this year being “Rethinking Kidney Health and Transforming Kidney Care”. The ERA 2024 will also mark the 60th anniversary of the ERA Registry. Four special sessions (Creative Labs), organized by the ERA Registry group, will provide insight into their expertise and knowledge.
The following MDPI journals will be represented:
If you plan on attending this conference, feel free to stop by our booth. Our delegates look forward to meeting you in person to answer any questions you may have.
For more information about the conference, please visit the following link: https://era-shop.interplan.de/.
2 May 2024
MDPI Insights: The CEO's Letter #11 - 2023 Annual Report, MDPI Awards, STM
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
2023 Annual Report
This is an exciting time of year at MDPI, as we have just released our annual report 2023, recapping the past year and sharing the progress and changes that took place during it.
Stefan Tochev (CEO, MDPI)
Reflecting on 2023, I can't help but think of the changes that have occurred not only at MDPI but also within our industry as a whole. In light of this, I’m reminded that change is the only constant, and that for a publishing enterprise that has experienced rapid growth, adapting to change becomes not only a necessity but also a catalyst for sustained success.
Looking back on the significant ground we covered in 2023, I am pleased to report that the year was marked by a rise in paper submissions, along with a range of initiatives aimed at improving our internal processes and delivering top services to our scientists.
2023 Top-line MDPI Numbers
An important priority for 2023 was to strengthen our editorial policies. Despite a notable increase in the number of papers submitted from 603,000 to 655,000 (+8.6%), there was a decrease in the number of papers published from 303,000 to 285,000 (-5.9%), consistent with the overall trend in the scholarly publishing market. MDPI’s market share in gold open access articles published reached 17% in 2023 (according to Dimensions data).
2023 Open Access Numbers
For over two decades, MDPI has been at the forefront of reshaping the academic publishing landscape, with OA surpassing subscription-based publishing in 2020. This trajectory is deeply rooted in our history and reflects our unwavering commitment to, and vision for, an open future. This momentum continued in 2023, with 39% of the 4.16 million articles and reviews published as gold full-OA, 15% as gold hybrid-OA, 8% as bronze-OA, and 3% as green-OA, relative to 35% behind a paywall. In terms of gold OA (full or hybrid) articles and reviews published, MDPI leads the way in terms of total articles published in 2023.
MDPI is the trusted and preferred OA publisher for the scholarly community
However, in 2023, we saw a downward trend in publication numbers compared to 2022. This trend was also seen in total OA publications. While the number of submissions increased, the decline in MDPI publications can be attributed to several factors, such as improved scrutiny in our peer-review process, including the evaluation of content scope and higher rejection rates, and a post-pandemic decrease in research related to COVID-19 papers.
Download 2023 MDPI Annual Report.
Access 2023 Digital Report.
Impactful Research
Recognizing Scholars – MDPI Awards
MDPI is committed to empowering young researchers as they embark on their careers. In 2023, our journals hosted a total of 400 awards, receiving 8,839 applications and nominations. The evaluation committees selected 959 winners, with the total budget for these awards amounting to CHF 546,500.
For more information about MDPI awards, applications, and winners, please click here
The following awards recognize scholars and the impact of their research, including Young Investigator Awards, Best PhD Thesis Awards, and Travel Awards for junior researchers.
MDPI Awards – The following awards require an application or a nomination.
Young Investigator Award (CHF 1000–2000 for each winner)
This award acknowledges the achievements of young investigators in research areas relevant to the journal’s scope. Candidates must have received their PhD no more than 10 years prior to the award announcement date and must be nominated.
Best PhD Thesis Award (CHF 500–800 for each winner)
This award recognizes young scholars who have completed outstanding PhD theses in research areas relevant to the journal’s scope. It aims to encourage them to continue their excellent work and make further contributions to their field.
Travel Award (CHF 500–800 for each winner)
This award encourages junior scientists to present their latest research at academic conferences relevant to the journal’s scope, thereby increasing their impact.
Distinguished Scholars
Additionally, 220 awards were granted to the most distinguished authors and reviewers in our journals through Best Paper Awards and Outstanding Reviewer Awards. The following awards are selected by the editorial staff of the journal and do not require an application or a nomination. They exemplify the excellent contributions made by our authors, reviewers, and editors.
These awards exemplify the excellent contributions made by our authors, reviewers, and editors
Best Paper Award (CHF 200–500 for each winner)
This award is granted annually to highlight publications of high quality, scientific significance, and extensive influence.
Outstanding Reviewer Award (CHF 500 for partial winners)
This award is given annually to recognize reviewers who generously contribute their time to reviewing papers and demonstrate thoroughness, professionalism, and timeliness in their reviews.
MDPI also offers awards for specific topics in various research fields:
Carbon Neutrality Award (CHF 500–800 for each winner)
Sponsored by MDPI journal Sustainability, this award recognizes applicants who have made exceptional academic or societal contributions to carbon neutrality, either in general or in relation to a specific carbon-neutrality-related issue.
Intelligent Manufacturing Award (CHF 500–800 for each winner)
Administered by MDPI journal Machines, this award is presented to an individual who has made outstanding academic or societal contributions to the field of intelligent manufacturing.
Granted: World Sustainability Awards
Inside MDPI
MDPI Opens Office in Seoul, Korea and Appoints Claude Seo as Office Manager
As CEO of the world’s leading OA publisher, I am pleased to announce the official opening of our Korean branch office. With this addition, MDPI now operates 21 offices in 12 countries worldwide, improving on our position as a truly global publisher. This expansion represents more than just an increase in our physical footprint; it is a pivotal step in our ongoing commitment to making scientific knowledge more accessible across the globe.
MDPI now operates 21 offices in 12 countries worldwide, improving on our position as a truly global publisher
Claude Seo (MDPI Korea Office Manager, Seoul)
Claude Seo, who has over 15 years of experience in the academic publishing industry, has been appointed as the Office Manager of the Seoul office. The launch of our Seoul office allows us to better support the Korean scientific community and to further promote the publication of OA journals in the region.
Reflecting on his role, Claude shared that he is:
“Delighted to have been entrusted with this position within MDPI, the no. 1 scholarly OA publisher. As we establish our presence in Korea, we are dedicated to integrating ourselves into the local community and contributing to its vibrant culture. Our commitment goes beyond business growth; it is about creating a more informed and innovative society by embracing and promoting diversity within the scientific community.”
Sungkyunkwan University Joins MDPI’s Institutional Open Access Program
Additionally, I am pleased to share that Sungkyunkwan University has joined MDPI’s Institutional Open Access Program (IOAP). This program offers free access to MDP’s online submission system for institutions and provides APC discounts to affiliated authors. Thirteen major Korean universities, including Sungkyunkwan University, Kyunghee University, Chung-Ang University, and the Catholic University of Korea, have adopted IOAP in Korea.
Learn more about MDPI’s collaboration in Korea in my previous CEO Letter, in which I recap our visit to Seoul, South Korea.
Coming Together for Science
4th MMCS: Harnessing the Power of New Drug Modalities
Our conference team successfully managed the 4th Molecules Medicinal Chemistry Symposium, held from 24–26 April in Barcelona, Spain. It was chaired by Prof. Dr. Diego Muñoz-Torrero from the Institute of Biomedicine (IBUB), University of Barcelona, Spain, and Prof. Dr. Simona Collina from the University of Pavia, Italy. In total, there were 84 accepted abstracts and 102 conference attendees from 22 different countries.
From left to right: Prof. Dr. Rino Ragno (Scientific Committee), Dr. Maria Emilia Sousa (Scientific Committee), Prof. Dr. Claudio Viegas Jr. (Scientific Committee), Prof. Dr. Simona Collina (Chair), Prof. Dr. Diego Muñoz-Torrero (Chair), Alvina Wu (Managing Editor, MDPI), Prof. Dr. Roman Dembinski (Scientific Committee), Prof. Dr. Mariana Spetea (Scientific Committee).
The event comprised 12 Invited Speakers, 35 Selected Talks, 10 Flash Poster Presentations, and 39 Posters. The overarching topic of the conference was the impact of the emergence of new drug modalities on drug discovery, with thematic sessions covering topics such as photoactivatable drugs, candidates targeting RNA and epigenetic targets, covalent modifiers, and the development of new anti-cancer agents, among other medicinal chemistry projects.
We are pleased to have received feedback from attendees highlighting the professional approach of the conference chairs and participants, the high quality of the talks, and the overall outstanding organization on the part of the MDPI conference team.
Thank you to the conference sponsors, Fluorochem and IBUB, and to our partnering societies, The Spanish Society for Biochemistry and Molecular Biology (SEBBM), and the Spanish Society of Medicinal Chemistry (SEQT).
Upcoming In-Person Event
28–31 May, 2024
Polymers 2024 – Polymers for a Safe and Sustainable Future
Location: Athens, Greece
Conference Chairs: Prof. Dr. Dimitrios Bikiaris, Prof. Dr. Konstantinos Triantafyllidis, Dr. Ioanna Deligkiozi
We look forward to welcoming experts Prof. Damià Barceló, Prof. Minna Hakkareinen, and Prof. Armando J. D. Silvestre to this event.
Find more upcoming MDPI events here.
Organize Your Event with MDPI’s Sciforum
Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.
Closing Thoughts
A Report from the Future – STM US Annual Conference 2024
Stefan Tochev (CEO, MDPI), Dr. Giulia Stefenelli and Dr. Ioana Craciun from MDPI’s Scientific Office Board.
MDPI has for a long time been a sponsor of the STM Annual Conferences, held yearly in the US and Frankfurt, and is a trusted partner and supporter of the STM organization. While I have attended the Frankfurt conference for the past three years, this was my first time visiting the Washington, DC session, and I am glad I did.
Although it was a brief trip, I greatly appreciated the opportunity to attend in the company of my colleagues Dr. Giulia Stefenelli and Dr. Ioana Craciun from MDPI’s Scientific Office Board. They always help map some of the new industry trends against MDPI’s operational framework and guidelines. It’s a great group for kicking ideas back and forth on what we can apply at MDPI.
In my experience, STM never fails to deliver. It’s always a great conference for reconnecting with fellow publishers, industry friends, and vendors. As usual, STM this year curated a diverse range of speakers and panels, who proferred valuable knowledge and insights from outside our industry, delivering thought-provoking insights into our field. An example of this was the ‘Trust Panel’ session, which included Alan Schiffres (Managing Director, InfoLinx), who shared a number of the learnings about fraud and risk management from his 40 years in financial services, to help address some of the challenges we are currently facing in the area of publishing integrity.
Launch of STM Trends 2028 Panel
I particularly enjoyed the ‘Launch of STM Trends 2028 Panel’, which presented a report focused on the integration of humans and machines in scholarly publishing. The session highlighted themes such as AI, digitization, and the evolving research ecosystem. The report envisions a future where technology blurs the lines between human and machine involvement in research processes, with significant implications for trust, reputation, and equity. While this presents opportunities for connectivity and knowledge dissemination, it also poses challenges such as disinformation, fragmentation, and geopolitical tensions. We must rely on a wise combination of technology and human agency to navigate this complex landscape and will have to carefully examine its potential impacts on communication and scholarly publishing.
MDPI has joined the STM Integrity Hub. Click here to learn more.
While every presenter brought their own knowledge and personal touch, I was particularly pleased to encounter new speakers such as Heather Whitney (Research Assistant Professor, Radiology, University of Chicago) and Igor Grossmann (Professor of Psychology, University of Waterloo, Canada). Having studied Sociology at the University of Guelph, I have a soft spot for fellow social scientists from Canada, and I was very impressed by Igor’s presentation on ‘The Social Scientist: A View from the Future’ and his participation in the panel session ‘The Future Beyond the Article,’ which was one of my favourites from the conference, given the diversity of perspectives from the panel speakers.
Memorial Park in Washington, DC
On a personal note, this was my first-time visiting Washington, DC, and I’m glad we took an afternoon to visit the Memorial Park, with its incredible monuments to figures ranging from Martin Luther King, Jr. to Abraham Lincoln. The magnitude of the monuments is deeply impressive. I particularly appreciated the Thomas Jefferson memorial and the following quote, which I think speaks to the importance of change and adaptation. It’s something we can apply not only in our industry but also in our personal lives.
"I am not an advocate for frequent changes in laws and constitutions, but laws and institutions must go hand in hand with the progress of the human mind. As that becomes more developed, more enlightened, as new discoveries are made, new truths discovered and manners and opinions change, with the change of circumstances, institutions must advance also to keep pace with the times. We might as well require a man to wear still the coat which fitted him when a boy as a civilized society to remain ever under the regimen of their barbarous ancestors."
– Excerpted from a letter to Samuel Kercheval, July 12, 1816.
Chief Executive Officer
MDPI AG
30 April 2024
MDPI Opens Office in Seoul, Korea and Appoints Claude Seo as Office Manager
MDPI, the leading Open Access (OA) publisher, announced on Monday that it opened its Korean branch office on 29th April 2024. With this addition, MDPI now operates 21 offices in 12 countries worldwide. Claude Seo, with over 20 years of experience in the academic journal publishing industry, including Nature Publishing Group (NPG), has been appointed as the Office Manager of the Seoul office.
With the establishment of a Seoul office, MDPI aims to actively support Korea scientific communities to further promote the publication of OA journals in the region. As of the end of 2023, Korea ranked sixth worldwide in both submissions and publications of MDPI research papers. MDPI is the number one OA publisher in Korea.
Sungkyunkwan University Joins MDPI’s Institutional Open Access Program
In addition, MDPI announced that Sungkyunkwan University joined MDPI’s Institutional Open Access Program (IOAP). This program offers free access to MDPI online submission system for the institutions and APC discounts to affiliated authors. Thirteen major Korean universities, including Sungkyunkwan University, Kyung Hee University, Chung-Ang University and Catholic University of Korea, have adopted IOAP in Korea.
OA aims to break down barriers that have traditionally restricted access to science, ensuring that knowledge is available to all, regardless of financial situation or institutional affiliations. Authors, academia, and scientific communities are rapidly moving toward OA. MDPI has been at the forefront of reshaping the academic publishing landscape, with OA surpassing subscription-based publishing in 2020.
MDPI CEO Visits Seoul, Korea
In March, Stefan Tochev, Chief Executive Officer (CEO) of MDPI, visited Korea and met with various stakeholders including government agencies, research and academic institutions, universities. During his visit, Stefan highlighted that MDPI continues to pave the way for a world where science is accessible to all, supporting a global community of inclusive innovation and collaborative solutions.
Stefan expressed excitement about the new venture, stating, "Today marks a significant milestone for MDPI as we celebrate the opening of our new office in Seoul, Korea. This expansion is more than just an increase in our physical footprint, it is a pivotal step in our ongoing commitment to making scientific knowledge more accessible, participatory, and inclusive across the globe."
Claude Seo, reflecting on his new role, commented, "I am delighted to have been offered this position of trust within MDPI, the no. 1 scholarly OA publisher. As we establish our presence in Korea, we are dedicated to integrating into the local community and contributing to its vibrant culture. Our commitment goes beyond business growth; it is about creating a more informed and innovative society by embracing and promoting diversity within the scientific community.”
For further inquiries, please contact our Seoul office directly.
About MDPI
A pioneer in scholarly, open access publishing, MDPI has supported academic communities since 1996. MDPI is leading the transition to open science by making more research free and accessible to everyone. Over 3.3 million researchers have entrusted MDPI with publishing their scientific discoveries. MDPI’s editorial process is bolstered by a network of dedicated reviewers, a team of 6000 diligent, well-trained staff members, and an in-house article submission platform that was designed to ensure efficient processes within its 430 fully OA titles.
26 April 2024
Journal of Personalized Medicine | Most Cited Papers about Neurological Disease in 2022–2023
We are pleased to invite you to read the most cited papers in 2022 and 2023 in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) about neurological disease. We hope this announcement will provide useful information for this field.
1. “Artificial Intelligence-Driven Prediction Modeling and Decision Making in Spine Surgery Using Hybrid Machine Learning Models”
by Babak Saravi, Frank Hassel, Sara Ülkümen, Alisia Zink, Veronika Shavlokhova, Sebastien Couillard-Despres, Martin Boeker, Peter Obid and Gernot Michael Lang
J. Pers. Med. 2022, 12(4), 509; https://doi.org/10.3390/jpm12040509
Available online: https://www.mdpi.com/2075-4426/12/4/509
2. “Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases”
by Giulia Gentile, Giovanna Morello, Valentina La Cognata, Maria Guarnaccia, Francesca Luisa Conforti and Sebastiano Cavallaro
J. Pers. Med. 2022, 12(5), 770; https://doi.org/10.3390/jpm12050770
Available online: https://www.mdpi.com/2075-4426/12/5/770
3. “The Contribution of “Individual Participant Data” Meta-Analyses of Psychotherapies for Depression to the Development of Personalized Treatments: A Systematic Review”
by Pim Cuijpers, Marketa Ciharova, Soledad Quero, Clara Miguel, Ellen Driessen, Mathias Harrer, Marianna Purgato, David Ebert and Eirini Karyotaki
J. Pers. Med. 2022, 12(1), 93; https://doi.org/10.3390/jpm12010093
Available online: https://www.mdpi.com/2075-4426/12/1/93
4. “Pathophysiology, Classification and Comorbidities after Traumatic Spinal Cord Injury”
by James Guest, Nilanjana Datta, George Jimsheleishvili and David R. Gater
J. Pers. Med. 2022, 12(7), 1126; https://doi.org/10.3390/jpm12071126
Available online: https://www.mdpi.com/2075-4426/12/7/1126
5. “Should Neurosurgeons Try to Preserve Non-Traditional Brain Networks? A Systematic Review of the Neuroscientific Evidence”
by Nicholas B. Dadario and Michael E. Sughrue
J. Pers. Med. 2022, 12(4), 587; https://doi.org/10.3390/jpm12040587
Available online: https://www.mdpi.com/2075-4426/12/4/587
6. “Diffuse Intrinsic Pontine Glioma: Molecular Landscape, Evolving Treatment Strategies and Emerging Clinical Trials”
by Sudarshawn Damodharan, Montserrat Lara-Velazquez, Brooke Carmen Williamsen, Jeffrey Helgager and Mahua Dey
J. Pers. Med. 2022, 12(5), 840; https://doi.org/10.3390/jpm12050840
Available online: https://www.mdpi.com/2075-4426/12/5/840
7. “Autonomic Dysfunction and Management after Spinal Cord Injury: A Narrative Review”
by Austin M. Henke, Zackery J. Billington and David R. Gater
J. Pers. Med. 2022, 12(7), 1110; https://doi.org/10.3390/jpm12071110
Available online: https://www.mdpi.com/2075-4426/12/7/1110
8. “Microbiome Changes in Humans with Parkinson’s Disease after Photobiomodulation Therapy: A Retrospective Study”
by Brian Bicknell, Ann Liebert, Craig S. McLachlan and Hosen Kiat
J. Pers. Med. 2022, 12(1), 49; https://doi.org/10.3390/jpm12010049
Available online: https://www.mdpi.com/2075-4426/12/1/49
9. “Sex-Related Differences of Matrix Metalloproteinases (MMPs): New Perspectives for These Biomarkers in Cardiovascular and Neurological Diseases”
by Alessandro Trentini, Maria Cristina Manfrinato, Massimiliano Castellazzi and Tiziana Bellini
J. Pers. Med. 2022, 12(8), 1196; https://doi.org/10.3390/jpm12081196
Available online: https://www.mdpi.com/2075-4426/12/8/1196
10. “Post-Stroke Depression and Cognitive Aging: A Multicenter, Prospective Cohort Study”
by Minyoung Shin, Min Kyun Sohn, Jongmin Lee, Deog Young Kim, Yong-Il Shin, Gyung-Jae Oh, Yang-Soo Lee, Min Cheol Joo, So Young Lee, Min-Keun Song et al.
J. Pers. Med. 2022, 12(3), 389; https://doi.org/10.3390/jpm12030389
Available online: https://www.mdpi.com/2075-4426/12/3/389
11. “Status of ALS Treatment, Insights into Therapeutic Challenges and Dilemmas”
by Mohammed Khamaysa and Pierre-François Pradat
J. Pers. Med. 2022, 12(10), 1601; https://doi.org/10.3390/jpm12101601
Available online: https://www.mdpi.com/2075-4426/12/10/1601
12. “The Role of BDNF as a Biomarker in Cognitive and Sensory Neurodegeneration
by Anna Pisani, Fabiola Paciello, Valeria Del Vecchio, Rita Malesci, Eugenio De Corso, Elena Cantone and Anna Rita Fetoni
J. Pers. Med. 2023, 13(4), 652; https://doi.org/10.3390/jpm13040652
Available online: https://www.mdpi.com/2075-4426/13/4/652
13. “Investigating the Role of Maintenance TMS Protocols for Major Depression: Systematic Review and Future Perspectives for Personalized Interventions”
by Giacomo d’Andrea, Gianluca Mancusi, Maria Chiara Santovito, Carlotta Marrangone, Fabrizio Martino, Mario Santorelli, Andrea Miuli, Francesco Di Carlo, Maria Salvina Signorelli, Massimo Clerici et al.
J. Pers. Med. 2023, 13(4), 697; https://doi.org/10.3390/jpm13040697
Available online: https://www.mdpi.com/2075-4426/13/4/697
14. “Prognostic Value of Malondialdehyde (MDA) in the Temporal Progression of Chronic Spinal Cord Injury”
by Sergio Haro Girón, Jorge Monserrat Sanz, Miguel A. Ortega, Cielo Garcia-Montero, Oscar Fraile-Martínez, Ana M. Gómez-Lahoz, Diego Liviu Boaru, Diego de Leon-Oliva, Luis G. Guijarro, Mar Atienza-Perez et al.
J. Pers. Med. 2023, 13(4), 626; https://doi.org/10.3390/jpm13040626
Available online: https://www.mdpi.com/2075-4426/13/4/626
15. “Age and Sex-Related Effects on Single-Subject Gray Matter Networks in Healthy Participants”
by Yoko Shigemoto, Noriko Sato, Norihide Maikusa, Daichi Sone, Miho Ota, Yukio Kimura, Emiko Chiba, Kyoji Okita, Tensho Yamao, Moto Nakaya et al.
J. Pers. Med. 2023, 13(3), 419; https://doi.org/10.3390/jpm13030419
Available online: https://www.mdpi.com/2075-4426/13/3/419
23 April 2024
Journal of Personalized Medicine | Most Viewed Papers in 2022–2023 in the Section “Personalized Critical Care”
We are pleased to invite you to read the most viewed papers in 2022 and 2023 in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) in the Section “Personalized Critical Care”. The list of papers is as follows:
by Victoriţa Şorodoc, Andreea Asaftei, Gabriela Puha, Alexandr Ceasovschih, Cătălina Lionte, Oana Sîrbu, Cristina Bologa, Raluca Ecaterina Haliga, Mihai Constantin, Adorata Elena Coman et al.
J. Pers. Med. 2023, 13(1), 140; https://doi.org/10.3390/jpm13010140
Available online: https://www.mdpi.com/2075-4426/13/1/140
2. “Non-Pharmacological Nursing Interventions to Prevent Delirium in ICU Patients—An Umbrella Review with Implications for Evidence-Based Practice”
by Sandra Lange, Wioletta Mędrzycka-Dąbrowska, Adriano Friganovic, Ber Oomen and Sabina Krupa
J. Pers. Med. 2022, 12(5), 760; https://doi.org/10.3390/jpm12050760
Available online: https://www.mdpi.com/2075-4426/12/5/760
3. “Broad Electrocardiogram Syndromes Spectrum: From Common Emergencies to Particular Electrical Heart Disorders”
by Anastasia Balta, Alexandr Ceasovschih, Victorița Șorodoc, Kyriakos Dimitriadis, Sara Güzel, Cătălina Lionte, Cristian Stătescu, Radu Andy Sascău, Emmanouil Mantzouranis, Athanasios Sakalidis et al.
J. Pers. Med. 2022, 12(11), 1754; https://doi.org/10.3390/jpm12111754
Available online: https://www.mdpi.com/2075-4426/12/11/1754
4. “Nurses’ Practices in the Peripheral Intravenous Catheterization of Adult Oncology Patients: A Mix-Method Study”
by Paulo Santos-Costa, Filipe Paiva-Santos, Liliana B. Sousa, Rafael A. Bernardes, Filipa Ventura, William David Fearnley, Anabela Salgueiro-Oliveira, Pedro Parreira, Margarida Vieira and João Graveto
J. Pers. Med. 2022, 12(2), 151; https://doi.org/10.3390/jpm12020151
Available online: https://www.mdpi.com/2075-4426/12/2/151
5. “Elements of Sleep Breathing and Sleep-Deprivation Physiology in the Context of Athletic Performance”
by Dimitra D. Papanikolaou, Kyriaki Astara, George D. Vavougios, Zoe Daniil, Konstantinos I. Gourgoulianis and Vasileios T. Stavrou
J. Pers. Med. 2022, 12(3), 383; https://doi.org/10.3390/jpm12030383
Available online: https://www.mdpi.com/2075-4426/12/3/383
6. “Dental and Skeletal Side Effects of Oral Appliances Used for the Treatment of Obstructive Sleep Apnea and Snoring in Adult Patients—A Systematic Review and Meta-Analysis”
by Ioannis A. Tsolakis, Juan Martin Palomo, Stefanos Matthaios and Apostolos I. Tsolakis
J. Pers. Med. 2022, 12(3), 483; https://doi.org/10.3390/jpm12030483
Available online: https://www.mdpi.com/2075-4426/12/3/483
7. “Biomarkers as Prognostic Predictors and Therapeutic Guide in Critically Ill Patients: Clinical Evidence”
by Rosa Méndez Hernández and Fernando Ramasco Rueda
J. Pers. Med. 2023, 13(2), 333; https://doi.org/10.3390/jpm13020333
Available online: https://www.mdpi.com/2075-4426/13/2/333
8. “Can Opioid-Free Anaesthesia Be Personalised? A Narrative Review”
by Jenna Goff, Morgan Hina, Nayaab Malik, Hannah McLardy, Finley Reilly, Matthew Robertson, Louis Ruddy, Faith Willox and Patrice Forget
J. Pers. Med. 2023, 13(3), 500; https://doi.org/10.3390/jpm13030500
Available online: https://www.mdpi.com/2075-4426/13/3/500
9. “The Effect of Interventions on Preventing Musculoskeletal Injuries Related to Nurses Work: Systematic Review”
by Armando David Sousa, Cristina Lavareda Baixinho, Maria Helena Presado and Maria Adriana Henriques
J. Pers. Med. 2023, 13(2), 185; https://doi.org/10.3390/jpm13020185
Available online: https://www.mdpi.com/2075-4426/13/2/185
10. “Medical/Surgical, Cloth and FFP/(K)N95 Masks: Unmasking Preference, SARS-CoV-2 Transmissibility and Respiratory Side Effects”
by Dimitra S. Mouliou, Ioannis Pantazopoulos and Konstantinos I. Gourgoulianis
J. Pers. Med. 2022, 12(3), 325; https://doi.org/10.3390/jpm12030325
Available online: https://www.mdpi.com/2075-4426/12/3/325
8 April 2024
Meet Us at the 2024 ASCO Annual Meeting, 31 May–4 June 2024, Chicago, IL, USA
The 2024 ASCO Annual Meeting will take you to discover state-of-the-art research, groundbreaking treatments, and visionary insights, igniting your passion for oncology. This year's program will feature over 200 sessions, complementing Dr. Lynn Schuchter’s Presidential theme “The Art and Science of Cancer Care: From Comfort to Cure”.
The following MDPI journals will be represented:
- Cancers;
- JPM;
- Pharmaceutics;
- Healthcare;
- JCM;
- CIMB;
- Medical Sciences;
- Clinics and Practice;
- Onco;
- Current Oncology;
- Dermato;
- Pharmacy;
- Biomedicines;
- Diseases;
- Immuno;
- Biologics;
- Vaccines;
- Diagnostics;
- Hemato;
- Venereology.
If you are attending this conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you in person at the booth at the conference and answering any questions you may have. For more information regarding the conference, please visit the following link: https://conferences.asco.org/am/attend.
2 April 2024
MDPI Insights: The CEO's Letter #10 - South Korea, IWD, U2A, Japan
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Left to right: Dr. Jisuk Kang (Scientific Officer, MDPI), Stefan Tochev (CEO, MDPI), and Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI), during media meetings at Prain Agency office in Seoul, South Korea.
Visit to Seoul, South Korea
During my recent visit to South Korea, I had the privilege of meeting various stakeholders, including representatives of government, research institutions, and academia, to understand their needs and communicate MDPI’s commitment to accessible science. Accompanied by my colleagues Dr. Giulia Stefenelli and Dr. Jisuk Kang, I engaged with the Korean scientific community, which is increasingly embracing open access (OA).
As the leading OA publisher in South Korea, MDPI is trusted by local authors and in 2023 enjoyed an approximately 30% share of the OA market. South Korea ranks sixth globally for MDPI in terms of research papers submitted and published.
MDPI and South Korea by Numbers
As at 30 March, over 76,000 MDPI articles have been authored by individuals affiliated with Korean institutions. We have over 1,800 active editorial board members (EBMs) from South Korea, with more than 880 EBMs having an H-index between 26 and 50, including 10 serving as Chief Editors.
“South Korea is the sixth-largest contributor to our total publications”
Over the past five years (2019–2023), nearly 120,000 authors affiliated with South Korean institutes have published with MDPI. Specifically in 2023, we received approximately 25,000 submissions from South Korean authors, publishing close to 13,000 articles, resulting in a rejection rate of 47.4%, which is not far below MDPI’s overall rejection rate of 56.4% in 2023.
Institutional Partnerships with South Korea
I am pleased to share that MDPI has more than 825 institutional partnerships worldwide, with 12 in South Korea, including Kyunghee University, Chung-Ang University, and Inha University, among others.
Left to right: Dr. Jisuk Kang (Scientific Officer, MDPI), Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI), and Stefan Tochev (CEO, MDPI) fielding media questions at Prain PR Agency office in Seoul, South Korea.
Over the past three years (2021–2023), we have had some of the most prestigious academic universities ranked among the top 10 Korean institutions publishing with MDPI. Seoul National University had the highest number of publications with MDPI during those three years, publishing nearly 6,000 papers. Universities such as Korea University and Yonsei University also rank among the top 10 Korean institutions publishing with MDPI.
MDPI Hosts Seminar for Academia and Media
As the world’s leading OA publisher, MDPI is actively democratizing science. This is reflected in the seminars we hosted on 21 March to address questions about our editorial processes and ethical standards. The visit garnered media coverage, reflecting our mission to providing high-quality services and fostering open dialogue in the community.
“MDPI is actively democratizing science”
MDPI in the News
Stefan Tochev (CEO, MDPI) leading a seminar on OA and MDPI at Prain PR Agency office in Seoul, South Korea.
Media coverage generated by our visit to Seoul included the following stories:
“Open access is an unstoppable trend…it will lead the development of the knowledge ecosystem.”
I greatly appreciate the contributions of everyone who took the time to meet with us, share their stories, and hold us accountable for continuing to provide high-quality publishing services while identifying areas for improvement. I am also excited to announce that we have opened an MDPI office in Seoul and will release a press release on MDPI.com, with details, by the end April 2024. The purpose of the office is to establish a local presence to connect with and support the South Korean academic community through institutional partnerships, conferences, author workshops, stakeholder communications, and more.
Impactful Research
Featured Articles on Women’s Leadership and Healthcare
In celebration of International Women’s Day (8 March 2024), MDPI curated a collection of research articles on various topics, including women’s leadership, reproductive health, preventive healthcare, and a selection of articles from our journal Women.
Women’s Leadership
- Women Entrepreneurship and Sustainable Development: Bibliometric Analysis and Emerging Research Trends
Sustainability 2022, 14, 9160. https://doi.org/10.3390/su14159160 - Refugee Women Business Mentors: New Evidence for Women’s Empowerment
Sustainability 2022, 14, 9154. https://doi.org/10.3390/su14159154 - Women and Leadership in Higher Education: A Systematic Review
Soc. Sci. 2023, 12, 555. https://doi.org/10.3390/socsci12100555 - Understanding Needs and Potentials for Gender-Balanced Empowerment and Leadership in Climate Change Adaptation and Mitigation in Africa
Sustainability 2022, 14, 9410. https://doi.org/10.3390/su14159410 - Challenges Women Experience in Leadership Careers: An Integrative Review
Merits 2023, 3, 366-389. https://doi.org/10.3390/merits3020021
Women’s Reproductive Health
- Recreational Female Athletes’ Understanding of and Perceived Impact of the Menstrual Cycle on Physical Performance, Mood, and Sleeping Behaviour
Women 2023, 3, 445-456. https://doi.org/10.3390/women3030034 - Difficulties in Adaptation of the Mother and Newborn via Cesarean Section versus Natural Birth—A Narrative Review
Life 2023, 13, 300. https://doi.org/10.3390/life13020300 - The Main Theories on the Pathogenesis of Endometriosis
Int. J. Mol. Sci. 2023, 24, 4254. https://doi.org/10.3390/ijms24054254
Women’s Preventive Healthcare
- Insulin Metabolism in Polycystic Ovary Syndrome: Secretion, Signaling, and Clearance
Int. J. Mol. Sci. 2023, 24, 3140. https://doi.org/10.3390/ijms24043140 - Assessing Barriers Encountered by Women in Cervical Cancer Screening and Follow-Up Care in Urban Bolivia, Cochabamba
Healthcare 2022, 10, 1604. https://doi.org/10.3390/healthcare10091604 - Updates on HPV Vaccination
Diagnostics 2023, 13, 243. https://doi.org/10.3390/diagnostics13020243
Featured Articles in MDPI Journal Women
Below are a few articles from Women, our journal focused on women’s health, the social determinants of health, and the healthcare system that serves women. The aim of Women is to encourage academics to publish their experimental and theoretical results in detail, to aid reproducibility, and in an engaging style, to aid comprehensibility.
- Premenstrual Syndrome and Exercise: A Narrative Review
Women 2023, 3, 348-364. https://doi.org/10.3390/women3020026 - Increasing Awareness of the Human Papillomavirus (HPV) Vaccine for Women 18–45 Years of Age
Women 2023, 3, 365-373. https://doi.org/10.3390/women3030027 - Addressing Women’s Needs with Human Immunodeficiency Virus (HIV) and Enhancing the Visibility of Pharmacists in the Public Health Arena
Women 2022, 2, 346-352. https://doi.org/10.3390/women2040032
Inside MDPI
Championing Women’s Healthcare and Access to Healthcare Information
MDPI colleagues from our offices joined in celebrating #IWD2024. In doing so, we emphasized key missions that encompass:
- Empowering women to assume leadership and decision-making roles in both business and science.
- Helping women and girls make informed decisions about their health.
- Recruiting and developing female talent and fostering inclusive workplace environments.
“We are thrilled to recognize the accomplishments of women scientists”
I am proud to see our colleagues enthusiastically supporting the International Women’s Day call to ‘Inspire Inclusion!’ The heart-hands in the collage below symbolize our appreciation of the achievements of women researchers and the recognition of the trailblazers who have courageously made a mark on societies past and present.
We are thrilled to recognize the accomplishments of women scientists through our many MDPI awards and by highlighting success stories. As inspirational figures, female scientists are paving the way for the next generation of women aspiring to pursue careers in engineering, life sciences, computing, and various other STEM fields.
“I consider myself lucky because I work with incredibly talented women who inspire me every day.”
– Dr. Alessandra Pasut, Winner of MDPI's ‘Biology 2023 Young Investigator Award’
“It’s really important to find a supportive and enabling environment in which to do your science; it would have a big impact on you as a person and on your scientific outputs.”
– Dr. Rhea Longley, Winner of the ‘Pathogens 2023 Young Investigator Award’
Open-access publishing, in particular, allows early-career women researchers to share their work more widely, potentially attracting mentorship opportunities and collaborations. This support is crucial for career development and advancement.
Coming Together for Science
MDPI Joins United2Act in Collective Fight to Stop Paper Mills
In my February 2024 CEO Letter, I highlighted some of our recent initiatives aimed at bolstering our commitment to research integrity, including joining the STM Integrity Hub and expanding our Research Integrity and Publication Ethics team (RIPE). Continuing our efforts in coming together for science, I am pleased to share our participation in the United2Act initiative.
The text below is taken from our official announcement:
United2Act represents an international group of stakeholders in the publishing industry committed to addressing the collective challenge posed to research integrity by paper mills.
Scientists and academic publishers have increasingly noted the alarming proliferation of paper mills, recognized as fraudulent entities seeking to manipulate the publication process for financial profit. These entities engage in fraudulent practices such as falsifying or fabricating data, selling co-authorship of fake papers, manipulating peer review, and including inappropriate citations. These actions pose a significant threat to the integrity of the scholarly record, prompting widespread concern among those involved in the academic community.
MDPI has been actively contributing to combat the undermining of the scientific record. Our editors employ a set of tools to detect potential ethical breaches within a manuscript and to tackle the issue of fake papers.
United2Act’s consensus statement is the outcome of a virtual summit held in May 2023. It involved the participation of research bodies, publishers, researchers/sleuths, universities, and publishing infrastructure from 15 countries and resulted in a Consensus Statement outlining five key areas of action for all stakeholders:
- Education and awareness
- Improve post-publication corrections
- Facilitate and organise research on paper mills
- Enable the development of trust markers
- Facilitate dialogue between stakeholders
MDPI is committed to promoting transparency and integrity in scholarly publishing and is continuing to work closely with the scientific community toward this goal.
Closing Thoughts
Left to right: Ryo Hirayama (Marketing Specialist, MDPI), Takashi Sasabe (Marketing Specialist, MDPI), Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI), Dr. Izumi Yamamoto (Marketing Manager, MDPI), and Stefan Tochev (CEO, MDPI), at MDPI’s office in Tokyo, Japan.
Visit to Tokyo and Kyoto, Japan
In March, I had the opportunity to visit our Tokyo office and engage with stakeholders in Tokyo and Kyoto. During the visit, I also recorded a video message to welcome Japanese scholars working with MDPI and to highlight our operations in Japan.
We held meetings with Editors-in-Chief, librarians, scholars, and external consultants to gather feedback on our efforts to enhance our reputation and explore additional steps we can take in that direction. Japan's rich cultural heritage, characterized by tradition, respect, and formality, provided valuable insights into meeting the publishing needs specific to Japan.
Japan’s Open Access statistics
Over the years, we have seen a shift from subscription-only to gold OA publishing in Japan, despite the lack of an official mandate. Here are some statistics:
- 2012: 68% of articles were subscription-only, 6% were green Open Access, and 8% were gold Open Access.
- 2016: 55% of articles were subscription-only, 6% were green Open Access, and 20% were gold Open Access.
- 2022: 43% of articles were subscription-only, 7% were green Open Access, and 39% were gold Open Access.
To learn more about the history of OA in Japan as well as about future trends, please read this blog post.
“Japan is the ninth-largest contributor to our total publications”
Left to right: Stefan Tochev (CEO, MDPI), Dr. Izumi Yamamoto (Marketing Manager, MDPI), and Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI) visiting Kyoto University in Kyoto, Japan.
MDPI and Japan by Numbers
As at 1 April, over 50,000 MDPI articles have been authored by scholars affiliated with Japanese institutions, making the country the ninth-largest contributor to our total publications. Over the past three years (2020–2023), nearly 90,000 authors affiliated with Japanese institutes have published with MDPI, and we have collaborated with over 4,600 Guest Editors from Japan.
In 2023, we published over 8,200 papers from authors associated with Japanese institutions. MDPI collaborates with 41 institutional partnerships in Japan, including the University of Tokyo, Hokkaido University, and Nagoya University. We have over 2,100 active EBMs from Japan, more than 1,050 EBMs having an H-index between 26 and 50, including 13 serving as Editors-in-Chief.
General Feedback – a side note
A general takeaway from our discussions with stakeholders from around the world is that negative perceptions of MDPI often stem from misinformation, misconceptions, or misunderstandings about MDPI and our practices. While we acknowledge our mistakes and work diligently to address them, maintaining a strong editorial procedure and robust peer-review process, I find that educating stakeholders about our how we do what we do and our ongoing improvements tends to help shift opinions.
That said, we recognize the importance of addressing individual concerns. We take feedback seriously and are continuously working to get better while not compromising the core principles that millions of authors appreciate about MDPI.
Chief Executive Officer
MDPI AG
29 March 2024
Journal of Personalized Medicine | Greetings from the Editor-in-Chief
On behalf of the Editorial Office and Editorial Board of the Journal of Personalized Medicine (JPM, ISSN: 2075-4426), the Editor-in-Chief, Prof. Dr. David Alan Rizzieri, invites you to reflect on the journal's development and endeavors in 2023, as well as its expectations for 2024. We would like to express our most sincere gratitude to all scholars!
We look forward to working more closely with all scholars in 2024 and to witnessing a brilliant future for the journal together!
26 March 2024
Journal of Personalized Medicine | Highly Cited Special Issues about Respiratory Disease in 2022–2023
We are pleased to invite you to read the highly cited Special Issues in 2022–2023 in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) about respiratory disease. We hope that this announcement will provide useful information for this field.
The Special Issues list is as follows:
“Asthma: From Phenotypes to Personalized Medicine” |
“Personalized Therapy of Asthma” |
“Challenges in COVID-19 and Related Complications” |
“Clinical Presentation, Treatment and Vaccination in COVID-19” |
You are welcome to view all the Special Issues and submit relevant papers to the Journal of Personalized Medicine. If you have any questions, you can contact the JPM Editorial Office.
Journal of Personalized Medicine Editorial Office
23 March 2024
Journal of Personalized Medicine | Most Cited Papers in 2022–2023 in the Section “Epidemiology”
We are pleased to invite you to read the most cited papers in 2022–2023 in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) in the Section “Epidemiology”. The list of papers is as follows:
1. “Oral Health among Elderly, Impact on Life Quality, Access of Elderly Patients to Oral Health Services and Methods to Improve Oral Health: A Narrative Review”
by Michael Janto, Raluca Iurcov, Cristian Marius Daina, Daniela Carmen Neculoiu, Alina Cristiana Venter, Dana Badau, Adrian Cotovanu, Marcel Negrau, Corina Lacramioara Suteu, Monica Sabau et al.
J. Pers. Med. 2022, 12(3), 372; https://doi.org/10.3390/jpm12030372
Available online: https://www.mdpi.com/2075-4426/12/3/372
2. “Cognitive Impairment after Post-Acute COVID-19 Infection: A Systematic Review of the Literature”
by Andrea Perrottelli, Noemi Sansone, Giulia Maria Giordano, Edoardo Caporusso, Luigi Giuliani, Antonio Melillo, Pasquale Pezzella, Paola Bucci, Armida Mucci and Silvana Galderisi
J. Pers. Med. 2022, 12(12), 2070; https://doi.org/10.3390/jpm12122070
Available online: https://www.mdpi.com/2075-4426/12/12/2070
3. “MicroRNAs—A Promising Tool for Asthma Diagnosis and Severity Assessment: A Systematic Review”
by Mohammed Aref Kyyaly, Elena Vladimirovna Vorobeva, Dilini M. Kothalawala, Wei Chern Gavin Fong, Peijun He, Collin L. Sones, Mohammad Al-Zahrani, Tilman Sanchez-Elsner, Syed Hasan Arshad and Ramesh J. Kurukulaaratchy
J. Pers. Med. 2022, 12(4), 543; https://doi.org/10.3390/jpm12040543
Available online: https://www.mdpi.com/2075-4426/12/4/543
4. “Prevalence of New-Onset Atrial Fibrillation and Associated Outcomes in Patients with Sepsis: A Systematic Review and Meta-Analysis”
by Bernadette Corica, Giulio Francesco Romiti, Stefania Basili and Marco Proietti
J. Pers. Med. 2022, 12(4), 547; https://doi.org/10.3390/jpm12040547
Available online: https://www.mdpi.com/2075-4426/12/4/547
5. “Resistin and IL-15 as Predictors of Invasive Mechanical Ventilation in COVID-19 Pneumonia Irrespective of the Presence of Obesity and Metabolic Syndrome”
by Carles Perpiñan, Laia Bertran, Ximena Terra, Carmen Aguilar, Jessica Binetti, Miguel Lopez-Dupla, Anna Rull, Laia Reverté, Elena Yeregui, Frederic Gómez-Bertomeu et al.
J. Pers. Med. 2022, 12(3), 391; https://doi.org/10.3390/jpm12030391
Available online: https://www.mdpi.com/2075-4426/12/3/391
6. “Neutralization Assessments Reveal High Cardiothoracic Ratio and Old Age as Independent Predictors of Low Neutralizing Antibody Titers in Hemodialysis Patients Receiving a Single Dose of COVID-19 Vaccine”
by Chun-Yu Chen, Kuan-Ting Liu, Shin-Ru Shih, Jung-Jr Ye, Yih-Ting Chen, Heng-Chih Pan, Heng-Jung Hsu, Chiao-Yin Sun, Chin-Chan Lee, Chun-Ying Wu et al.
J. Pers. Med. 2022, 12(1), 68; https://doi.org/10.3390/jpm12010068
Available online: https://www.mdpi.com/2075-4426/12/1/68
7. “Impact of Smoking Status on Lung Cancer Characteristics and Mortality Rates between Screened and Non-Screened Lung Cancer Cohorts: Real-World Knowledge Translation and Education”
by Fu-Zong Wu, Yun-Ju Wu, Chi-Shen Chen and Shu-Ching Yang
J. Pers. Med. 2022, 12(1), 26; https://doi.org/10.3390/jpm12010026
Available online: https://www.mdpi.com/2075-4426/12/1/26
8. “Antidepressants Drug Use during COVID-19 Waves in the Tuscan General Population: An Interrupted Time-Series Analysis”
by Ippazio Cosimo Antonazzo, Carla Fornari, Sandy Maumus-Robert, Eleonora Cei, Olga Paoletti, Pietro Ferrara, Sara Conti, Paolo Angelo Cortesi, Lorenzo Giovanni Mantovani, Rosa Gini et al.
J. Pers. Med. 2022, 12(2), 178; https://doi.org/10.3390/jpm12020178
Available online: https://www.mdpi.com/2075-4426/12/2/178
9. “COVID-19 Vaccines during Pregnancy and Breastfeeding: A Systematic Review”
by Blanca Novillo and Alicia Martínez-Varea
J. Pers. Med. 2023, 13(1), 40; https://doi.org/10.3390/jpm13010040
Available online: https://www.mdpi.com/2075-4426/13/1/40
10. “Changes in the Incidence Rates of Gastrointestinal Diseases Due to the COVID-19 Pandemic in South Korea: A Long-Term Perspective”
by Hyo Geun Choi, Ho Suk Kang, Hyun Lim, Joo-Hee Kim, Ji Hee Kim, Seong-Jin Cho, Eun Sook Nam, Kyueng-Whan Min, Ha Young Park, Nan Young Kim et al.
J. Pers. Med. 2022, 12(7), 1144; https://doi.org/10.3390/jpm12071144
Available online: https://www.mdpi.com/2075-4426/12/7/1144
4 March 2024
MDPI Insights: The CEO's Letter #9 - Romania, Research Integrity, Viruses
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Reka Kovacs (Deputy Office Manager, MDPI), Stefan Tochev (CEO, MDPI), and Sandra Ana Spatariu (Office Manager, MDPI) at the MDPI office in Cluj, Romania.
MDPI’s Impact on Romania
In February, I visited our office in Cluj, Romania. I worked closely with our senior office managers and various teams, including the departments of training, marketing and conferences, as well as our journal relationship specialists, reviewing our service to the local scholarly community. During the visit, I also met with representatives from Babes-Bolyai University and the Technical University of Cluj-Napoca. Our multifunctional Romanian office plays an important role in supporting our collaborations with the local market as well as helping to meet MDPI’s overall business needs.
Feedback and strategy meeting with a group of MDPI’s Journal Relationship Specialists at the MDPI office in Cluj, Romania.
With 22,436 articles, Romania ranks as a top 20 contributing country to MDPI’s total number of papers published as at 28 February 2024. This highlights the importance of our collaboration with Romanian-affiliated authors and the growing opportunity to support their publishing needs. MDPI is one of the few academic publishers with a significant presence in Romania, boasting over 360 colleagues across our offices in Bucharest and Cluj. We are also proud to hire colleagues from local institutions to launch their careers within publishing.
Romania ranks as a top 20 contributing country.
The Numbers: 2019–2023
MDPI has seen a healthy increase in submissions from Romanian authors over the past three years, from 8,439 in 2021 to 11,866 by end of 2023, with most submissions going to journals such as Sustainability, Medicina, Diagnostics, IJMS, Applied Sciences, and JCM. From 2019 to 2023, MDPI published articles from 32,145 authors affiliated with Romanian institutions. Over those years, we have worked with Romanian Guest Editors on nearly 3,000 occasions to support their Special Issue and Topical collections.
With more than 300 Editorial Board Members from Romania, 34 appear on the board of Mathematics, 27 on Materials, 19 on Polymers, 18 on Coatings, and 16 on Molecules, while three serve as Section Editors-in-Chief (SEiC) on our journals Coatings (3.4 IF, 4.6 Citescore), Magnetochemistry (2.7 IF, 3.5 Citescore), and Chemosensors (4.2 IF, 3.9 Citescore).
Institutional Open Access Programs
Our commitment to working with institutions is evident in Romania, where we have established eight Institutional Open Access Programs (IOAP) with esteemed institutions such as the University of Bucharest, the University of Medicine and Pharmacy Cluj-Napoca, and most recently the National Institute for Laser, Plasma and Radiation Physics.
Our growth and presence in Romania are a true testament.
We also have IOAP agreements with Babes-Bolyai University and the Technical University of Cluj-Napoca, where I had the opportunity to meet senior stakeholders during my visit. Below are a few photos capturing our meeting with Prof. Radu Silaghi-Dumitrescu (Head of Faculty of Chemistry, Babes-Bolyai University) at the MDPI office in Cluj, Romania, along with a photo from our meeting with Vice Deans Nicoleta Cobarzan, Nicoleta Ilies, and Hoda Gavril, from the faculty of Civil Engineering at the Technical University of Cluj, Romania.
Our growth and presence in Romania are a true testament to the service we provide to the scholarly community and the relationships we foster in that region. We look forward to continuing to support Romanian scholars and institutions by providing a valuable and trusted experience with MDPI, the leader in open access publishing.
Impactful Research
MDPI Joins the STM Integrity Hub
MDPI has long been a supporter and partner of STM, with our involvement ranging from sponsoring and attending events to helping organize event programs. By joining the STM Integrity Hub, we aim to further our commitment to STM initiatives aimed at safeguarding the integrity of science.
“We are pleased to welcome MDPI as the 35th organisation participating in the Hub. This expansion is critical, as every new member enhances our capacity to prevent fraudulent submissions from entering the academic record.”
Joris van Rossum, Director of Research Integrity, STM
MDPI operates in full alignment with STM Integrity Hub's values of shared data and experiences. We strongly believe in collaboration and open exchange for the purposes of creating a holistic approach to support research integrity at MDPI itself and across the entire academic publishing industry. The Integrity Hub is an excellent example of how publishers can come together to jointly address industry-wide challenges related to research integrity, such as manuscripts that breach research integrity standards and paper-mills.
I look forward to our Research Integrity and Publication Ethics Team (RIPE) team immersing themselves in this initiative, exchanging information, best practices, and tools for the benefit of the entire scholarly ecosystem. We believe that ethical publishing standards should be implemented across the board, and we aim to be rigorous in our approach, addressing research integrity issues and improving the impact of published research.
Inside MDPI
MDPI Expands Research Integrity and Publication Ethics Team (RIPE)
In addition to external collaborations and joint initiatives aimed at further strengthening our commitment to research integrity, we are also enhancing our internal efforts. This includes improving our processes and guidelines and expanding our teams and departments to ensure quality assurance throughout our publishing process.
We are pleased to announce the expansion of our Research Integrity and Publication Ethics Team (RIPE) at MDPI. The RIPE team has recently welcomed new colleagues, each bringing unique skills and a personal commitment to prioritize ethical considerations in all our work.
The demand for research integrity and high ethical standards in academic publishing is steadily rising across our industry. Our expanded RIPE team will work to enhance and align our practices with industry best practices, ensuring excellence in research integrity and publication ethics.
Stefan Tochev (CEO, MDPI) introduces Dr. Tim Tait-Jamieson (Research Integrity Lead, MDPI) for his presentation on MDPI’s Retraction and Approval Process to a group of Journal Relationship Specialists at the MDPI office in Cluj, Romania: “The demand for research integrity and publication ethics is steadily rising across our industry.”
Introducing our Research Integrity and Publication Ethics Team
Led by Dr. Tim Tait-Jamieson (Research Integrity Lead), the RIPE team comprises Dr. Ivana Resanovic (Research Integrity Manager), Dr. Lavinia Rogojina (Research Integrity Manager), Ms. Diana Apodaritei (Research Integrity Specialist), Dr. Zoltan Mihaly (Research Integrity Specialist), Mr. Aleksandar Đukić (Research Integrity Specialist), Ms. Ana Stankovic (Research Integrity Specialist), and Ms. Anna Pena (Publication Ethics Assistant).
Please click here to access everything that you need to know about MDPI’s Research and Publication Ethics.
With this span of complementary roles, the RIPE team collaborates directly with journal editorial teams and works closely with various departments, including our Scientific Office Board and our Journal Relationship Specialists. The team’s primary objectives are to help prevent issues regarding research integrity and publication ethics during peer review, uphold MDPI’s ethics policies, adhere to industry standards, and resolve publication ethics and research integrity issues and complaints.
Quality Updates to Special Issues Oversight
At MDPI, we are committed to reviewing policies pertaining to the quality of research. In this blog post, Shaheena Patel (Communications Associate, MDPI), outlines two recent updates to MDPI journal processes. These updates pertain to Special Issue (SI) quality guidelines, in line with criteria provided by COPE and DOAJ. Alongside the SI updates, details regarding the new minor corrections policy introduced in 2024 are provided in the blog.
The two updates we implemented include greater oversight and the verification of Guest Editor credentials. These guidelines require that Editors-in-Chief (EiCs) and Editorial Board Members (EBMs) take responsibility for overseeing SIs.
PS. Thank you, James Butcher, for featuring this up in your 67th issue of the Journalogy newsletter.
Read more:
Coming Together for Science
Viruses 2024 – A World of Viruses
I am pleased to share the success of our MDPI conference Viruses 2024 – A World of Viruses, held 14-16 February, in Barcelona. With 240 registrations, this event brought together top scientists, researchers, and industry experts from 40 countries to share their findings on the latest developments in viral pathogenesis and immune responses.
Attendees gathered for the 5th edition of the Viruses’ conference, where we hosted influential keynote speeches from Nobel Prize laureate Dr. Charles M. Rice and ‘Distinguished Senior Virologist’ Prof. Luis Enjuanes, along with 14 invited speakers, 47 selected speakers, and nine flash poster presenters, to discuss the most significant issues in virology today.
Recap on the #Viruses2024 Conference
Take a look at the key moments from MDPI’s Viruses event and please join us in commemorating a gathering for global knowledge and cooperation. A heartfelt thank-you to all attendees; their passion and engagement played a crucial role in making this event an engaging success!
Below are calls to action from the keynote speakers encouraging collaboration and communication:
“There’s never been a better time than now to really take the power that we have both in terms of basic research and also in biotech and pharma to develop antiviral agents.” - Dr. Charles M. Rice, The Rockefeller University, New York, USA
“The collaboration between labs is absolutely essential. Improving initial detection and improving communication is a must for all of us working in science.” - Prof. Dr. Luis Enjuanes, National Center of Biotechnology (CNB-CSIC), Madrid, Spain
Our thanks go to our sponsors and partnering societies, our Viruses journal and editorial team, our Barcelona colleagues, and the social media, conference and other MDPI teams for making this event a memorable occasion. View the event gallery here.
Upcoming In-Person Event
24–26 April, 2024
4th MMCS – Harnessing the Power of New Drug Modalities
Location: Barcelona, Spain
Esteemed speakers at MMCS 2024 include Prof. Arun K. Ghosh, the mind behind the Darunavir molecule, and Prof. Paul Brennan, CSO of Alzheimer's Research UK Oxford Drug Discovery Institute.
Find more upcoming MDPI events here.
Organize Your Event with MDPI’s Sciforum
Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.
Closing Thoughts
Researcher to Reader (R2R) Conference
From 20–21 February 2024, I had the pleasure of attending the Researcher to Reader (R2R) conference in London, which MDPI has proudly sponsored over the years. The conference programme offered a variety of session formats, including workshops, panel discussions, debates, interviews, presentations, and lightning talks, with opportunities to discuss relevant topics.
We take pride in supporting the scientific community, bringing researchers across the world together to network, exchange ideas and share the latest in science and publishing. In 2023, MDPI invested close to 2 million CHF in sponsoring over 2,000 scientific and publishing-related conferences worldwide.
R2R Peer Review Innovations Workshop
I found the R2R conference to be engaging, with the workshops being particularly enjoyable. My colleague Giulia Stefenelli (Chair of Scientific Office Board) and I participated in the “Peer Review Innovations” workshop, which spanned four sessions over the two days. These sessions explored the future of peer review and how we can improve the peer review process for everyone involved. Notably, the large majority of attendees expressed their opinion that peer review, as currently practiced, requires significant improvement. Together, we collaborated on potential immediate and long-term improvements and innovative processes, aiming to create an ecosystem beneficial to all stakeholders by strengthening submission systems with the aim of reducing threats and making authors more responsible for their work. We also discussed the opportunity for academic institutions to better scrutinize the quality of the work produced and submitted to journals.
Our group comprised publishers, software providers, librarians, and more, bringing diverse perspectives to the discussions. These interactions were relevant to MDPI’s ongoing conversations, providing insights to our efforts. The session also made me appreciate that MDPI is doing well, as the group discussions included the subject of various quality checks that we have already embedded in our processes, ensuring that we keep abreast of industry standards.
The need for an optimized system to incentivize the activities of editors and reviewers was also a focus of discussion, as well as the support that reviewers need from publishers via the provision of strong reports through fixed forms, questionnaires and training.
At MDPI, we are currently auditing our reviewer program to improve reviewer recognition, guidelines, and methods for identifying suitable reviewers, while maintaining our commitment to quality and timeliness.
Congratulations to Mark Carden, Conference Director, and the R2R team for organizing a productive and successful event. PS: The break times were greatly appreciated as well!
Chief Executive Officer
MDPI AG
29 February 2024
Journal of Personalized Medicine | Most Viewed Special Issues in 2022–2023 in the Section “Clinical Medicine, Cell, and Organism Physiology”
We are pleased to invite you to read the most viewed Special Issues from 2022 and 2023 in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) in the Section “Clinical Medicine, Cell, and Organism Physiology”. We hope this announcement will provide useful information for this field.
The Special Issue list is as follows:
“The Current State of Psychiatry: Personalized Medicine and Treatment” |
“Personalized Medicine in Acute Care Surgery: Postoperative Complications and Prognosis” |
“Establishment and Characterization of Novel Patient-Derived Cancer Cell Line” |
“Care Personalization in Parkinson Disease” |
“Advancements in Minimally Invasive Urological Surgery and Endourology” |
“Applied Invasive Coronary Physiology for Tailored Treatment of Coronary Artery Disease” |
You are welcome to view all the Special Issues and submit relevant papers to the Journal of Personalized Medicine. If you have any questions, you can contact the Editorial Office at [email protected].
Journal of Personalized Medicine Editorial Office
23 February 2024
Journal of Personalized Medicine | Most Viewed Papers in 2022 in the Section “Pharmacogenetics”
We are pleased to invite you to read the most viewed papers in 2022 in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) in the Section “Pharmacogenetics”. The list of papers is as follows:
1. “Sex Differences in Response to Treatment with Glucagon-like Peptide 1 Receptor Agonists: Opportunities for a Tailored Approach to Diabetes and Obesity Care”
by Elpiniki Rentzeperi, Stavroula Pegiou, Theocharis Koufakis, Maria Grammatiki and Kalliopi Kotsa
J. Pers. Med. 2022, 12(3), 454; https://doi.org/10.3390/jpm12030454
Available online: https://www.mdpi.com/2075-4426/12/3/454
2. “Advances in Preclinical In Vitro Models for the Translation of Precision Medicine for Cystic Fibrosis”
by Iris A. L. Silva, Onofrio Laselva and Miquéias Lopes-Pacheco
J. Pers. Med. 2022, 12(8), 1321; https://doi.org/10.3390/jpm12081321
Available online: https://www.mdpi.com/2075-4426/12/8/1321
3. “Clinical and Genetic Predictors of Glycemic Control and Weight Loss Response to Liraglutide in Patients with Type 2 Diabetes”
by Artemis Kyriakidou, Angeliki V. Kyriazou, Theocharis Koufakis, Yiannis Vasilopoulos, Maria Grammatiki, Xanthippi Tsekmekidou, Iakovos Avramidis, Stefanos Baltagiannis, Dimitrios G. Goulis, Pantelis Zebekakis et al.
J. Pers. Med. 2022, 12(3), 424; https://doi.org/10.3390/jpm12030424
Available online: https://www.mdpi.com/2075-4426/12/3/424
4. “The Rise of Population Genomic Screening: Characteristics of Current Programs and the Need for Evidence Regarding Optimal Implementation”
by Kimberly S. Foss, Julianne M. O’Daniel, Jonathan S. Berg, Sabrina N. Powell, Rosemary Jean Cadigan, Kristine J. Kuczynski, Laura V. Milko, Katherine W. Saylor, Megan Roberts, Karen Weck et al.
J. Pers. Med. 2022, 12(5), 692; https://doi.org/10.3390/jpm12050692
Available online: https://www.mdpi.com/2075-4426/12/5/692
5. “CFTR and Gastrointestinal Cancers: An Update”
by Rahul Bhattacharya, Zachary Blankenheim, Patricia M. Scott and Robert T. Cormier
J. Pers. Med. 2022, 12(6), 868; https://doi.org/10.3390/jpm12060868
Available online: https://www.mdpi.com/2075-4426/12/6/868
6. “Pharmacogenomics-Guided Pharmacotherapy in Patients with Major Depressive Disorder or Bipolar Disorder Affected by Treatment-Resistant Depressive Episodes: A Long-Term Follow-Up Study”
by Antonio Del Casale, Leda Marina Pomes, Luca Bonanni, Federica Fiaschè, Clarissa Zocchi, Alessio Padovano, Ottavia De Luca, Gloria Angeletti, Roberto Brugnoli, Paolo Girardi et al.
J. Pers. Med. 2022, 12(2), 316; https://doi.org/10.3390/jpm12020316
Available online: https://www.mdpi.com/2075-4426/12/2/316
7. “Evidence for Cardiorenal Protection with SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Patients with Diabetic Kidney Disease”
by Panagiotis I. Georgianos, Vasilios Vaios, Stefanos Roumeliotis, Konstantinos Leivaditis, Theodoros Eleftheriadis and Vassilios Liakopoulos
J. Pers. Med. 2022, 12(2), 223; https://doi.org/10.3390/jpm12020223
Available online: https://www.mdpi.com/2075-4426/12/2/223
8. “Development and Validation of the Minnesota Assessment of Pharmacogenomic Literacy (MAPL)”
by Josiah D. Allen, Lusi Zhang, Alyssa N. K. Johnson, Pamala A. Jacobson, Catherine A. McCarty, Amy L. Pittenger and Jeffrey R. Bishop
J. Pers. Med. 2022, 12(9), 1398; https://doi.org/10.3390/jpm12091398
Available online: https://www.mdpi.com/2075-4426/12/9/1398
9. “Factors Predisposing the Response to Lumacaftor/Ivacaftor in People with Cystic Fibrosis”
by Julie Mésinèle, Manon Ruffin, Loïc Guillot, Pierre-Yves Boëlle, Harriet Corvol and on behalf of the French CF Modifier Gene Study Investigators
J. Pers. Med. 2022, 12(2), 252; https://doi.org/10.3390/jpm12020252
Available online: https://www.mdpi.com/2075-4426/12/2/252
10. “Pharmacogenetic Profiling in High-Risk Soft Tissue Sarcomas Treated with Neoadjuvant Chemotherapy”
by Anna C. Virgili Manrique, Juliana Salazar, María Jesús Arranz, Silvia Bagué, Ruth Orellana, Antonio López-Pousa, Paula Cerdà, Isidre Gracia, Katarina Majercakova, Ana Peiró et al.
J. Pers. Med. 2022, 12(4), 618; https://doi.org/10.3390/jpm12040618
Available online: https://www.mdpi.com/2075-4426/12/4/618
23 February 2024
Meet Us at the 144th Annual Meeting of the Pharmaceutical Society of Japan, 28–31 March 2024, Yokohama, Japan
Conference: The 144th Annual Meeting of the Pharmaceutical Society of Japan
Date: 28–31 March 2024
Location: Yokohama, Japan
MDPI will be attending the 144th Annual Meeting of the Pharmaceutical Society of Japan at Booth #79, and we welcome researchers from different backgrounds to visit and share their latest ideas with us.
The theme of the 144th Annual General Meeting is: “Creation of a Pharmaceutical Culture that Co-prosperity with “Genes” and “Environment”: Toward the Integration of Sustainable “Digital Therapy”.
With the introduction of vaccines, the sale of therapeutic drugs, and the establishment of treatment systems, the fight against COVID-19 has become a coexistent situation. We hope that this annual general meeting will be an opportunity for many researchers, medical professionals, and educators involved in pharmaceutical research to gather, present the latest research results, and discuss how pharmaceutical education should be. We hope that it will be an opportunity to create sustainable innovations for the future.
The following MDPI journals will be represented:
- Biomedicines;
- JPM;
- Molecules;
- Pharmaceuticals;
- Pharmaceuticals.
If you are planning on attending this conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://confit.atlas.jp/guide/event/pharm144/top.
6 February 2024
Meet Us at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024), 27–30 April 2024, Barcelona, Spain
MDPI will attend the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) as an exhibitor. This conference will be held in Barcelona, Spain, from 27 to 30 April 2024.
The following MDPI journals will be represented:
- JCM;
- JPM;
- Pathogens;
- Antibiotics;
- Diagnostics;
- Biomolecules;
- Life;
- Venereology;
- IJMS;
- Microorganisms;
- TropicalMed;
- Medical Sciences;
- CIMB.
If you are attending this conference, please feel free to start a conversation with us at our booth. Our delegates look forward to meeting you in person and answering any questions that you may have.
For more information about the conference, please visit https://www.eccmid.org/.
2 February 2024
Acknowledgment of the Reviewers of JPM in 2023
In recognizing the exceptional efforts of our reviewers in 2023, we express our sincere gratitude for upholding the high standards of JPM. Their commitment ensured the rigorous peer review that is integral to quality academic publishing.
In 2023, JPM received 4960 review reports, from 4226 reviewers. This past year, we worked with reviewers from 92 countries and regions, reflecting the diversity in our collaboration with research communities. Their dedication shapes scholarly discourse and advances global research. The editorial team expresses gratitude for the vital role played by each reviewer in the JPM family throughout 2023, and we look forward to their continued support in 2024.
The following are the reviewers who have consented to show their names:
Abbirami Elangovan | Koichi Taira |
Abdelrahman Elsayid | Komsun Suwannarurk |
Abdolreza Jamilian | Komuraiah Myakala |
Abdou Zoure | Konstantin Yarygin |
Abdulqadir Nashwan | Konstantinos Arvanitakis |
Abdussalam Elhanashi | Konstantinos Sidiropoulos |
Abhijit Nair | Konstantinos Tigkiropoulos |
Abhishek Jha | Konstantinos Tsaknakis |
Abid Hussain | Korhan Kilic |
Abiola Adepoju | Kota Kodama |
Abouzar Najafi | Kousalya Prabahar |
Abraham Pouliakis | Koustav Sarkar |
Abraham Wall-Medrano | Kresimir Basic |
Abuzer Coskun | Kristin Nieman |
Ach Taieb | Krisztina Martha |
Adam Halinski | Krzysztof Dowgierd |
Adel Girgis | Krzysztof Nowosielski |
Adina Marza | Kshama Gupta |
Adina Thomaidis | KuanJung Chen |
Adity Pore | Kulandaisamy Arulsamy |
Adli Ali | Kundlik Gadhave |
Adrian Costache | Kunihiko Umekita |
Adriana Alexandru | Lakshmi Menon |
Adriana Grigoraș | Lalu Muhammad Irham |
Adriana Objelean | Lan Zhao |
Agata Pietrzak | Lana Ei Osta |
Agnieszka Drozdzik | Laszlo Zavori |
Agnieszka Jeleń | Lateef Ahmad |
Agnieszka Owczarczyk-Saczonek | Laura Gilbertson |
Agostino Guida | Laura Hays |
agostino roasio | Laura Pittari |
Ahmed Abdelnaser Mohamed | Laura Zlibinaite |
Ahmed Abu-Awwad | Laurence Hamard |
Ahmed Afify | Laurentiu Simion |
Ahmed Al-Abd | Leandro Da Silva |
Ahmed Bakillah | Lee Nguyen |
Ahmed Doghish | Lenycia de Cassya Lopes Neri |
Ahmed Elmasry | Leonardo Euripedes de Andrade Silva |
Ahmed Elshahat | Leonardo Tariciotti |
Ahmed Hamdan | Leonardo Vivarelli |
Ahmed Imran | Leonid Bystrykh |
Aida Petca | Lesley Storey |
Aiken Dao | Lidia Perenc |
Ajinkya Pawar | Lidija Savić |
Ajith Polopnowita | Lilya Dzhemileva |
Akihiko Katayama | Lin Yang |
Alberto Alperi | Lincoln Faria da Silva |
Alberto Martino | Linda Frintrop |
Aldo Bove | Linda Hazlett |
Alejandra García-Gasca | Linda Peters |
Aleksander Zwierz | Ling Luo |
Aleksandr Poliakov | Liudmyla V. Garmanchuk |
Aleksandras Vilionskis | Livia Bobu |
Alena Lochmannova | livia nastri |
Alessandra Sinopoli | Ljiljana Jeličić |
Alessandra Verzelloni Sef | Lorenzo Caruso |
Alessandro Alaimo | Lorenzo Menicanti |
Alessandro Mariani | Lubomir Skladany |
Alexander Korthaus | Luca Di Gianfrancesco |
Alexander Zemchenkov | Luca Lazzari |
Alexandra Filippopoulou | Luca Potestio |
Alexandrina Muntean | Lucía Ortiz-Comino |
Alexey Lipengolts | Lucia Stanciakova |
Alexey Piskunov | Lucian Evdochim |
Alfredo Téllez Valencia | Lucio Mango |
Ali Memarian | Ludovica Anna Cimini |
Alice Chiara Manetti | Luigi Irace |
Alin Nedelcu | Luigi La Via |
Alina Dima | Luis Apaza Ticona |
Alina González-Quevedo | Luis Espejo-Antúnez |
Alina Popa | Luis Jacinto-Alemán |
Alina Zorina Stuparu Stroe | Luis López-Fernández |
Alin-Constantin Pînzariu | Luis Soares Luis |
Alireza Baratloo | Luka Clarke |
Alireza Tafazoli | Luka Matak |
Allen Titus | Lukas Holzer |
Alperen Degirmenci | Lukas Müller-Wirtz |
Álvaro Dowling | Lukasz Nawacki |
Álvaro López-Díaz | Łukasz Pulik |
Alvaro Macias | Łukasz Rzepiński |
Alvaro Manuel Rodriguez-Rodriguez | Lung-Chi Lee |
Álvaro Plaza Reyes | Lusi Zhang |
Amany Abdel-Rahman | Lut Tamam |
Amaranta De Miguel-Rubio | Luz Moran |
Amin Nakhostin-Ansari | Lyudmila Bel'skaya |
Amit Chougule | M. Belén Alonso Ortiz |
Ammad Ahmad Farooqi | M. Esperanza Cerdán |
Ana I. Faustino-Rocha | Maciej Skotak |
Ana Leticia Fornari Caprara | Maciej Zieliński |
Ana Martins | Madankumar Ghatge |
Ana Teresa Gabriel | Made Suandika |
Ana Tomas | Magdalena Chirilă |
Anand Joshi | Magdalena Emilia Grzybowska |
Anand Paramasivam | Magdalena Kurnik-Łucka |
Anastasia Karlsen | Magdalena Stasiak |
Anastasios Potiris | Magdalena Wujak |
Anastasiya Kazantseva | Mahesh Nepal |
Ancuta Mihai | Mahmoud Abdallah |
Anders Örbom | Makoto Nakamura |
Andor Molnár | Malene Pedersen |
Andre Luiz Costa | Małgorzata Klimek |
Andrea Cassoni | Małgorzata Matysek |
Andrea Furka | Małgorzata Sobiecka |
Andrea Perrelli | Mana Mukherjee |
Andreas Brodehl | manohar kodavati |
Andreas Savelsbergh | Manoj Temnjre |
Andreas Schmutzler | Mansoor Fateh |
Andrei Colita | Mansoor-Ali Vaali-Mohammed |
Andrei Marian Feier | Manuel Coheña-Jimenez |
Andrej Belančić | Manuel Florian Struck |
Andrey Glotov | Manuel López-Baamonde |
Andrzej Brudnicki | Manuel Muro |
Andrzej Konieczny | Manuel Rebollo Salas |
Aneta Klotzka | Maochun Wang |
Aneta Wieczorek | Marcello Della Corte |
Ángel Luis García-Otín | Marchel Vetrile |
Angel Vértiz-Hernández | Márcio Formiga |
Angela De Palma | Marco Dolci |
Angela Madalina Lazar | Marco Manzetti |
Angelo Naselli | Marco Zedda |
Anish Ray | Marcos Brioschi |
Ankit Tanwar | Marcus Horstmann |
Ankona Banerjee | Marcus Mareel |
Ankush Jamthikar | Marek Paul |
Anna Charuta | Mária Belovičová |
Anna Drabczyk | Maria Blanco-Diaz |
Anna Kasielska-Trojan | Maria Cristina Cangussú |
Anna Koumarianou | Maria Guembe |
Anna Pieczyńska | Maria Kalafati |
Anna Staniszewska | Maria Lasalvia |
Anna Szumilewicz | Maria Loureiro |
Anna Zalewska | Maria Malvina Tsamouri |
Annalisa Pace | Maria P Ntalouka |
Anson Kai Chun Chau | Maria Papasavva |
Anthony Valverde | Maria Paulino |
Antigoni Sakellaropoulou | Maria Radanova |
Anton Kiselev | María Rúa-Alonso |
Anton Tkachenko | Maria Simonenko |
Antonella De Luca | Maria Szubert |
Antonino Di Pino | Maria Zavala-Cerna |
Antonio Borzelli | Marialuisa Zedde |
Antonio Pontoriero | Marian Simka |
Antonio Santagostini | Marilena Mangiardi |
Antonio Vinci | Marin Lozić |
Anwar Sayed | Marin Ogorevc |
Apostolos Agrafiotis | Marina Chukalina |
Apostolos Zaravinos | Marina Quartu |
Arianna Di Stadio | Marino Paroli |
Arif Sabta Aji | Mario Šokac |
Aris Kaltsas | Mário Sousa |
Arlette Setiawan | Marios Spanakis |
armencea gabriel | Mariusz Niemczyk |
Aron Tendler | Mariusz Siemiński |
Arrigo Cicero | Mariza Vorster |
arshiya Sultana | Marjan Mirsalehi |
Arun Pandian J | Marko Baralić |
Asaad Babker | Marko Bašković |
Ashton Theakstone | Marko Tarle |
Ashwani Sharma | Marouan Zoghbi |
Asmaa Khafaga | Marta Rogalska |
Atar Singh Kushwah | Marta Woldanska-Okonska |
Athanasia Proklou | Martha Sierra-Vargas |
Athanasios Kiourtis | Martin Meier |
Atheer Zgair | Martin Richter |
Athikhun Suwannakhan | Martina Kleber |
Atsushi Kawahara | Mary Kosmidis |
Attila Frigy | Masahiro Tajika |
Atukuri Dorababu | Masaki Ueno |
Aydin Eresen | Masoud Keikha |
Ayman Elsamanoudy | Massimo D'Archivio |
Azam Shirinabadi Farahani | Matias Ferrán Escobedo |
Azamossadat Hosseini | Matteo Bradicich |
Ba Thong Nguyen | Matteo Mario Carlà |
Bálint Tamaskovics | Matteo Ripa |
Baotong Zhang | Matthias Unterhuber |
Barbara Mognetti | Mau-Ern Poh |
Barbara Ruaro | Maurizio Marchesini |
Barbara Verro | Mayur Doke |
Baris Eser | Mayur Virarkar |
Bartłomiej Henryk Noszczyk | Md Ariful Haque |
Beatrice Gallo | Md Daud Mohd Khairi |
Beatrice Heim | Md Sofiqul Islam |
Beenish Chaudhry | Mehdi Moghanibashi |
Benjamin Rolles | Mehran Ghasemzadeh |
Beom Sun Chung | Mehrnaz Shoushtarian |
Berenika Szczęśniak-Sięga | Meir Barak |
Bernard Speculand | Melissa Burmeister |
Beth Thielen | Melvin Ambele |
Bilal Haj Najeeb | Mercedes Bermúdez |
Bin Du | Mercedes gimeno |
Blanca Bazán-Perkins | Mercedes Mitjavila Casanovas |
Blažen Marijić | Michael Garnet Irwin |
Bogdan Amuzescu | Michael Joachim |
Bogdan Iliescu | Michael Kovalev |
Boris Kozlov | Michail Papafaklis |
Boris Malyugin | Michał Łobacz |
Boris Tadic | Michela D'Ascanio |
Branimir Anić | Michele Coviello |
Bruno Fionda | Michele Finotti |
Cai-Ping Zhang | Mieszko Wieckiewicz |
Camelia Cojocariu | Miguel Á. Castro Villamor |
Camelia Gurban | Miguel Gonzalez-Gay |
Camil Mirestean | Miguel Mendoza-Catalán |
Camillo Fulchignoni | Mihaela Ionica |
Caner Günaydın | Mihaela Luca |
Carina Balcoş | Mihai Dumitru |
Carla Pisani | Mihai Georgescu |
Carlos Delgado-Miguel | Mikhail Dubinin |
Carlos Escobar | Mikhail Kostik |
Carlos Fernandez-Patron | Mikołaj Maga |
Carlos Martín Ardila | Milan D. Perovic |
Carlos Oliveira | Milan R. Nikolić |
Carlos Ortiz-Mendoza | Min Deng |
Carmelina Zirafa | Ming Yang |
Carmen Álvarez-Nieto | Mingfei Sheng |
Carmen Pavelescu | Mingming Zhao |
Carol Nash | Mircea Lițescu |
Cassiano Gonçalves-de-Albuquerque | Mircea Vasile Milaciu |
Catalin Bulai | Miriam Sanchez-SanSegundo |
Catarina Tomás | Mithun Rudrapal |
Caterina Piazza | MK Nieuwenhuis |
Chaemoon Lim | Mohamed Abuzaid |
Chaitanya Gadepalli | Mohamed Ali |
Chaiyaboot Ariyachet | Mohamed Lounis |
Chakradhara Rao S Uppugunduri | Mohamed Mokhtar Nagy |
Chandrabose Selvaraj | Mohammad Alwahsh |
Chandrakanta Mahanty | Mohammad Athar |
Chao Shen | Mohammad Barary |
Chao Yin Kuo | Mohammad Basha |
Chao-Hui Yang | Mohammad Khalil |
Charles D. Ponte | Mohammad Khan |
Che Hsueh Yang | Mohammad Qneibi |
Chen-Cheng Yang | Mohammed Abuzaid |
Cheng Yang | Mohammed Ezzat |
Chengquan Ma | Mohammed Sayed |
Chethan Kn | Mohammed Shuaib |
Chih-Kun Hsiao | Mohd Kausar |
Chris DeVera | mohsen Norouzinia |
Christian Colcuc | mohsin shah |
Christian Schubert | Moises Leon Juarez |
Christian Selinger | Mojtaba Moradi |
Christian Smolle | Mona Alshahawey |
Christina Anna Stratopoulou | Mona Batish |
Christoph Faschinger | Mona Sadat Larijani |
Christopher Lievens | Mona Tan |
Christos Orovas | Monica Mendoza-Rodriguez |
Christos Rizos | Monica Rusticeanu |
Cicero Benjamim | Monika Łopuszańska-Dawid |
Cihad Dundar | Monika Prakash |
Cinzia Rotondo | Monika Ruszala |
Ciprian Ilea | Monika Zawadka-Kunikowska |
Ciprian Tanasescu | Mounir M. Salem Bekhit |
Cipriana Stefanescu | Mubarak Mustapha |
Clara Hjalmarsson | Muhammad Kibriya |
Claudia Tregnago | Muhammad Sarfaraz Iqbal |
Claudio Sorino | Muhammad Ubaid Hafeez |
Claudiu Morgovan | Muhammet Sayan |
Claudiu Popescu | Murat Akand |
Clemens Schopper | Murat Tuğcu |
Corrado Ciatti | Mustafa Kursat Sahin |
Corrado Zengarini | Nabil Hasona |
Cosimo Galletti | Nadeem Ullah |
Cristian Baicus | Nader Bakheet |
Cristian Mornos | Namdev Togre |
Cristiana Sieiro Santos | Nan Miao |
Cristina Vassalle | Nancy Monroy-Jaramillo |
Cristina Zbârcea | Naomichi Okamoto |
Cynthia Munoz | Naresh Kumar Ravichandran |
Dagmara Szmajda-Krygier | Naresh Poondla |
Damiano Patrono | Narongchai Autsavapromporn |
Dana Lawrence | Naseer Ahmed |
Daniel Costache | Nasui Bogdana Adriana |
Daniel Dalla Torre | Natalia Piekuś-Słomka |
Daniel Lindegger | Natalia Shnayder |
Daniel Meier | Navid Abedpoor |
Daniel Piskorz | Navin Kumar Ojha |
Daniele Corbo | Nawaz Muhammad |
Daniele Sola | Nazanin Ebrahimiadib |
Danieli Andrade | Neal Davies |
Danijela Cvetković | Neelanjan Vishnu |
Daria Piacentino | Nejc Kozar |
David Areshidze | Nejc Umek |
David Bar-Or | Nenad Bukvic |
Davide Agnoletti | Nessr Abu Rached |
Davide Brotto | Nestor Cabrera-Munoz |
Davide Giuseppe Ribaldone | Nicola Alberto Valente |
Davor Plavec | Nicola Mondanelli |
Debashis Dutta | Nicolae Gica |
Deepali Mathur | Nicolas Nunez |
Demin Cai | Nicolò Brandi |
Denis Dupoiron | Nikola Štoković |
Dhan Shrestha | Nikolaos Sideris |
Dhanya Ravindran | Nikolaos Stavropoulos |
Diego de Ortueta | Nikolina Mihaylova |
Diletta Ami | Nina Novozhilova |
Dimitrios A. Liakopoulos | Nisarat Phithakwatchara |
Dimitrios Rikos | Nishant Kumar |
Dimitris Tatsis | Niya Mileva |
Dinko Vitezic | Noemi Salmeri |
Dino Sgarabotto | Noha Hammad |
Dipak Kumar Sahoo | Noor Jahan |
Divya Gupta | Norhafiza Mat Lazim |
Divya Radhakrishnan | Norizzati Amsah |
Divya Sahu | Norma Ab Rahman |
Diwakar Guragain | Norzawani Jaffar |
Dmitri Panfilov | Nouran salah |
Dmitrii Maltsev | Oana Sirbu |
Dobromira Shopova | Octavian Neagoe |
Doina Todea | Olga Balafa |
Dolors Rodriguez-Pardo | Olgica Mihaljevic |
Domen Vozel | Oliver Riesenbeck |
Domenico Lio | Oliver Sander |
Domenico Plantone | Olivier Rukundo |
Dominic Amuzu | Omar Hamdy |
Dominic Augustine | Omneya Attallah |
Dominik Pruski | Oriol Cantó Navés |
Domiziano Tarantino | osama Gheith |
Donghwa Kim | Ouafa Sijilmassi |
Donghwan Park | P. Radhakrishnanand |
Dorin Novacescu | Paloma Malagón |
Doris F. Oberle | Paolo Santini |
Douglas Lightstone | Paria Motahari |
Do-Youn Lee | Partha Narayan Dey |
Dr Jaya Shanker Tedla | Patrick Weydt |
Drago Jelovac | Pattharawin Pattharanitima |
Dragos Predescu | Paul Amieux |
Dragos Serban | Paul Bălănescu |
Dzintra Kazoka | Paulina Adamska |
Edit Xhajanka | Paulo Santos |
Edith Gjevjon | Paulo Schwingel |
Eduardo Vieira Neto | Pawel Grabala |
Edward Bliss | Paweł Wałek |
Edwin Chang | Paweł Wańkowicz |
Edyta Urbanska | Pedro Dorado |
Eftihia Polyzogopoulou | Pedro Guillen |
Egidijus Šimoliūnas | Pedro Serralheiro |
Einas Yousef | Peggy Sekula |
Eirini Christodoulou | Pejman Rohani |
Ekaterina Garbaruk | Pengyu Zong |
Ekaterina Georgieva | Per Olof Lundgren |
Eleftherios Gkioulekas | Pere Planellas |
Elena Dantes | Peter Adatara |
Elena Dinte | Peter Kanizsai |
Elena Grakova | Peter Keogh |
Elena Nemtsova | Philipp Kriechling |
Elena R Lebedeva | Pierre Tennstedt |
Elena V. Shakhtshneider | Pietro Mesirca |
Elena Valeeva | Pilar Paredes |
Eleni Timotheadou | pinar cevik |
Eleni-Myrto Trifylli | Pınar Cihan |
Elenko Popov | Piotr Gabryel |
Eleuterio A. Sánchez Romero | Plamen Todorov |
Elham Hosseini | Poay Sian Sabrina Lee |
Elisa Belluzzi | Ponti Donatella |
Elisa Russo | Pornchai Sathirapanya |
Elizabeth Lee | Pramodkumar Gupta |
Elizeu Carvalho | Pranothi Mulinti |
Elvira Orduna-Hospital | Prapaporn Suprasert |
Elżbieta Grześk | Prasath Manogaran |
Eman Mehanna | Qian Chen |
Eman Toraih | Qinying Yu |
Emanuele Bernardinelli | qixin wang |
Emilia Severin | Rada Kazakova |
Emiliano Tesoro-Cruz | Rada Miskovic |
Emina Sudar-Milovanovic | Radosław Balwierz |
Enita Nakas | Radoslaw Kiedrowicz |
Enrique Cervantes-Pérez | Radu Chicea |
Enrique Gea-Izquierdo | Radu Crisan-Dabija |
Enwu Liu | Radu Racovita |
Erand Llanaj | Rafaela Gutiérrez Cáceres |
Erdogan Bulut | Raffaele Frazzi |
Eric Huet | Raffaele Pellegrino |
Erica Neri | Raghunadharao Digumarti |
Esma Inan Yuksel | Raid Al-Ani |
Essam Ahmed Mohammed | Rajmohan Dharmaraj |
Estefania Nuñez | Rakshit Shah |
Estela Sanguesa | Raluca Roman |
Eugen Ionescu | Ramcés Falfán-Valencia |
Eugene Loos | Ramesh G.P |
Evgeniya Kaigorodova | Rami Al-Rohil |
Evi Fleischhacker | Ramit Maoz Segal |
Ewa Toporowska-Kowalska | Ramona Meanti |
Fabiano Vilhena | Ramu Inala |
Fábio Lanferdini | Rana Youness |
Fabrizio Ceresa | Rares Mircea Birlutiu |
Fahad Kidwai | Raul Díaz |
Farah Hamandi | Ravindra Samarth |
Farhan Siddique | Ravindra Thakkar |
Faris Khan | Ray-Chang Wu |
Fatemeh Khatami | Razieh Rabani |
Fatih Hatipoglu | Razvan Ionescu |
Fausto Maffini | Rebecca Eshraghi |
Fedele Lembo | Reka Varnai |
Federica Scarfì | Remington L. Nevin |
Federico Mazza | Reza Zolfaghari Emameh |
FELIPE CHAVES | Ricardo Dias |
Fenglei Li | Ricardo González-Ramírez |
Feras Darwish Darwish El-Hajji | Ricardo Ribeiro |
Ferdinando Antonio Gulino | Richard N. Merchant |
Fernanda Gentil | Rini Arianti |
Fernanda Mesquita | Rita Kiss |
Fernando Guerra-Infante | Robert Adamu Shey |
Fernando Muñoz-Hernández | Robert Gerwin |
Fernando Sanchez Lasheras | Roberta Monzani |
Filippo Confalonieri | Roberto Cemin |
Filippo Manelli | Roberto de la Plaza Llamas |
Filippo Mariano | Roberto Lazzarini |
Filomena Puntillo | Roberto Scicali |
Flaviu Moldovan | Robin Cooper |
Florian Ebel | Robinson Sabino-Silva |
Florin Achim | Rodolfo Abarca-Vargas |
Forogh Soltaninejad | Rodolfo Reda |
Frada Burstein | Rodolfo Valtuille |
Francesco Bianco | Rodrigo Torres |
Francesco Bosco | Rogério Manuel Ferreira |
Francesco Claps | Rosa Di Liddo |
Francesco Doglietto | Rosa María Giráldez-Pérez |
Francesco D'Oria | Rosa María Oliart-Ros |
Francesco Meani | Roshan Katekar |
Francesco Menzella | Roshanak Ghods |
Francesk Mulita | Roxana Liana Lucaciu |
Francisco Malano | Ruben Sanchez-Gomez |
Franco Alchiede Simonato | Runzhuo Ma |
Fuat Demirkíran | Ruta Vaiciuniene |
Gabriel Magrin | Rute Pereira |
Gabriela Mellado-Sanchez | Rute Santos |
Gabriele Melegari | Ruxandra Diana Sinescu |
Gabriele Reinartz | Ryszard Antkowiak |
Gabriele Sorce | S. Ramkumar |
Gaddi Blumrosen | Sabina Antonela Antoniu |
Gennadi Saiko | Sachin Chaugule |
George E. MacKinnon III | Sadashige Uemura |
George Imataka | Safaa Elkholi |
Georgiana Nemeti | Sajal Sen |
Georgiana-Emmanuela Gilca-Blanariu | salvatore crimi |
Georgios Katsaras | Samar Tharwat |
Georgios Panos | Samo Fokter |
Gerald Lushington | Sanam Dolati |
Gerardo Cazzato | Sandeep Kumar Mishra |
Gerardo Santos-Lopez | Sandro Glumac |
Gerson Aparecido Foratori-Junior | Sandro Jose Ribeiro Bonatto |
Ghulam Mustafa | Sanjit Mukherjee |
Giacomo Papotto | Santhosh Kumar Pasupuleti |
Giacomo Zaccherini | Santi Mandal |
Gian Pio Sorice | Santiago Perez-Lloret |
Giancarlo Micheletto | Sarabjeet Sudan |
Gianluca Manni | Sarah Shueb |
Gilles Lesieur | Sarawut Lapmanee |
Gina Mendez-Callejas | Sasho Stoleski |
Giordano D'Urso | Sasi Viktor |
Giorgio Prouse | Satish Sagar |
Giorgos Dritsakis | Satoru Munakata |
Giovanna Salata | Saumya Shah MD |
Giovanni De Angelis | saurabh chaturvedi |
Giovanni Guglielmo Laracca | Saverio Muscoli |
Giovanni Pennisi | Sayed Abdelwahab |
Giovanni Viroli | Sayed Goda |
Giulia Pellecchia | Sebastian Tranca |
Giulia Santo | Sedigheh Sadat Naimi |
Giuliano Tocci | Sehar Iqbal |
Giulio Mengozzi | Selim Ayhan |
Giuseppe Basile | Semer Maksoud |
Giuseppe Lisco | Senija Eminović |
Giuseppe Seghieri | Sergey Igumnov |
Giuseppe Stefani | Sergey Lytaev |
Gjin Ndrepepa | Sezer Okay |
Gladiol Zenunaj | Shadma Wahab |
Gonçalo Garcia | Shahjada Selim |
Goohyeon Hong | Shaina Schwartz |
Gopinath M. Sundaram | Sheila Veronese |
Goran Augustin | Sherihan AbdelHamid |
Goran Kvaščev | Shibo Yu |
Gotam Das | Shiek Ahmed |
Gözde Şengül Ayçiçek | Shifu Aggarwal |
Grazyna Puto | Shi-hua Xiang |
Grigorios Dimas | Shinya Suzuki |
Grzegorz Bartosz | shivani Bansal |
Guillaume Drevin | Shobana Navaneethabalakrishnan |
Guillermina Ferro-Flores | Shruthi Mohan |
Guillermo Til-Perez | Shuo-Chen Chien |
Gulali Aktas | Sigmar Schnutenhaus |
Gülay Taşcı | Siladitya Khan |
Gülden Gülden | Silvia Pianigiani |
Gule Cinar | Sima Romina-Marina |
Gündüz Yümün | Simon Allen |
Güneş Şenol | Simona Coniac |
Gunnar Wichmann | Simone Cilio |
Gurpreet Chhabra | Siva Prasad Panda |
Guy Friedrich | Sivabaskari Pasupathy |
Habib Karim | Siwei Zhang |
Hadia Almahli | Sladjan Pavlovic |
Hailong Hu | Slavica Kvolik |
Hamid Morovati | So Young Yoo |
Hamidreza Khaleghzadeh | Socorro Retana-Marquez |
Hana Rauchová | Sofia Bhatia |
hani Chanbour | Sofia Perazzo |
Hany H. Arab | Soha Albeitawi |
Hao Du | Solomon Viswas Raja |
Harikesh Dubey | Song Wang |
Harikumar Rajaguru | Sonia Regina Pasian |
Harpreet Kaur | Sorana-Maria Bucur |
Harshraj Leuva | Sorin Radu Fleaca |
Haruhiko Sugimura | Sorina Mihaela Solomon |
Hasnaa Jalou | Soutik Ghosal |
Hatem El-Shanti | Srdjan Kesic |
He Sun | Srdjan Masic |
He Zhang | Srijit Das |
Heba Abdelal | Stankovska Gordana |
Heba Sahyon | Stefan Brocke |
Heber Arbildo Vega | Stefan Naydenov |
Hege F. Berg | Stefan Pusch |
Helen Cohen | Stefan Russmann |
Henk Maria Koning | Stefania Troise |
Henrique Pauna | Stefano Fornasaro |
Henry Atkinson | Stefano Priola |
Hermínia Dias | Stefano Saran |
Hervé Reychler | Stephen Gerfer |
Hideo Kato | Stephen T Sonis |
Hideo Wada | Sudhir Kshirsagar |
Himanshu Khajuria | Sudipta Panja |
Hiren Mewada | Sugandh Kumar |
Hiro Sato | Sujith Pereira |
Hiroaki Neki | Sulea Daniela |
Hiroshi Inui | Sumeet Nayak |
Hiroshi Matsushita | Sunil Rai |
Hisayoshi Kawahara | Surajit Basak |
Hon Cheong So | Suyanto Suyanto |
Honglei Ren | Svetlana Guryanova |
Hongyang Ma | Syed Ali Raza Naqvi |
Hoon Park | Syed Furqan Qadri |
hosam habib | Syed Mohd Faisal |
Hossam Donya | Tadashi Kawai |
Hossam El-Sherbiny | Taha Koray Sahin |
Hsiang-Ning Luk | Takahiro Nemoto |
Hsin-Hua Lee | Takao Hamamoto |
Huacheng Zhang | Tamer Hamdy |
Hubert Hackl | Tanja M. Luković |
Hugo Martiniano | Tarek Mohamed |
Hui Liu | Tariq Ali |
Huiling Hong | Tariq Malik |
Hülya Şimşek | Társis Vieira |
Husam Qanash | Tasneem Arsiwala |
Hüsamettin Vatansev | Tatiana Arefieva |
hussein hamade | Tatiana Berezina |
Huyentran Tran | Tatiana Kalinina |
Iakovos Armenis | Tatsuji Mizukami |
Ibrahim Bello | Taweegrit Siripongboonsitti |
Ie-bin Lian | Telma Almeida |
Ignazio Marino | Teng Zhou |
Iman Tavassoly | Thach Nguyen |
Imran Ali Khan | ThankGod Onyiche |
Ina Sevic | Thayne Kowalski |
Inaki Elio | Theodoros Tokas |
Inbar Levkovich | Thijs Van Der Zijden |
Inés Llamas-Ramos | Thomas Ducret |
Ioana Pavaleanu | Thomas Lindner |
Ioannis Kanakis | Thomas Mayer |
Ioannis Kougioumtzis | Tijana Išić Denčić |
Ioannis Lyros | Tim Hulsen |
Ionuț Jeican | Tim Reynolds |
Irena Galić | Tim Wende |
Irena Wojsyk – Banaszak | Timothy Hardcastle |
Irene Baroni | Tina Didari |
Irene Lorrai | Tito Brambullo |
Irene Madrigal | Tomáš Čajka |
Irfan Idris | Tomas Fait |
Iride Francesca Ceresa | Tomasz Banas |
Irina Kologrivova | Tomasz Frączyk |
Irina Pronina | Tommaso Greco |
Irshad Ahmad | Tommaso Lombardi |
Isabel Escobio Prieto | Tommaso Torresin |
Isabelle Piazza | Tongtong Lu |
Isac Medeiros | Toni Lassila |
Isha Singh | Tran Nguyen |
Ismini Lasithiotaki | Tsukasa Okiyoneda |
Iuliana Magdalena Starcea | Tuba Taslamacioglu Duman |
Iuliu Gabriel Cocuz | Tudor Olariu |
Ivan Bratchenko | Tudor Pop |
Ivan Pavić | Tunc Eren |
Ivana Banic | Ujjawal Sharma |
Ivana Fratrić | Ulises de la Cruz-Mosso |
Ivo Bozovic | Ulrich Frey |
Ivo Soares | Ulrich Ronellenfitsch |
Jacob Genizi | Uri Farkash |
Jacopo Di Gregorio | Usein M Dzhemilev |
Jacopo Lisoni | Usman Illahi |
Jaime Mella-Raipán | Utibe-Abasi Udoh |
Jakub Bargiel | Valentino Natoli |
Jakub Kufel | Valeria Dionisi |
James Russell | Valerio Ricci |
Jamir Pitton Rissardo | Vasile Valeriu Lupu |
Jan Azarov | Vasile-Bogdan Halatiu |
Jan Damoiseaux | Vasileios P. Papadopoulos |
Jan de Laat | Vasiliki Karava |
Jan Lowery | Venkata Nagaraj Kakaraparthi |
Janko Samardzic | Venkata Rajesh Yella |
Jasper van Assche | Vera Larina |
Javier Martinez-Useros | Vicente León-Muñoz |
Jeanne Wilson-Rawls | Victor Díaz-Flores García |
Jennifer Pursley | Víctor Hernández-Beltrán |
Jenny Vilchis-Gil | Victoria McKenna |
Jeong Heo | Victoria Sanchez-Martin |
Jeong Min Han | Vidya Rattan |
Jeremy Lavine | Vijaya Anand Arumugam |
Jessica Zuñiga-Hernandez | Vincenzo Zanon |
Jessie Poquérusse | Vinícius Simão |
Jesus Oliva Pascual-vaca | Vinod Kumar |
Jianhai Chen | Vivian Paraskevi Douglas |
Jie Liu | Vjekoslav Peitl |
Jie Qian | Vladimir Bilim |
Jing Zhang | Vladimir Chobot |
Jiraporn Leanpolchareanchai | Vladimir Poroch |
Jitbanjong Tangpong | Vladimira Boyadzhieva |
Jitendra Kumar Sinha | Vlasios Karageorgos |
Jochen D Schipke | Volkan Karataşlı |
Jochen Winter | Walter Flapper |
John Bernat | Warawut Chaiwong |
John W. Berkenbosch | Waseem Jerjes |
Johnny Ionut Efanov | Wasim Ahmad |
Johnson Retnaraj Samuel Selvan Christyraj | Wassim Abou-Kheir |
Jonathan Pan | Wei Feng |
Jorge González-Gutiérrez | Wei Ni |
José A. Carrión | Wei Shi |
José Antonio Picó-Monllor | Weita Chen |
José Jaime Martínez-Magaña | Weiting Wang |
José López Castro | Wen-Chih Liu |
José Prieto | Wenjun Zhu |
Josefa Gonzalez-Santos | Werner Cordier |
Joseph Hornak | Wilhelm Mistiaen |
Joshua Tobias | William Hammond |
Jovanka Gencel-Augusto | Wirawan Adikusuma |
Joydeep Chakraborty | Wladimir Beck |
József Furák | Wojciech Konarski |
Juan Maza-Solano | Wojciech Paslawski |
Judita Kinkorová | Wojciech Szlasa |
Judith Catella | Woo-Jong Kim |
Juergen Grauvogel | Xiaobo Wu |
Juergen Taxis | Xiaojing Huang |
Julian Freen-van Heeren | Xiaokang Wu |
Julian Künzel | Xin Tong |
Julio Plaza-Diza | Xinglin Yang |
Julius Höhne | Xinli Li |
Juliusz Huber | Xiruo Li |
Junaidi Khotib | Xun Tao |
junchao Guo | Yanira Vasquez |
Jung Eun Kim | Yaniv Steinfeld |
Junhel Dalanon | Yanning Zuo |
Jure Urbančič | Yanpeng Li |
K. Sreedhara Pai | Yansong Qi |
Ka Huen YIP | Yanying Huo |
Kacper Nijakowski | Yavuz Samanci |
Kah Teik Chew | Yedukondala Rao Veeranki |
Kaloyan Georgiev | Yen Tan |
Kamalakannan Radhakrishnan | Ying Qing |
Kamil Gill | Yoichi Watanabe |
Kamil Nelke | Yong-Moon Lee |
Kanon Jatuworapruk | Yongqiang Wang |
Kaori Ueda | Youakim Saliba |
Karel Kostev | Yuan Fang |
Karen Kyuregyan | Yue Hui Lau |
Karolina Filipska-Blejder | Yuichi Adachi |
Karolina Pieniawska-Śmiech | Yuichi Yoshii |
Karthiga M | Yuko Ono |
Katarina Savic Vujovic | Yung-Taek Ouh |
Katarzyna Kwiecień-Jaguś | Yuriy Vasil'ev |
Katarzyna Ogrodzka-Ciechanowicz | Yury Zhernov |
Katarzyna Zorena | Yuta Hikichi |
Kate Kloot | Yuval Krieger |
Katharina M. Rentsch | Zainub Jooma |
Katharina Roeher | Zeljko Vlaisavljevic |
Katsuhiro Ito | Zesergio Melo |
Katsushi Okuyama | Zhanchao Li |
Kazim Arga | Zhaoqing Cong |
Kazuyuki Matsushita | Zhiyuan Xu |
Keitaro Kanie | Zhonglei Wang |
Kelsey Cook | zhongshan cheng |
Ken Takahashi | Zoran Gluvic |
Kenji Nakamura | Zoran Todorovic |
Kenji Yamagata | Zorana Dobrijević |
Kentaro Kawabe | Zsolt Kőszegi |
Kevin Bain | Zsolt Piróth |
Kevin Fricka | Zulfan Zazuli |
Kevin T. Batty | Zulvikar Ulhaq |
Khaled Saad | Zuzana Hudáková |
Kirk Stephenson | Zvonko Rumboldt |
Kodai Kitagawa | Artem Ovchinnikov |
31 January 2024
MDPI Insights: The CEO's Letter #8 - Altmetric and Flat Fee Agreement
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
MDPI and Digital Science Meeting
At MDPI, we are committed to providing our authors with the essential tools to publish, promote, and track their research. In line with this commitment, we have established a longstanding collaboration with Digital Science, a company specializing in research data and analytical insights for the research community. Our collaboration integrates their Altmetric tool, offering us and our authors the ability to track a variety of sources that monitor and report attention surrounding publications.
As part of our collaboration, we recently hosted Cathy Holland, Director of Global Publisher Business Development, and Helen Cooke, Managing Director of Publisher Sales, from Digital Science, at our MDPI headquarters in Basel, Switzerland.
Left to right: Facundo Santomé (Senior Marketing Manager, MDPI), Constanze Shelhorn (Indexing Manager, MDPI), Cathy Holland (Director of Global Publisher Business Development, Digital Science), Helen Cooke (Managing Director of Publisher Sales, Digital Science), and Stefan Tochev (CEO, MDPI) in front of MDPI headquarters in Basel, Switzerland.
During our meeting, we discussed MDPI’s publishing philosophy and explored further avenues for collaboration. We look forward to continuing our partnership with Digital Science, aiming to improve our services yet further and meet the needs of our authors more closely than ever.
What is Altmetric?
You will notice that MDPI articles feature an Altmetric score, a colourful doughnut capturing the score in the upper right corner of the article page. This score represents ‘alternative metrics,’ as distinct from traditional metrics such as Impact Factor, CiteScore, and Scimago Journal Rank.
Altmetrics complement traditional citation-based metrics by capturing online discussions related to a specific research topic. By analyzing both sets of data, we can obtain a comprehensive understanding of the attention a particular research output receives and the sources in which it is mentioned.
“Almetric provides visual insights into where research is being discussed”
Sources Tracked by Altmetric
Altmetric badge showing the Altmetric score and colour-coded mention sources.
Altmetric monitors various sources, categorizing them into segments such as policy documents, peer reviews, Wikipedia, news and blogs, and social media, among other sources. Each category is identifiable by a specific colour.
The Altmetric badge provides visual insights into where the research is being discussed. A more colourful badge indicates broader mentions across multiple platforms. Such tracking enables us to gauge the extent of an article’s online dissemination, noting that increased visibility may correlate with higher citation rates.
Read more:
Impactful Research
Ten High-Altmetric Articles Published by MDPI
As at 30 January 2024, Altmetric has tracked 670,500 MDPI research outputs from MDPI, resulting in over 4.3 million mentions. This includes over 71,894 mentions in policy and patents and 294,714 mentions in news and blogs, with some achieving an Altmetric score as high as 28,754.
So, what is a good Altmetric score? There are various ways to put this score into context. You can find out more about the score in context and how to evaluate your work by this means.
Here are ten MDPI papers ranking in the top 5% of all research outputs scored by Altmetric.
“Accuracy in Wrist-Worn, Sensor-Based Measurements of Heart Rate and Energy Expenditure in a Diverse Cohort” J. Pers. Med. 2017, 7(2), 3; https://doi.org/10.3390/jpm7020003 Altmetric page: https://mdpi.altmetric.com/details/20477344 Altmetric shows that this article appeared in 253 news stories from 209 outlets including Forbes, BBC, and Fox News. |
|
“Daylight Saving Time and Acute Myocardial Infarction: A Meta-Analysis” J. Clin. Med. 2019, 8(3), 404; https://doi.org/10.3390/jcm8030404 Altmetric page: https://mdpi.altmetric.com/details/57654628 Altmetric shows that this article appeared in 295 news stories from 207 outlets including Forbes, The Atlantic, and New York Times. |
|
“The Preliminary Analysis of Cave Lion Cubs Panthera spelaea (Goldfuss, 1810) from the Permafrost of Siberia” Quaternary 2021, 4(3), 24; https://doi.org/10.3390/quat4030024 Altmetric page: https://mdpi.altmetric.com/details/111086701 Altmetric shows that this article appeared in 182 news stories from 134 outlets including CBC News, CNN, and National Geographic. |
|
“Not the Cat’s Meow? The Impact of Posing with Cats on Female Perceptions of Male Dateability” Animals 2020, 10(6), 1007; https://doi.org/10.3390/ani10061007 Altmetric page: https://mdpi.altmetric.com/details/83796184 Altmetric shows that this article appeared in 124 news stories from 98 outlets including VICE, CNN and The Guardian. |
|
“Behaviour and Welfare Impacts of Releasing Elephants from Overnight Tethers: A Zimbabwean Case Study” Animals 2022, 12(15), 1933; https://doi.org/10.3390/ani12151933 Altmetric page: https://mdpi.altmetric.com/details/133463915 Altmetric shows that this article appeared in 192 news stories from 186 outlets. |
How do I use altmetrics?
Altmetric Explorer provides a detailed step-by-step guide and instruction video for first-time users of the tool. The guide includes useful diagrams that make it easy to get started.
Sharing Research Online
For research to be tracked across different sources, Altmetric needs a research output with a persistent identifier: a DOI, ISBN, PubMed ID, handle ID, etc. When sharing research, it is important to include a link to the original research output.
“An Update on Eukaryotic Viruses Revived from Ancient Permafrost” Viruses 2023, 15(2), 564; https://doi.org/10.3390/v15020564 Altmetric page: https://mdpi.altmetric.com/details/142929875 Altmetric shows that this article appeared in 250 news stories from 180 outlets including CTV, Fox News, and CNN. |
|
“The Global Problem of Insufficient Sleep and Its Serious Public Health Implications” Healthcare 2019, 7(1), 1; https://doi.org/10.3390/healthcare7010001 Altmetric page: https://mdpi.altmetric.com/details/53406248 Altmetric shows that this article appeared in 252 news stories from 168 outlets including BBC, Harvard Business Review, and Forbes. |
|
“A Detailed Review Study on Potential Effects of Microplastics and Additives of Concern on Human Health” Int. J. Environ. Res. Public Health 2020, 17(4), 1212; https://doi.org/10.3390/ijerph17041212 Altmetric page: https://mdpi.altmetric.com/details/86529137 Altmetric shows that this article appeared in 197 news stories from 150 outlets including BBC, The Tribune, and World Economic Forum. |
|
“An Empirical Study of Chronic Diseases in the United States: A Visual Analytics Approach to Public Health” Int. J. Environ. Res. Public Health 2018, 15(3), 431; https://doi.org/10.3390/ijerph15030431 Altmetric page: https://mdpi.altmetric.com/details/34714141 Altmetric shows that this article appeared in 232 news stories from 149 outlets including Forbes, New York Times, and Harvard Business Review. |
|
“Garden Scraps: Agonistic Interactions between Hedgehogs and Sympatric Mammals in Urban Gardens” Animals 2023, 13(4), 590; https://doi.org/10.3390/ani13040590 Altmetric page: https://mdpi.altmetric.com/details/142934305 Altmetric shows that this article appeared in 172 news stories from 168 outlets including BBC. |
Inside MDPI
MDPI Annual Meeting Celebrations in China
On Thursday 25 January, over 1,300 MDPI colleagues from our two offices in Beijing gathered to kick off MDPI’s traditional ‘Annual Meetings.’ These celebrations take place in MDPI’s offices across China, including Dalian, Tianjin, Wuhan, and Nanjing.
The evenings include performances, informative talks and presentations, awards, and entertainment, providing an ideal platform to recognize our colleagues, celebrate their achievements, and set our sights on the future.
“It is essential that we stay connected and share best practices”
I sent a video congratulating everyone on their work and sharing our vision of building MDPI into the most trusted OA publisher, highlighting the roles each of us has to play in achieving that goal.
Unfortunately I could not join in person, but you may recall my recent trip, when I visited our offices in Beijing and Wuhan, which I look forward to visiting again this year.
Although our headquarters are in Basel, Switzerland, and we are expanding throughout Europe and North America, the majority of MDPI’s workforce is in China and throughout the Asia-Pacific region, including offices in Singapore, Thailand, Japan, and newly opened office in South Korea. It is essential that as a global organization, we stay connected and share best practices in order to grow collectively and continue providing the exceptional service to our authors.
The Annual Meeting is a moment to reflect and enjoy the year’s hard work and dedication.
I extend our best wishes to all for the Chinese New Year (Xīnnián kuàilè)!
Coming Together for Science
MDPI and TU Delft Adopt Flat Fee Model in Extended Partnership
We are excited to announce a renewed three-year partnership with Delft University of Technology (TU Delft) in the Netherlands. This collaboration introduces a fixed lump-sum fee, covering publishing costs from 2024 to 2026.
“This initiative reflects our dedication to transparent and inclusive publishing”
TU Delft-affiliated authors will enjoy cost-free publishing in any MDPI journal during this period, aligning with our commitment to removing barriers for open access publishing. The agreement supports Plan S compliance and facilitates a seamless publishing process for TU Delft corresponding authors. This initiative reflects our dedication to transparent and inclusive publishing, providing stability and predictability both for authors and for institutions.
For further details on our Institutional Open Access Program (IOAP), please contact us.
Benefits to MDPI’s IOAP
At MDPI we have a long tradition of partnerships, including our Institutional Open Access Program (IOAP). IOAP supports institutions through simplification, access, transparency, APC discounts, and institutional repository deposits. The program simplifies administrative processes, offers central payment, and allows easy opting in and out. Participants gain free access to Susy, MDPI’s online submission system, with extensive article metadata and exportable data. APC discounts and Book Processing Charge discounts are available for affiliated authors. Automated deposits to institutional repositories and streamlined matching of papers to IOAP participants enhance the overall experience.
For further information, see our IOAP FAQ.
Closing Thoughts
Reflections on the 2024 APE Conference
MDPI was proud to co-sponsor the Academic Publishing in Europe (APE) 2024 Conference that took place in Berlin, Germany, from 9–10 January 2024.
The conference theme, ‘Keep the Conversation Going!’, explored the evolving landscape of scholarly communication. APE is one of the key conferences I make a point to attend each year. January offers a valuable opportunity to engage with new contacts, reconnect with familiar faces, and participate in impactful discussions and presentations among professionals, scholars, and practitioners in the field.
“It's fascinating to see how other publishers are leveraging AI”
Highlights
Some of the standout panels for me include: the role of the UN Sustainable Development Goals (SDGs) within the publishing industry. It was encouraging to hear the current status quo, though I was eager also to learn about the exciting projects planned for 2024 and beyond. These will allow us to track progress in subsequent years. At MDPI, we remain committed to promoting Open–Access (OA) content on SDGs through scientific articles and books. Furthermore, we extend our commitment to sustainability by financially supporting researchers through initiatives such as the World Sustainability Award and the Emerging Sustainability Leader Award, as well as waiving the APC for feature papers on each SDG.
In recent years, discussions on AI have become increasingly prominent at such conferences. It’s fascinating to see how other publishers are leveraging AI to meet the evolving needs of their audiences while at the same time using it to safeguard the scientific process. Other engaging panels that I enjoyed included updates on transformation beyond transformative agreements, the principles of lean change, incentive structures related to research integrity, and the panel on reviewer incentives.
“We can share best practices and lessons learned”
Incorporating MDPI’s Insights into Conferences
I must confess that I sometimes feel overlooked when MDPI is not invited to participate in crucial industry discussions. As the leading open access publisher and the third-largest publisher overall, we possess extensive experience in many of these areas and can offer valuable contributions to these discussions. We can share best practices, lessons learned, and our thinking about future trajectories. For instance, in panels discussing reviewer incentives, at MDPI we offer a discount voucher to reviewers for future submissions, reflecting our commitment to fostering a robust peer review process. In 2022 alone, MDPI collected over 1.4 million peer review reports, informing the decision-making processes of our editors. Given our expertise in these areas, it would be natural to include MDPI in such discussions. I therefore extend an invitation to future conference organizers to consider MDPI for speaking engagements and collaborative opportunities.
Chief Executive Officer
MDPI AG
24 January 2024
Journal of Personalized Medicine | Most Viewed Papers in 2023
1. “Effects of Red and Infrared Laser Therapy in Patients with Tinnitus: A Double-Blind, Clinical, Randomized Controlled Study Combining Light with Ultrasound, Drugs and Vacuum Therapy”
by Vitor Hugo Panhóca, Antônio Eduardo de Aquino Junior, Viviane Brocca de Souza, Simone Aparecida Ferreira, Lais Tatiane Ferreira, Karina Jullienne de Oliveira Souza, Patricia Eriko Tamae, Marcelo Saito Nogueira and Vanderlei Salvador Bagnato
J. Pers. Med. 2023, 13(4), 581; https://doi.org/10.3390/jpm13040581
Available online: https://www.mdpi.com/2075-4426/13/4/581
2. “Neuropsychiatric Manifestations of Mast Cell Activation Syndrome and Response to Mast-Cell-Directed Treatment: A Case Series”
by Leonard B. Weinstock, Renee M. Nelson and Svetlana Blitshteyn
J. Pers. Med. 2023, 13(11), 1562; https://doi.org/10.3390/jpm13111562
Available online: https://www.mdpi.com/2075-4426/13/11/1562
3. “Management of Hyponatremia in Heart Failure: Practical Considerations”
by Victoriţa Şorodoc, Andreea Asaftei, Gabriela Puha, Alexandr Ceasovschih, Cătălina Lionte, Oana Sîrbu, Cristina Bologa, Raluca Ecaterina Haliga, Mihai Constantin, Adorata Elena Coman et al.
J. Pers. Med. 2023, 13(1), 140; https://doi.org/10.3390/jpm13010140
Available online: https://www.mdpi.com/2075-4426/13/1/140
4. “Vasopressin in Sepsis and Other Shock States: State of the Art”
by Raquel García-Álvarez and Rafael Arboleda-Salazar
J. Pers. Med. 2023, 13(11), 1548; https://doi.org/10.3390/jpm13111548
Available online: https://www.mdpi.com/2075-4426/13/11/1548
5. “Ratings of the Effectiveness of 13 Therapeutic Diets for Autism Spectrum Disorder: Results of a National Survey”
by Julie S. Matthews and James B. Adams
J. Pers. Med. 2023, 13(10), 1448; https://doi.org/10.3390/jpm13101448
Available online: https://www.mdpi.com/2075-4426/13/10/1448
6. “Fenugreek and Its Effects on Muscle Performance: A Systematic Review”
by Waleed I. Albaker
J. Pers. Med. 2023, 13(3), 427; https://doi.org/10.3390/jpm13030427
Available online: https://www.mdpi.com/2075-4426/13/3/427
7. “A Review of the Role of Artificial Intelligence in Healthcare”
by Ahmed Al Kuwaiti, Khalid Nazer, Abdullah Al-Reedy, Shaher Al-Shehri, Afnan Al-Muhanna, Arun Vijay Subbarayalu, Dhoha Al Muhanna and Fahad A. Al-Muhanna
J. Pers. Med. 2023, 13(6), 951; https://doi.org/10.3390/jpm13060951
Available online: https://www.mdpi.com/2075-4426/13/6/951
8. “White Matter Hyperintensities in Young Patients from a Neurological Outpatient Clinic: Prevalence, Risk Factors, and Correlation with Enlarged Perivascular Spaces”
by Qiaoqiao Zou, Mingliang Wang, Danni Zhang, Xiaoer Wei and Wenbin Li
J. Pers. Med. 2023, 13(3), 525; https://doi.org/10.3390/jpm13030525
Available online: https://www.mdpi.com/2075-4426/13/3/525
9. “The Correlation between Metformin Use and Incident Dementia in Patients with New-Onset Diabetes Mellitus: A Population-Based Study”
by Kuang-Hua Huang, Ya-Fang Tsai, Chiachi Bonnie Lee, Shuo-Yan Gau, Tung-Han Tsai, Ning-Jen Chung and Chien-Ying Lee
J. Pers. Med. 2023, 13(5), 738; https://doi.org/10.3390/jpm13050738
Available online: https://www.mdpi.com/2075-4426/13/5/738
10. “L-Carnitine and Chronic Kidney Disease: A Comprehensive Review on Nutrition and Health Perspectives”
by Bharti Sharma and Dinesh Kumar Yadav
J. Pers. Med. 2023, 13(2), 298; https://doi.org/10.3390/jpm13020298
Available online: https://www.mdpi.com/2075-4426/13/2/298
11. “The Rationale for Vitamin, Mineral, and Cofactor Treatment in the Precision Medical Care of Autism Spectrum Disorder”
by Neluwa-Liyanage R. Indika, Richard E. Frye, Daniel A. Rossignol, Susan C. Owens, Udara D. Senarathne, Andreas M. Grabrucker, Rasika Perera, Marielle P. K. J. Engelen and Nicolaas E. P. Deutz
J. Pers. Med. 2023, 13(2), 252; https://doi.org/10.3390/jpm13020252
Available online: https://www.mdpi.com/2075-4426/13/2/252
12. “COVID-19 and New-Onset Psychosis: A Comprehensive Review”
by Lorenzo Moccia, Georgios D. Kotzalidis, Giovanni Bartolucci, Sara Ruggiero, Laura Monti, Marco Biscosi, Beatrice Terenzi, Ottavia M. Ferrara, Marianna Mazza, Marco Di Nicola et al.
J. Pers. Med. 2023, 13(1), 104; https://doi.org/10.3390/jpm13010104
Available online: https://www.mdpi.com/2075-4426/13/1/104
13. “The Relationship between Gastroesophageal Reflux Disease and Chronic Kidney Disease”
by Xiaoliang Wang, Zachary Wright, Eva D. Patton-Tackett and Gengqing Song
J. Pers. Med. 2023, 13(5), 827; https://doi.org/10.3390/jpm13050827
Available online: https://www.mdpi.com/2075-4426/13/5/827
14. “Lung Dysfunction and Chronic Kidney Disease: A Complex Network of Multiple Interactions”
by Guido Gembillo, Sebastiano Calimeri, Valeria Tranchida, Salvatore Silipigni, Davide Vella, Domenico Ferrara, Claudia Spinella, Domenico Santoro and Luca Visconti
J. Pers. Med. 2023, 13(2), 286; https://doi.org/10.3390/jpm13020286
Available online: https://www.mdpi.com/2075-4426/13/2/286
15. “ARIA Care Pathways 2019: Next-Generation Allergic Rhinitis Care and Allergen Immunotherapy in Malaysia”
by Amir Hamzah Abdul Latiff, Salina Husain, Baharudin Abdullah, Palaniappan Suppiah, Vincent Tan, Tang Ing Ping, Kent Woo, Yoke-Yeow Yap, Claus Bachert, Holger J. Schunemann et al.
J. Pers. Med. 2023, 13(5), 835; https://doi.org/10.3390/jpm13050835
Available online: https://www.mdpi.com/2075-4426/13/5/835
16. “A Narrative Review on REM Sleep Deprivation: A Promising Non-Pharmaceutical Alternative for Treating Endogenous Depression”
by Cătălina Angela Crișan, Zaki Milhem, Roland Stretea, Ioan-Marian Țața, Răzvan Mircea Cherecheș and Ioana Valentina Micluția
J. Pers. Med. 2023, 13(2), 306; https://doi.org/10.3390/jpm13020306
Available online: https://www.mdpi.com/2075-4426/13/2/306
17. “Patient Self-Inflicted Lung Injury—A Narrative Review of Pathophysiology, Early Recognition, and Management Options”
by Peter Sklienka, Michal Frelich and Filip Burša
J. Pers. Med. 2023, 13(4), 593; https://doi.org/10.3390/jpm13040593
Available online: https://www.mdpi.com/2075-4426/13/4/593
18. “Causes of Polyserositis: A Systematic Review”
by Laura Elena Stoichitoiu, Georgeta Daniela Ionescu, Ingrid Neatu and Cristian Baicus
J. Pers. Med. 2023, 13(5), 834; https://doi.org/10.3390/jpm13050834
Available online: https://www.mdpi.com/2075-4426/13/5/834
19. “Tramadol May Increase Risk of Hip Fracture in Older Adults with Post-Traumatic Osteoarthritis”
by Ting-Yu Wu, Wen-Tien Wu, Ru-Ping Lee, Ing-Ho Chen, Tzai-Chiu Yu, Jen-Hung Wang and Kuang-Ting Yeh
J. Pers. Med. 2023, 13(4), 580; https://doi.org/10.3390/jpm13040580
Available online: https://www.mdpi.com/2075-4426/13/4/580
20. “Mast Cell Activation Syndrome Update—A Dermatological Perspective”
by Dana Mihaela Mihele, Paul Andrei Nistor, Gabriela Bruma, Cristina Iulia Mitran, Madalina Irina Mitran, Carmen Elena Condrat, Mihaela Tovaru, Mircea Tampa and Simona Roxana Georgescu
J. Pers. Med. 2023, 13(7), 1116; https://doi.org/10.3390/jpm13071116
Available online: https://www.mdpi.com/2075-4426/13/7/1116
19 January 2024
Journal of Personalized Medicine | Most Cited Papers in 2023
1. “Predicting the Onset of Diabetes with Machine Learning Methods”
by Chun-Yang Chou, Ding-Yang Hsu and Chun-Hung Chou
J. Pers. Med. 2023, 13(3), 406; https://doi.org/10.3390/jpm13030406
Available online: https://www.mdpi.com/2075-4426/13/3/406
2. “A Review of the Role of Artificial Intelligence in Healthcare”
by Ahmed Al Kuwaiti, Khalid Nazer, Abdullah Al-Reedy, Shaher Al-Shehri, Afnan Al-Muhanna, Arun Vijay Subbarayalu, Dhoha Al Muhanna and Fahad A. Al-Muhanna
J. Pers. Med. 2023, 13(6), 951; https://doi.org/10.3390/jpm13060951
Available online: https://www.mdpi.com/2075-4426/13/6/951
3. “The Rationale for Vitamin, Mineral, and Cofactor Treatment in the Precision Medical Care of Autism Spectrum Disorder”
by Neluwa-Liyanage R. Indika, Richard E. Frye, Daniel A. Rossignol, Susan C. Owens, Udara D. Senarathne, Andreas M. Grabrucker, Rasika Perera, Marielle P. K. J. Engelen and Nicolaas E. P. Deutz
J. Pers. Med. 2023, 13(2), 252; https://doi.org/10.3390/jpm13020252
Available online: https://www.mdpi.com/2075-4426/13/2/252
4. “Three-Dimensional Accuracy and Stability of Personalized Implants in Orthognathic Surgery: A Systematic Review and a Meta-Analysis”
by Alexandru Diaconu, Michael Boelstoft Holte, Gabriele Berg-Beckhoff and Else Marie Pinholt
J. Pers. Med. 2023, 13(1), 125; https://doi.org/10.3390/jpm13010125
Available online: https://www.mdpi.com/2075-4426/13/1/125
5. “Efficacy and Safety of Distal Radial Access for Transcatheter Arterial Chemoembolization (TACE) of the Liver”
by Roberto Minici, Raffaele Serra, Marco Giurdanella, Marisa Talarico, Maria Anna Siciliano, Gianpaolo Carrafiello and Domenico Laganà
J. Pers. Med. 2023, 13(4), 640; https://doi.org/10.3390/jpm13040640
Available online: https://www.mdpi.com/2075-4426/13/4/640
6. “Is Ozone a Valid Adjuvant Therapy for Periodontitis and Peri-Implantitis? A Systematic Review”
by Francesco D’Ambrosio, Mario Caggiano, Alfonso Acerra, Massimo Pisano and Francesco Giordano
J. Pers. Med. 2023, 13(4), 646; https://doi.org/10.3390/jpm13040646
Available online: https://www.mdpi.com/2075-4426/13/4/646
7. “Biomarkers as Prognostic Predictors and Therapeutic Guide in Critically Ill Patients: Clinical Evidence”
by Rosa Méndez Hernández and Fernando Ramasco Rueda
J. Pers. Med. 2023, 13(2), 333; https://doi.org/10.3390/jpm13020333
Available online: https://www.mdpi.com/2075-4426/13/2/333
8. “Long COVID: Clinical Framing, Biomarkers, and Therapeutic Approaches”
by Valeria Conti, Graziamaria Corbi, Francesco Sabbatino, Domenico De Pascale, Carmine Sellitto, Berenice Stefanelli, Nicola Bertini, Matteo De Simone, Luigi Liguori, Ilenia Di Paola et al.
J. Pers. Med. 2023, 13(2), 334; https://doi.org/10.3390/jpm13020334
Available online: https://www.mdpi.com/2075-4426/13/2/334
9. “Multi-Modal Stacking Ensemble for the Diagnosis of Cardiovascular Diseases”
by Taeyoung Yoon and Daesung Kang
J. Pers. Med. 2023, 13(2), 373; https://doi.org/10.3390/jpm13020373
Available online: https://www.mdpi.com/2075-4426/13/2/373
10. “COVID-19 and New-Onset Psychosis: A Comprehensive Review”
by Lorenzo Moccia, Georgios D. Kotzalidis, Giovanni Bartolucci, Sara Ruggiero, Laura Monti, Marco Biscosi, Beatrice Terenzi, Ottavia M. Ferrara, Marianna Mazza, Marco Di Nicola et al.
J. Pers. Med. 2023, 13(1), 104; https://doi.org/10.3390/jpm13010104
Available online: https://www.mdpi.com/2075-4426/13/1/104
11. “Ethical Implications of Chatbot Utilization in Nephrology”
by Oscar A. Garcia Valencia, Supawadee Suppadungsuk, Charat Thongprayoon, Jing Miao, Supawit Tangpanithandee, Iasmina M. Craici and Wisit Cheungpasitporn
J. Pers. Med. 2023, 13(9), 1363; https://doi.org/10.3390/jpm13091363
Available online: https://www.mdpi.com/2075-4426/13/9/1363
12. “A Summary on Tuberculosis Vaccine Development—Where to Go?”
by Fan Jiang, Tiehui Sun, Peng Cheng, Jie Wang and Wenping Gong
J. Pers. Med. 2023, 13(3), 408; https://doi.org/10.3390/jpm13030408
Available online: https://www.mdpi.com/2075-4426/13/3/408
13. “A Multi-Task Convolutional Neural Network for Semantic Segmentation and Event Detection in Laparoscopic Surgery”
by Giorgia Marullo, Leonardo Tanzi, Luca Ulrich, Francesco Porpiglia and Enrico Vezzetti
J. Pers. Med. 2023, 13(3), 413; https://doi.org/10.3390/jpm13030413
Available online: https://www.mdpi.com/2075-4426/13/3/413
14. “Use of Telemedicine Healthcare Systems in Children and Adolescents with Chronic Disease or in Transition Stages of Life: Consensus Document of the Italian Society of Telemedicine (SIT), of the Italian Society of Preventive and Social Pediatrics (SIPPS), of the Italian Society of Pediatric Primary Care (SICuPP), of the Italian Federation of Pediatric Doctors (FIMP) and of the Syndicate of Family Pediatrician Doctors (SIMPeF)”
by Susanna Esposito, Cristiano Rosafio, Francesco Antodaro, Alberto Argentiero, Marta Bassi, Paolo Becherucci, Fabio Bonsanto, Andrea Cagliero, Giulia Cannata, Fabio Capello et al.
J. Pers. Med. 2023, 13(2), 235; https://doi.org/10.3390/jpm13020235
Available online: https://www.mdpi.com/2075-4426/13/2/235
15. “Mechanisms of Allergen Immunotherapy and Potential Biomarkers for Clinical Evaluation”
by Umit M. Sahiner, Mattia Giovannini, Maria M. Escribese, Giovanni Paoletti, Enrico Heffler, Montserrat Alvaro Lozano, Domingo Barber, Giorgio Walter Canonica and Oliver Pfaar
J. Pers. Med. 2023, 13(5), 845; https://doi.org/10.3390/jpm13050845
Available online: https://www.mdpi.com/2075-4426/13/5/845
16. “Immunoinformatic-Based Multi-Epitope Vaccine Design for Co-Infection of Mycobacterium tuberculosis and SARS-CoV-2”
by Cong Peng, Fengjie Tang, Jie Wang, Peng Cheng, Liang Wang and Wenping Gong
J. Pers. Med. 2023, 13(1), 116; https://doi.org/10.3390/jpm13010116
Available online: https://www.mdpi.com/2075-4426/13/1/116
17. “The Association between Alexithymia and Social Media Addiction: Exploring the Role of Dysmorphic Symptoms, Symptoms Interference, and Self-Esteem, Controlling for Age and Gender”
by Alessio Gori and Eleonora Topino
J. Pers. Med. 2023, 13(1), 152; https://doi.org/10.3390/jpm13010152
Available online: https://www.mdpi.com/2075-4426/13/1/152
18. “The Role of BDNF as a Biomarker in Cognitive and Sensory Neurodegeneration”
by Anna Pisani, Fabiola Paciello, Valeria Del Vecchio, Rita Malesci, Eugenio De Corso, Elena Cantone and Anna Rita Fetoni
J. Pers. Med. 2023, 13(4), 652; https://doi.org/10.3390/jpm13040652
Available online: https://www.mdpi.com/2075-4426/13/4/652
19. “The Role of Cold Atmospheric Plasma in Wound Healing Processes in Critically Ill Patients”
by Tatiana Bolgeo, Antonio Maconi, Menada Gardalini, Denise Gatti, Roberta Di Matteo, Marco Lapidari, Yaroslava Longhitano, Gabriele Savioli, Andrea Piccioni and Christian Zanza
J. Pers. Med. 2023, 13(5), 736; https://doi.org/10.3390/jpm13050736
Available online: https://www.mdpi.com/2075-4426/13/5/736
20. “Epidemiology and Risk Factors of UTIs in Children—A Single-Center Observation”
by Maria Daniel, Hanna Szymanik-Grzelak, Janusz Sierdziński, Edyta Podsiadły, Magdalena Kowalewska-Młot and Małgorzata Pańczyk-Tomaszewska
J. Pers. Med. 2023, 13(1), 138; https://doi.org/10.3390/jpm13010138
Available online: https://www.mdpi.com/2075-4426/13/1/138
10 January 2024
Meet Us at the 53rd Annual Meeting of the Japanese Society for Spine Surgery and Related Research, 18–20 April 2024, Yokohama, Japan
MDPI will attend the 53rd Annual Meeting of the Japanese Society for Spine Surgery and Related Research as an exhibitor. This conference will be held in Yokohama, Japan, from 18 to 20 April 2024.
The following MDPI journals will be represented:
- JCM;
- JPM;
- JFMK;
- Osteology;
- Surgeries;
- Clinics and Practice;
- Surgical Techniques Development (STD);
- Biomechanics;
- Pathophysiology;
- Reports.
If you are attending this conference, please feel free to start a conversation with us at our booth. Our delegates look forward to meeting you in person and answering any questions that you may have.
For more information about the conference, please visit https://site2.convention.co.jp/jssr2024/index_en.html.
2 January 2024
MDPI Insights: The CEO's Letter #7 - Nobel Laureates Entrust MDPI with Their Research
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Nobel Prize Laureates Entrust MDPI with Their Research
The Nobel Prize stands as a hallmark of distinction, honouring ground-breaking research across disciplines. Annually, the Nobel Prizes are awarded in six categories: Physics, Chemistry, Medicine or Physiology, Literature, Peace, and Economic Sciences.
Through the years, renowned scholars have entrusted MDPI with their work. As at December 2023, 26 Nobel laureates have contributed to more than 75 articles across 25 MDPI journals, including: Antibiotics, Applied Sciences, Biology, Biomedicines, Cancers, Catalysts, Cells, Crystals, Entropy, Games, IJMS, Life, Materials, Micromachines, Molecules, Pharmaceuticals, Pharmaceutics, Photonics, Quantum Beam Science, Remote Sensing, Sensors, Solids, Universe, Vaccines, and Viruses.
The best of the best trust us with their work.
Nobel Prize Laureates Who Have Published with MDPI
We are proud to list the names of Pierre Agostini, Hiroshi Amano, Werner Arber, Aaron Ciechanover, Robert H. Grubbs, Oliver Hart, Gerard ‘t Hooft, Michael Houghton, Harald zur Hausen, Katalin Karikó, Jean-Marie Lehn, Gérard Mourou, Ferid Murad, Shuji Nakamura, William Nordhaus, Kostya S. Novoselov, Giorgio Parisi, Charles M. Rice, Alvin E. Roth, Donna Strickland, K. Barry Sharpless, George F. Smoot, Anne L’Huillier, Drew Weissman, Kurt Wüthrich, Ada Yonath.
The privilege of hosting such contributors resonates deeply with our editorial teams. For instance, in this interview, the Editor-in-Chief (EiC) of Universe speaks on the significance of publishing a paper by Nobel laureate Gerard ’t Hooft within the journal.
2023 Nobel Prize Winners Published by MDPI
Nobel Prize Winners, 2023: Katalin Karikó, Drew Weissman, Anne L’Huillier (Ill. Niklas Elmehed © Nobel Prize Outreach)
Three laureates from the 2023 Nobel Prize cohort have trusted MDPI as their publishing platform. Notably, in a 2022 Pharmaceutics paper, molecular biologist Katalin Karikó and her team presented a methodology for evaluating mRNA capping efficiency, pivotal for therapeutic applications. Pharmaceutics had previously dedicated a Special Issue to “mRNA Therapeutics: A Themed Issue in Honor of Professor Katalin Karikó”, spotlighting ten articles from August 2021 to February 2022.
In the journal Vaccines, Professor Drew Weissman, collaborating with scholars from Pennsylvania University and George Mason University, contributed an influential review titled “Nanomaterial Delivery Systems for mRNA Vaccines”. His collaborative efforts spanned five papers across MDPI journals between 2021 and 2023.
Furthermore, Anne L'Huillier of Lund University, only the fifth female recipient of the Physics Prize, co-authored an article in Applied Sciences focusing on "Advanced EUV and X-Ray Optics". Similarly, Pierre Agostini, an Emeritus Professor from Ohio State University, co-authored an article featured in the special issue "Attosecond Science and Technology: Principles and Applications".
We extend heartfelt congratulations to all Nobel Prize laureates and express sincere gratitude for their confidence in MDPI as a platform for their scholarly contributions.
Read more:
Impactful Research
MDPI Journals Newly Indexed in 2023
The aim of indexing is to enhance the quality and credibility of published research, ensuring that researchers access the most credible resources available. While the principle behind citation indexing is straightforward, it remains one of the most dependable methods for tracking an idea's evolution across various scientific disciplines.
Throughout the year, MDPI works to expand the reach of our publications across premier multidisciplinary databases like Web of Science, Scopus, EBSCO, and ProQuest. This initiative is spearheaded by MDPI's Indexing team, under the leadership of Dr. Constanze Schelhorn.
In 2023, MDPI achieved 54 new acceptances in Scopus, 29 in Web of Science, 52 in EBSCO, and 83 in DOAJ: Directory of Open Access Journals.
The team prioritizes ensuring that our journals feature in numerous specialized databases, including PMC, PubMed, MEDLINE, Inspec, CAS, and FSTA, among others. Currently, MDPI collaborates with over 65 renowned international databases, consistently enhancing our database affiliations annually.
MDPI’s journals are indexed in all major global databases.
Furthermore, we collaborate with universities and government organizations to list our journals in country-specific ranking lists and relevant institutional repositories. This ensures compliance with requirements often set by funders or institutions for authors to publish in specific journals.
Web of Science Adds 24 MDPI Journals to Emerging Sources Citation Index (ESCI)
Clarivate recently analysed MDPI’s new journals, resulting in 24 journals, mainly established in 2020, being added to the ESCI in November and December 2023. Additionally, five journals passed this assessment earlier in the year. For a complete list of our journals in Web of Science, refer here. Journals in the ESCI meet 24 quality criteria, ensuring editorial rigor. They may be considered for inclusion in broader indices like the Science Citation Index Expanded (SCIE), the Social Sciences Citation Index (SSCI), or the Arts and Humanities Citation Index (AHCI), based on four impact criteria.
Read more:
Inside MDPI
MDPI Appoints New Chief Operating Officer (COO)
Alistair Freeland returned to MDPI and assumed the role of Chief Operating Officer in November 2023, a position he previously held from 2013 to 2019. He succeeds Dr. Yu Lin, who will remain a member of MDPI’s Board of Directors, overseeing significant financial decisions for the company. I would like to express my sincere thanks to Dr. Yu Lin for his service as COO.
Alistair brings extensive experience not only in scholarly publishing but also in technology and business management. Prior to rejoining MDPI, he was associated with SIX Group, the entity responsible for Switzerland's financial market infrastructure. There, he played a pivotal role in developing the blockchain-based platform SDX (SIX Digital Exchange), which has gained traction among major Swiss banks and the Swiss National Bank.
As COO, Alistair will collaborate with the MDPI management team to improve the practices and services we offer to scholarly communities. I am pleased to welcome Alistair back to MDPI and look forward to his contributions going forward.
Coming Together for Science
MDPI’s 2024 In-Person Academic Events Schedule
MDPI's Conference Team is dedicated to organizing and hosting in-person academic events across Europe, Asia-Pacific, and North America. We recognize conferences as invaluable platforms for scientific collaboration, scholarly exchange, discussions on contemporary topics, networking, and forging collaborations.
Here's a glimpse of the notable events we currently have scheduled for 2024:
14–16 February, 2024 |
|
24–26 April, 2024 |
|
28–31 May, 2024 |
|
1–4 August, 2024 |
Upcoming events with details to be announced:
- September 2024, Materials 2024 – Basel, Switzerland
- 19–21 September 2024, International Conference on Nanomaterials Sciences 2024 – Beijing, China
- October 2024, ncRNA 2024 – Basel, Switzerland
- November 2024, Pharmaceuticals 2024 – Barcelona, Spain
- 22–26 November 2024, International Conference on Science of Electronics – Wuhan, China
- Stay tuned for more details on the Sustainable Publishing Forum 2024.
Click here for all upcoming MDPI events.
Organize Your Event with MDPI’s Sciforum
Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.
Closing Thoughts
Reflecting on 2023 and Looking Ahead to 2024
As we approach 2024, I reflect on the incredible journey we’ve had together at MDPI this year. The past 12 months have been marked by ambitious projects and initiatives to improve our internal processes, and a commitment to continue delivering top-notch services to our stakeholders. I’d like to thank each and every one of our staff members for contributing to the positive experiences our stakeholders have reported in our surveys. Your dedication to speed, efficiency, and effective communication with our stakeholders is very much recognized and appreciated.
Becoming a stronger organisation
While we have encountered challenges in 2023, it’s important to understand that these are a part of our growth process. Difficulties provide us with opportunities to reflect, address problems at their roots, and ultimately evolve into a stronger organization. Our stakeholders expect us to overcome tough times, and it’s an expectation that we have for ourselves.
I extend my sincere appreciation to every MDPI employee, from our editorial office and IT department to marketing, indexing, IOAP, societies, Scientific Office board, products, production, conferences, finance, operations, admin, and beyond. To our newest team members, a warm welcome; to our longstanding colleagues, your dedication is invaluable.
“I am committed to taking MDPI to a new level of excellence.”
Interacting with many of you during my visits to our offices and representing MDPI at external events has been a personal highlight. I am deeply grateful to Dr. Lin for entrusting me with the role of CEO of MDPI. Looking forward, I am committed to working closely with our management team to lead MDPI and take it to a new level of excellence, aiming to establish it as the most trusted publisher in open access worldwide. This is a collective endeavour, with each of us shaping MDPI’s reputation. I therefore encourage us to take pride in our work, as it represents not only our craft but also MDPI as a whole.
Accountability and communication
As we look forward to 2024, there’s a lot to be excited about. Together, we’ll navigate challenges, seize growth opportunities, and refine our practices. To solidify MDPI’s position as the premier open access publisher globally, we must bolster accountability, improve stakeholder communication, share MDPI’s best practices, champion the open access philosophy, and educate stakeholders about our mission, methodologies, and motivations.
Thank you for engaging with the CEO Letter over the past six months of 2023. I will continue to release this newsletter as a method of sharing the great work being done at MDPI. Please feel free to connect directly with any insights or questions.
Here’s to a joyous and prosperous 2024!
Chief Executive Officer
MDPI AG
25 December 2023
Journal of Personalized Medicine | Top 10 Cited Papers in 2022 in the Section “Omics/Informatics”
We are pleased to invite you to read the top 10 cited papers in 2022 in Journal of Personalized Medicine (ISSN: 2075-4426) in the Section “Omics/Informatics”. The list of papers is as follows:
1. “Global Challenges to Public Health Care Systems during the COVID-19 Pandemic: A Review of Pandemic Measures and Problems”
by Roxana Filip, Roxana Gheorghita Puscaselu, Liliana Anchidin-Norocel, Mihai Dimian and Wesley K. Savage
J. Pers. Med. 2022, 12(8), 1295; https://doi.org/10.3390/jpm12081295
Available online: https://www.mdpi.com/2075-4426/12/8/1295
2. “Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases”
by Giulia Gentile, Giovanna Morello, Valentina La Cognata, Maria Guarnaccia, Francesca Luisa Conforti and Sebastiano Cavallaro
J. Pers. Med. 2022, 12(5), 770; https://doi.org/10.3390/jpm12050770
Available online: https://www.mdpi.com/2075-4426/12/5/770
3. “CDK1 and HSP90AA1 Appear as the Novel Regulatory Genes in Non-Small Cell Lung Cancer: A Bioinformatics Approach”
by Nirjhar Bhattacharyya, Samriddhi Gupta, Shubham Sharma, Aman Soni, Sali Abubaker Bagabir, Malini Bhattacharyya, Atreyee Mukherjee, Atiah H. Almalki, Mustfa F. Alkhanani, Shafiul Haque et al.
J. Pers. Med. 2022, 12(3), 393; https://doi.org/10.3390/jpm12030393
Available online: https://www.mdpi.com/2075-4426/12/3/393
4. “miR-155: A Potential Biomarker for Predicting Mortality in COVID-19 Patients”
by Reut Kassif-Lerner, Keren Zloto, Nadav Rubin, Keren Asraf, Ram Doolman, Gidi Paret and Yael Nevo-Caspi
J. Pers. Med. 2022, 12(2), 324; https://doi.org/10.3390/jpm12020324
Available online: https://www.mdpi.com/2075-4426/12/2/324
5. “Computational Models for Clinical Applications in Personalized Medicine—Guidelines and Recommendations for Data Integration and Model Validation”
by Catherine Bjerre Collin, Tom Gebhardt, Martin Golebiewski, Tugce Karaderi, Maximilian Hillemanns, Faiz Muhammad Khan, Ali Salehzadeh-Yazdi, Marc Kirschner, Sylvia Krobitsch, EU-STANDS4PM consortium and Lars Kuepfer
J. Pers. Med. 2022, 12(2), 166; https://doi.org/10.3390/jpm12020166
Available online: https://www.mdpi.com/2075-4426/12/2/166
6. “The Penn Medicine BioBank: Towards a Genomics-Enabled Learning Healthcare System to Accelerate Precision Medicine in a Diverse Population”
by Anurag Verma, Scott M. Damrauer, Nawar Naseer, JoEllen Weaver, Colleen M. Kripke, Lindsay Guare, Giorgio Sirugo, Rachel L. Kember, Theodore G. Drivas, Scott M. Dudek et al.
J. Pers. Med. 2022, 12(12), 1974; https://doi.org/10.3390/jpm12121974
Available online: https://www.mdpi.com/2075-4426/12/12/1974
7. “Three-Dimensional Semantic Segmentation of Diabetic Retinopathy Lesions and Grading Using Transfer Learning”
by Natasha Shaukat, Javeria Amin, Muhammad Sharif, Faisal Azam, Seifedine Kadry and Sujatha Krishnamoorthy
J. Pers. Med. 2022, 12(9), 1454; https://doi.org/10.3390/jpm12091454
Available online: https://www.mdpi.com/2075-4426/12/9/1454
8. “Image Analysis in Digital Pathology Utilizing Machine Learning and Deep Neural Networks”
by Paris Amerikanos and Ilias Maglogiannis
J. Pers. Med. 2022, 12(9), 1444; https://doi.org/10.3390/jpm12091444
Available online: https://www.mdpi.com/2075-4426/12/9/1444
9. “Epigenetics in Precision Nutrition”
by Xiang Li and Lu Qi
J. Pers. Med. 2022, 12(4), 533; https://doi.org/10.3390/jpm12040533
Available online: https://www.mdpi.com/2075-4426/12/4/533
10. “Personalized Immunotherapies for Type 1 Diabetes: Who, What, When, and How?”
by Claire Deligne, Sylvaine You and Roberto Mallone
J. Pers. Med. 2022, 12(4), 542; https://doi.org/10.3390/jpm12040542
Available online: https://www.mdpi.com/2075-4426/12/4/542
15 December 2023
Journal of Personalized Medicine | Highly Cited Special Issues in the Section “Mechanisms of Diseases” in 2022
We are pleased to invite you to read the highly cited Special Issues in 2022 in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426), in the Section “Mechanisms of Diseases”. We hope this announcement will provide useful information for this field.
The Special Issues list is as follows:
“Personalized Medicine for COVID-19 Patients-Clinical Considerations” Edited by Dr. Paraskevi Katsaounou, Prof. Dr. Dimitrios B. Georgopoulos and Dr. Nikoletta Rovina Views: 75000+ | Cited by 230+ |
“Cardiovascular Disease Prevention in the Era of Personalized Medicine” Edited by Dr. Konstantinos Tziomalos Views: 49000+ | Cited by 150+ |
“Personalized Medicine in the Field of Inflammatory Skin Disorders” Edited by Dr. Mircea Tampa, Prof. Dr. Monica Neagu, Prof. Dr. Constantin Caruntu and Prof. Dr. Simona Roxana Georgescu Views: 48000+ | Cited by 190+ |
“Personalized Medicine for Parkinson's Disease: New Concepts and Future of Individualized Management” Edited by Dr. Nataliya Titova and Prof. Dr. Kallol Ray Chaudhuri Views: 44000+ | Cited by 90+ |
“Asthma: From Phenotypes to Personalized Medicine” Edited by Prof. Dr. Petros Bakakos Views: 26000+ | Cited by 70+ |
“Personalized Molecular Neurobiology of Brain Mapping of Global Pain and Mental Illness” Edited by Prof. Dr. Kenneth Blum, Dr. Babak Kateb, Dr. Vicky Yamamoto, Prof. Dr. Igor Elman, Dr. Mark S. Gold and Dr. Kai-Uwe Lewandrowski Views: 37000+ | Cited by 60+ |
You are welcome to view all the Special Issues and submit relevant papers to the Journal of Personalized Medicine. If you have any questions, you can contact the Editorial Office at [email protected].
Journal of Personalized Medicine Editorial Office
30 November 2023
MDPI Insights: The CEO's Letter #6 - MDPI Spain Summit and ResearchGate
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
MDPI Spain Summit
Stefan Tochev (CEO, MDPI) gives the opening speech at the MDPI Spain Summit.
On Friday 10 November 2023 I was in Barcelona, Spain, to deliver the opening presentation and participate in a panel at MDPI’s Spain Summit, a two-day event, inspired by our salon events in China.
With 16 Editors-in-Chief (EiCs) and 20 Editorial Board Members (EBMs) in attendance, the event, organized by our conference team and Barcelona office, featured presentations on open access (OA), MDPI, and publishing market trends in Spain.
The event provided a great opportunity to engage with stakeholders from various MDPI journals, including Nutrients, Vaccines, Buildings, IJMS, and others. We were able to gather feedback and have open conversations around manuscript quality, the peer-review process, and journal development, as well as accreditation agencies.
The main objective of this Summit was to bring together Editors representing MDPI journals across various disciplines within Spanish universities and research centers, primarily from the Barcelona area. The aim was to facilitate an open and fruitful discussion regarding the development of their journals, the future of OA in Spain, and to provide meaningful interactions and networking opportunities.
Connecting with Editorial Board Members
Stefan Tochev in conversation with Summit participants: "Our EBMs are passionate about the journals they serve."
Interacting with our EBMs in person provides a valuable opportunity to show how important it is to us to connect with them, hear their perspectives on their journals and learn more about their own experience collaborating with MDPI.
From my conversations, it was clear that our EBMs are passionate about the journals they serve. I know the advice they provide may sometimes involve just small tweaks, but these can lead to important improvements. As the saying goes, small hinges swing open big doors.
As at November 2023, MDPI has over 6,300 EBMs affiliated with Spanish institutions, with more than 30 of them serving as EiCs or section EiCs. Furthermore, over 68,000 Spanish scholars have contributed as reviewers in MDPI journals.
Open Access in Spain
In 2023, Spain implemented legislation mandating immediate OA for all publicly funded research, aligning with the EU’s Plan S initiative to expedite the transition to OA. The Spanish government also approved a four-year, €23.8 million annual budget for the first national OA strategy, aiming to make publicly funded research freely accessible upon publication. This strategy aims to strengthen the quality and transparency of research in Spain, and to help promote movement towards a digital, low-carbon economy.
For further details of Spain's OA policy and the history of government mandates, click here.
Spain has already seen a notable decline in subscription-only articles, decreasing by 62% over a 10-year period, while gold OA increased by 42%. Green OA slightly decreased, suggesting a shift towards publishing in gold OA journals rather than traditional subscription-based ones. Here are some statistics from Scopus.
A big thank-you to the various MDPI teams, including our conference team and the Barcelona office, for organizing this very successful event!
MDPI colleagues from various offices gathered to host and support the first MDPI Spain Summit, in Barcelona, Spain.
I think this type of gathering has the potential to become an annual event in various locations. For example, Manchester could be an option, as we have over 30 EiCs and over 3,000 EBMs in the UK, a top market for MDPI that publishes high-quality research.
Impactful Research
769 Editorial Board Members of MDPI Journals Recognized as Highly Cited Researchers in 2023
Congratulations to our 769 Editorial Board Members from 40 countries/territories who have been awarded Highly Cited Researcher status for 2023 by Clarivate. This recognition is based on their outstanding scientific research contributions and significant influence in various fields, as evidenced by Web of Science data.
Click here to view the full list of 769 Editorial Board Members.
Clarivate's Highly Cited ResearchersTM list identifies individuals with exceptional impact in scientific and social science domains over the past decade. Their papers rank in the top 1% of citations in 21 fields analysed in ‘Essential Science Indicators,’ showcasing their substantial influence.
This year, 7,125 Highly Cited Researcher 2023 designations were issued to 6,849 individuals from 67 countries, representing just 1 in 1,000 researchers worldwide.
These researchers demonstrate exceptional influence, representing a small fraction of contributors pushing the boundaries of knowledge, contributing to global well-being, sustainability, and security.
Congratulations to these scholars for their remarkable achievement: we are honoured to have them on board with our journals!
Inside MDPI
Corporate Marketing and Communications Strategy Session
Members of MDPI’s Corporate Marketing & Communications team.
For the past few years, I have led the Corporate Marketing & Communications department in our annual strategy session.
This typically involves 2–3 days of focused sessions covering key topics including budgeting, hiring targets, campaign reviews, and planning for the upcoming year, department strategy, and structure.
We are constantly exploring ways to optimize the Corporate Marketing & Communications department to support MDPI’s primary objectives and better convey the MDPI story while serving the scholarly community.
The strategy session also serves as a team-building activity, during which the team voted on bowling!
Strategy Session
In this strategy session, we looked at how to align our teams in order to better streamline our content with our campaigns, build a dedicated marketing team to strategically support our core MDPI products, expand our communications teams and functionalities to focus on company-critical campaigns and press releases, align our new brand design system with our marketing initiatives, set up a community and engagement team to support various teams with their outreach and communication efforts, and increase our use of data in the evaluation of campaign performance.
To grow in these areas, we will be hiring for various positions, including those of Public Relations Manager, Communications Manager, Internal Communications Manager, Campaign Manager, Marketing Associate, and Editorial Engagement Manager.
I am grateful for the way our Corporate Marketing & Communications department has grown and gelled over the years, and I look forward to supporting the department teams and their ideas for the future.
Coming Together for Science
ResearchGate and MDPI Partner to Boost the Visibility of Open Access Content through Journal Home
Stefan Tochev (CEO, MDPI) and Sören Hofmayer (Co-Founder and Chief Strategy Officer, ResearchGate) meet in Berlin, Germany to take their ongoing discussion further.
When I assumed the role of CEO at MDPI, my primary focus was to initiate the building of essential partnerships and collaborations within our industry. After all, I am a firm believer in achieving our goals by helping others achieve theirs and focusing on co-opetition wherever there is an opportunity. I first touched on the notion of co-opetition in MDPI Insights: The CEO's Letter #3, particularly when discussing collaborations with Elsevier.
In light of this, Sören Hofmayer (Co-Founder and Chief Strategy Officer at ResearchGate) and I connected recently to continue a discussion that had been ongoing for months. I was quickly brought up to speed and felt there was an opportunity for MDPI journals to pilot the Journal Home service that ResearchGate had launched. This would provide a new way for MDPI to engage with authors and readers and amplify the visibility of our journals.
While I receive many offers and opportunities for discussions with vendors, I am a firm believer that timing is everything, and in this case, the time for us is now. Sören and I met in person during my recent visit to Berlin and decided to proceed with piloting ten MDPI journals with the Journal Home service.
The press release below provides further details.
Press Release: Berlin (Germany) and Basel (Switzerland), 15 November 2023
ResearchGate, the professional network for researchers, and MDPI, the largest open access publisher in the world and a pioneer in open access publishing, today announced a partnership that will see ten of MDPI’s open access journals benefit from an enhanced presence on ResearchGate through its innovative Journal Home offering.
This new partnership will expand the reach and visibility of MDPI’s participating flagship journals with ResearchGate’s highly relevant community of more than 25 million researchers globally.
Around 210,000 version-of-record articles from these 10 titles will be readily available on ResearchGate, including the full archive material and all new articles as they are published. These journals also benefit from enhanced brand visibility, with dedicated journal profiles, prominent representation on all associated article pages and all relevant touchpoints across the ResearchGate network – keeping the journals top-of-mind with their reader and author audiences. All articles covered by the new partnership will automatically be added to the authors’ publication records in ResearchGate. This not only reduces MDPI authors’ needs for direct management but also offers them valuable insights into the impact of their work, including data about readership and citations.
Closing Thoughts
November is Men’s Health Awareness Month
Stefan Tochev (CEO, MDPI) listening to music as he writes at a coffee shop in Basel, Switzerland.
November is dedicated to raising awareness of various men’s health issues. I have been fortunate to have positive male role models in my life, and I strive to share my experiences with others.
I used to take part in Movember, growing my moustache throughout November to raise awareness and funds and to help “change the face of men’s health.” With male family and friends impacted by physical and mental health issues, I have recently become more interested in men’s overall well-being.
Men often face stigma involving the perceived need always to be strong and have things figured out. Recently, I’ve had meaningful conversations with male friends and colleagues about issues we rarely discuss, and it was a positive experience.
Various factors impact men’s health and well-being, all too easily leading to risky health behaviours including a lack of health awareness, poor health education, and negative, culturally induced, behaviour patterns in our work and personal lives. I hope we can break down these barriers in our work environment.
Healthy men help build healthy families and a healthy society
Men are less likely than women to seek help with their physical and mental health struggles. This is a reminder to prioritize your overall well-being. I hope that as men, we will continue to open up to one another, becoming vulnerable in order to share what we are going through. By sharing and by supporting each other, we can learn and grow together. You are not alone, and when you fall, you can still get up and stand tall.
From one broski to another, you are loved and appreciated. I hope this mindset carries into December and beyond.
Mindfulness
Our content team recently released a handful of articles on mindfulness, a practice that I believe provides a good opportunity for stress release and self-reflection:
Chief Executive Officer
MDPI AG
29 November 2023
Journal of Personalized Medicine | Top 15 Cited Papers on Disease Biomarkers in 2022
We are pleased to invite you to read the following 15 most highly cited papers published on the topic of disease biomarkers in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) in 2022.
1. “Emerging Biomarkers for Early Detection of Chronic Kidney Disease”
by Maja Mizdrak, Marko Kumrić, Tina Tičinović Kurir and Joško Božić
J. Pers. Med. 2022, 12(4), 548; https://doi.org/10.3390/jpm12040548
Available online: https://www.mdpi.com/2075-4426/12/4/548
2. “Sensory Ion Channel Candidates Inform on the Clinical Course of Pancreatic Cancer and Present Potential Targets for Repurposing of FDA-Approved Agents”
by Wenjie Shi, Chen Li, Thomas Wartmann, Christoph Kahlert, Renfei Du, Aristotelis Perrakis, Thomas Brunner, Roland S. Croner and Ulf D. Kahlert
J. Pers. Med. 2022, 12(3), 478; https://doi.org/10.3390/jpm12030478
Available online: https://www.mdpi.com/2075-4426/12/3/478
3. “Multi-Omics Profiling Approach to Asthma: An Evolving Paradigm”
by Yadu Gautam, Elisabet Johansson and Tesfaye B. Mersha
J. Pers. Med. 2022, 12(1), 66; https://doi.org/10.3390/jpm12010066
Available online: https://www.mdpi.com/2075-4426/12/1/66
4. “Deep Learning-Based Diagnosis of Alzheimer’s Disease”
by Tausifa Jan Saleem, Syed Rameem Zahra, Fan Wu, Ahmed Alwakeel, Mohammed Alwakeel, Fathe Jeribi and Mohammad Hijji
J. Pers. Med. 2022, 12(5), 815; https://doi.org/10.3390/jpm12050815
Available online: https://www.mdpi.com/2075-4426/12/5/815
5. “The Importance of SNPs at miRNA Binding Sites as Biomarkers of Gastric and Colorectal Cancers: A Systematic Review”
by Fatemeh Hajibabaie, Navid Abedpoor, Nazanin Assareh, Mohammad Amin Tabatabaiefar, Laleh Shariati and Ali Zarrabi
J. Pers. Med. 2022, 12(3), 456; https://doi.org/10.3390/jpm12030456
Available online: https://www.mdpi.com/2075-4426/12/3/456
6. “Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases”
by Giulia Gentile, Giovanna Morello, Valentina La Cognata, Maria Guarnaccia, Francesca Luisa Conforti and Sebastiano Cavallaro
J. Pers. Med. 2022, 12(5), 770; https://doi.org/10.3390/jpm12050770
Available online: https://www.mdpi.com/2075-4426/12/5/770
7. “Machine Learning-Assisted FTIR Analysis of Circulating Extracellular Vesicles for Cancer Liquid Biopsy”
by Riccardo Di Santo, Maria Vaccaro, Sabrina Romanò, Flavio Di Giacinto, Massimiliano Papi, Gian Ludovico Rapaccini, Marco De Spirito, Luca Miele, Umberto Basile and Gabriele Ciasca
J. Pers. Med. 2022, 12(6), 949; https://doi.org/10.3390/jpm12060949
Available online: https://www.mdpi.com/2075-4426/12/6/949
8. “CDK1 and HSP90AA1 Appear as the Novel Regulatory Genes in Non-Small Cell Lung Cancer: A Bioinformatics Approach”
by Nirjhar Bhattacharyya, Samriddhi Gupta, Shubham Sharma, Aman Soni, Sali Abubaker Bagabir, Malini Bhattacharyya, Atreyee Mukherjee, Atiah H. Almalki, Mustfa F. Alkhanani, Shafiul Haque et al.
J. Pers. Med. 2022, 12(3), 393; https://doi.org/10.3390/jpm12030393
Available online: https://www.mdpi.com/2075-4426/12/3/393
9. “Current Status, Issues and Future Prospects of Personalized Medicine for Each Disease”
by Yuichi Yamamoto, Norihiro Kanayama, Yusuke Nakayama and Nobuko Matsushima
J. Pers. Med. 2022, 12(3), 444; https://doi.org/10.3390/jpm12030444
Available online: https://www.mdpi.com/2075-4426/12/3/444
10. “miR-155: A Potential Biomarker for Predicting Mortality in COVID-19 Patients”
by Reut Kassif-Lerner, Keren Zloto, Nadav Rubin, Keren Asraf, Ram Doolman, Gidi Paret and Yael Nevo-Caspi
J. Pers. Med. 2022, 12(2), 324; https://doi.org/10.3390/jpm12020324
Available online: https://www.mdpi.com/2075-4426/12/2/324
11. “Olfaction Recovery following Dupilumab Is Independent of Nasal Polyp Reduction in CRSwNP”
by Elena Cantone, Eugenio De Corso, Filippo Ricciardiello, Claudio Di Nola, Giusi Grimaldi, Viviana Allocca and Gaetano Motta
J. Pers. Med. 2022, 12(8), 1215; https://doi.org/10.3390/jpm12081215
Available online: https://www.mdpi.com/2075-4426/12/8/1215
12. “Use of Circulating Tumour DNA (ctDNA) for Measurement of Therapy Predictive Biomarkers in Patients with Cancer”
by Michael J. Duffy and John Crown
J. Pers. Med. 2022, 12(1), 99; https://doi.org/10.3390/jpm12010099
Available online: https://www.mdpi.com/2075-4426/12/1/99
13. “Theratyping of the Rare CFTR Variants E193K and R334W in Rectal Organoid-Derived Epithelial Monolayers”
by Fabiana Ciciriello, Marcel J. C. Bijvelds, Federico Alghisi, Kelly F. Meijsen, Luca Cristiani, Claudio Sorio, Paola Melotti, Alessandro G. Fiocchi, Vincenzina Lucidi and Hugo R. De Jonge
J. Pers. Med. 2022, 12(4), 632; https://doi.org/10.3390/jpm12040632
Available online: https://www.mdpi.com/2075-4426/12/4/632
14. “Personalized Management of Myocarditis and Inflammatory Cardiomyopathy in Clinical Practice”
by Agata Tymińska, Krzysztof Ozierański, Aleksandra Skwarek, Agnieszka Kapłon-Cieślicka, Anna Baritussio, Marcin Grabowski, Renzo Marcolongo and Alida LP Caforio
J. Pers. Med. 2022, 12(2), 183; https://doi.org/10.3390/jpm12020183
Available online: https://www.mdpi.com/2075-4426/12/2/183
15. “From Skin Barrier Dysfunction to Systemic Impact of Atopic Dermatitis: Implications for a Precision Approach in Dermocosmetics and Medicine”
by Laura Maintz, Thomas Bieber, Helen D. Simpson and Anne-Laure Demessant-Flavigny
J. Pers. Med. 2022, 12(6), 893; https://doi.org/10.3390/jpm12060893
Available online: https://www.mdpi.com/2075-4426/12/6/893
21 November 2023
769 Editorial Board Members of MDPI Journals Achieve Highly Cited Researcher Recognition in 2023
We extend our sincere congratulations to the 769 Editorial Board Members of our journals – from 40 different countries/territories – who have been recognized as Highly Cited Researchers for the year 2023 by Clarivate. They are being recognized for their high-quality scientific research achievements and outstanding contributions to their professional fields, as indicated by Web of Science data.
Clarivate's annual list of Highly Cited ResearchersTM identifies the most highly cited scientists for the past decade who stand out for their significant and broad influence in various scientific and social science domains. Their impactful papers are among the top 1 per cent in the citation distribution of one or more of 21 fields analyzed in the "Essential Science Indicators", distinguishing them as hugely influential among their peers.
This year, 7,125 Highly Cited Researcher 2023 designations were issued to 6,849 individuals from 67 countries, representing just 1 in 1,000 researchers worldwide.
This means that these researchers have demonstrated an incredible level of significant and broad influence in their chosen field or fields over the last decade. They represent a small fraction of the researcher population whose contributions disproportionately push the boundaries of knowledge, enhancing global well-being, sustainability, and security.
Congratulations to the scholars for their noteworthy achievement – we are honored to have them on board with our journals!
Abate, Antonio |
Jaiswal, Amit K. |
Shen, Zexiang |
14 November 2023
Journal of Personalized Medicine | Top 15 Cited Papers on Precision Oncology in 2022
We are pleased to invite you to read the highly cited papers in 2022 from the Journal of Personalized Medicine (JPM, ISSN: 2075-4426), on the topic of precision oncology. The paper list is as follows:
1. “Atlas of PD-L1 for Pathologists: Indications, Scores, Diagnostic Platforms and Reporting Systems”
by Stefano Marletta, Nicola Fusco, Enrico Munari, Claudio Luchini, Alessia Cimadamore, Matteo Brunelli, Giulia Querzoli, Maurizio Martini, Elena Vigliar, Romano Colombari et al.
J. Pers. Med. 2022, 12(7), 1073; https://doi.org/10.3390/jpm12071073
Available online: https://www.mdpi.com/2075-4426/12/7/1073
2. “Sensory Ion Channel Candidates Inform on the Clinical Course of Pancreatic Cancer and Present Potential Targets for Repurposing of FDA-Approved Agents”
by Wenjie Shi, Chen Li, Thomas Wartmann, Christoph Kahlert, Renfei Du, Aristotelis Perrakis, Thomas Brunner, Roland S. Croner and Ulf D. Kahlert
J. Pers. Med. 2022, 12(3), 478; https://doi.org/10.3390/jpm12030478
Available online: https://www.mdpi.com/2075-4426/12/3/478
3. “Identification of Early Esophageal Cancer by Semantic Segmentation”
by Yu-Jen Fang, Arvind Mukundan, Yu-Ming Tsao, Chien-Wei Huang and Hsiang-Chen Wang
J. Pers. Med. 2022, 12(8), 1204; https://doi.org/10.3390/jpm12081204
Available online: https://www.mdpi.com/2075-4426/12/8/1204
4. “Towards Machine Learning-Aided Lung Cancer Clinical Routines: Approaches and Open Challenges”
by Francisco Silva, Tania Pereira, Inês Neves, Joana Morgado, Cláudia Freitas, Mafalda Malafaia, Joana Sousa, João Fonseca, Eduardo Negrão, Beatriz Flor de Lima et al.
J. Pers. Med. 2022, 12(3), 480; https://doi.org/10.3390/jpm12030480
Available online: https://www.mdpi.com/2075-4426/12/3/480
5. “Design and Development of an Intelligent Clinical Decision Support System Applied to the Evaluation of Breast Cancer Risk”
by Manuel Casal-Guisande, Alberto Comesaña-Campos, Inês Dutra, Jorge Cerqueiro-Pequeño and José-Benito Bouza-Rodríguez
J. Pers. Med. 2022, 12(2), 169; https://doi.org/10.3390/jpm12020169
Available online: https://www.mdpi.com/2075-4426/12/2/169
6. “Machine Learning-Assisted FTIR Analysis of Circulating Extracellular Vesicles for Cancer Liquid Biopsy”
by Riccardo Di Santo, Maria Vaccaro, Sabrina Romanò, Flavio Di Giacinto, Massimiliano Papi, Gian Ludovico Rapaccini, Marco De Spirito, Luca Miele, Umberto Basile and Gabriele Ciasca
J. Pers. Med. 2022, 12(6), 949; https://doi.org/10.3390/jpm12060949
Available online: https://www.mdpi.com/2075-4426/12/6/949
7. “CDK1 and HSP90AA1 Appear as the Novel Regulatory Genes in Non-Small Cell Lung Cancer: A Bioinformatics Approach”
by Nirjhar Bhattacharyya, Samriddhi Gupta, Shubham Sharma, Aman Soni, Sali Abubaker Bagabir, Malini Bhattacharyya, Atreyee Mukherjee, Atiah H. Almalki, Mustfa F. Alkhanani, Shafiul Haqu et al.
J. Pers. Med. 2022, 12(3), 393; https://doi.org/10.3390/jpm12030393
Available online: https://www.mdpi.com/2075-4426/12/3/393
8. ”Construction of a miRNA-Based Nomogram Model to Predict the Prognosis of Endometrial Cancer”
by Leyi Ni, Chengyun Tang, Yuning Wang, Jiaming Wan, Morgan G. Charles, Zilong Zhang, Chen Li, Ruijie Zeng, Yiyao Jin, Penghao Song et al.
J. Pers. Med. 2022, 12(7), 1154; https://doi.org/10.3390/jpm12071154
Available online: https://www.mdpi.com/2075-4426/12/7/1154
9. “Explainable Artificial Intelligence for Prediction of Complete Surgical Cytoreduction in Advanced-Stage Epithelial Ovarian Cancer”
by Alexandros Laios, Evangelos Kalampokis, Racheal Johnson, Amudha Thangavelu, Constantine Tarabanis, David Nugent and Diederick De Jong
J. Pers. Med. 2022, 12(4), 607; https://doi.org/10.3390/jpm12040607
Available online: https://www.mdpi.com/2075-4426/12/4/607
10. “Thyroid Diseases and Breast Cancer”
by Enke Baldini, Augusto Lauro, Domenico Tripodi, Daniele Pironi, Maria Ida Amabile, Iulia Catalina Ferent, Eleonora Lori, Federica Gagliardi, Maria Irene Bellini, Flavio Forte et al.
J. Pers. Med. 2022, 12(2), 156; https://doi.org/10.3390/jpm12020156
Available online: https://www.mdpi.com/2075-4426/12/2/156
11. “Use of Circulating Tumour DNA (ctDNA) for Measurement of Therapy Predictive Biomarkers in Patients with Cancer”
by Michael J. Duffy and John Crown
J. Pers. Med. 2022, 12(1), 99; https://doi.org/10.3390/jpm12010099
Available online: https://www.mdpi.com/2075-4426/12/1/99
12. “CD24: A Novel Target for Cancer Immunotherapy”
by Emmanouil Panagiotou, Nikolaos K. Syrigos, Andriani Charpidou, Elias Kotteas and Ioannis A. Vathiotis
J. Pers. Med. 2022, 12(8), 1235; https://doi.org/10.3390/jpm12081235
Available online: https://www.mdpi.com/2075-4426/12/8/1235
13. “Diffuse Intrinsic Pontine Glioma: Molecular Landscape, Evolving Treatment Strategies and Emerging Clinical Trials”
by Sudarshawn Damodharan, Montserrat Lara-Velazquez, Brooke Carmen Williamsen, Jeffrey Helgager and Mahua Dey
J. Pers. Med. 2022, 12(5), 840; https://doi.org/10.3390/jpm12050840
Available online: https://www.mdpi.com/2075-4426/12/5/840
14. “Multi-Class Classification of Breast Cancer Using 6B-Net with Deep Feature Fusion and Selection Method”
by Muhammad Junaid Umer, Muhammad Sharif, Seifedine Kadry and Abdullah Alharbi
J. Pers. Med. 2022, 12(5), 683; https://doi.org/10.3390/jpm12050683
Available online: https://www.mdpi.com/2075-4426/12/5/683
15. “Precision Medicine for Hepatocellular Carcinoma: Clinical Perspective”
by Danijel Galun, Dragana Mijac, Aleksandar Filipovic, Aleksandar Bogdanovic, Marko Zivanovic and Dragan Masulovic
J. Pers. Med. 2022, 12(2), 149; https://doi.org/10.3390/jpm12020149
Available online: https://www.mdpi.com/2075-4426/12/2/149
1 November 2023
MDPI Insights: The CEO's Letter #5 - OA Week, UK, and Strategy
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Open Access Week 2023 – the Global Drive to Open Continues
As the world's largest open-access (OA) publisher, we believe that unrestricted access to research findings is the cornerstone of transparency, efficiency, and quality control across scientific disciplines. At MDPI, we provide free, immediate access to scientific papers, empowering scientists to examine, validate, replicate, and build upon existing results. This minimizes redundancy, optimizes resources, and fosters innovative approaches.
International OA Week, held from 23 to 29 October 2023, provided a unique opportunity to link the global movement toward open sharing and open science with the progress of policy changes at the local level. Our mission, during OA Week and all the year round, is to offer educational resources highlighting the benefits of open-access publishing. The MDPI Blog is a valuable resource for information on open access and open science.
Core principles of OA publishing
Accessibility, transparency, and collaboration are core principles of OA publishing. OA aims to break down barriers that have traditionally restricted research access, ensuring that knowledge is available to all, regardless of financial situation or institutional affiliations. Our commitment to diverse pathways for OA publishing worldwide includes discounts for researchers. You can learn more about how MDPI supports scientific communities here.
One of the key strengths of OA publishing is its ability to facilitate interdisciplinary research. By removing paywalls and promoting knowledge-sharing across disciplines, OA encourages collaboration and innovation. Researchers from various fields can access and build upon each others’ work, fostering a holistic approach to addressing complex global challenges.
OA holds the potential to democratize knowledge, advance science, and drive positive societal change.
Policy driving change
Governments, institutions, and funding agencies have recognized the transformative potential of OA and have implemented policies to promote it. These policies often require publicly funded research to be made openly accessible, accelerating the growth of OA repositories and journals. Check out our spotlights on OA policies in the US, EU and China.
OA publishing is continuously evolving, with community-driven models and technologies shaping its future. Initiatives such as “Plan S” and “cOAlition S” promote OA publishing from the perspective of national funders, requiring grantees to publish their research openly. A new policy announced by the US administration last year mandates that, with effect from January 2026, all US federally funded research should be freely and immediately available after publication.
Additionally, preprint servers such as MDPI's Preprints.org, which allow researchers to share their findings before formal peer review, have gained popularity, enhancing the speed at which new knowledge is disseminated. The rise of blockchain technology is also being explored to ensure transparency and authenticity in scholarly publishing.
For more than two decades, OA publishing has been revolutionizing academic publishing by promoting accessibility, transparency, and collaboration. Its support for interdisciplinary research, evolving policies, and innovative practices all contribute to its growing influence in the global research community. As OA continues to expand, it holds the potential to democratize knowledge, advance science, and drive positive societal change.
MDPI is proud to lead the transition to open access.
Read more:
Impactful Research
Spotlight on Smart Cities
Smart cities will serve as a cornerstone for future human development. Their implementation will help us tackle many of the significant challenges we are facing – climate change, ageing populations, waste management, public safety, travel, and so on. Recognising the importance of this multifaceted field, MDPI launched the inaugural issue of Smart Cities in 2018 to provide an advanced forum for research into smart technology and society. Here we take a look at how this journal has developed, and its impact in this exciting field.
As at 30 October, 2023, Smart Cities has published 421 papers and has an Impact Factor of 6.4. It also has a CiteScore of 8.5, and more than one quarter of its published papers – 124 – have been cited 10 times or more.
Highly cited papers in Smart Cities
Below are several highly cited papers recently published in Smart Cities. Citation metrics are current as at 31 October 2023.
1. “Introducing the “15-Minute City”: Sustainability, Resilience and Place Identity in Future Post-Pandemic Cities”
Authors: Carlos Moreno, Zaheer Allam, Didier Chabaud, Catherine Gall and Florent Pratlong
Smart Cities 2021, 4(1), 93-111; https://doi.org/10.3390/smartcities4010006
Citations: Crossref (338), Scopus (366), Web of Science (270), Google Scholar (710)
The paper discusses the socio-economic impacts of the COVID-19 on cities, including increasing inequalities and rising unemployment. It introduces the concept of the "15-Minute City," a form of "chrono-urbanism," as a response to the challenges posed by the pandemic.
2. “A Review on Electric Vehicles: Technologies and Challenges”
Authors: Julio A. Sanguesa, Vicente Torres-Sanz, Piedad Garrido, Francisco J. Martinez and Johann M. Marquez-Barja
Smart Cities 2021, 4(1), 372-404; https://doi.org/10.3390/smartcities4010022
Citations: Crossref (359), Scopus (363), Web of Science (268), Google Scholar (558)
This paper provides an overview of the progress in Electric Vehicles (EVs), focusing on battery technology, charging methods, and emerging research challenges. It also analyzes the global EV market and its future outlook.
3. “IoT in Smart Cities: A Survey of Technologies, Practices and Challenges”
Authors: Abbas Shah Syed, Daniel Sierra-Sosa, Anup Kumar and Adel Elmaghraby
Smart Cities 2021, 4(2), 429-475; https://doi.org/10.3390/smartcities4020024
Citations: Crossref (121), Scopus (151), Web of Science (91), Google Scholar (215)
This paper gives an overview of the Internet of Things (IoT) in the context of Smart Cities, discussing the fundamental components, technologies, architectures, networking technologies, and artificial algorithms that underpin IoT-based Smart City systems.
4. “Artificial Intelligence Techniques in Smart Grid: A Survey”
Authors: Olufemi A. Omitaomu and Haoran Niu
Smart Cities 2021, 4(2), 548-568; https://doi.org/10.3390/smartcities4020029
Citations: Crossref (76), Scopus (94), Web of Science (57), Google Scholar (120)
This survey paper reviews the utilization of artificial intelligence (AI) techniques in the context of the smart grid. It covers various applications of AI in load forecasting, power grid stability assessment, fault detection, and security issues in the smart grid and power systems.
5. “The Metaverse as a Virtual Form of Smart Cities: Opportunities and Challenges for Environmental, Economic, and Social Sustainability in Urban Futures”
Authors: Zaheer Allam, Ayyoob Sharifi, Simon Elias Bibri, David Sydney Jones and John Krogstie
Smart Cities 2022, 5(3), 771-801; https://doi.org/10.3390/smartcities5030040
Citations: Crossref (72), Scopus (75), Web of Science (43), Google Scholar (176)
This paper discusses the concept of the Metaverse, a virtual world introduced by Meta (formerly Facebook), and its potential impact on urban life. It explores how emerging technologies such as AI, Big Data, IoT, and Digital Twins could reshape urban design and services in the context of the Metaverse.
Testimonial
“It was indeed a great and pleasant experience with MDPI regarding our recent publication. The submission process was very straightforward and less time-consuming than the norm. The review process was very fast compared to many other open access journals, which is praiseworthy. The support from the Editorial Office during the revision process was highly useful as well. We look forward to publishing with MDPI in the future, and I will most definitely recommend MDPI to my colleagues and collaborators.” – Dr. Luís Rosa, University of Minho
Article in Smart Cities: Mobile Networks and Internet of Things Infrastructures to Characterize Smart Human Mobility
Inside MDPI
MDPI Manchester office, UK Visit
Allie Shi (Editorial Director, MDPI), Stefan Tochev (CEO, MDPI), Jamie Anderson (Manchester Office Manager, MDPI), Michael O’Sullivan (Senior Scientific Officer, MDPI), Hushneara Akhtar, and Becky Castellon (IOAP Team Lead, MDPI), dining out in Manchester, UK.
In October, I visited MDPI’s new office in Manchester. During the visit, I connected with our English Editing (EE) managers, Scientific Officer, members of the Editorial team, the Marketing team, and IOAP Team Lead.
Our Manchester office focuses primarily on EE services and provides local support for the UK market. Additionally, we regularly visit Editorial Board members and participate in local conferences.
I would like to thank Jamie Anderson, Manchester Office Manager, and her team, for their deep commitment to our Manchester staff and to MDPI’s impact on the UK market.
The UK by numbers
The UK is a hub for the world’s top universities, making it a key market for MDPI and the publishing world in general. It is home to two of the top-five-ranked universities globally, 11 in the top 100, and 15 in the top 200.
As a result, the UK plays a key role in MDPI’s global market. As at October 2023, it ranks as the seventh-largest contributor to the total number of papers published by MDPI. We have 3,500 Editorial Board members affiliated with UK institutions, including 34 serving as Editors-in-Chief (EiCs). Our commitment to collaboration with institutions is evident in the UK, where we have successfully established some 60 Institutional Open Access Program (IOAP) agreements with esteemed institutions, such as the University of Oxford, the University of Cambridge, Imperial College London, the University of Edinburgh, and more.
According to InCites Dataset + ESCI for the period 2018–2022, as at October 2023, nearly 65% of UK papers are now published as OA. Just over 10% of total OA publications are by UK authors. UK papers are known for their high quality, with an average of 11 citations per paper. Furthermore, 2.16% of UK papers are in the top 1% of cited papers, and 14.61% are in the top 10% of cited papers, showcasing their impact.
We are currently hiring EEs in various locations worldwide.
English Editing at MDPI
Our English Editing (EE) department consists of two main branches, Quality Control and Learning and Development, reflecting our priorities. We are continuously enhancing the quality of our English Editing services and have raised the relevant standards, which now extend to company-wide communications. English editors participate in international interviews, conduct English assessments, and provide colleagues with presentations on ways to improve their use of written and spoken English.
While expanding, the EE department has proactively refocused its efforts on the quality of our work and how the English Editing department can benefit the company more broadly. We currently have approximately 140 full-time English Editors based across five offices worldwide, supplemented by over 700 freelance English editors.
Our Manchester office serves as the hub for the EE Department, with EE Managers situated there, except for Kurtis Jackson, who serves as the Head of EE and is located in our Basel office. Manchester EEs play a critical role in establishing and developing EE teams in our other offices, overseeing management and recruitment. The EE department plays a vital role in MDPI’s operations, as it is the department that touches every published paper. If this work interests you, I encourage you to explore our available EE positions, whether you are seeking full-time or freelance opportunities.
Testimonials
“MDPI provides an excellent service compared to any other previously used services. It delivers fast and high-quality results but at an affordable price.” – Ardha Apriyanto, University of Potsdam
“In my role as a professor, I consider that MDPI Author Services offer an excellent quality in the editing of Western academic writing while maintaining the required standards of clarity, precision and rigor. Additionally, delivery times are fast compared to other available services.” – Jesus Insuasti, University of Nariño
Read more:
Coming Together for Science
STM and Frankfurt Book Fair
Attending STM
MDPI has been a proud sponsor of the STM Conference for several years. The STM Conference is a dynamic event featuring interactive sessions, expert panellists, idea-sharing, and ample networking opportunities. On 16 October, the event kicked off with arrival drinks, sponsored by MDPI, followed by a welcoming dinner, providing a great chance to connect and network with industry professionals. The following day was filled with speakers, sessions, and further opportunities to connect. STM exemplifies the collaborative spirit of the scientific community, with session topics including achieving open, visible, and impactful research at scale; maintaining research integrity in a rapidly changing world; and exploring the impact of ever-evolving technology in the scholarly community.
Meeting with Web of Science
On a personal note, one of the highlights of STM was a candid and productive conversation with Nandita Quaderi, Editor-in-Chief and SVP at Web of Science. During our discussion, we talked about MDPI, Web of Science, the IJERPH delisting, and ways of moving forward. This open conversation aimed at fostering better collaboration for the future.
“We discussed ways to improve our communication and collaboration.”
I appreciated our frank discussion and felt that Nandita wholeheartedly supports open access. She also expressed her appreciation for the monthly CEO Letter, which she sees as a way to add personality to the MDPI brand and provide insight into the great work we do at MDPI. While we highlighted the positives, we also discussed ways to improve our communication and collaboration moving forward. This meeting alone made the trip worthwhile, and I hope Nandita doesn’t mind my sharing that she found our chat to be “the most honest and constructive discussion” she’s had with someone from MDPI in recent years.
75th Frankfurt Book Fair
Jelena Milojevic (Book Editor, MDPI), Jovana Dubajic (Book Editor, MDPI), Evan Escamilla (Project Manager, MDPI), Laura Wagner (Head of Books, MDPI), and Jenny Knowles (Commissioning Editor, MDPI), at the Frankfurt Book Fair in Frankfurt am Main, Germany.
For the 75th time, the Frankfurter Buchmesse opened its doors in October to celebrate exciting stories and their authors. If you haven’t yet had the chance to visit the Frankfurt Book Fair, I highly recommend it. It’s the largest book fair in the world, attracting thousands of visitors from around the globe. This is the place to gain valuable industry insights from top-class publishing professionals, connect with publishers directly, and learn about the latest trends in publishing.
MDPI Books
Our Books team was also present at the Frankfurt Book Fair, networking and learning from various panels. Did you know that our MDPI Books department publishes OA Books?
The book publishing program includes monographs, book series, edited books and reprints of special issues and topical collections, among other book types.
If you have a book proposal you would like to discuss, please feel free to contact our Books team to understand the benefits and methods of publishing your next book with the OA model.
Closing Thoughts
MDPI Strategy Meeting
As the newly appointed CEO, this is my first year leading the MDPI Senior Management Strategy session. I saw it as an opportunity to explore what MDPI has the potential to become in the next five years. Guided by the vision of its founder and President, Dr. Shu-kun Lin, the company has accomplished remarkable feats over the past 27 years and currently holds the position as the world’s third-largest academic publisher, following Springer Nature and Elsevier.
Our primary objective is to build upon the milestones of the past decades and consolidate MDPI’s position as well-established publishing brand. The two-day meeting emphasized the importance of communicating MDPI’s values more actively via its brand and adopting a straightforward yet impactful approach to managing MDPI as a mature academic publisher.
“Our primary objective is to consolidate MDPI’s position as well-established publishing brand”
As the world’s number one open-access publisher, MDPI has long been a game-changer in the scholarly community, serving millions of authors. The challenge in being a trailblazer is the need to continuously improve and at the same time explore the next blue-ocean strategy, while also maintaining the smooth operation of the business. Our collection model, featuring guest-curated thematic topics in the form of Special Issues, has disrupted the industry. Other publishers closely study us and attempt to replicate our models. The future of this collection model is something we are actively addressing – while, of course, looking ahead to what comes next!
Chief Executive Officer
MDPI AG
27 October 2023
Journal of Personalized Medicine | 2022 Impact Factor of 3.4 Officially Released
We are glad to announce that the 2022 Impact Factor for the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) is officially released! The journal’s Impact Factor is 3.4, ranking 67/169 (Q2) in the category “Medicine, General & Internal” and 42/106 (Q2) in the category “Health Care Sciences & Services”.
For JCR details, please visit the following link: https://jcr.clarivate.com/jcr-jp/journal-profile?journal=J%20PERS%20MED&year=2022&fromPage=%2Fjcr%2Fhome.
JPM is indexed within Scopus, SCIE (Web of Science), PubMed, PMC, Embase, and other databases. More details can be found on the journal's website: https://www.mdpi.com/journal/jpm.
The performance of the journal is inseparable from the support and dedication of all journal editors, reviewers, authors, and readers. We want to take this opportunity to thank all of you who have contributed to the journal.
19 October 2023
Open Access Week 2023 – the Global Drive to Open Continues
MDPI has been a strong proponent of the open access publishing model right from the beginning. As one of the pioneering fully open access publishers, we firmly believe that unrestricted access to research findings forms the foundation for better transparency, efficiency, and quality control across all scientific disciplines.
In December 2022, we reached a significant milestone by surpassing one million articles published. That is one million articles freely available to all, to circulate and build upon!
Offering free and immediate access to scientific papers empowers scientists to examine, validate, replicate, and expand upon existing results. This not only helps prevent redundancy and optimizes how resources are used but also paves the way for innovative new approaches.
The International Open Access Week takes place from 23 to 29 October 2023, providing a unique opportunity to connect the global movement towards open sharing and open science with the progress of policy transformations at the local level.
Our goal, during Open Access Week as well as throughout the year, is to offer resources for educating people about the benefits of open access publishing. The MDPI Blog offers a wealth of information around open access and open science.
Promoting the values of accessibility, transparency, and collaboration
Open access publishing embodies the fundamental values of democratizing knowledge and fostering global accessibility. It aims to break down barriers that have traditionally limited access to scholarly work, ensuring that knowledge is available to all, regardless of their financial or institutional affiliations.
Discounts are part of our commitment to ensuring there are diverse pathways to Open Access publishing for researchers worldwide. MDPI supports scientific communities in several different ways.
One of the key strengths of open access publishing lies in its ability to facilitate interdisciplinary research. By removing paywalls and promoting the sharing of knowledge across disciplines, OA encourages collaboration and innovation. Researchers from diverse fields can access and build upon each other's work, fostering a holistic approach to addressing complex global challenges.
Funders' policies are getting aligned with open science
Governments, institutions, and funding agencies have recognized the transformative potential of open access and have implemented policies to promote it. These policies often mandate that publicly funded research should be made openly accessible. Such initiatives have accelerated the growth of open access repositories and journals, reinforcing the commitment to open access principles. Check our spotlights on OA policies in the US, EU and China.
Open access publishing is continually evolving, with innovative and community-driven models and technologies shaping its future. Initiatives like "Plan S" and "cOAlition S" promote the adoption of OA publishing from the national funders’ perspective by requiring grantees to publish their research openly. A new policy announced by the US administration last year requires that, as of January 2026, all US federally funded research be made freely and immediately available after publication.
Additionally, preprint servers such as MDPI's Preprints.org, which allow researchers to share their findings before formal peer review, have gained popularity, enhancing the speed at which new knowledge is disseminated. The rise of blockchain technology is also being explored to ensure transparency and authenticity in scholarly publishing.
For more than twenty years, open access scholarly publishing has been revolutionizing academia by promoting the values of accessibility, transparency, and collaboration. Its support for interdisciplinary research, evolving policies, and innovative practices all contribute to its growing influence in the global research community. As open access continues to expand, it holds the potential to democratize knowledge, advance science, and drive positive societal change.
MDPI is proud to be a leader in the transition to open access.
18 October 2023
Meet Us at Neuroscience 2023, 11–15 November 2023, Washington, DC, USA
Neuroscience 2023 will be held from 11 to 15 November 2023 in Washington, DC, USA. The conference is organized by the Society for Neuroscience.
The conference will gather scientists, clinicians, and decision makers from around the world, creating a platform for the communication of knowledge and the sharing of groundbreaking research on the brain as well as nervous system. As stated in the introduction to the conference, you can “Present new research. Exchange ideas. Expand collaborations. Strengthen your career.”
As one of the exhibitors of Neuroscience 2022 last year, MDPI will be a part of Neuroscience 2023 this year, and looks forward to meeting our scholars as well as new friends, hoping to impress you with our open access publishing model face-to-face.
The following MDPI journals will be represented:
- Brain Sciences.
- JCM.
- Cells.
- NeuroSci.
- J. Intell.
- Neuroglia.
- JPM.
- Biomedicines.
- Clinics and Practice.
- Diagnostics.
- Neurology International.
- Pathophysiology.
- Psych.
If you are attending this conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you in person at the booth and answering any questions that you may have. For more information about the conference, please visit the following link: https://www.sfn.org/meetings/neuroscience-2023.
13 October 2023
Meet Us at the 34th Annual Meeting of the Japanese Society of Clinical Sports Medicine, 11–12 November 2023, Tokyo, Japan
MDPI will be attending the 34th Annual Meeting of the Japanese Society of Clinical Sports Medicine, which will be held from 11 to 12 November in Tokyo, Japan.
The theme of this academic conference is "Cooperation and Evolution". As many academic conferences have been held online due to the coronavirus pandemic, we are now realizing that one of the most important aspects of academic conferences is the face-to-face exchange of information inside and outside the academic venue. This academic conference will aim to promote the future progress of sports medicine by disseminating the research results of each person who has made progress during the coronavirus pandemic and by bringing together many participants for full discussions.
The following MDPI journals will be represented:
- Sports;
- Medicina;
- JPM;
- Nutrients;
- JCM;
- IJERPH;
- STD;
- Geriatrics.
If you are planning to attend this conference, please feel free to stop by our booth and chat with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.34rinspo.jp/index.html.
2 October 2023
MDPI Insights: The CEO's Letter #4 - MDPI Presence in China
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Open Access in China
It is Saturday, 23 September, and I have just returned from an unforgettable 12-day trip to China, visiting our main offices in Beijing and Wuhan. In the wake of a packed and very enjoyable agenda of internal and external meetings, I would like to use this edition of the CEO Letter to showcase how MDPI supports the scholarly community in China.
Coincidentally, Jack McKenna, Communications Associate from MDPI’s corporate content team, has just released a blog article discussing China’s open access (OA) policy. It is a timely read, providing a concise overview of the development of the OA movement in China and reflecting on its future. I shall draw some content from Jack’s piece and use this edition of the CEO Letter to highlight the various ways in which MDPI is involved in this market. And it would be remiss of me not to include some pictures and highlights from my travels!
Open Access Policy in China
As per Jack’s post, in 2020, China became the world’s leading producer of research articles. Today, China is experiencing a “substantial growth rate in OA [Open Access] publication”. This growth is supported by the State’s commitment to research & development and its policy “requiring the promotion of open science”.
Over the past two decades, there have been gradual developments in China’s OA framework, with repositories and platforms being developed in a consistent manner. Currently, key institutions across China – including the National Science Library, the National Science and Technology Library, and the Natural Science Foundation of China – support OA. The State aims to establish consistent policies across government agencies – a framework for a more encompassing embrace of OA across institutions.
In China, the number of subscription-only articles decreased by nearly 30% over the 10-year period of 2011–2021, while gold OA increased by 22%. Between 2017 and 2020 alone, China published 800,921 academic papers in an OA format.
In 2023, as the leading publisher of academic research, China is pursuing “self-reliance”. Therefore, the State will be establishing consistent policies across government agencies, including those related to OA. Additionally, it will want to ensure that Chinese people can access the research that is supported by Chinese funding and produced by Chinese academics. For this reason, “Open Access is a matter of priority in China”.
MDPI Offices in China
While the history of MDPI begins in Basel, Switzerland, the story of MDPI’s founder is very much rooted in China. Dr. Shu-kun Lin, Founder and President of MDPI, graduated with a BSc from Wuhan University in 1982. He also studied physical chemistry at the Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences (1982–1986; MSc in 1985), and at the University of Louisville, USA (1987–1989). Dr. Lin completed his doctorate in organic chemistry at the Swiss Federal Institute of Technology (ETH-Zürich) in 1992.
Stefan Tochev (CEO, MDPI) at MDPI’s Wuhan office.
In 2002, MDPI’s Basel headquarters moved to Matthäusstrasse 11, 4052 Basel, and Dr. Lin opened an editorial office in Qingdao, China, which launched the journal Marine Drugs in the following year. Below is a list of MDPI’s current offices in China and their respective dates of inauguration:
- 2008: Beijing (Tongzhou, Haidian)
- 2013: Wuhan (Hankou, Guanggu)
- 2019: Tianjin
- 2021: Dalian
- 2021: Nanjing
Our Strength is in Our People
With over 6,000 MDPI staff, across 20 offices in 11 countries, MDPI is able to offer authors responsive and efficient round-the-clock support, enabling a rapid publication process.
In my experience, stakeholders are genuinely surprised when they realize the extent of our global operations. My response is to reiterate that our people are our strength. This is why we have fast and efficient processes and top-notch responsiveness. Our global presence ensures that your manuscript is constantly attended to, rather than sitting on someone’s desk. We prioritize our authors’ needs and act quickly to move things through the various stages of publication. MDPI is built on speed, convenience, and competence, which I believe are core pillars for success in any industry. We continually strive to improve our systems and processes on the basis of these core strengths. We literally have over 6,000 staff worldwide dedicated to serving your needs. It’s not magic: it’s people; it’s real.
Impactful Research
MDPI Awards
To support the academic community, and especially young researchers, and also to enhance communication among scientists, MDPI journals offer various awards in specific fields. We serve the scientific community by funding research to facilitate the development of sustainable global solutions through our annual World Sustainability Award and Emerging Sustainability Leader Award.
In 2022, MDPI made awards totalling over US$1 million in recognition and support of researchers worldwide.
Across our journal catalogue, we have granted over 2,000 awards to recognize and support researchers from all disciplines. Since 2016, these awards have served as a source of recognition, acknowledging the impact of research by heightening the influence of talented individuals. The award types mainly include the Young Investigator Award, the Best PhD Thesis Award, the Best Paper Award, and the Outstanding Reviewer Award.
To learn more about MDPI Awards and to find out which are currently available, please click here.
MDPI Awards to Scholars from China
Since 2021, there have been 23 Best Paper Awards granted to authors affiliated with Chinese institutions, identifying their papers as having high-quality scientific impact. A total of 45 Chinese scholars have received awards such as the Young Investigator Award, the Best PhD Thesis Award, the Outstanding Reviewer Award, and the Tu Youyou Award, among others. Prizes for these awards include MDPI grants for paid publications, totalling over CHF 70,000 for scholars affiliated with Chinese institutions.
MDPI’s Tu Youyou Award
Prof. Tu Youyou (left), Dr. Shu-Kun Lin (President, MDPI).
In 2015, Professor Tu Youyou was awarded the Nobel Prize in Physiology or Medicine “for her discoveries concerning a novel therapy against Malaria.” In order to commemorate Professor Tu’s contributions to human health and to promote the passion and spirit conveyed by her experiences, MDPI in 2016 established the ‘Tu Youyou Award’, which runs biennially to recognize outstanding scholars dedicated to the research of natural products and medicinal chemistry.
The 2022 Tu Youyou Award was granted to Prof. Dr. Xiaoguang Lei of Peking University. Click here to access the interview with the winner.
2015 Nobel Prize for Medicine Awarded to Professor Youyou Tu
Professor Tu’s work was celebrated in a Special Issue from Molecules on the occasion of her 80th birthday. The Special Issue: 'Artemisinin (Qinghaosu): Commemorative Issue in Honor of Professor Youyou Tu on the Occasion of her 80th Anniversary” was created five years before she won the Nobel Prize, highlighting the visibility MDPI provides researchers and their work.
Highly Cited Articles by Chinese Scholars Published in MDPI
Click here to access the most cited MDPI papers published by scholars affiliated with Chinese institutions. This list presents the most influential research from the more than 287,000 MDPI papers published by Chinese scholars. With over 9 million total citations, I encourage you to maximize your visibility and impact by publishing with MDPI, the number one most cited open access publisher.
Read more:
- Tu Youyou Award
- World Sustainability Awards
- Available Awards
Inside MDPI
Stefan Tochev (CEO, MDPI) with the Beijing Marketing team.
Marketing Department in China
During my visit to our offices in Beijing and Wuhan, I had the opportunity to meet with, and to present to, our local marketing teams. These teams are responsible for various journal-related and corporate promotional activities, including newsletters, conferences, seminars, author training, journal awards, content creation, digital marketing, and social media.
I was pleased by the ambition and curiosity of our marketing colleagues. They showed a strong desire to collaborate and acquire knowledge and tactics to effectively market and promote MDPI-journal-related activities. I presented some of the principles and objectives that we apply in the Corporate Marketing and Communications department, and used the opportunity to strengthen our collaborative communications across offices.
Stefan Tochev (CEO, MDPI) with the Wuhan Marketing team.
Coming Together for Science
Collaborations, Scholarships and Meetings
MDPI maintains partnerships with nearly 190 learned societies and over 800 institutions and consortia, helping to facilitate the transition to OA publishing. Our commitment to working with institutions is evident in China, where we have successfully established over 35 Institutional Open Access Programs (IOAP) with esteemed institutions such as the Tsinghua University, Huazhong University of Science and Technology, and Shanghai Jiao Tong University.
Our institutional partnerships, waiver programs, and article processing cost discounts create diverse pathways to OA publishing for researchers worldwide.
Scholarships in China
Since 2021, several MDPI journals (Sensors, Photonics, Coatings, Materials, Energies, and Journal of Fungi) have funded full scholarships for four Master’s and five Ph.D. projects in China. These scholarships align with Tianjin University, Wuhan University of Technology, Central South University, the Chinese Academy of Sciences, and the China University of Petroleum (Beijing).
Meeting with the Society of Chinese University Journals (CUJS)
Prof. Tieming Zhang (President of CUJS, centre) and MDPI colleagues at CUJS office.
I am pleased to have participated in some highly productive meetings during my visit to China, including one with the Society of Chinese University Journals (CUJS). The meeting involved Prof. Tieming Zhang (President of CUJS), Assoc. Prof. Xin Zhang (Vice President and Secretary General), and Dr. Fei Gao (Executive Member of CUJS). Alongside my colleagues Dr. Guoshi Liu, Dr. Giulia Stefenelli, and Anita Sun, I represented MDPI and held an open discussion to address any questions regarding OA and MDPI.
We discussed several methods for collaboration, including a workshop on the future of peer review, MDPI sponsoring a funding grant for early-career researchers, and transitioning journals from diamond to gold OA. I am thankful for the opportunity to have met our colleagues at CUJS in person and feel very confident about our future collaborations in support of OA publishing in China.
MDPI hosts free academic seminars, author training sessions, and academic conferences as part of its commitment to enrich and support the scholarly community. CUJS often stages academic events (e.g., conferences, editor training, and editor competitions), and I believe there are great opportunities for CUJS and MDPI to collaborate accordingly.
Meeting with National Science Library, Chinese Academy of Sciences (NSLC)
Stefan Tochev (CEO, MDPI), Dr. Giulia Stefenelli (Chair of Scientific Officers, MDPI), Anita Sun (PR Manager, MDPI) and Dr. Guoshi Liu (Managing Director, MDPI) at the National Science Library, Chinese Academy of Sciences.
We also visited the NSLC Director, Xiwen Liu, and colleagues Ying Jin, Zhesi Shen, and Sichao Tong. Following our introductions, we gave a presentation on the history and editorial process at MDPI, discussing specific details related to MDPI’s business and data. We highlighted the status of our IOAP collaborations in China and the makeup of our author base, specifically in China, and drew attention to the fact that MDPI has published research by authors from every country in the world. We then discussed the design indicators, calculation methods and implementation purposes of the ‘Early Warning Journal List’ and how we can have open communication to provide any data regarding MDPI journals. I am pleased to report that we reached a consensus on future communications, and am grateful to NSLC for hosting us in their offices.
In-person meetings with stakeholders provide an invaluable opportunity to communicate what MDPI is about and the various ways in which we serve the scholarly community. While digital marketing and online communication are essential, they are no replacement for the understanding and trust that come about through in-person interactions.
The Numbers
As at September 2023, China holds the largest position in MDPI’s global market, ranking as the largest contributor to the total number of papers published by MDPI.
At this point in time, there were more than 847,000 China mainland scholars who have published with MDPI, 51 of whom are Section-Editors-in-Chief (SEiC) of MDPI journals, with seven serving as Editors-in-Chief (EiCs) for journals such as Air, Big Data and Cognitive Computing, Blockchains, Future, Nanoenergy Advances, and Targets.
Our growth and presence in China are a true testament to the service we provide to the scholarly community, and to the relationships we foster through collaborative activities. We look forward to continuing to support the growth of the scholarly community in China, providing a valuable and trusted experience with MDPI.
Closing Thoughts
Final Reflections on our MDPI Offices in Beijing and Wuhan
Stefan Tochev (CEO, MDPI), Dr. Constanze Schelhorn (Indexing Manager, MDPI), Jiale Shang (Admin, Tongzhou, MDPI) at Beijing Capital International Airport, Beijing.
I spent approximately two weeks visiting some of our offices in China, and the first word that comes to mind when describing my experience is ‘hospitality.’ My colleagues and I were met with enthusiasm and delight at the airport by the Tongzhou Admin team (thank you, Jiale Shang, and thank you, Eric Wang, for keeping us organized on this trip!) and were taken care of with great attention. From hotels to transportation, dinners, and meetings, our stay was catered for perfectly.
Perhaps this is where MDPI’s focus on customers and service originates. At our core, we are a service company that provides a publishing platform for its authors. It’s therefore no surprise that authors consistently rate their experience with MDPI very highly.
95% of submitting authors rate their overall experience with the MDPI publication process as Excellent or Good (Springer Nature report 90%).
91% of submitting authors rate their overall experience with the MDPI peer review process as Excellent or Good.
Speed/Efficiency and Editorial Relationship are two key reasons underlying this high satisfaction score. ‘Editorial Relationship’ can be further explored, but in the past month, the most commonly noted aspects were the professionalism, kindness, availability, communicativeness, and personalized assistance provided by our editorial staff throughout the process. These attributes are at the core of our work across all our offices and continents.
Hospitality and Service
Just as our Chinese colleagues strove to keep us engaged by showing us the city sights (thank you, Thea Pan, and Jason Wu from the Wuhan Marketing team!) and sharing a variety of wonderful meals, our editorial staff are committed to serving our authors throughout their publishing journey. Our aim is to place the author at the centre of everything we do, eager to welcome our ‘guests’ and provide them with a pleasant publishing experience.
I asked my colleague Francis Wu (Senior Publisher, Wuhan office) where this hospitality originates. He responded that it is part of Chinese culture. I reflected long and deep on this answer. China is a vast country, and when visitors arrive, hosts want to ensure they feel welcomed and taken care of in order to maximize their time and visit. I can’t think of a better analogy for how I would want our authors to feel when they visit MDPI for their publishing needs. A company culture that prioritizes service, something that goes beyond products and productivity, and focuses on the overall experience. Over 6,000 people, across all MDPI offices, are ready, willing and able to go the extra mile for their colleagues and their customers. This is something I am truly proud of.
Chief Executive Officer
MDPI AG
25 September 2023
Meet Us at the Gerontological Society of America (GSA) 2023 Annual Scientific Meeting, 8–12 November 2023, Tampa, Florida, USA
MDPI will attend the Gerontological Society of America (GSA) 2023 Annual Scientific Meeting. The Gerontological Society of America is the oldest and largest interdisciplinary organization devoted to research, education, and practice in the field of aging.
The GSA 2023 Annual Scientific Meeting draws professionals in the field of aging on a global scale. Attendees represent specialties including geriatrics, biological sciences, nursing, nutrition, medicine, social work, economics, policy, psychology, and more. The Annual Scientific Meeting offers an extensive amount of stimulating and high-level scholarship, from a diverse variety of aging research disciplines. It is this new, enriching knowledge that will inform policy, practice, and research for years to come.
The following MDPI journals will be represented:
- Healthcare;
- Medicina;
- Epidemiologia;
- Nutrients;
- JCM;
- JPM;
- IJERPH;
- Nursing Reports;
- Geriatrics;
- Life;
- BioMedInformatics;
- Behavioral Sciences;
- Societies;
- JAL.
If you plan on attending this conference, please feel free to stop by our booth #119 and start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have.
For more information about the conference, please visit https://www.gsa2023.org.
22 September 2023
Journal of Personalized Medicine | Media Partnership with the Biomarkers Europe 2023 Conference, 14–15 November 2023, Berlin, Germany
Gain insights into biomarker approaches and accelerate timelines in drug development for oncology and immuno-related therapies at Oxford Global’s Biomarkers Europe 2023 conference. Hear from and meet with the visionary leading experts in biomarker discovery, development, and analysis, expand your knowledge and discuss future priorities in the advancement and acceleration of drug development in oncology and immuno-related therapies.
View the agenda here.
Register here.
Co-located with Targets & Cell Types in Immuno-Oncology Europe 2023 and Precision Oncology Europe 2023 this is the event to attend to stay ahead of the research and scientific innovations.
For more information contact [email protected].
22 September 2023
Journal of Personalized Medicine | Media Partnership with the Precision Oncology Europe 2023 Conference, 14–15 November 2023, Berlin, Germany
Advance key molecular characterizations for the emergence of more targeted and precise treatments in oncology at Oxford Global’s Precision Oncology Europe 2023 conference. Hear from and meet with visionary leading figures in precision oncology, expand your knowledge and discuss future priorities in how companies are innovating in precision medicine, digital pathology, and molecular testing to accelerate timelines and reduce risk in drug development.
View the agenda here.
Register here.
Co-located with Targets & Cell Types in Immuno-Oncology Europe 2023 and Biomarkers Europe 2023, this is the event to attend to stay ahead of the research and scientific innovations.
For more information contact [email protected].
22 September 2023
Journal of Personalized Medicine | Media Partnership with the 7th Annual Biomarkers US 2023 Conference, 12–13 October 2023, San Diego, USA
Gain a US perspective on the latest technologies and novel biomarkers driving forward translational research and precision medicine at Oxford Global’s 7th Annual Biomarkers US 2023 conference. The event will bring together over 300 visionary leaders to discuss the latest innovations in the field. Meet key decision makers representing leading pharma, biotech, and academic organizations working in the biomarker industry across multiple therapeutic areas.
View the agenda here.
Register here.
Co-located with the 5th Annual Advances in Immuno-Oncology USA Congress, if you wish to stay ahead of research and scientific innovations, this is the event to attend.
For more information, contact [email protected].
20 September 2023
Meet Us at the 109th Radiological Society of North America Scientific Assembly and Annual Meeting (RSNA 2023), 26–29 November 2023, Chicago, USA
Conference: RSNA 2023
Organization: The Radiological Society of North America
Date: 26–29 November 2023
Place: McCormick Place, 2301 S. Lake Shore Drive, Chicago, IL 60616 USA
Booth: #1103
The Radiological Society of North America (RSNA) is a non-profit organization. RSNA’s annual meeting provides radiology professionals and industry partners with endless opportunities to learn, connect, exchange ideas, and see the latest technology in action. This year’s theme—Leading through Change—focuses on how radiology professionals can be intentional and proactive while leading teams and organizations through change.
The following MDPI journals will be represented as exhibitors:
- Diagnostics;
- JPM;
- Tomography;
- JCM;
- Osteology;
- Radiation;
- Cancers.
If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions you may have. For more information about the conference, please visit the following website: https://www.rsna.org/annual-meeting.
14 September 2023
Journal of Personalized Medicine | Top 20 Cited Papers in 2021
1. “The Enhanced Permeability and Retention (EPR) Effect: The Significance of the Concept and Methods to Enhance Its Application”
by Jun Wu
J. Pers. Med. 2021, 11(8), 771; https://doi.org/10.3390/jpm11080771
Available online: https://www.mdpi.com/2075-4426/11/8/771
2. “Recent Advances in Tumor Targeting via EPR Effect for Cancer Treatment”
by Md Abdus Subhan, Satya Siva Kishan Yalamarty, Nina Filipczak, Farzana Parveen and Vladimir P. Torchilin
J. Pers. Med. 2021, 11(6), 571; https://doi.org/10.3390/jpm11060571
Available online: https://www.mdpi.com/2075-4426/11/6/571
3. “Digital Twins: From Personalised Medicine to Precision Public Health”
by Maged N. Kamel Boulos and Peng Zhang
J. Pers. Med. 2021, 11(8), 745; https://doi.org/10.3390/jpm11080745
Available online: https://www.mdpi.com/2075-4426/11/8/745
4. “The 35th Anniversary of the Discovery of EPR Effect: A New Wave of Nanomedicines for Tumor-Targeted Drug Delivery—Personal Remarks and Future Prospects”
by Hiroshi Maeda
J. Pers. Med. 2021, 11(3), 229; https://doi.org/10.3390/jpm11030229
Available online: https://www.mdpi.com/2075-4426/11/3/229
5. “A Rare Case of Cerebral Venous Thrombosis and Disseminated Intravascular Coagulation Temporally Associated to the COVID-19 Vaccine Administration”
by Vincenzo D’Agostino, Ferdinando Caranci, Alberto Negro, Valeria Piscitelli, Bernardino Tuccillo, Fabrizio Fasano, Giovanni Sirabella, Ines Marano, Vincenza Granata, Roberta Grassi et al.
J. Pers. Med. 2021, 11(4), 285; https://doi.org/10.3390/jpm11040285
Available online: https://www.mdpi.com/2075-4426/11/4/285
6. “Breast Cancer Treatments: Updates and New Challenges”
by Anna Burguin, Caroline Diorio and Francine Durocher
J. Pers. Med. 2021, 11(8), 808; https://doi.org/10.3390/jpm11080808
Available online: https://www.mdpi.com/2075-4426/11/8/808
7. “Breast Cancer Type Classification Using Machine Learning”
by Jiande Wu and Chindo Hicks
J. Pers. Med. 2021, 11(2), 61; https://doi.org/10.3390/jpm11020061
Available online: https://www.mdpi.com/2075-4426/11/2/61
8. “Making Radiomics More Reproducible across Scanner and Imaging Protocol Variations: A Review of Harmonization Methods”
by Shruti Atul Mali, Abdalla Ibrahim, Henry C. Woodruff, Vincent Andrearczyk, Henning Müller, Sergey Primakov, Zohaib Salahuddin, Avishek Chatterjee and Philippe Lambin
J. Pers. Med. 2021, 11(9), 842; https://doi.org/10.3390/jpm11090842
Available online: https://www.mdpi.com/2075-4426/11/9/842
9. “Nanodrug Delivery Systems Modulate Tumor Vessels to Increase the Enhanced Permeability and Retention Effect”
by Dong Huang, Lingna Sun, Leaf Huang and Yanzuo Chen
J. Pers. Med. 2021, 11(2), 124; https://doi.org/10.3390/jpm11020124
Available online: https://www.mdpi.com/2075-4426/11/2/124
10. “Comparing the Impact of COVID-19 on Nurses’ Turnover Intentions before and during the Pandemic in Qatar”
by Abdulqadir J. Nashwan, Ahmad A. Abujaber, Ralph C. Villar, Ananth Nazarene, Mahmood M. Al-Jabry and Evangelos C. Fradelos
J. Pers. Med. 2021, 11(6), 456; https://doi.org/10.3390/jpm11060456
Available online: https://www.mdpi.com/2075-4426/11/6/456
11. “Pharmacogenetics of Direct Oral Anticoagulants: A Systematic Review”
by Johanna Raymond, Laurent Imbert, Thibault Cousin, Thomas Duflot, Rémi Varin, Julien Wils and Fabien Lamoureux
J. Pers. Med. 2021, 11(1), 37; https://doi.org/10.3390/jpm11010037
Available online: https://www.mdpi.com/2075-4426/11/1/37
12. “Current Trends in Advanced Alginate-Based Wound Dressings for Chronic Wounds”
by Andreea Barbu, Bogdan Neamtu, Marius Zăhan, Gabriela Mariana Iancu, Ciprian Bacila and Vioara Mireșan
J. Pers. Med. 2021, 11(9), 890; https://doi.org/10.3390/jpm11090890
Available online: https://www.mdpi.com/2075-4426/11/9/890
13. “Liquid Biopsy Biomarkers in Urine: A Route towards Molecular Diagnosis and Personalized Medicine of Bladder Cancer”
by Matteo Ferro, Evelina La Civita, Antonietta Liotti, Michele Cennamo, Fabiana Tortora, Carlo Buonerba, Felice Crocetto, Giuseppe Lucarelli, Gian Maria Busetto, Francesco Del Giudice et al.
J. Pers. Med. 2021, 11(3), 237; https://doi.org/10.3390/jpm11030237
Available online: https://www.mdpi.com/2075-4426/11/3/237
14. “The Epidemiology and Genetics of Hyperuricemia and Gout across Major Racial Groups: A Literature Review and Population Genetics Secondary Database Analysis”
by Faven Butler, Ali Alghubayshi and Youssef Roman
J. Pers. Med. 2021, 11(3), 231; https://doi.org/10.3390/jpm11030231
Available online: https://www.mdpi.com/2075-4426/11/3/231
15. “TRANS-TACE: Prognostic Role of the Transient Hypertransaminasemia after Conventional Chemoembolization for Hepatocellular Carcinoma”
by Alessandro Granito, Antonio Facciorusso, Rodolfo Sacco, Laura Bartalena, Cristina Mosconi, Ugo Vittorio Cea, Alberta Cappelli, Matteo Antonino, Francesco Modestino, Nicolò Brandi et al.
J. Pers. Med. 2021, 11(10), 1041; https://doi.org/10.3390/jpm11101041
Available online: https://www.mdpi.com/2075-4426/11/10/1041
16. “Artificial Intelligence and COVID-19 Using Chest CT Scan and Chest X-ray Images: Machine Learning and Deep Learning Approaches for Diagnosis and Treatment”
by Roberta Fusco, Roberta Grassi, Vincenza Granata, Sergio Venanzio Setola, Francesca Grassi, Diletta Cozzi, Biagio Pecori, Francesco Izzo and Antonella Petrillo
J. Pers. Med. 2021, 11(10), 993; https://doi.org/10.3390/jpm11100993
Available online: https://www.mdpi.com/2075-4426/11/10/993
17. “Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation (PERSPECTIVE I&I)”
by Jennifer D. Brooks, Hermann Nabi, Irene L. Andrulis, Antonis C. Antoniou, Jocelyne Chiquette, Philippe Després, Peter Devilee, Michel Dorval, Arnaud Droit, Douglas F. Easton et al.
J. Pers. Med. 2021, 11(6), 511; https://doi.org/10.3390/jpm11060511
Available online: https://www.mdpi.com/2075-4426/11/6/511
18. “How Do Machines Learn? Artificial Intelligence as a New Era in Medicine”
by Oliwia Koteluk, Adrian Wartecki, Sylwia Mazurek, Iga Kołodziejczak and Andrzej Mackiewicz
J. Pers. Med. 2021, 11(1), 32; https://doi.org/10.3390/jpm11010032
Available online: https://www.mdpi.com/2075-4426/11/1/32
19. “Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types”
by Minghui Li, Jing Yuan, Gang Lv, Jacob Brown, Xiangxiang Jiang and Zhiqiang Kevin Lu
J. Pers. Med. 2021, 11(11), 1106; https://doi.org/10.3390/jpm11111106
Available online: https://www.mdpi.com/2075-4426/11/11/1106
20. “Treatment-Resistant Depression Revisited: A Glimmer of Hope”
by Angelos Halaris, Emilie Sohl and Elizabeth A. Whitham
J. Pers. Med. 2021, 11(2), 155; https://doi.org/10.3390/jpm11020155
Available online: https://www.mdpi.com/2075-4426/11/2/155
6 September 2023
Recap of Awards Granted to Scholars in 2022
MDPI is committed to supporting the academic community, nurturing talent and advancing science. Awards are an important part of the research landscape and play a vital role in helping academics gain recognition, especially young researchers as they embark on new research avenues.
In 2022, our journals presented a total number of 394 Awards, including Travel Awards, Young Investigator Awards, Best PhD Thesis Awards, Best Paper Awards, and Outstanding Reviewer Awards, with several winners announced for some of the awards. The total prize sum amounted to just under 580,000 Swiss francs (CHF), or approximately 650,000 US dollars. Overall, more than 720 scholars were awarded.
The majority of the awards were dedicated to young researchers in relatively early stages of their careers. This encompassed 66 of the afore-mentioned Travel Awards, 60 Young Investigator Awards, supporting research projects and conference attendance, as well as 51 Best PhD Thesis Awards. Additionally, 113 Best Paper Awards were given by our journals. The selection committees were entrusted with identifying the most impactful and novel research and review articles published in their journal within a given year.
MDPI will continue its support and recognition for the academic community moving forward, sponsoring new awards across disciplines. To learn more about all the awardees and their research projects in your field of study, please visit the following pages:
To explore more MDPI awards, please click here.
30 August 2023
MDPI Insights: The CEO's Letter #3 - Sustainability and Co-opetition
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Our Commitment to Sustainability
As a pioneer in academic open access publishing since 1996, MDPI has always been dedicated to facilitating scientific exchange across all disciplines. Our approach to open science is guided by principles such as Open Access (OA), Timeliness and Efficiency, Simplicity, High-Quality Service, Flexibility, and a commitment to Sustainability. This commitment involves preserving published papers for the long term and supporting the future of science through partnerships, sponsorships, and awards.
In this edition of the CEO Letter, I will delve into MDPI’s various sustainability initiatives. As a leader in OA publishing, we are able to provide the public with a significant amount of environment-related content at no cost.
MDPI and the Sustainable Development Goals (SDGs)
In 2020, the SDG Publishers Compact was launched to accelerate implementation of the SDGs by promoting content that informs, develops, and inspires action. MDPI joined this initiative in 2021 and subsequently launched the MDPI SDG Hub in 2022, offering free access to recent research within the scope of each of the 17 SDGs. We also support authors from underrepresented communities by waiving publication charges for selected SDG-related papers. Detailed sustainability practices and supported publications are available in the report under each Goal page.
“More than 80% of MDPI articles and reviews published in 2022 relate to the Sustainable Development Goals.” [source: InCites, Accessed on 21.08.2023]
As at August 2023, MDPI boasts 14 journals dedicated to sustainability-related topics. Our first journal in this area, Sustainability, has published over 29,000 articles on the SDGs, accumulating over 240,000 citations (source: InCites, as at 1 January 2023). These journals serve as vital platforms for researchers to share insights and address environmental challenges. In addition:
MDPI journals specializing in sustainability-related topics:
- 2009: Sustainability
- 2012: Resources
- 2013: Climate
- 2014: Environments
- 2016: Recycling
- 2019: Clean Technologies
- 2020: Sustainable Chemistry
- 2021: Wind, Biomass, Conservation, Pollutants, Solar
- 2022: Waste, Microplastics
Read more:
Impactful Research
Highly Cited Articles in Sustainability
In 2022, content published in Sustainability and indexed in Journal Citation Reports (JCR) received nearly 190,000 citations. This highlights the fact that Sustainability publishes highly cited research articles related to environmental sciences and SDG-related topics such as climate action.
We are pleased to share that Sustainability received a 2022 CiteScore of 5.8, marking a 16% increase from the 2021 metric. Specifically, the CiteScore positions Sustainability as follows: Q1 (27 out of 163) in the “Environmental Science (miscellaneous)” category, and Q1 (101 out of 779) in the “Geography Planning and Development” category. For additional journal statistics, please visit here.
“Sustainability received a 2022 CiteScore of 5.8”
While MDPI journals such as Climate and Atmosphere have a distinct focus on atmosphere pollution and its impact on climate processes, journals like Sustainability, Environments, Water, Remote Sensing, and IJERPH publish content related to climate change. These journals have published over 32,300 articles related to SDG 13: Climate Action.
Highly Cited Papers in Sustainability
Below are several highly cited papers published in Sustainability over the past three years. Citation metrics are current as at 15 August 2023.
1. “A Global Assessment: Can Renewable Energy Replace Fossil Fuels by 2050?”Authors: Jerry L. Holechek, Hatim M. E. Geli, Mohammed N. Sawalhah, and Raul Valdez
Sustainability 2022, 14(8), 4792; https://doi.org/10.3390/su14084792
Citations: Crossref (97), Scopus (91), Web of Science (82), Google Scholar (125)
This paper addresses one of the most significant challenges of climate change – achieving Net Zero Carbon by 2050. The meta-analysis suggests that while difficult, this transition is possible through the concerted application of pathways, lifestyle changes, and global cooperation.
2. “Anxiety and the Ecological Crisis: An Analysis of Eco-Anxiety and Climate Anxiety”Author: Panu Pihkala
Sustainability 2020, 12(19), 7836; https://doi.org/10.3390/su12197836
Citations: Crossref (144), Scopus (121), Web of Science (159), Google Scholar (382)
This paper has received substantial media attention, including coverage by The Guardian, BBC, Vice, and CNBC. An interview with Dr. Panu Pihkala, a leading interdisciplinary researcher on the topic, can be found on MDPI’s podcast: Insight Faster, Episode 1.
3. “Impact of Climate Change on Agriculture and Its Mitigation Strategies: A Review”Authors: Gurdeep Singh Malhi, Manpreet Kaur, and Prashant Kaushik
Sustainability 2021, 13(3), 1318; https://doi.org/10.3390/su13031318
Citations: Crossref (207), Scopus (221), Web of Science (186), Google Scholar (355)
This paper reviews literature on climate change, addressing its causes, future projections, impact on agriculture, including plant physiology, growth, productivity, pest infestation, and the economic implications of mitigation strategies.
4. “Impacts of Plastic Pollution on Ecosystem Services, Sustainable Development Goals, and Need to Focus on Circular Economy and Policy Interventions”Authors: Rakesh Kumar, Anurag Verma, Arkajyoti Shome, Rama Sinha, Srishti Sinha, Prakash Kumar Jha, Ritesh Kumar, Pawan Kumar, Shubham, Shreyas Das, Prabhakar Sharma, and P. V. Vara Prasad
Sustainability 2021, 13(17), 9963; https://doi.org/10.3390/su13179963
Citations: Crossref (134), Scopus (136), Web of Science (113), Google Scholar (184)
This review aims to assess the adverse effects of plastic pollution on ecosystems, link the management of plastic with the SDGs, and propose policy measures using transdisciplinary approaches. Empowering communities to reduce plastic use is crucial. Addressing global plastic pollution is a priority.
Sustainability is an international, cross-disciplinary, open access journal that explores environmental, cultural, economic, and social sustainability of human beings. It provides a forward-looking platform for research on sustainability and sustainable development, and is published semi-monthly online by MDPI. Sustainability is affiliated with The Canadian Urban Transit Research & Innovation Consortium (CUTRIC) and The International Council for Research and Innovation in Building and Construction (CIB).
Read more:
- Testimonials: See what our editors and authors say about Sustainability.
Inside MDPI
President of Ireland Authors Editorial in MDPI Journal Sustainability
It’s a very special occasion when the president of a country takes the initiative to write an editorial for a journal. Michael D. Higgins, President of the Republic of Ireland, has contributed his insights to a forthcoming Special Issue in Sustainability:
This Special Issue, focusing on “making sustainable development happen” at grassroots levels, allows for perspectives from, and on, the major world faiths, exploring how challenges have been conceptualised and addressed, in addition to case studies of faith-based sustainability initiatives in practice.
The experience of faith institutions and communities in translating theological and moral commitments to sustainable development into action is now a topic we must examine with urgency; one on which I am so glad this Special Issue focuses.
As President of Ireland, I very much support this Special Issue of Sustainability. It is my great hope that the contents of the papers contained herein will assist in making sustainable development happen at grassroots levels across the world so that we can cooperate together, people of faith and of none, to ensure a just, inclusive and sustainable future for all on our fragile planet.
Read the completed editorial here:
Special Issue “Faith and Sustainable Development: Exploring Practice, Progress and Challenges among Faith Communities and Institutions”: Foreword by the President of Ireland
Author: Michael D. Higgins
Sustainability 2023, 15(12), 9683; https://doi.org/10.3390/su15129683
Coming Together for Science
The World Sustainability Forum 2023
The World Sustainability Forum (WSF) is a biennial MDPI event focused on sustainability. WSF 2023 marks the tenth anniversary of the conference series, taking place on 14 September. For the first time, the event will be hosted as a 24-hour conference across three locations – Singapore, Basel in Switzerland, and Toronto in Canada – alongside virtual streaming.
This unique format allows us to span three time zones, providing live coverage of critical sustainability-related topics throughout the day:
- The Singapore Hub, chaired by Professor Horn Mun Cheah and Associate Professor Renee Tan, will explore “Sustainability for Social and Community Impact”.
- The Basel Hub, chaired by Prof. Dr. Anet Režek Jambrak and Dr. Lela Mélon, will delve into “Sustainability in the industry, and at university and corporate settings”.
- The Toronto Hub, led by Dr. Umberto Berardi, will discuss “The Sustainable Built Environment”.
MDPI Sustainability Foundation: Recognizing Excellence in Sustainability Research
The MDPI Sustainability Foundation supports researchers through two sustainability-focused awards:
- The World Sustainability Award, amounting to USD 100,000, is given to senior researchers.
- The Emerging Sustainability Leader Award, valued at USD 20,000, sponsored by the journal Sustainability, is presented to early-career researchers.
The winners of the Sustainability Foundation will be formally awarded during the WSF2023 on 14 September. Interviews with the award winners and finalists are available below.
2023 World Sustainability Award Winners
Interviews with 2023 Emerging Sustainability Leader Award Finalists
- Dr. Bahareh Kamranzad
- Dr. Youjin Kim
- Dr. Julia Lohmann
As a hybrid event, WSF23 provides scholars with the option to attend in person at one of the conference sites or, for a more sustainable approach, virtually. All sessions will be recorded and archived for future access. Registration is open until 3 September 2023, with in-person and virtual tickets available here.
Read more:
Closing Thoughts
“Co-opetition”: Collaboration Plus Healthy Competition – A Visit to Elsevier
I firmly believe in fostering collaboration and at the same time promoting healthy competition within the academic publishing industry. The market offers ample room for publishers and related companies to provide valuable services and products that enrich the academic community. While MDPI is recognized for its efficient and streamlined processes –thanks to our over 6,000 colleagues, in-house tools, and initiatives that support the author journey – our ethos has always involved learning from and collaborating with other organizations.
MDPI’s Interaction with Elsevier
In January 2023, I had a brief conversation with Judy Verses, President of Global Academic and Government Markets at Elsevier, following her participation in a panel discussion at the Academic Publishers Europe event in Berlin. One of the highlights for me was Judy’s insight into the impact of research, particularly her emphasis on the role of collaboration, including policy and showing the impact of research to influence on funding decisions.
“Such collaborations drive forward-looking strategies to elevate our support for the scholarly community”
Judy and I resumed our discussion in August, when I visited Elsevier's office to review current projects, such as our recent agreement with Science Direct and the continued indexing of MDPI journals in Scopus (indexing database owned by Elsevier). We also explored possible opportunities for the future, including a potential collaboration to expand MDPI’s Scilit data infrastructure. This endeavour aims to aggregate and provide access to scholarly metadata encompassing journal articles, conference papers, books, preprints, and more. While these discussions are ongoing, the underlying principle remains that such collaborations drive forward-looking strategies to elevate our services and support for the scholarly community.
It was great that Judy and I acknowledged the merits of 'co-opetition,' a concept based of the belief that fostering cooperation alongside healthy competition can lead to shared advancements for both individual companies and the industry at large.
‘Fully OA’ Organizations Dedicated to Open Access
MDPI proudly aligns with the ‘Fully OA’ group, a collaborative initiative comprising nine organizations dedicated to Open Access. Our monthly meetings, including an OASPA representative, serve as platforms to share non-confidential information, resources, and projects. These gatherings also facilitate discussions on topics relevant to fully OA organizations. Occasionally, joint actions spring from these interactions, such as collaborative blog posts on pertinent subjects and joint statements, such as a recent response to the House Appropriations Committee.
This display of cooperation among competing entities forms a strategic alliance focused on nurturing the best interests of the OA publishing model.
As I wrap up this third edition of the CEO Letter, I encourage you to seize opportunities for collaboration and contribute to advancing our shared academic culture. As the African proverb has it, “If you want to go fast, go alone; if you want to go far, go together.”
Chief Executive Officer
MDPI AG
30 August 2023
Recruiting Reviewer Board Members for Journal of Personalized Medicine
We are recruiting Reviewer Board Members for Journal of Personalized Medicine (JPM, ISSN: 2075-4426). If you are an active researcher in the field and are passionate about promoting the publication of cutting-edge research, please contact the Journal of Personalized Medicine Editorial Office ([email protected]) to apply for this role.
Journal of Personalized Medicine is an international, peer-reviewed, open access journal on personalized medicine, published monthly online by MDPI. The aims and scope of the journal can be found at the following link: https://www.mdpi.com/journal/jpm/about. Journal of Personalized Medicine publishes cutting-edge, innovative preclinical and translational scientific research and technologies related to personalized medicine (e.g., precision medicine, pharmacogenomics/proteomics, systems biology, ‘omics association analysis).
The benefits of joining our Reviewer Board are as follows:
- We will announce your entry information on the journal's Reviewer Board;
- We award discounts for comprehensive and timely reviews. These vouchers can be used for all MDPI journals;
- You will receive a personalized reviewer certificate;
- Review frequency is flexible and based on your schedule;
- You can showcase your peer reviews and editorial contributions to our journal readers.
If you are interested in this position, please send your application, including a full academic CV, to the Journal of Personalized Medicine Editorial Office ([email protected]). We look forward to collaborating with you.
25 August 2023
Meet Us at the American Congress of Rehabilitation Medicine (ACRM) 100th Annual Conference, 30 October–2 November 2023, Atlanta, USA
MDPI will attend the American Congress of Rehabilitation Medicine (ACRM) 100th Annual Conference. The 2023 annual meeting of ACRM is the world’s largest interdisciplinary rehabilitation research event. Rehabilitation professionals and community members from around the globe are encouraged to join. With 150+ inter-professional groups at ACRM, including community groups, committees, and task forces, the 100th anniversary conference is planning 4 powerful plenaries, 15+ symposia, 300+ educational sessions, symposia and lectures, and 600+ scientific papers and digital poster presentations, etc.
To enhance patient care, the presentation of science by researchers is required, and to inform and improve research, feedback from the clinicians is required. The aim of the ACRM 100th annual conference is to encourage attendees to join the discussions and collaborations in order to help move the field of physical medicine and rehabilitation forward.
The following MDPI journals will be represented:
If you plan on attending this conference, please feel free to stop by our booth #413 and start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://conference.acrm.org/.
24 August 2023
Meet Us at the ASHG Annual Meeting 2023, 1–5 November 2023, Washington D.C., USA
MDPI will attend the ASHG Annual Meeting 2023, held in Washington, D.C., USA, from 1 to 5 November 2023.
The ASHG Annual Meeting is the largest human genetics and genomics meeting and exposition in the world. Held in the fall, it provides a forum for the presentation and discussion of cutting-edge science in all areas of human genetics. Highlights include invited symposia; abstract-driven plenary, platform, and poster sessions; education/trainee workshops; and career opportunities and networking events.
The following MDPI journals will be represented:
- Genes;
- JPM;
- Biomolecules;
- Medicina;
- Diagnostics;
- Cancers;
- Biomedicines;
- Humans;
- Applied Biosciences;
- DNA;
- IJMS;
- Brain Sciences;
- Cardiogenetics;
- Vaccines;
- Life;
- Epigenomes;
- BioTech;
- Biology;
- CIMB;
- Biomedinformatics.
If you plan on attending this conference, please stop by our booth and speak with us. Our delegates look forward to meeting you in person and answering any questions that you may have.
For more information about the conference, please visit https://www.ashg.org/meetings/.
18 August 2023
Meet Us at the American Academy of Pediatrics 2023 National Conference & Exhibition, 20–24 October 2023, Washington, USA
MDPI will attend the American Academy of Pediatrics 2023 National Conference & Exhibition. This event will be held in Washington D.C. for five days from Friday, 20 October, to Tuesday, 24 October 2023.
The following MDPI journals will be represented:
- Children;
- JCM;
- Medicina;
- Healthcare;
- IJERPH;
- JPM;
- Clinpract;
- Diagnostics;
- Medicines.
If you plan on attending this conference, please stop by our booth and speak with us. Our delegates look forward to meeting you in person and answering any questions that you may have.
For more information about the conference, please visit https://aapexperience.org/.
18 August 2023
MDPI’s 2022 Young Investigator Awards in Medicine and Pharmacology—Winners Announced
MDPI’s Young Investigator Awards recognize promising young researchers, acknowledge their contributions, and enhance communication among scientists. We are proud to present the winners for the year 2022 in medicine and pharmacology. The winners were selected by the journals’ Award Evaluation Committee.
We would like to warmly congratulate the awarded young investigators for their outstanding contributions. MDPI will continue to provide support and recognition to the academic community.
- Yuyan Jiang, Stanford University, USA
- Billy Wai-Lung Ng, Chinese University of Hong Kong, China
- Ashleigh Poh, The Olivia Newton-John Cancer Research Institute, Australia
- Miranda Fidler-Benaoudia, University of Calgary, Canada
- Bishal Gyawali, Queen’s University, Canada
- Shahnawaz Anwer, Hong Kong Polytechnic University, Hong Kong
- Jan Bednarsch, Universitätsmedizin Berlin, Germany
- Anda Mihaela Naciu, Fondazione Policlinico Universitario Campus Bio-Medico, Italy
- Jerome Lechien, University of Mons, Belgium
- Daniele Bertoglio, University of Antwerp, Belgium
- Gregor Fuhrmann, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany
- Haley Adcox, Virginia Commonwealth University, USA
About MDPI Awards:
In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and a form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to the advancement of their fields.
For more MDPI awards, please click here.
18 August 2023
MDPI’s 2022 Travel Awards in Medicine and Pharmacology—Winners Announced
We are proud to recognize the winners of MDPI’s 2022 Travel Awards in medicine and pharmacology category for their outstanding presentations.
MDPI journals regularly offer Travel Awards to encourage talented junior scientists to present their research at academic conferences in specific fields, which helps to enhance their influence.
The winners mentioned below were carefully selected by the journal editors based on an outline of their research and the work to be presented at an academic conference.
We would like to congratulate the winners of the 2022 Travel Awards and wish them success with their future research endeavors. MDPI will continue to enhance communication among scientists.
- Filip Jansåker, Lund University, Lund, Sweden
- Vanessa Silva, University of Trás-os-Montes and Alto Douro, Portugal
- Diego de Miguel Perez, Icahn School of Medicine at Mount Sinai, USA
- Luigi Russo, Italian Institute of Technology (IIT), Italy
- Sneha Sethi, University of Adelaide, Australia
- Xiyin Wang, Indiana University School of Medicine, USA
- Sonia Nath, University of Adelaide, Australia
- Konstantina Kritikou, Carol Davila University of Medicine and Pharmacy, Romania
- Adrien Holzgreve, The University Hospital of Munich, Germany
- Antonella Padella, Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l., Italy
- Susanna Cooper, St. George’s University of London, UK
- Renée Tillie, Maastricht University Medical Center, the Netherlands
- Max Lennart Eckstein, University of Bayreuth, Germany
- Lorenzo Bertani, University of Pisa, Italy
- Yuxue Cao, University of Queensland, Australia
- Flávia Sousa, Italian Institute of Technology, Italy
About MDPI Awards:
In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form ot recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.
See more MDPI awards, please click here.
18 August 2023
MDPI’s 2022 Outstanding Reviewer Awards in Medicine and Pharmacology—Winners Announced
In order to acknowledge our reviewers, who so generously dedicate their time to reviewing papers and demonstrate diligence, professionalism, and timeliness when reviewing manuscripts, MDPI journals regularly offer outstanding reviewer awards to scholars who participate in the peer-review process.
We are proud to recognize the winners for the year 2022 in medicine and pharmacology for their outstanding contributions among the extensive competition by presenting them with an Outstanding Reviewer Award.
We would like to take this opportunity to congratulate all of the winners on their achievements. MDPI will continue to provide support and recognition to the academic community.
- Maxime Pichon, Centre Hospitalier Universitaire de Poitiers, France
- Violeta Popovici, Ovidius University of Constanta, Romania
- Yosra A. Helmy, University of Kentucky, USA
- Antonio G. Solimando, Aldo Moro University of Bari, Italy
- Linlin Guo, The Ohio State University Medical Center, USA
- Ravindra Deshpande, Wake Forest School of Medicine, USA
- Songli Zhu, Fred Hutchinson Cancer Research Center, USA
- Antonella Argentiero, IRCCS Istituto Tumori “Giovanni Paolo II” of Bari, Italy
- Camelia Coada, Alma Mater Studiorum-University of Bologna, Italy
- Chenghui Li, University of Arkansas for Medical Sciences, USA
- Laurentiu Pop, University of Texas Southwestern Medical Center, USA
- Muhammad Fazal Ijaz, Dongguk University, Republic of Korea
- Rafał Watrowski, University of Freiburg, Germany
- Ruben C. Petreaca, The Ohio State University, USA
- Ruchi Roy, Rush University Medical Center, USA
- Salvatore Cocuzza, University of Catania, Italy
- Santosh Kumar Singh, Morehouse School of Medicine, USA
- Sergei Boichuk, Kazan State Medical University, Russia
- Simon John Christoph Soerensen, Stanford University, USA
- Takuya Koie, Gifu University, Japan
- Teresa Rubio-Tomás, Foundation for Research and Technology Hellas, Greece
- Teruki Nii, Kyushu University, Japan
- Tomasz Marjanski, Medical University of Gdansk, Poland
- Kristen Haase, The University of British Columbia, Canada
- Ravi Ramjeesingh, Nova Scotia Cancer Centre and Dalhousie University, Canada
- Makoto Endo, Kyushu University, Japan
- Tefera Tadesse, Addis Ababa University, Ethiopia
- Ravi Ramjeesingh, Nova Scotia Cancer Centre and Dalhousie University, Canada
- Ryuichi Ohta, Unnan City Hospital, Japan
- Henry Sutanto, Cardiovascular Research Institute Maastricht, the Netherlands
- José-María Sánchez-González, University of Seville, Spain
- Emmanouil Kapetanakis, General Hospital of Piraeus “Tzaneio”, Greece
- Eleonora Topino, Libera Università Maria Santissima Assunta (LUMSA), Italy
- Rodolfo Reda, Sapienza University of Rome, Italy
- Giulio Francesco Romiti, Sapienza University of Rome, Italy
- Maria Gabriella Melchiorre, IRCCS INRCA—National Institute of Health and Science on Ageing, Italy
- James Walter, 1Hines VA Hospital, USA; 2 Loyola Medical Center, USA
- Vasiliki Tsigkou, Sotiria Hospital, Greece
- Flavia Zacconi, Pontificia Universidad Católica de Chile, Chile
- Bhupendra Prajapati, Ganpat University, India
- Van-An Duong, Gachon University, Republic of Korea
- Ashish Agrawal, Indian Institute of Technology (BHU), India
- Aydin Eresen, University of California Irvine, USA
About MDPI Awards:
In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.
See more MDPI awards, please click here.
18 August 2023
MDPI’s 2022 Best PhD Thesis Awards in Medicine and Pharmacology—Winners Announced
MDPI’s Best PhD Thesis Awards aim to recognize young scholars who are deemed to have produced the most outstanding PhD thesis in their fields of research and to encourage them to continue their outstanding work and further contributions to their field.
We would like to congratulate the winners of the 2022 Best PhD Thesis Awards in medicine and pharmacology and wish them success with their future research endeavors. MDPI will continue to enhance communication among scientists.
- “Uncovering Novel Prognostic and Predictive Epigenetic Biomarkers in Malignant Testicular Germ Cell Tumors”
by João Pedro da Silva Machado Lobo, University of Porto, Portugal
- “Metastatic Recurrence in Colorectal Cancer Arises from Residual EMP1+ Cells”
by Adrià Cañellas Socias, University of Barcelona, Spain
- “Investigating Novel Aspects of the Blood–Brain Barrier Using High-Resolution Electron Microscopy”
by Shireen Mentor, University of Cape Town, South Africa
- “An Epidemiological Approach to Study The Interplay between Genome, Epigenome and Exposome in Women”
by Roberta Magnano San Lio, University of Catania, Italy
- “Intravitreal Liposomes as Ocular Drug Delivery Systems: Vitreal Interactions, Retinal Permeation and Drug Release Characteristics”
by Shirin Tavakoli, University of Helsinki, Finland
- “Microbiome-Mediated Colonization Resistance: Defense against Enteropathogens and Multi-Drug Resistant Organisms”
by Quinten Ducarmon, Leiden University Medical Center, the Netherlands
About MDPI Awards:
In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.
For more MDPI awards, please click here.
18 August 2023
MDPI’s Best Paper Awards in Medicine and Pharmacology—Winners Announced in 2022
The purpose of our Best Paper Awards is to promote and recognize the most impactful contributions published within MDPI journals.
The editors of each journal carefully selected review and research papers through a rigorous evaluative process based on criteria such as the scientific merit, overall impact, and quality of presentation of the papers published in the journal.
We are honored to present the winners for the year 2022 in medicine and pharmacology, who were selected amongst extensive competition, and congratulate the authors for their outstanding scientific publications. MDPI will continue to provide support and recognition to the academic community.
- “Development and Challenges of Antimicrobial Peptides for Therapeutic Applications”
by Charles H. Chen and Timothy K. Lu
Antibiotics 2020, 9(1), 24; https://doi.org/10.3390/antibiotics9010024
- “Antimicrobial Usage and Resistance in Companion Animals: A Cross-Sectional Study in Three European Countries”
by Philip Joosten, Daniela Ceccarelli, Evelien Odent, Steven Sarrazin, Haitske Graveland, Liese Van Gompel, Antonio Battisti, Andrea Caprioli, Alessia Franco, Jaap A. Wagenaar et al.
Antibiotics 2020, 9(2), 87; https://doi.org/10.3390/antibiotics9020087
- “Management of Peri-Implantitis Lesions without the Use of Systemic Antibiotics: A Systematic Review”
by Ahsen Khan, Ankit Goyal, Scott D. Currell and Dileep Sharma
Dent. J. 2020, 8(3), 106; https://doi.org/10.3390/dj8030106
- “Associations among Primary Stability, Histomorphometric Findings, and Bone Density: A Prospective Randomized Study after Alveolar Ridge Preservation with a Collagen Cone”
by Sigmar Schnutenhaus, Werner Götz, Jens Dreyhaupt, Heike Rudolph, Ralph G. Luthardt and Cornelia Edelmann
Dent. J. 2020, 8(4), 112; https://doi.org/10.3390/dj8040112
- “Novel Prefrontal Synthesis Intervention Improves Language in Children with Autism”
by Andrey Vyshedskiy, Edward Khokhlovich, Rita Dunn, Alexander Faisman, Jonah Elgart, Lisa Lokshina, Yuriy Gankin, Simone Ostrovsky, Lauren deTorres, Stephen M. Edelson et al.
Healthcare 2020, 8(4), 566; https://doi.org/10.3390/healthcare8040566
- “The Effects of Long-Term 40-Hz Physioacoustic Vibrations on Motor Impairments in Parkinson’s Disease: A Double-Blinded Randomized Control Trial”
by Abdullah Mosabbir, Quincy J. Almeida and Heidi Ahonen
Healthcare 2020, 8(2), 113; https://doi.org/10.3390/healthcare8020113
- “Racial Disparities-Associated COVID-19 Mortality among Minority Populations in the US”
by Donald J. Alcendor
J. Clin. Med. 2020, 9(8), 2442; https://doi.org/10.3390/jcm9082442
- “Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence”
by Celestino Sardu, Jessica Gambardella, Marco Bruno Morelli, Xujun Wang, Raffaele Marfella and Gaetano Santulli
J. Clin. Med. 2020, 9(5), 1417; https://doi.org/10.3390/jcm9051417
- “Estimation of the Transmission Risk of the 2019-nCoy and Its Implication for Public Health Interventions”
by Biao Tang, Xia Wang, Qian Li, Nicola Luigi Bragazzi, Sanyi Tang, Yanni Xiao and Jianhong Wu
J. Clin. Med. 2020, 9(2), 462; https://doi.org/10.3390/jcm9020462
- “Molecular and Cellular Mechanisms Affected in ALS”
by Laura Le Gall, Ekene Anakor, Owen Connolly, Udaya G. Vijayakumar, William J. Duddy and Stephanie Duguez
J. Pers. Med. 2020, 10(3), 101; https://doi.org/10.3390/jpm10030101
- “Postulated Adjuvant Therapeutic Strategies for COVID-19”
by Anderson O. Ferreira, Hudson C. Polonini and Eli C. F. Dijkers
J. Pers. Med. 2020, 10(3), 80; https://doi.org/10.3390/jpm10030080
- “Evidences of CTLA-4 and PD-1 Blocking Agents-Induced Cardiotoxicity in Cellular and Preclinical Models”
by Vincenzo Quagliariello, Margherita Passariello, Domenica Rea, Antonio Barbieri, Martina Iovine, Annamaria Bonelli, Antonietta Caronna, Gerardo Botti, Claudia De Lorenzo and Nicola Maurea
J. Pers. Med. 2020, 10(4), 179; https://doi.org/10.3390/jpm10040179
- "Manufacturing Considerations for the Development of Lipid Nanoparticles Using Microfluidics”
by Carla B. Roces, Gustavo Lou, Nikita Jain, Suraj Abraham, Anitha Thomas, Gavin W. Halbert and Yvonne Perrie
Pharmaceutics 2020, 12(11), 1095; https://doi.org/10.3390/pharmaceutics12111095
- “Development of Remdesivir as a Dry Powder for Inhalation by Thin Film Freezing”
by Sawittree Sahakijpijarn, Chaeho Moon, John J. Koleng, Dale J. Christensen and Robert O. Williams III
Pharmaceutics 2020, 12(11), 1002; https://doi.org/10.3390/pharmaceutics12111002
- “Skin Wound Healing Process and New Emerging Technologies for Skin Wound Care and Regeneration”
by Erika Maria Tottoli, Rossella Dorati, Ida Genta, Enrica Chiesa, Silvia Pisani and Bice Conti
Pharmaceutics 2020, 12(8), 735; https://doi.org/10.3390/pharmaceutics12080735
- “The Role of Hospital and Community Pharmacists in the Management of COVID-19: Towards an Expanded Definition of the Roles, Responsibilities, and Duties of the Pharmacist”
by Nicola Luigi Bragazzi, Muhammad Mansour, Alessandro Bonsignore and Rosagemma Ciliberti
Pharmacy 2020, 8(3), 140; https://doi.org/10.3390/pharmacy8030140
- “Association of a Novel Medication Risk Score with Adverse Drug Events and Other Pertinent Outcomes Among Participants of the Programs of All-Inclusive Care for the Elderly”
by David L. Bankes, Hubert Jin, Stephanie Finnel, Veronique Michaud, Calvin H. Knowlton, Jacques Turgeon and Alan Stein
Pharmacy 2020, 8(2), 87; doi.org/10.3390/pharmacy8020087
About MDPI Awards:
In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.
See more MDPI awards, please click here.
27 July 2023
MDPI Insights: The CEO's Letter #2 - Open Peer-Review and IJERPH
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Open Peer Review Reports
Continuing the topic of openness from my inaugural monthly CEO letter, in these Opening Thoughts, I highlight the growth and importance of open peer-review reports at MDPI. Open peer reports align with the principles of open science, making the publishing process more transparent and facilitating rigorous peer review.
MDPI journals operate an open peer-review option by default, allowing authors to publish review reports and author responses (often referred to as open reports) together with the published paper. Publishing the reviewer reports and author responses together with the article provides greater transparency and trust for readers, as this allows them to track the editorial decision-making process. Open peer-review also encourages reviewers and editors to provide high-quality comments, as these will be made public if the article is accepted for publication.
Start and Growth of Open Peer Review at MDPI
The MDPI journal Life was a pioneer in offering this opportunity to its authors in 2014. The first MDPI article with peer-review reports openly published was a review by the Nobel Laureate Werner Arber, in which the review reports were published as supplementary material. By 2018, open peer-review was available across all MDPI journals. As such, MDPI authors have embraced the open peer-review model, providing a steady increase in the number of MDPI articles. As of 2023, approximately one-third (34.0%) of MDPI articles were published with open review reports.
As at July 2023, the percentage of MDPI articles published with open peer review has increased to 36.2% of the total papers published in 2023 so far, indicating ongoing growth in adoption.
Open peer review continues to play a critical role in the assessment of the peer-review process in Life. For further insights, please see the recent editorial by Dr. Pabulo Henrique Rampelotto, the former Editor-in-Chief of Life, who spearheaded the implementation of the open peer-review process.
Benefits of Open Peer Review
The benefits of open peer review include increased transparency, trust and constructive feedback. To promote open communication further and increase the robustness of the peer-review process, we encourage reviewers to sign their reports so that their name appears on the review report (this process is referred to as open identity). The default option is for reviewers to remain anonymous; however, by signing the reports, reviewers receive direct credit for their contribution to the peer-review process and show their commitment towards open science.
As the leading open access publisher, MDPI remains committed to promoting open peer-review and encourages authors to choose this approach. Our goal is to provide a rigorous and transparent peer-review process that benefits the scientific community, and we believe that open peer-review is a vital step in fostering openness and collaboration in scientific communication.
Impactful Research
MDPI Papers Cited in the News – IJERPH edition
Every month, our corporate marketing team compiles data from Altmetrics to create a list of MDPI papers that have been cited in the news. This list continues to grow as renowned news outlets regularly reference research published by MDPI in their articles.
During 2022, a total of 111,965 MDPI research papers were mentioned in prominent news outlets such as National Geographic, The Washington Post, Forbes, The Guardian, the BBC, CNN, Time, and Harvard Business Review.
Highly Cited Journal Publications
IJERPH, known for publishing impactful research, received the most news mentions among all MDPI journals in 2022, based on Altmetrics data:
- International Journal of Environmental Research and Public Health: 3509 mentions
- Nutrients: 2698 mentions
- International Journal of Molecular Sciences: 1701 mentions
- Journal of Clinical Medicine: 1131 mentions
- Viruses: 1111 mentions
These numbers show the recognition and impact of the articles published in IJERPH. For a more detailed view of the journal’s most cited and viewed papers, you can visit here. In total, IJERPH has garnered over 28,000 mentions in prominent news outlets, and as at July 2023, an impressive count of over 17,000 papers cited 10 times or more. These figures highlight the impactful contribution of IJERPH publications to the scientific community.
Example of Recent Mentions
During May and June 2023, a noteworthy selection of articles from IJERPH was cited in news articles, including:
The Washington Post: “Bringing nature inside can improve your health. Here’s how to do it.”
IJERPH paper: “Physiological Benefits of Viewing Nature: A Systematic Review of Indoor Experiments”
Harvard Business Review: “How to Take Better Breaks at Work, According to Research”
IJERPH paper: “Canine-Assisted Therapy Improves Well-Being in Nurses”
National Geographic: “Lyme disease is spreading fast—but a vaccine may be on the way”
IJERPH paper: “Range Expansion of Tick Disease Vectors in North America: Implications for Spread of Tick-Borne Disease”
Inside MDPI
MDPI Develops an Artificial Intelligence Tool to Enhance the Peer-Review Process
At MDPI, we believe that rigorous peer-review is the corner-stone of high-quality academic publishing. We are grateful to the scholars who generously dedicate their time to peer-review articles submitted to MDPI journals. Their contributions are invaluable to the advancement of science.
Peer-review is a critical part of the publication process, ensuring that MDPI upholds the highest quality standards for the papers we publish. Every manuscript submitted to our journals undergoes a comprehensive peer-review process conducted by subject-matter experts.
To further enhance our peer-review process, our Data Analytics team has developed an Artificial Intelligence (AI) tool designed to support the selection of reviewers. This proprietary tool utilizes Natural Language Processing (NLP), a specially designed AI language model, to extract information from the title and abstract of submitted papers. It then searches our database for similar manuscripts and suggests potential reviewers based on this analysis. Integrated with MDPI's submission system (SuSy), the AI tool cross-references the suggested candidates with our reviewer database to verify their invitation status and availability.
The goal of this tool is to provide better targeted peer-review invitations, reducing the number of emails sent for each paper and increasing the efficiency of our editorial staff.
In the near future, our Data Analytics team plans to deploy similar AI projects to improve other critical aspects of our services, offering an enhanced experience to our authors and readers.
Click here to learn about MDPI’s review process, including procedures, responsibilities, and benefits.
Read more:
Coming Together for Science
The Future of IJERPH
On 5 July 2023, Prof. Dr. Paul B. Tchounwou, the founding Editor-in-Chief of IJERPH, along with five Section Editors in Chief (Prof. Dr. Germán Vicente-Rodríguez, Prof. Dr. Karl Goodkin, Prof. Dr. William A. Toscano, Prof. Dr. Jimmy T. Efird, and Prof. Dr. William Douglas Evans), gathered in Basel to discuss the future of the journal. The meeting provided an opportunity to address the recent decision by The Web of Science to delist IJERPH due to the journal failing the Content Relevance criterion, and propose best strategies that will ensure high scientific rigor as well as a clear scope and aim of IJERPH, going forward.
While the delisting is disappointing for IJERPH, as well as for our authors, academic editors, and the entire scientific community supporting our journal, we see it as an opportunity to reflect and prepare for the future direction of the journal.
Since its launch in 2004, IJERPH’s vision and mission have evolved to be more complete and comprehensive in engaging scientific communities. In light of this, we will refresh the journal’s aims and scope, ensuring they align with the organic expansion of IJERPH. Additionally, we will restructure the journal sections into broader categories, encouraging collaborative research and transdisciplinary approaches for authors. This is designed to foster collaboration and knowledge exchange among diverse fields, contributing to a holistic understanding of health promotion and disease prevention. We are confident that these next steps will enhance the scientific strength and societal impact of our journal.
Journal Achievements
In addition to the productive discussions, we took the time to celebrate some of the remarkable achievements of IJERPH, which I highlight below:
- Founded by Prof. Dr. Paul B. Tchounwou in 2004
- Indexed in PubMed in 2008
- Received its first Impact Factor in 2012
- Published its 5000th paper in 2017
- Over 60,000 papers published as at June 30, 2023
- 131,628,173 paper views in 2018–2022
- Over 28,000 mentions in prominent news outlets
- 17,000 papers cited 10 times or more as at June 30, 2023
- No.1 journal in the 2022 Google Scholar Metrics in the category of Public Health
- Awarded several editions of Young Investigator Awards, Travel Awards, and Outstanding Reviewer Awards since 2018.
These achievements showcase the journal’s significant contributions to the field and its impact on global health. We are proud of the exceptional work accomplished by the IJERPH team and look forward to building upon this success in the years to come.
Closing Thoughts
MDPI’s Impact in Spain
During the past month, I had the opportunity to visit our new office building in Barcelona, where I met with our local colleagues to discuss the ways we serve the scholarly community, particularly in Spain. The multi-functional office plays a vital role in supporting various business needs, including editorial, design, conference management, data analytics, journal relationship management, publishing partnerships, and collaborations with societies.
Spain holds a significant position in MDPI’s global market, ranking as the fourth-largest contributor to the total number of papers published by MDPI as at July 2023, ranking next to Italy, the USA, and China, with Germany completing the top five.
The Numbers
Out of the 1,680,000 total MDPI articles published as at 25 July, almost 80,000 articles are contributed by Spanish authors, representing nearly 40,000 unique authors affiliated with Spanish institutions. Remarkably, over 6,300 of these authors hold editorial board member (EBM) positions within MDPI journals, with 30 of them serving as Editors-in-Chief (EiCs).
Our commitment to working with institutions is very evident in Spain, where we have successfully established over 40 Institutional Open Access Programs (IOAP) with esteemed institutions such as the University of Barcelona, the Autonomous University of Barcelona, Pompeu Fabra University, the University of Navarre, and Complutense University of Madrid.
Over the past five years, we have successfully organized eight in-person conferences in Barcelona, attracting over 1,150 registrations, with two forthcoming events scheduled for 2024. Barcelona's excellent connectivity to international airports makes it easily accessible to participants from around the world. Its welcoming atmosphere provides us with the perfect environment for knowledge-sharing, networking, and contributing to the local economy.
Our growth and presence in Spain are a true testament to the incredible service we provide to the scholarly community and the relationships we foster through responsive and collaborative communication. We look forward to continuing to support Spanish scholars, providing them a valuable and trusted experience with MDPI, the leader in open access publishing.
Testimonials
I close this letter as I did in the first edition, by sharing testimonials from our stakeholders. Here are a few IJERPH testimonials from a Spanish guest editor and an author:
Guest Editor
“I want to thank the kindness, attention and professionalism of the MDPI team throughout the editorial process of the Special Issue. I believe that it is a very professional and quality editorial process.”
- Professor Víctor Arufe-Giráldez, University of A Coruña
Special Issue in International Journal of Environmental Research and Public Health: Physical Activity in Childhood and Adolescence
Special Issue in International Journal of Environmental Research and Public Health: Physical Education: Present and Future
__
Author
“I want to thank the rigor of the revisions made to the manuscripts to improve their quality, the support to the authors for the editor assignment system they have and the follow-up they carry out, for the speed in answering and in carrying out the entire process of the revision, and for doing all this at an affordable price.”
- Dr. María Paz García-Caro, University of Granada
Article in International Journal of Environmental Research and Public Health: Factors Associated with Suicide Attempts and Suicides in the General Population of Andalusia (Spain)
Chief Executive Officer
MDPI AG
26 July 2023
Prof. Dr. Yves A. Lussier Appointed Section Editor-in-Chief of Section “Mechanisms of Diseases” in Journal of Personalized Medicine
We are pleased to announce that Prof. Dr. Yves A. Lussier has been appointed Section Editor-in-Chief of the Section “Mechanisms of Diseases” in the Journal of Personalized Medicine (JPM, ISSN 2075-4426).
Name: Prof. Dr. Yves A. Lussier |
Prof. Dr. Yves A. Lussier, MD, FACMI, is the Chair of Biomedical Informatics at the University of Utah School of Medicine, USA. As a professional engineer and physician-scientist, he is an international expert in translational bioinformatics and a pioneer in research informatics techniques including systems biology, data representation through ontologies, and high-throughput methods in personalized medicine.
We wish Prof. Dr. Lussier every success in his position as Section Editor-in-Chief and we look forward to his contributions to the continued success of the journal.
26 July 2023
Journal of Personalized Medicine | Top 20 Cited Papers in 2022
1. “A Multi-Agent Deep Reinforcement Learning Approach for Enhancement of COVID-19 CT Image Segmentation”
by Hanane Allioui, Mazin Abed Mohammed, Narjes Benameur, Belal Al-Khateeb, Karrar Hameed Abdulkareem, Begonya Garcia-Zapirain, Robertas Damaševičius and Rytis Maskeliūnas
J. Pers. Med. 2022, 12(2), 309; https://doi.org/10.3390/jpm12020309
Available online: https://www.mdpi.com/2075-4426/12/2/309
2. “Emergency Department Overcrowding: Understanding the Factors to Find Corresponding Solutions”
by Gabriele Savioli, Iride Francesca Ceresa, Nicole Gri, Gaia Bavestrello Piccini, Yaroslava Longhitano, Christian Zanza, Andrea Piccioni, Ciro Esposito, Giovanni Ricevuti and Maria Antonietta Bressan
J. Pers. Med. 2022, 12(2), 279; https://doi.org/10.3390/jpm12020279
Available online: https://www.mdpi.com/2075-4426/12/2/279
3. “Artificial Intelligence-Driven Prediction Modeling and Decision Making in Spine Surgery Using Hybrid Machine Learning Models”
by Babak Saravi, Frank Hassel, Sara Ülkümen, Alisia Zink, Veronika Shavlokhova, Sebastien Couillard-Despres, Martin Boeker, Peter Obid and Gernot Michael Lang
J. Pers. Med. 2022, 12(4), 509; https://doi.org/10.3390/jpm12040509
Available online: https://www.mdpi.com/2075-4426/12/4/509
4. “Correlation between Peri-Implant Marginal Bone Loss Progression and Peri-Implant Sulcular Fluid Levels of Metalloproteinase-8”
by Renzo Guarnieri, Alessio Zanza, Maurilio D’Angelo, Dario Di Nardo, Andrea Del Giudice, Alessandro Mazzoni, Rodolfo Reda and Luca Testarelli
J. Pers. Med. 2022, 12(1), 58; https://doi.org/10.3390/jpm12010058
Available online: https://www.mdpi.com/2075-4426/12/1/58
5. “Usefulness of Magnetic Mallet in Oral Surgery and Implantology: A Systematic Review”
by Francesco Bennardo, Selene Barone, Camillo Vocaturo, Ludovica Nucci, Alessandro Antonelli and Amerigo Giudice
J. Pers. Med. 2022, 12(1), 108; https://doi.org/10.3390/jpm12010108
Available online: https://www.mdpi.com/2075-4426/12/1/108
6. “Atlas of PD-L1 for Pathologists: Indications, Scores, Diagnostic Platforms and Reporting Systems”
by Stefano Marletta, Nicola Fusco, Enrico Munari, Claudio Luchini, Alessia Cimadamore, Matteo Brunelli, Giulia Querzoli, Maurizio Martini, Elena Vigliar, Romano Colombari et al.
J. Pers. Med. 2022, 12(7), 1073; https://doi.org/10.3390/jpm12071073
Available online: https://www.mdpi.com/2075-4426/12/7/1073
7. “COVID-19 Detection in CT/X-ray Imagery Using Vision Transformers”
by Mohamad Mahmoud Al Rahhal, Yakoub Bazi, Rami M. Jomaa, Ahmad AlShibli, Naif Alajlan, Mohamed Lamine Mekhalfi and Farid Melgani
J. Pers. Med. 2022, 12(2), 310; https://doi.org/10.3390/jpm12020310
Available online: https://www.mdpi.com/2075-4426/12/2/310
8. “Emerging Biomarkers for Early Detection of Chronic Kidney Disease”
by Maja Mizdrak, Marko Kumrić, Tina Tičinović Kurir and Joško Božić
J. Pers. Med. 2022, 12(4), 548; https://doi.org/10.3390/jpm12040548
Available online: https://www.mdpi.com/2075-4426/12/4/548
9. “LungNet22: A Fine-Tuned Model for Multiclass Classification and Prediction of Lung Disease Using X-ray Images”
by F. M. Javed Mehedi Shamrat, Sami Azam, Asif Karim, Rakibul Islam, Zarrin Tasnim, Pronab Ghosh and Friso De Boer
J. Pers. Med. 2022, 12(5), 680; https://doi.org/10.3390/jpm12050680
Available online: https://www.mdpi.com/2075-4426/12/5/680
10. “Precision Nomothetic Medicine in Depression Research: A New Depression Model, and New Endophenotype Classes and Pathway Phenotypes, and A Digital Self”
by Michael Maes
J. Pers. Med. 2022, 12(3), 403; https://doi.org/10.3390/jpm12030403
Available online: https://www.mdpi.com/2075-4426/12/3/403
11. “Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe”
by Denis Horgan, Giuseppe Curigliano, Olaf Rieß, Paul Hofman, Reinhard Büttner, Pierfranco Conte, Tanja Cufer, William M. Gallagher, Nadia Georges, Keith Kerr et al.
J. Pers. Med. 2022, 12(1), 72; https://doi.org/10.3390/jpm12010072
Available online: https://www.mdpi.com/2075-4426/12/1/72
12. “Relationship between Epicardial and Coronary Adipose Tissue and the Expression of Adiponectin, Leptin, and Interleukin 6 in Patients with Coronary Artery Disease”
by Olga V. Gruzdeva, Yulia A. Dyleva, Ekaterina V. Belik, Maxim Y. Sinitsky, Aleksandr N. Stasev, Aleksandr N. Kokov, Natalia K. Brel, Evgenia O. Krivkina, Evgenia E. Bychkova, Roman S. Tarasov et al.
J. Pers. Med. 2022, 12(2), 129; https://doi.org/10.3390/jpm12020129
Available online: https://www.mdpi.com/2075-4426/12/2/129
13. “Endotypes of Prematurity and Phenotypes of Bronchopulmonary Dysplasia: Toward Personalized Neonatology”
by Maria Pierro, Karen Van Mechelen, Elke van Westering-Kroon, Eduardo Villamor-Martínez and Eduardo Villamor
J. Pers. Med. 2022, 12(5), 687; https://doi.org/10.3390/jpm12050687
Available online: https://www.mdpi.com/2075-4426/12/5/687
14. “Sensory Ion Channel Candidates Inform on the Clinical Course of Pancreatic Cancer and Present Potential Targets for Repurposing of FDA-Approved Agents?”
by Wenjie Shi, Chen Li, Thomas Wartmann, Christoph Kahlert, Renfei Du, Aristotelis Perrakis, Thomas Brunner, Roland S. Croner and Ulf D. Kahlert
J. Pers. Med. 2022, 12(3), 478; https://doi.org/10.3390/jpm12030478
Available online: https://www.mdpi.com/2075-4426/12/3/478
15. “Dendrimers, an Emerging Opportunity in Personalized Medicine?”
by Anne-Marie Caminade
J. Pers. Med. 2022, 12(8), 1334; https://doi.org/10.3390/jpm12081334
Available online: https://www.mdpi.com/2075-4426/12/8/1334
16. “Sex Differences in Response to Treatment with Glucagon-like Peptide 1 Receptor Agonists: Opportunities for a Tailored Approach to Diabetes and Obesity Care”
by Elpiniki Rentzeperi, Stavroula Pegiou, Theocharis Koufakis, Maria Grammatiki and Kalliopi Kotsa
J. Pers. Med. 2022, 12(3), 454; https://doi.org/10.3390/jpm12030454
Available online: https://www.mdpi.com/2075-4426/12/3/454
17. “Should Neurosurgeons Try to Preserve Non-Traditional Brain Networks? A Systematic Review of the Neuroscientific Evidence”
by Nicholas B. Dadario and Michael E. Sughrue
J. Pers. Med. 2022, 12(4), 587; https://doi.org/10.3390/jpm12040587
Available online: https://www.mdpi.com/2075-4426/12/4/587
18. “Identification of Early Esophageal Cancer by Semantic Segmentation”
by Yu-Jen Fang, Arvind Mukundan, Yu-Ming Tsao, Chien-Wei Huang and Hsiang-Chen Wang
J. Pers. Med. 2022, 12(8), 1204; https://doi.org/10.3390/jpm12081204
Available online: https://www.mdpi.com/2075-4426/12/8/1204
19. “Can SARS-CoV-2 Infection Exacerbate Alzheimer’s Disease? An Overview of Shared Risk Factors and Pathogenetic Mechanisms”
by Chiara Villa, Eleonora Rivellini, Marialuisa Lavitrano and Romina Combi
J. Pers. Med. 2022, 12(1), 29; https://doi.org/10.3390/jpm12010029
Available online: https://www.mdpi.com/2075-4426/12/1/29
20. “Current Status, Issues and Future Prospects of Personalized Medicine for Each Disease”
by Yuichi Yamamoto, Norihiro Kanayama, Yusuke Nakayama and Nobuko Matsushima
J. Pers. Med. 2022, 12(3), 444; https://doi.org/10.3390/jpm12030444
Available online: https://www.mdpi.com/2075-4426/12/3/444
21 July 2023
Journal of Personalized Medicine Receives an Updated Impact Factor of 3.4
We are glad to announce the new Impact Factor of the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) is 3.4. This information is available in JCR Help Data, which includes the total number of citations, the JIF and the 5-year JIF, and can be found using the following link: https://jcr.help.clarivate.com/Content/data-updates.htm.
As for the official update of the Impact Factor, Clarivate stated that the journal profile and full set of data will be included in the JCR data reload in October of this year.
13 July 2023
Journal of Personalized Medicine Impact Factor Delay
As of 28 June 2023, new journal impact factors (IFs) were released. However, we were informed by ClarivateTM that for some journals, Journal of Personalized Medicine (JPM, ISSN: 2075-4426) included, there has been a delay. Unfortunately, this is the reason that the new IF is not present on the journal webpage, nor can it be found on JCR. With that in mind, we would like to inform you that the new IF for JPM will be announced in the next few weeks. Please note that the journal is listed in the official JCR 2022 journal list available for download here.
11 July 2023
MDPI’s Newly Launched Journals in June 2023
With the first issue released in June 2023, five new MDPI journals disseminating multi-disciplinary science are due to launch, which will cover the subjects of medicine & pharmacology, biology and physical sciences.
The newly launched journals will be overseen by professional Editorial Board Members and Editors to ensure an accurate and rapid publication, rigorous peer review and broad visibility.
Please feel free to browse and discover more about the new journals below.
Journal | Founding Editor-in-Chief | Journal topics (selected) |
Prof. Dr. Jun Ma, Peking University, China| Editorial | view inaugural issue | growth and development; diet and nutrients; school health promotion policies and practices; child health and care; adolescent health and wellbeing | view journal scope | submit an article |
|
Prof. Dr. Bernd Rehm, Griffith University, Australia | Editorial | view inaugural issue | DNA and gene synthesis; synthetic transcription factors; protein engineering; viral engineering; metabolic engineering | view journal scope | submit an article | |
Prof. Dr. Varsha Gandhi, University of Texas MD Anderson Cancer Center, USA | Editorial | view inaugural issue | lymphatics; cancers associated with lymphocytes and lymphoblasts; lymphatic tissues; lymphoma; lymphoid leukemia | view journal scope | submit an article | |
Dr. Bradley Turner, University of Melbourne, Australia | Editorial | view inaugural issue | multiple sclerosis; amyotrophic lateral sclerosis; primary lateral sclerosis; atherosclerosis; systemic sclerosis | view journal scope | submit an article | |
Prof. Dr. Clemens Burda, Case Western Reserve University, USA | Editorial | view inaugural issue | Gamma ray, X-ray, and UV–Vis spectroscopies; NIR/mid-infrared/Raman spectroscopy; microwave and THz spectroscopy; high-resolution gas-phase atomic, molecular, and cluster spectroscopy; MS, NMR, and EPR spectroscopy | view journal scope | submit an article |
We wish to thank everyone who has supported the development of open access publishing. You are welcome to submit an application to the New Journal Committee ([email protected]) if you would like to create more new journals.
7 July 2023
Journal of Personalized Medicine Webinar | Applied Invasive Coronary Physiology for Diagnosis and Tailored Treatment of Coronary Microvascular Disease, 12 July 2023
Coronary physiological assessment is a rapidly developing field in cardiology. Precise invasive or less-invasive (image based) physiological evaluation can provide reliable support for the tailored treatment of coronary macro- and microvascular coronary diseases and consequently have an important impact on the efficacy and safety of therapy.
In our webinar, we summarize the current scientific results concerning the advances of specific coronary microvascular indices determined via both invasive and less invasive methods. The relevance of clinical implications and therapeutical options will be discussed as well, including specific patient populations, e.g., ACS, CCS, (M)INOCA and COVID-19 cases.
Date: 12 July 2023 at 10:00 a.m. CEST
Webinar ID: 898 6464 8512
Register now for free!
Program:
Speaker/Presentation | Time in CEST |
Dr. Gábor Tamás Szabó Welcome and brief introduction |
10:00–10:05 a.m. |
Dr. Zsolt Piróth Invasive methods for the assessment of coronary flow reserve and the microcirculation |
10:05–10:25 a.m. |
Dr. Yongzhen Fan Computational approach to assess coronary microcirculation |
10:25–10:45 a.m. |
Q&A Session | 10:45–10:55 a.m. |
Dr. Zsolt Kőszegi Closing remarks and summary |
10:55–11:00 a.m. |
After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.
Unable to attend? Register anyway and we’ll let you know when the recording is available to watch.
Webinar Chairs and Keynote Speakers:
- Dr. Gábor Tamás Szabó, Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary and Center for Biomedical Research and Translational Surgery, Medical University Vienna, Vienna, Austria;
- Dr. Zsolt Kőszegi, Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary and Szabolcs – Szatmár – Bereg County Hospitals and University Teaching Hospital, Nyíregyháza, Hungary;
- Dr. Zsolt Piróth, Gottsegen National Cardiovascular Center, 29 Haller Str., Budapest, Hungary;
- Dr. Yongzhen Fan, Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan Institute of Myocardial Injury and Repair, Wuhan University, Wuhan, China.
Relevant Special Issue:
“Applied Invasive Coronary Physiology for Tailored Treatment of Coronary Artery Disease”
Guest Editors: Dr. Gábor Tamás Szabó and Dr. Zsolt Kőszegi
3 July 2023
MDPI Insights: The CEO's Letter #1 - Open Access and Impactful Research
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
The Future is Open, and MDPI is Leading the Way
I strongly believe in a future that embraces openness, where open source, open information, and open access (OA) take center stage. This belief that led me to join MDPI in 2020, and I am honored to have recently been appointed as Chief Executive Officer (CEO). In this capacity, and operating in close liaison with Dr. Lin and MDPI’s senior management, I shall work to build on Dr. Lin’s achievements of the past quarter-century. In this role, I will focus on communication initiatives to promote MDPI's remarkable work and continue to build our company as a trusted leader in OA publishing. For over two decades, MDPI has been at the forefront of reshaping the academic publishing landscape, with OA surpassing subscription-based publishing in 2020. This trajectory is deeply rooted in our history and reflects our unwavering commitment and vision for an open future.
1 Million Published Articles
2023 began with a remarkable achievement for MDPI, as we became the first OA publisher to reach the milestone of 1 million published articles. This represents 2.7 million unique authors who have trusted us with their work, or about a third of all researchers worldwide. As the world's most cited OA publisher, we are proud in sharing these significant milestones.
Our mission remains unchanged: to make science open and accessible to all. We understand the importance of knowledge access, empowering researchers to stay at the forefront of a rapidly changing world. Our diverse range of journals covers a wide spectrum of disciplines, offering cutting-edge insights, trusted tools, and crucial knowledge to address global challenges.
Liberating Science
As the world’s leading OA publisher, MDPI is actively liberating science. We are committed to eliminating the frustrations researchers and the general public face when accessing information, ensuring it is not locked behind paywalls. We firmly believe that everyone has a right to information, and our commitment to open access publishing drives our work.
In this inaugural edition of Insights: The CEO's Letter, I draw inspiration from the upcoming 20th anniversary of the Berlin Declaration on Open Access. Its stated mission reminds us that true impact is achieved when knowledge is widely and readily available to society:
"Our mission of disseminating knowledge is only half complete if the information is not made widely and readily available to society”
Impactful Research
MDPI Publishes Impactful Research: Recognized by Leading Indexing Databases
MDPI journals are indexed in every single top database in the world.
As of June 2023, we have 214 journals indexed within Web of Science, 223 indexed within Scopus, 87 indexed within PubMed and PMC, and 17 indexed within MEDLINE, and these numbers increase every month. We constantly strive to expand the coverage of our journals within leading multi-disciplinary and scope-specific databases, resulting in an incredibly broad range of journals that are indexed within a variety of databases. MDPI has active relationships with approximately 65 well-known databases around the world, and we continue to expand our portfolio every year so that your work can be found, cited, and referenced with ease.
Continued Growth of MDPI Journals
The 2022 Scopus and Web of Science journal citation metrics were officially released in June, and I am pleased to report that 31 MDPI journals received their first CiteScore, taking the total number of journals with a CiteScore to 216. The number of MDPI journals receiving an Impact Factor (IF) also continues to grow with 111 receiving their first, by being covered in the ESCI, bringing our total number of journals with an IF to 208 of which 41 journals received an IF above 4.0. Looking at 2022 CiteScores in the Scopus database, 80% of MDPI journals have a score that ranks them in Q1 or Q2 in at least one subject category.
Publishing impactful science would not be possible without all of our authors, editors and reviewers. Thank you for your contribution and continued support! Together we share the latest scientific insights faster and ensure that your work is accessible to all.
Read more
Inside MDPI
Preprints.org: Clarivate adds the Preprint Citation Index to the Web of Science
At MDPI, we are dedicated to driving the advancement of science. Through our initiative, Preprints.org, researchers can publish their work and gain valuable feedback from the broader research community, ensuring rapid progress in their respective fields. This is particularly crucial during times of health and climate challenges, where timely dissemination of findings is essential.
Increased Visibility for Preprints
I am pleased to share that Clarivate recognizes the significance of preprints and has taken a crucial step to enhance their visibility. Clarivate has added the Preprint Citation Index to the Web of Science, encompassing preprints published not only on Preprints.org but also on other reputable repositories.
Looking ahead, the future of preprints appears promising, bolstered by the recent indexing announcement from the Web of Science. As a result, preprints will receive increased visibility, serving as a valuable resource for staying informed about the latest research developments.
Read more
What are Preprints?
The Pros and Cons of Preprints
Preprints and COVID-19
Preprints—The Future of Open Access Publishing?
Coming Together for Science
The First International Conference on Antioxidants: Sources, Methods, Health Benefits and Industrial Applications
In this edition of ‘Coming Together for Science,’ I am pleased to highlight the First International Conference on Antioxidants organized by our conference team in the beautiful city of Barcelona, Spain. The conference attracted over 130 attendees, who engaged in 42 talks, and 89 poster presentations spread across several sessions.
Working Together
Under the leadership of Prof. Dr. Alessandra Napolitano (Department of Chemical Sciences, University of Naples ‘Federico II’, Naples, Italy) and Prof. Dr. Rosa M. Lamuela Raventos (Department of Nutrition, Food Sciences and Gastronomy, University of Barcelona, Spain) as chairs, and supported by the committee members, 10 invited keynote speakers, poster presenters, and all the attendees, this dedicated group of academics came together to discuss the natural sources, methodologies, health benefits, and industrial applications of antioxidants.
Especially noteworthy is the positive feedback received from attendees, with 94% rating the overall organization of the conference as good or excellent. I particularly love the picture above, capturing the gathering of some of the participants. You can browse through more photos in the event gallery located here.
Managing Events With Sciforum
If you are considering hosting your own academic event, I highly recommend checking out Sciforum, MDPI's event management platform. Sciforum simplifies the entire process, making it easy to host your own event by allowing you to focus on what really matters: Science!
Read more
Closing Thoughts
Stefan Tochev, Dr. Shu-Kun Lin, Dr. Eric O. Freed, Peter Roth, Wynne Wang, Allison Yang
Viruses and Editorial Quality: Acknowledging the Dedication of our Viruses Journal Team
During a June meeting with Dr. Eric O. Freed, the founding and current Editor-in-Chief of our journal Viruses, I was reminded of the exceptional dedication of our editorial board. Meeting with Eric is a pleasure, as he has a strong commitment and clear vision for the journal. Over the course of two days, we gained a deep understanding of the journal’s expectations and focus on strategic growth, editorial board representation, and engagement.
I am pleased to share that Viruses holds a CiteScore of 7.1 (an increase of 7.57% versus the 2021 metric) and an Impact Factor of 4.7. You can view the journal statistics here. Viruses publishes highly cited papers, and is indexed in renowned databases such as Scopus, SCIE (Web of Science), PubMed, and others, and maintains affiliations with prestigious societies. Moreover, the Viruses team has recently announced an exciting upcoming event titled ‘Viruses 2024 – A World of Viruses,’ scheduled to take place in Barcelona, Spain, from 14–16 February 2024.
Testimonials
If you notice my enthusiasm regarding our editorial service, it’s because the surveys and testimonials we receive speak volumes about the experiences of our authors, reviewers, and guest editors who collaborate with MDPI. The purpose of these letters is to highlight the exceptional work that we do and the experiences we create for the scholars – thus, let me end with this testimonial from an author:
“It was a great pleasure to publish in Viruses Special Issue [Emerging Viruses in Aquaculture]. The submission process was easy. Guest editors were very helpful and provided all the guidance and support as needed. The handling of the manuscript by the Editorial Team was very fast, efficient, and professional. The reviewer’s comments were insightful, and the publication processes were remarkably rapid.”
– Ms. Magdalena Stachnik, Państwowy Instytut Weterynaryjny | PIWet
Article in Viruses: Emerging Viral Pathogens in Sturgeon Aquaculture in Poland: Focus on Herpesviruses and Mimivirus Detection
Chief Executive Officer
MDPI AG
29 June 2023
Meet Us at the 38th Annual Meeting of the Japanese Society for Infection Prevention and Control, 20–22 July 2023, Yokohama, Japan
MDPI will be attending the 38th Annual Meeting of the Japanese Society for Infection Prevention and Control (JSIPC), which will be held from 20 to 22 July 2023, in Yokohama, Japan.
JSIPC was founded in 1986 as the Japanese Society for Environmental Infection (JSEI). The first annual meeting was attended by about 230 participants. Over the last 30 years, the number of annual meeting participants has notably increased to over 7,000, with the membership total exceeding 9,500. JSIPC was founded to address not only the primary issue of nosocomial infection, but all other infectious diseases caused by environmental changes. The theme of the 38th Annual Meeting of the Japanese Society for Infection Prevention and Control is “Professionalism”. The conference will cover various topics related to infection prevention and control, such as occupational safety and health, oral health, environmental health, infectious disease, antibiotic administration, vaccination, antibiotic resistance and misuse, and health education.
The following MDPI journals will be represented:
- Antibiotics;
- Vaccines;
- Infectious Disease Reports;
- Journal of Personalized Medicine (JPM);
- Tropical Medicine and Infectious Disease (TropicalMed).
If you plan on attending this conference, please feel free to stop by our booth (#B21) and have a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following link: http://jsipc38.umin.jp/.
28 June 2023
2022 Impact Factors for MDPI Journals
The 2022 citation metrics have been released in the Journal Citation Reports (JCR), and we’re pleased to announce the following results for MDPI journals:
We are thrilled to announce that 90% of our ranked MDPI journals, specifically 86 out of 96 (captured in the table below), are performing above average in Q1 or Q2. This year, Clarivate has expanded its Impact Factor (IF) awards to include journals in the Emerging Sources Citation Index (ESCI) and the Arts and Humanities Citation Index (AHCI), providing greater transparency for the full set of journals indexed in the Web of Science Core Collection. As a result, 111 of MDPI journals have received their first IF in 2023, with 37 journals surpassing an IF of 3.0. In total, 208 MDPI journals have been honored with an IF.
Clarivate explains that by "expanding the coverage but holding to highly selective standards, the [Impact Factor] is now a reliable indicator of trustworthiness, as well as a measure of scholarly impact, at the journal level."
Please visit our blog post where we discuss the release of the latest citation metrics with our Indexing Manager, Dr. Constanze Schelhorn, to find out what's different this time around and how to make use of different metrics available.
Journal | Impact Factor | Rank Quartile | Category |
Vaccines | 7.8 | Q1 | Immunology |
Medicine, Research & Experimental | |||
Antioxidants | 7.0 | Q1 | Food Science & Technology |
Biochemistry & Molecular Biology | |||
Chemistry, Medicinal | |||
Cells | 6.0 | Q2 | Cell Biology |
Nutrients | 5.9 | Q1 | Nutrition & Dietetics |
International Journal of Molecular Sciences | 5.6 | Q1 | Biochemistry & Molecular Biology |
Q2 | Chemistry, Multidisciplinary | ||
Journal of Theoretical and Applied Electronic Commerce Research | 5.6 | Q2 | Business |
Biomolecules | 5.5 | Q1 | Biochemistry & Molecular Biology |
Biosensors | 5.4 | Q1 | Chemistry, Analytical |
Instruments & Instrumentation | |||
Q2 | Nanoscience & Nanotechnology | ||
Fractal and Fractional | 5.4 | Q1 | Mathematics, Interdisciplinary Applications |
Marine Drugs | 5.4 | Q1 | Chemistry, Medicinal |
Pharmacology & Pharmacy | |||
Pharmaceutics | 5.4 | Q1 | Pharmacology & Pharmacy |
Nanomaterials | 5.3 | Q1 | Physics, Applied |
Q2 | Chemistry, Multidisciplinary | ||
Materials Science, Multidisciplinary | |||
Nanoscience & Nanotechnology | |||
Cancers | 5.2 | Q2 | Oncology |
Foods | 5.2 | Q1 | Food Science & Technology |
Polymers | 5.0 | Q1 | Polymer Science |
Remote Sensing | 5.0 | Q1 | Geosciences, Multidisciplinary |
Q2 | Remote Sensing | ||
Imaging Science & Photographic Technology | |||
Environmental Sciences | |||
Antibiotics | 4.8 | Q1 | Pharmacology & Pharmacy |
Q2 | Infectious Diseases | ||
Drones | 4.8 | Q2 | Remote Sensing |
Journal of Functional Biomaterials | 4.8 | Q2 | Engineering, Biomedical |
Materials Science, Biomaterials | |||
Biomedicines | 4.7 | Q1 | Pharmacology & Pharmacy |
Q2 | Biochemistry & Molecular Biology | ||
Medicine, Research & Experimental | |||
Journal of Fungi | 4.7 | Q2 | Mycology |
Microbiology | |||
Viruses | 4.7 | Q2 | Virology |
Bioengineering | 4.6 | Q2 | Engineering, Biomedical |
Gels | 4.6 | Q1 | Polymer Science |
Molecules | 4.6 | Q2 | Chemistry, Multidisciplinary |
Biochemistry & Molecular Biology | |||
Pharmaceuticals | 4.6 | Q2 | Pharmacology & Pharmacy |
Chemistry, Medicinal | |||
Toxics | 4.6 | Q1 | Toxicology |
Q2 | Environmental Sciences | ||
Biomimetics | 4.5 | Q1 | Engineering, Multidisciplinary |
Q2 | Materials Science, Biomaterials | ||
Microorganisms | 4.5 | Q2 | Microbiology |
Plants | 4.5 | Q1 | Plant Sciences |
Biology | 4.2 | Q2 | Biology |
Chemosensors | 4.2 | Q2 | Instruments & Instrumentation |
Chemistry, Analytical | |||
Electrochemistry | |||
Membranes | 4.2 | Q2 | Engineering, Chemical |
Materials Science, Multidisciplinary | |||
Chemistry, Physical | |||
Polymer Science | |||
Toxins | 4.2 | Q1 | Toxicology |
Q2 | Food Science & Technology | ||
Metabolites | 4.2 | Q2 | Biochemistry & Molecular Biology |
Batteries | 4.0 | Q2 | Electrochemistry |
Materials Science, Multidisciplinary | |||
Q3 | Energy & Fuels | ||
Catalysts | 3.9 | Q2 | Chemistry, Physical |
Journal of Clinical Medicine | 3.9 | Q2 | Medicine, General & Internal |
Land | 3.9 | Q2 | Environmental Studies |
Sensors | 3.9 | Q2 | Instruments & Instrumentation |
Chemistry, Analytical | |||
Engineering, Electrical & Electronic | |||
Sustainability | 3.9 | Q2 | Environmental Sciences (SCIE) |
Environmental Studies (SSCI) | |||
Q3 | Green & Sustainable Science & Technology (SCIE) | ||
Green & Sustainable Science & Technology (SSCI) | |||
Buildings | 3.8 | Q2 | Construction & Building Technology |
Engineering, Civil | |||
Agronomy | 3.7 | Q1 | Agronomy |
Q2 | Plant Sciences | ||
Fermentation | 3.7 | Q2 | Biotechnology & Applied Microbiology |
Pathogens | 3.7 | Q2 | Microbiology |
Agriculture | 3.6 | Q1 | Agronomy |
Diagnostics | 3.6 | Q2 | Medicine, General & Internal |
Genes | 3.5 | Q2 | Genetics & Heredity |
Journal of Intelligence | 3.5 | Q2 | Psychology, Multidisciplinary |
Lubricants | 3.5 | Q2 | Engineering, Mechanical |
Processes | 3.5 | Q2 | Engineering, Chemical |
Coatings | 3.4 | Q2 | Materials Science, Coatings & Films |
Physics, Applied | |||
Q3 | Materials Science, Multidisciplinary | ||
ISPRS International Journal of Geo-Information | 3.4 | Q2 | Geography, Physical |
Q3 | Computer Science, Information Systems | ||
Remote Sensing | |||
Materials | 3.4 | Q2 | Metallurgy & Metallurgical Engineering |
Physics, Applied | |||
Physics, Condensed Matter | |||
Q3 | Materials Science, Multidisciplinary | ||
Chemistry, Physical | |||
Micromachines | 3.4 | Q2 | Instruments & Instrumentation |
Physics, Applied | |||
Chemistry, Analytical | |||
Q3 | Nanoscience & Nanotechnology | ||
Water | 3.4 | Q2 | Water Resources |
Environmental Sciences | |||
Brain Sciences | 3.3 | Q3 | Neurosciences |
Energies | 3.2 | Q3 | Energy & Fuels |
Fire | 3.2 | Q1 | Forestry |
Q2 | Ecology | ||
Life | 3.2 | Q2 | Biology |
Current Issues in Molecular Biology | 3.1 | Q3 | Biochemistry & Molecular Biology |
Horticulturae | 3.1 | Q1 | Horticulture |
Animals | 3.0 | Q1 | Agriculture, Dairy & Animal Science |
Veterinary Sciences | |||
Insects | 3.0 | Q1 | Entomology |
Atmosphere | 2.9 | Q3 | Meteorology & Atmospheric Sciences |
Environmental Sciences | |||
Electronics | 2.9 | Q2 | Engineering, Electrical & Electronic |
Physics, Applied | |||
Q3 | Computer Science, Information Systems | ||
Forests | 2.9 | Q1 | Forestry |
Inorganics | 2.9 | Q2 | Chemistry, Inorganic & Nuclear |
Journal of Marine Science and Engineering | 2.9 | Q1 | Engineering, Marine |
Q2 | Oceanography | ||
Engineering, Ocean | |||
Metals | 2.9 | Q2 | Metallurgy & Metallurgical Engineering |
Q3 | Materials Science, Multidisciplinary | ||
Tropical Medicine and Infectious Disease | 2.9 | Q2 | Tropical Medicine |
Parasitology | |||
Q3 | Infectious Diseases | ||
Universe | 2.9 | Q2 | Astronomy & Astrophysics |
Physics, Particles & Fields | |||
Healthcare | 2.8 | Q2 | Health Policy & Services (SSCI) |
Q3 | Health Care Sciences & Services (SCIE) | ||
Applied Sciences | 2.7 | Q2 | Engineering, Multidisciplinary |
Physics, Applied | |||
Q3 | Chemistry, Multidisciplinary | ||
Materials Science, Multidisciplinary | |||
Crystals | 2.7 | Q2 | Crystallography |
Q3 | Materials Science, Multidisciplinary | ||
Entropy | 2.7 | Q2 | Physics, Multidisciplinary |
Magnetochemistry | 2.7 | Q2 | Chemistry, Inorganic & Nuclear |
Q3 | Chemistry, Physical | ||
Materials Science, Multidisciplinary | |||
Symmetry | 2.7 | Q2 | Multidisciplinary Sciences |
Actuators | 2.6 | Q2 | Instruments & Instrumentation |
Engineering, Mechanical | |||
Aerospace | 2.6 | Q1 | Engineering, Aerospace |
Behavioral Sciences | 2.6 | Q2 | Psychology, Multidisciplinary |
Current Oncology | 2.6 | Q3 | Oncology |
Machines | 2.6 | Q2 | Engineering, Mechanical |
Q3 | Engineering, Electrical & Electronic | ||
Medicina | 2.6 | Q3 | Medicine, General & Internal |
Separations | 2.6 | Q3 | Chemistry, Analytical |
Minerals | 2.5 | Q2 | Mining & Mineral Processing |
Mineralogy | |||
Geochemistry & Geophysics | |||
Children | 2.4 | Q2 | Pediatrics |
Diversity | 2.4 | Q2 | Biodiversity Conservation |
Q3 | Ecology | ||
Journal of Cardiovascular Development and Disease | 2.4 | Q3 | Cardiac & Cardiovascular Systems |
Mathematics | 2.4 | Q1 | Mathematics |
Photonics | 2.4 | Q3 | Optics |
Veterinary Sciences | 2.4 | Q1 | Veterinary Sciences |
Fishes | 2.3 | Q2 | Marine & Freshwater Biology |
Fisheries | |||
Axioms | 2.0 | Q2 | Mathematics, Applied |
Systems | 1.9 | Q2 | Social Sciences, Interdisciplinary |
Tomography | 1.9 | Q3 | Radiology, Nuclear Medicine & Medical Imaging |
Note: The Journal of Personalized Medicine's Impact Factor was omitted in the original release and will be assigned separately. Please find the data on the journal webpage in due course.
Source: 2022 Journal Impact Factors, Journal Citation Reports TM (Clarivate, 2023)
14 June 2023
Journal of Personalized Medicine Receives an Increased CiteScore of 2.6
We are pleased to inform you that the Journal of Personalized Medicine’s 2022 CiteScore is 2.6. JPM’s CiteScore ranks 153 among 309 titles (Q2) in the “Medicine (miscellaneous)” category, continuing to build momentum in its field. We would like to extend our congratulations to all concerned.
For more journal statistics, please visit https://www.mdpi.com/journal/jpm/stats.
25 May 2023
Meet Us at the 60th European Renal Association (ERA) Congress, 15–17 June 2023, Milan, Italy
Conference: 60th European Renal Association (ERA) Congress
Date: 15–17 June 2023
Location: Milan, Italy
MDPI will be attending the 60th ERA Congress as an exhibitor; we welcome researchers from different backgrounds to visit and share their latest ideas with us.
This conference is being organized by the European Renal Association, and it will offer a clearly structured scientific program, combining presentations of cutting-edge research with a broad view of the currently most relevant fields in the prevention, detection, and treatment of kidney disease. At the conference, specialists will share knowledge on the clinical assessment and treatments of renal diseases to improve disease prevention and patients’ quality of life.
The following MDPI journals will be represented:
- JCM;
- JPM;
- Kidney and Dialysis;
- Diagnostics;
- Clinics and Practice;
- Uro;
- Cells;
- BioChem;
- Transplantology.
16 May 2023
Meet Us at the 19th Annual International Conference of the Metabolomics Society, 18–22 June 2023, Niagara Falls, Ontario, Canada
Conference: 19th Annual International Conference of the Metabolomics Society
Date: 18–22 June 2023
Place: Niagara Falls Convention Centre, 6815 Stanley Avenue, Niagara Falls, Ontario, Canada L2G 3Y9
Booth: #T12
MDPI will be attending the 19th Annual International Conference of the Metabolomics Society, which will be held from 18 to 22 June 2023 in downtown Niagara Falls, Canada, at the Niagara Falls Convention Centre.
The conference is the official annual meeting of the Metabolomics Society, and the largest metabolomics meeting worldwide. It will cover the major scientific themes of: technology advances; computational metabolomics, statistics, and bioinformatics; metabolomics in health and disease; and metabolomics of plants, food, environment and microbes. A special theme for this conference will focus on mental health, drug addiction and medicinal cannabis. The scientific program will include plenary and keynote talks, three parallel scientific sessions, interactive poster sessions, sponsor lunches, other networking events and a specially organized parallel session to promote metabolomics research in industry. A strong line-up of both introductory and advanced workshops will take place on Sunday, 18 June, and the morning of Monday, 19 June. To complement the exciting scientific program, the conference will offer a welcome reception, vibrant early career events, a conference dinner and other engaging social activities.
The following MDPI journals will be represented:
- Metabolites;
- Agronomy;
- Antioxidants;
- Applied Biosciences;
- BioMed;
- BioMedInformatics;
- Biomolecules;
- Cancers;
- Cells;
- Children;
- CIMB;
- Diseases;
- Foods;
- Genes;
- JPM;
- Nutrients;
- Plants.
Please do not hesitate to reach out ([email protected]) if you plan on attending this conference. Our delegates look forward to meeting you in person and answering any questions that you might have.
For more information about the conference, please visit the following website: https://www.metabolomics2023.org/.
10 May 2023
Meet Us at the ATS (American Thoracic Society) Conference 2023, 21–23 May 2023, Washington DC, USA
Conference: ATS (American Thoracic Society) Conference 2023
Date: 21–23 May 2023
Location: Washington DC, USA
MDPI will be attending ATS 2023 as an exhibitor; we welcome researchers from different backgrounds to visit and share their latest ideas with us.
This conference has been organized by the American Thoracic Society, and it will showcase the latest advances and discoveries in respiratory science, patient care and global respiratory health. At the conference, specialists will share and discuss the latest research and its applications to clinical, basic, and translational science in pulmonary, critical care, and sleep medicine.
The following MDPI journals will be represented:
- JCM;
- Medicina;
- Clinics and Practice;
- JPM;
- Cancers;
- Medicines;
- Healthcare;
- Metabolites;
- Children;
- Brain Sciences.
If you are planning to attend this conference, please do not hesitate to talk with us online. Our delegates look forward to meeting you in person at booth #2606, and answering any questions that you may have. For more information about the conference, please visit the following website: https://conference.thoracic.org/.
5 May 2023
Meet Us at the 20th International Congress of the European Society for Child and Adolescent Psychiatry (ESCAP 2023), 29 June–1 July 2023, Copenhagen, Denmark
Conference: 20th International Congress of the European Society for Child and Adolescent Psychiatry (ESCAP 2023)
Date: 29 June–1 July 2023
Location: Copenhagen, Denmark
MDPI will be attending ESCAP 2023 as an exhibitor; we welcome researchers from different backgrounds to visit and share their latest ideas with us.
This conference is organized by the European Society for Child and Adolescent Psychiatry. The theme of the conference is “Mental health of children and adolescents”. At the conference, specialists will share and discuss the latest research and applications of environmental and chemical substances in relation to society.
The following MDPI journals will be represented:
If you are planning to attend this conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.escap2023.eu/.
21 April 2023
Journal of Personalized Medicine Webinar | Metabolic Syndrome and Cardiovascular Disease, 26 April 2023
Metabolic syndrome pathophysiology is multifactorial and involves abdominal obesity, hyperinsulinemia, and hyperglycemia. The activation of lipoprotein lipase and the inhibition of secretion of very low-density lipoproteins are central factors. Atherogenic dyslipidemia is causally linked to cardiovascular disease. At the same time, there is new evidence regarding genetic predisposition in metabolic syndrome causation. From early studies on twins to genome-wide association studies, the genetic origin of metabolic syndrome was found to span different genetic loci. Thus, environmental factors play a key role. Knowledge of increased genetic susceptibility to the syndrome permits a personalized approach to treatment and prevention. In this context, oxidative stress augments and Nrf-2 pathways are involved, the activation of which are equally favorable targets for oxidative stress suppression after treatment with natural product derivatives and phytotherapy. This attempt can also reduce the costs and side effects.
In the current webinar, firstly, lipid metabolism dysfunction in the pathogenesis of metabolic syndrome will be discussed. Genes and metabolic syndrome heritability will be analyzed, focusing on specific genes along with interaction with environmental factors. Last but not least, specific benefits from natural products’ utilization in the treatment of metabolic syndrome will be presented along with molecular pathways modification and cell signal regulation from phytotherapy.
Date: 26 April 2023 at 10:00 a.m. CEST
Webinar ID: 843 2926 3596
Register now for free!
Speaker/Presentation | Time in CEST |
Dr. Konstantinos Tsarouhas Chair Introduction |
10:00–10:10 am |
Dr. Genovefa Kolovou Lipids Contribution in Metabolic Syndrome |
10:10–10:30 am |
Dr. Lina Florentin Genetic Aspects of Metabolic Syndrome and Cardiovascular Implications |
10:30–10:50 am |
Dr. Ramin Rezaee Value of Natural Products in Cardiometabolic Medicine |
10:50–11:10 am |
Q&A | 11:10–11:25 am |
Dr. Konstantinos Tsarouhas Closing of Webinar |
11:25–11:30 am |
After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.
Unable to attend? Register anyway, and we will let you know when the recording is available to watch.
Webinar Chair and Keynote Speakers:
- Dr. Konstantinos Tsarouhas, Department of Cardiology, University Hospital of Larissa, Larissa, Greece.
- Dr. Genovefa Kolovou, Preventive Cardiology, Lipoprotein apheresis Unit and Lipid Disorders Clinic, Metropolitan Hospital, Athens Greece.
- Dr. Lina Florentin, A-Lab Genetic and Genomic Centre, Athens, Greece.
- Dr. Ramin Rezaee, International UNESCO Center for Health-Related Basic Sciences and Human Nutrition, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran, Assistant Professor.
Relevant Special Issue:
- “Metabolic Syndrome and Cardiovascular Disease”
Edited by Dr. Konstantinos Tsarouhas
30 March 2023
Meet Us at the European Human Genetics Conference 2023 (ESHG 2023), 10–13 June 2023, Glasgow, UK
MDPI will be attending the European Human Genetics Conference 2023 (ESHG 2023), held in Glasgow, UK, from 10 to 13 June 2023.
The following MDPI journals will be represented:
If you plan on attending this conference, feel free to stop by our booth #824. Our delegates look forward to meeting you in person to answer any questions you may have.
For more information about the conference, please visit the following link: https://2023.eshg.org/.
29 March 2023
Meet Us at the 112th Annual Meeting of the Japanese Society of Pathology, 13–15 April 2023, Shimonoseki, Japan
Conference: The 112th Annual Meeting of the Japanese Society of Pathology
Date: 13–15 April 2023
Place: Shimonoseki, Japan
MDPI will be attending the 112th Annual Meeting of the Japanese Society of Pathology as an exhibitor. This meeting will be held in Shimonoseki, Japan, from 13 to 15 April 2023. This conference is held every year, and the theme of the 112th edition is “Doors to Overcoming Intractable Diseases: Potential of Pathology and Pathological Diagnostics”. The aim of this meeting is to provide an opportunity for all the members who chose the path of pathology to engage in hot discussions and introduce new perspectives to pathology and diagnostic pathology.
The following MDPI journals will be represented:
If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://site2.convention.co.jp/112jsp/english/.
29 March 2023
Meet Us at the 19th World Congress of Basic & Clinical Pharmacology 2023, 2–7 July 2023, Glasgow, Scotland
This conference organized by the British Pharmacological Society and International Union of Basic and Clinical Pharmacologists (IUPHAR) will be held in Glasgow, Scotland, from 2 July to 7 July 2023. The topic of the conference focuses on pharmacology and drug discovery, research, and development, and the conference will include six days of symposia, keynote lectures, workshops, and debates. Discover the latest in pharmacology research and developments across 10 content themes.
Pharmaceuticals (ISSN: 1424-8247) is a peer-reviewed, open access journal of medicinal chemistry and related drug sciences, published monthly online by MDPI. Pharmaceuticals will participate in this event as an exhibitor together with nine other MDPI journals, among which Pharmaceuticals, Journal of Personalized Medicine and Biomedicines will have journal representatives at our booth.
The following MDPI journals will be represented:
- Pharmaceuticals (leading journal);
- Biomedicines;
- JPM;
- JCM;
- Marine Drugs;
- Children;
- Current Oncology;
- BioMedInformatics;
- JoX;
- Rheumato.
If you are attending this conference, please feel free to start a conversation with us at our booth #A22. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://wcp2023.org/ or contact the Pharmaceuticals Editorial Office at [email protected].
16 March 2023
Meet Us at the Chinese Academic Conference on Tumor Biomarker, 7–9 April 2023, Shanghai, China
MDPI will be attending the Chinese Academic Conference on Tumor Biomarker, held in Shanghai, China, from 7 to 9 April 2023. This conference aims to achieve an in-depth exchange of the latest research results in the field of basic research, clinical application, cutting-edge technology, and industrial development in the field of tumor markers over the year. During this conference, MDPI will welcome researchers from different backgrounds to visit and share their latest inspirations with us.
The following MDPI journals will be represented:
- Biomedicines;
- Cancers;
- Cells;
- Diagnostics;
- Current Oncology;
- JPM;
- JCM;
- Onco;
- CIMB;
- BioMedInformatics.
If you plan on attending this conference, feel free to stop by our booth, #B155. Our delegates look forward to meeting you in person to answer any questions you may have.
For more information about the conference, please follow the link below: https://biomarker2022.sciconf.cn/cn/web/index/13496.
13 March 2023
MDPI’s Newly Launched Journals in December 2022
As a leading open access publisher, MDPI provides scholars with a high-quality and rich academic exchange platform by continuously expanding into new and exciting research areas.
In December 2022, MDPI launched five new journals, covering multiple subjects such as life sciences, biology, medicine and pharmacology, social sciences and humanities. These new journals are being edited by established scholars across the world.
Journal |
Founding Editor-in-Chief |
Journal Topics (Selected) |
Prof. Dr. Fabio Gresta, University of Messina, Italy| Editorial | view inaugural issue |
grass/forage/turf production; grassland management; pasture monitoring; grazing and livestock; grass agro-ecosystems| view journal scope | submit an article |
|
Prof. Dr. Christos G. Athanassiou, University of Thessaly, Greece| Editorial | view inaugural issue |
pesticides; fungicides; herbicides; fertilizers; soil conditioners| view journal scope | submit an article |
|
Prof. Dr. Stephen H. Safe, Texas A&M University, USA| Editorial | view inaugural issue |
receptor structure; receptor function; receptor signaling; receptor expression and regulation; receptor interactions with drugs| view journal scope | submit an article |
|
Dr. Jean Jacques Vanden Eynde, University of Mons-UMONS, Belgium| Editorial | view inaugural issue |
drug discovery; medicinal chemistry; preclinical and clinical research; marketed drugs; intellectual property and regulatory affairs| view journal scope | submit an article |
|
Prof. Dr. Heather Kanuka, University of Alberta, Canada| Editorial | view inaugural issue |
higher education; tertiary education; policy and practice in higher education; educational leadership in higher education; educational administration and management in higher education| view journal scope | submit an article |
If you are interested in creating more open access journals with us to publish cutting-edge research, please send your journal proposal application to [email protected].
7 March 2023
Displaying Co-Authors’ Email Addresses on the Webpage of Published Papers
MDPI is pleased to announce that we now display the co-authors’ email addresses in addition to the corresponding author’s email address on the webpage of published papers, protected by Captcha. For more information about this change, please visit the journal’s instructions for authors page.
We believe this change will facilitate academic discussions and advance our cause of open science and research. The corresponding authors are responsible for communicating with their co-authors and indicating in our system (https://susy.mdpi.com/) if co-authors would prefer for their email addresses not to be displayed.
3 March 2023
Recruiting Co-Editor-in-Chief for the Journal of Personalized Medicine
Journal of Personalized Medicine (JPM; ISSN: 2075-4426) is an international journal published monthly online by the leading open access publisher MDPI with Prof. Dr. David Alan Rizzieri serving as the Editor-in-Chief. JPM publishes cutting-edge, innovative preclinical and translational scientific research and technologies related to personalized medicine (e.g., precision medicine, pharmacogenomics/proteomics, systems biology, and ‘omics association analysis). To ensure the continued efficient and high-quality production of our journal, we are currently seeking nominations and applications for the position of Co-Editor-in-Chief to assist Prof. Dr. David Alan Rizzieri.
The responsibilities of the Co-Editor-in-Chief include the following:
- Advising on the strategic development of the journal;
- Nominating/inviting Guest Editors and optionally delegating to them the authority to make final acceptance decisions for submitted articles;
- Nominating and leading the Editorial Board;
- Promoting the journal at scientific conferences or through other venues.
As an Co-Editor-in-Chief, you will have the unique opportunity to network and communicate with scholars in the personalized medicine community, building long-term relationships and establishing your influence within your discipline. Appointed members will also receive an Editor Certificate confirming this role. In addition, you will have the opportunity to publish two paper per year free of charge in JPM. The term for this position is two years and can be renewed.
If you are a researcher in a related field and are passionate about participating in the publication of cutting-edge research, please do not hesitate to get in touch about joining the Editorial Board (https://www.mdpi.com/journal/jpm). To apply for this position, please contact the Journal of Personalized Medicine Editorial Office ([email protected]) with the following two files attached:
- A full academic CV;
- A short cover letter that details your interests and enthusiasm for the position.
JPM Editorial Office
21 February 2023
Journal of Personalized Medicine | New Section “Life-Stage-Specific Medicine (LSSM)” Established
The Journal of Personalized Medicine (JPM, ISSN: 2075-4426) editorial team is pleased to announce the launch of a new Section, “Life-Stage-Specific Medicine (LSSM)”. The aim of this Section is to offer a platform for researchers and professionals in the field of personalized medicine on which they can demonstrate the influence of genetic and environmental factors on different life stages, in addition to how different life stages affect disease development, treatments, and longevity.
Topics could include, but are not limited to, the following:
- Disease development of different life stages and responses to disease treatments;
- Hormone levels in different life stages and their impact on disease development and treatments;
- The immune system at different life stages and its relationship with disease development, drugs, and disease treatments;
- Changes in hormone levels and immune statements during translations of life stages;
- How the length of life stages affects the total lifespan of humans;
- Clinical practice, clinical trials, and drug dosages with regard to the principal law of lifespan (PLOSP);
- Racial and sex differences in terms of life stages and lifespan;
- Menopause; puberty; and reproduction.
We are currently recruiting Editorial Board Members (EBMs) for this Section. If you are an active researcher in this field and are passionate about publishing cutting-edge research, please contact us at [email protected]. Alternatively, you may wish to submit your work directly via the following link: https://susy.mdpi.com/user/manuscripts/upload/786489cd3ae44f21e922b7fa879d33fc?form%5Bjournal_id%5D=65.
JPM Editorial Office
21 February 2023
Meet Us at the 143rd Annual Meeting of the Pharmaceutical Society of Japan, 25–28 March 2023, Sapporo, Japan
Conference: 143rd Annual Meeting of the Pharmaceutical Society of Japan
Date: 25–28 March 2023
Place: Sapporo, Japan
MDPI will be attending the 143rd Annual Meeting of the Pharmaceutical Society of Japan as the exhibitor. This meeting will be held at Hokkaido University, Sapporo, Japan, from 25 to 28 March 2023. The organizing committee comprises the Faculty of Pharmaceutical Sciences, Hokkaido University. The theme of the 143rd annual meeting is "PharmaScience: Integration for Breakthroughs". Through this meeting, we wish to contribute to the progress of research leading to the development of innovative drugs and therapies by bringing together researchers from various research fields.
The following MDPI journals will be represented:
If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://confit.atlas.jp/guide/event/pharm143/top.
16 February 2023
Increasing Visibility for Preprints.org – Clarivate adds the Preprint Citation Index to the Web of Science
On 9 February 2023, Clarivate, a global leader in providing trusted insights and analytics, added the Preprint Citation Index to the Web of Science platform, streamlining the research process by allowing researchers to locate and link to preprints alongside other trusted content in the database.
The Preprint Citation Index will act as a bridge to connect cutting-edge preprints with peer-reviewed journal articles published within the Web of Science Core Collection. Alerts can be easily set to monitor new research across several repositories and authors will also be able to include preprints on their Web of Science Research Profile to more accurately display their various research outputs.
As of its launch, the Preprint Citation Index will provide nearly two million preprints from various repositories, including MDPI’s own Preprints.org.
MDPI's Preprints Platform – Preprints.org
To advance Open Science and the fast dissemination of research, MDPI offers researchers a free multidisciplinary preprint platform. Preprints.org accepts submissions from all research areas and offers authors high visibility, permanent archiving, article-level Metrics and immediately citable content by assigning a Digital Object Identifier (DOI) to all preprints.
During submission to any MDPI journal, authors have the option to share their research as a preprint. After an initial screening, the manuscript is available online in 48 hours or less. Once online, preprints can be downloaded, shared, commented on, and cited, providing authors maximum visibility.
We invite you to join the ranks of the over 100k researchers using Preprints.org and share your research.
For more information, please visit Preprints.org.
14 February 2023
Meet Us at the 11th National Conference on Bioinformatics and Systems Biology, 25–27 February 2023, Guangzhou, China
Conference: 11th National Conference on Bioinformatics and Systems Biology
Date: 25–27 February 2023
Place: Guangzhou, China
MDPI will be attending the 11th National Conference on Bioinformatics and Systems Biology (CCBSB2023) as the exhibitor. The National Academic Conference on Bioinformatics and Systems Biology has been successfully held for ten sessions since its first session in 1998. It is a national event with the highest academic level and the greatest influence in the field of bioinformatics research in China. The theme of the conference is "The Latest Frontier Research of Bioinformatics and Systems Biology and Their Applications", and the topics cover translational informatics and data sharing security, biomedical data mining and computing, genome informatics, artificial intelligence and life sciences, group bioinformatics and integrated biology, non-coding RNA and RNA informatics, network biology, major disease omics informatics, biological macromolecular structure prediction and simulation, bioinformatics algorithm research, biological data resources, bioinformatics and drugs discovery, computational synthetic biology, agricultural and forestry informatics and other bioinformatics, and other frontier directions.
The following MDPI journals will be represented:
- Genes;
- JPM;
- Cardiogenetics;
- Bioengineering;
- Biomolecules;
- Metabolites;
- Cells;
- Symmetry;
- Biomedicines;
- Computers;
- COVID;
- Epigenomes.
If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://ccbsb2022.casconf.cn/.
22 December 2022
Special Issue Mentor Program
We are pleased to announce the launch of a new initiative—the MDPI Special Issue Mentor Program.
This program will enable early career researchers (who must hold a Ph.D. in a related field) to experience editing a Special Issue in MDPI journals, under the mentorship of our experienced Editorial Board Members or other experienced scientists. The mentor program will provide an excellent opportunity for early career scientists to gain editorial experience, and to cultivate their ability to edit scientific research.
The mentee’s responsibilities include:
- Proposing a Special Issue title and assisting the mentor in preparing a summary (around 200–400 words) and 3–10 keywords describing the background, importance, and goal of the Issue;
- Writing a brief promotion plan for the Special Issue;
- Preparing a list of scholars who may be interested in the Issue and personally e-mailing invitations on behalf of Guest Editors;
- Writing an editorial for the online Special Issue together with the mentor.
The mentor’s responsibilities include:
- Conducting a final check before the Special Issue is published online;
- Performing editorial control of the Special Issue and quality control of the publications, both of which must be carried out in a timely manner;
- Providing suggestions to younger scholars if they have any doubts or concerns regarding submissions;
- Organizing video calls with young scholars and the Editorial Office regularly to discuss problems and improvement suggestions for the Special Issue;
- Making and submitting decisions regarding submissions with the assistance of mentees.
Certificates and awards:
After the Special Issue closes, the Editorial Office will provide official certificates for all the mentors and early career researchers.
If you are interested in this opportunity, please send your Special Issue proposal to the Editorial Office of a journal you choose, and we will discuss the process (i.e., mentor collaboration, Special Issue topic feasibility analysis, etc.) in further detail. The full list of MDPI journals is as follows: https://www.mdpi.com/about/journals.
In addition to the new Special Issue Mentor Program, we will continue to welcome all Special Issue proposals focusing on hot research topics.
14 December 2022
"Thanks a Million!" – One Million Articles Published in MDPI Journals
MDPI has just become the first open access (OA) publisher to reach the milestone of one million articles published. That is one million articles freely available to all, to circulate and build upon! We are proud to share this special moment with the global scientific community.
This landmark has been reached thanks to the immeasurable support of more than 600,000 expert reviewers, 66,000 editorial board members and 6700 hard-working colleagues across MDPI’s global offices.
Within more than 25 years of publishing, our journals received 2.1 million manuscripts and generated 4.6 million peer review reports to get to one million papers published.
Reaching the milestone of one million articles published reinforces our mission to remove any existing barriers and to make scientific research accessible to all. Since its inception, MDPI’s goal has been to create reliable processes to make science open. This is a path towards facilitating the dissemination of novel insights in scientific communities.
Regular feedback from authors and reviewers shows that our service is greatly appreciated and needed. At the same time, the feedback helps us identify areas for further improvement.
As it stands, a significant share of published research findings remain closed access. More than half of the content published with the most well-known legacy publishers stays behind a paywall, and that is not including articles published in hybrid OA journals, or made available months or years after publication.
A new policy announced by the US administration in August 2022 requires that, as of January 2026, all US federally funded research be made freely and immediately available after publication. While the new policy does not mandate articles be published under an open access license, it is aligned with the open access movement in removing all barriers to research. Similarly, some of the most advanced research institutions in the world intend to have all funded research articles published in open access by 2025.
MDPI is proud to be the leading agent of the transition to open access.
"Thanks a Million" to all the contributors!
8 December 2022
MDPI Sustainability Foundation: New Look and Nominations for the 2023 Sustainability Awards Now Open
We are pleased to announce that the website of the MDPI Sustainability Foundation has been revamped! For the past couple of months, our UX UI team and front-end developers have been working hard to launch the website in time for the opening of the Sustainability Awards nominations.
The website is not the only thing that has had a remodeling. Indeed, the format of the Emerging Sustainability Leader Award (ESLA) has been updated. ESLA is now a competition open to individual researchers or start-ups founded by researchers under the age of 35. Nominee applications will go through 2 rounds of selection until the final 3 are decided. The finalists will then be invited to give pitch presentations during the Award Ceremony to win either first place (10,000 USD) or runner-up (2 x 5000 USD).
The World Sustainability Award, on the other hand, remains the same: a total prize money of 100,000 USD is up for grabs by senior individual researchers or groups of researchers from the international research community.
Nominations for both the World Sustainability Award and the Emerging Sustainability Leader award are now open! Check out our new website for more information on how to nominate.
4 November 2022
Meet Us at the 27th Congress of the Chinese Pediatric Society, 15–18 December 2022, Changsha, China
MDPI will be attending the 27th Congress of the Chinese Pediatric Society, held in Changsha, China, from 15–18 December 2022.
The following MDPI journals will be represented:
- Children (leading journal);
- JPM;
- Medicina;
- Audiology Research;
- JCM;
- Healthcare;
- Diagnostics;
- Metabolites;
- Cancers;
- Nutrients.
If you plan on attending this conference, feel free to stop by our booth: #B67. Our delegates look forward to meeting you in person to answer any questions that you may have.
For more information about the conference, please see the following link: https://nccps2022.tiemeeting.com/CN.
25 October 2022
Journal of Personalized Medicine | Special Issue Mentor Program
We are pleased to announce the launch of a new initiative—the Special Issue Mentor Program.
This program intends to provide an opportunity for early career scientists to enhance their editing, networking, and organizational skills, and to work closely with our journal to gain more editorial experience. Early career scientists who have novel ideas for new Special Issues in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) will act as Guest Editors under the mentorship of an experienced scientist; this mentor could be a member of the Editorial Board of JPM, or from other well-established research institutes or laboratories.
If you are interested in this opportunity, please send your Special Issue proposal to the JPM Editorial Office ([email protected]), and we will discuss the process (i.e., mentor collaboration, Special Issue topic feasibility analysis, etc.) in further detail.
In addition to the new Special Issue Mentor Program, JPM will continue to welcome all Special Issue proposals based on hot research topics.
28 September 2022
Peer Review Week 2022 – Research Integrity: Creating and Supporting Trust in Research
Peer Review Week began 19 September 2022 under the theme of “Research Integrity: Creating and Supporting Trust in Research”. Through various blog articles, podcast, and webinar, we discussed this crucial subject throughout the week, celebrating the essential role peer review plays in maintaining research quality.
To begin, we held a Webinar on the topic. Professor Peter W. Choate and Dr. Emmanuel Obeng-Gyasi joined Dr. Ioana Craciun, one of MDPI’s scientific officers, for an in-depth discussion.
We invite you to view the event recording:
During the week, the MDPI Blog in a series articles highlighted how good Peer Review safeguards research integrity. The following topics were covered:
- Peer Review Week 2022
- Research Integrity
- What We’ve Learned About Peer Review Reports
- 4 Steps to the Perfect Peer Review Report
- How to Write the Perfect Peer Review Report: An Interview
- Inviting Great Peer Reviewers
In a new edition of Insight Faster, an MDPI podcast, we were delighted to talk to the co-chairs of the Peer Review Week committee, Jayashree Rajagopalan (Senior Manager of Global Community Engagement for CACTUS) and Danielle Padula (Head of Marketing and Community Development at Scholastica) to get their take on this year’s event and its related topics.
You can find the Podcast here.
We hope you enjoy the contents!
23 September 2022
Recruiting Section Editors-in-Chief for the Journal of Personalized Medicine
The Journal of Personalized Medicine (JPM, ISSN: 2075-4426) is an international, peer-reviewed, open access journal on personalized medicine that is published monthly online by MDPI. To develop different research areas and continue to attract high-quality papers, JPM is recruiting Section Editors-in-Chief. More details can be found at https://www.mdpi.com/journal/jpm/sections.
At present, the following Sections have not yet found suitable scholars to lead them:
- “Regenerative Medicine and Therapeutics”;
- “Epigenetic Therapy”;
- “Sex, Gender and Hormone Based Medicine”.
We are now recruiting Section Editors-in-Chief (SEiC) for these Sections. If you are an active researcher in one of the aforementioned fields and are passionate about publishing cutting-edge research, please do not hesitate to contact us at: [email protected]/[email protected]. You can find more information on our homepage: https://www.mdpi.com/journal/jpm.
The Section Editor-in-Chief has the following responsibilities:
- Making decisions on whether a manuscript can be accepted based on the reports we collect;
- Reviewing a small number of papers per year and managing the Section together with other journal editors;
- Promoting JPM and increasing its visibility at related academic conferences.
We believe that by combining our rigorous editorial policies with your expertise, we can build a high-quality journal. We thank you in advance for your interest and look forward to collaborating with you in the future.
JPM Editorial Office
7 September 2022
Meet Us at the ASHG Annual Meeting 2022 (ASHG 2022), 25–29 October 2022, Los Angeles, USA
MDPI will be attending ASHG 2022, held in Los Angeles, USA, from 25 to 29 October 2022.
The following MDPI journals will be represented:
- Genes;
- JPM;
- Biomedicines;
- Biomolecules;
- Cardiogenetics;
- Cancers;
- Brain Science;
- Symmetry;
- Diagnostics;
- Metabolites;
- Cells;
- Biology;
- Humans;
- DNA.
If you plan on attending this conference, feel free to stop by our booth: #1844. Our delegates look forward to meeting you in person to answer any questions you may have.
For more information about the conference, please see the following link:
28 July 2022
Meet Us at EuroBioFilms 2022, 31 August–3 September 2022, Palma de Mallorca, Spain
MDPI will be attending EuroBioFilms 2022 (EBF), hosted by the ESCMID Study Group for Biofilms (ESGB), which will be held from 31 August to 3 September 2022 in Palma de Mallorca, Spain. The conference will be held at the Meliá Palma Marina Hotel, Av. de Gabriel Roca, 29, 07014 Palma, Balearic Islands.
The multidisciplinary program will cover many subjects and will be a mix of basic and clinical biofilm-related topics. Leading scientists in the field will be present as keynote speakers and/or chairpersons. Oral presentations will be presented during various parallel sessions. On 31st of August, several educational preconference workshops will be organized.
The following MDPI journals will be represented:
- Antibiotics (leading);
- Pathogens;
- Membranes;
- Biology;
- Journal of Personalized Medicine.
If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference and our booth, please visit the following link: https://eurobiofilms2022.com/, or contact the Antibiotics Editorial Office at [email protected].
28 June 2022
2021 Impact Factors - Released
The 2021 citation metrics have been released in the Journal Citation Reports (JCR), and we’re pleased to announce the following results for MDPI journals:
Journal | Impact Factor | Rank | Category |
Antioxidants | 7.675 | Q1 | Food Science & Technology |
Biochemistry & Molecular Biology | |||
Chemistry, Medicinal | |||
Cells | 7.666 | Q2 | Cell Biology |
Nutrients | 6.706 | Q1 | Nutrition & Dietetics |
Cancers | 6.575 | Q1 | Oncology |
Pharmaceutics | 6.525 | Q1 | Pharmacology & Pharmacy |
International Journal of Molecular Sciences | 6.208 | Q1 | Biochemistry & Molecular Biology |
Q2 | Chemistry, Multidisciplinary | ||
Marine Drugs | 6.085 | Q1 | Chemistry, Medicinal |
Pharmacology & Pharmacy | |||
Biomolecules | 6.064 | Q2 | Biochemistry & Molecular Biology |
Batteries * | 5.938 | Q2 | Electrochemistry |
Energy & Fuels | |||
Materials Science, Multidisciplinary | |||
Viruses | 5.818 | Q2 | Virology |
Biosensors | 5.743 | Q1 | Chemistry, Analytical |
Instruments & Instrumentation | |||
Q2 | Nanoscience & Nanotechnology | ||
Journal of Fungi | 5.724 | Q1 | Mycology |
Q2 | Microbiology | ||
Nanomaterials | 5.719 | Q1 | Physics, Applied |
Q2 | Chemistry, Multidisciplinary | ||
Materials Science, Multidisciplinary | |||
Nanoscience & Nanotechnology | |||
Metabolites | 5.581 | Q2 | Biochemistry & Molecular Biology |
Foods | 5.561 | Q1 | Food Science & Technology |
Drones * | 5.532 | Q2 | Remote Sensing |
Remote Sensing | 5.349 | Q1 | Geosciences, Multidisciplinary |
Imaging Science & Photographic Technology | |||
Q2 | Remote Sensing | ||
Environmental Sciences | |||
Journal of Theoretical and Applied Electronic Commerce Research | 5.318 | Q2 | Business |
Antibiotics | 5.222 | Q1 | Pharmacology & Pharmacy |
Q2 | Infectious Diseases | ||
Pharmaceuticals | 5.215 | Q1 | Pharmacology & Pharmacy |
Q2 | Chemistry, Medicinal | ||
Biology | 5.168 | Q1 | Biology |
Fermentation | 5.123 | Q2 | Biotechnology & Applied Microbiology |
Toxins | 5.075 | Q1 | Toxicology |
Q2 | Food Science & Technology | ||
Bioengineering * | 5.046 | Q2 | Engineering, Biomedical |
Polymers | 4.967 | Q1 | Polymer Science |
Journal of Clinical Medicine | 4.964 | Q2 | Medicine, General & Internal |
Vaccines | 4.961 | Q2 | Immunology |
Medicine, Research & Experimental | |||
Molecules | 4.927 | Q2 | Chemistry, Multidisciplinary |
Biochemistry & Molecular Biology | |||
Microorganisms | 4.926 | Q2 | Microbiology |
Journal of Functional Biomaterials * | 4.901 | Q2 | Engineering, Biomedical |
Materials Science, Biomaterials | |||
Biomedicines | 4.757 | Q2 | Medicine, Research & Experimental |
Pharmacology & Pharmacy | |||
Biochemistry & Molecular Biology | |||
Plants | 4.658 | Q1 | Plant Sciences |
International Journal of Environmental Research and Public Health | 4.614 | Q1 | Public, Environmental & Occupational Health (SSCI) |
Q2 | Public, Environmental & Occupational Health (SCIE) | ||
Environmental Sciences (SCIE) | |||
Membranes | 4.562 | Q1 | Polymer Science |
Q2 | Engineering, Chemical | ||
Materials Science, Multidisciplinary | |||
Chemistry, Physical | |||
Pathogens | 4.531 | Q2 | Microbiology |
Catalysts | 4.501 | Q2 | Chemistry, Physical |
Toxics | 4.472 | Q2 | Toxicology |
Environmental Sciences | |||
Gels | 4.432 | Q1 | Polymer Science |
Journal of Cardiovascular Development and Disease | 4.415 | Q2 | Cardiac & Cardiovascular Systems |
Chemosensors | 4.229 | Q1 | Instruments & Instrumentation |
Q2 | Chemistry, Analytical | ||
Q3 | Electrochemistry | ||
Genes | 4.141 | Q2 | Genetics & Heredity |
Diagnostics | 3.992 | Q2 | Medicine, General & Internal |
Agronomy | 3.949 | Q1 | Agronomy |
Plant Sciences | |||
Land | 3.905 | Q2 | Environmental Studies |
Sustainability | 3.889 | Q2 | Environmental Sciences (SCIE) |
Environmental Studies (SSCI) | |||
Q3 | Green & Sustainable Science & Technology (SCIE) | ||
Q4 | Green & Sustainable Science & Technology (SSCI) | ||
Sensors | 3.847 | Q2 | Instruments & Instrumentation |
Chemistry, Analytical | |||
Engineering, Electrical & Electronic | |||
Materials | 3.748 | Q1 | Metallurgy & Metallurgical Engineering |
Q2 | Physics, Applied | ||
Physics, Condensed Matter | |||
Q3 | Materials Science, Multidisciplinary | ||
Chemistry, Physical | |||
Biomimetics * | 3.743 | Q2 | Engineering, Multidisciplinary |
Q3 | Materials Science, Biomaterials | ||
Tropical Medicine and Infectious Disease * | 3.711 | Q1 | Tropical Medicine |
Q2 | Parasitology | ||
Q3 | Infectious Diseases | ||
Lubricants * | 3.584 | Q2 | Engineering, Mechanical |
Fractal and Fractional | 3.577 | Q1 | Mathematics, Interdisciplinary Applications |
Water | 3.530 | Q2 | Water Resources |
Q3 | Environmental Sciences | ||
Micromachines | 3.523 | Q2 | Instruments & Instrumentation |
Physics, Applied | |||
Chemistry, Analytical | |||
Q3 | Nanoscience & Nanotechnology | ||
Journal of Personalized Medicine | 3.508 | Q2 | Medicine, General & Internal |
Health Care Sciences & Services | |||
Agriculture | 3.408 | Q1 | Agronomy |
Processes | 3.352 | Q2 | Engineering, Chemical |
Separations | 3.344 | Q2 | Chemistry, Analytical |
Magnetochemistry | 3.336 | Q2 | Chemistry, Inorganic & Nuclear |
Q3 | Chemistry, Physical | ||
Materials Science, Multidisciplinary | |||
Brain Sciences | 3.333 | Q3 | Neurosciences |
Buildings | 3.324 | Q2 | Construction & Building Technology |
Engineering, Civil | |||
Forests | 3.282 | Q1 | Forestry |
Energies | 3.252 | Q3 | Energy & Fuels |
Life | 3.251 | Q2 | Biology |
Coatings | 3.236 | Q2 | Materials Science, Coatings & Films |
Physics, Applied | |||
Q3 | Materials Science, Multidisciplinary | ||
Animals | 3.231 | Q1 | Agriculture, Dairy & Animal Science |
Veterinary Sciences | |||
Journal of Intelligence * | 3.176 | Q2 | Psychology, Multidisciplinary |
Fishes | 3.170 | Q1 | Marine & Freshwater Biology |
Q2 | Fisheries | ||
Healthcare | 3.160 | Q2 | Health Policy & Services (SSCI) |
Health Care Sciences & Services (SCIE) | |||
Inorganics * | 3.149 | Q2 | Chemistry, Inorganic & Nuclear |
Insects | 3.139 | Q1 | Entomology |
Atmosphere | 3.110 | Q3 | Meteorology & Atmospheric Sciences |
Environmental Sciences | |||
Current Oncology | 3.109 | Q3 | Oncology |
ISPRS International Journal of Geo-Information | 3.099 | Q2 | Geography, Physical |
Q3 | Computer Science, Information Systems | ||
Remote Sensing | |||
Diversity | 3.029 | Q2 | Biodiversity Conservation |
Ecology | |||
Tomography | 3.000 | Q3 | Radiology, Nuclear Medicine & Medical Imaging |
Current Issues in Molecular Biology | 2.976 | Q3 | Biochemistry & Molecular Biology |
Medicina | 2.948 | Q3 | Medicine, General & Internal |
Symmetry | 2.940 | Q2 | Multidisciplinary Sciences |
Horticulturae | 2.923 | Q1 | Horticulture |
Machines | 2.899 | Q2 | Engineering, Mechanical |
Engineering, Electrical & Electronic | |||
Systems * | 2.895 | Q2 | Social Sciences, Interdisciplinary |
Applied Sciences | 2.838 | Q2 | Engineering, Multidisciplinary |
Physics, Applied | |||
Q3 | Chemistry, Multidisciplinary | ||
Materials Science, Multidisciplinary | |||
Children | 2.835 | Q2 | Pediatrics |
Minerals | 2.818 | Q2 | Mining & Mineral Processing |
Mineralogy | |||
Geochemistry & Geophysics | |||
Universe | 2.813 | Q2 | Astronomy & Astrophysics |
Q3 | Physics, Particles & Fields | ||
Journal of Marine Science and Engineering | 2.744 | Q1 | Engineering, Marine |
Q2 | Oceanography | ||
Engineering, Ocean | |||
Entropy | 2.738 | Q2 | Physics, Multidisciplinary |
Fire * | 2.726 | Q2 | Forestry |
Q3 | Ecology | ||
Metals | 2.695 | Q2 | Metallurgy & Metallurgical Engineering |
Q3 | Materials Science, Multidisciplinary | ||
Electronics | 2.690 | Q3 | Engineering, Electrical & Electronic |
Computer Science, Information Systems | |||
Physics, Applied | |||
Crystals | 2.670 | Q2 | Crystallography |
Q3 | Materials Science, Multidisciplinary | ||
Aerospace | 2.660 | Q1 | Engineering, Aerospace |
Mathematics | 2.592 | Q1 | Mathematics |
Photonics | 2.536 | Q3 | Optics |
Actuators | 2.523 | Q2 | Instruments & Instrumentation |
Q3 | Engineering, Mechanical | ||
Veterinary Sciences | 2.518 | Q2 | Veterinary Sciences |
Behavioral Sciences * | 2.286 | Q3 | Psychology, Multidisciplinary |
Axioms * | 1.824 | Q2 | Mathematics, Applied |
For more information on Impact Factors and what it means to index academic journals, please visit our related blog posts.
* Journals given their first Impact Factor in 2022
Source: 2021 Journal Impact Factors, Journal Citation Reports TM (Clarivate, 2022)
20 June 2022
MDPI’s 2021 Young Investigator Awards in “Medicine & Pharmacology”—Winners Announced
MDPI’s Young Investigator Awards recognize promising junior researchers, acknowledge their contributions, and enhance communication among scientists. We are proud to present the winners for the year 2021 in the “Medicine & Pharmacology” category. The winners were selected by the journals’ editors.
We warmly congratulate the awarded young investigators for their outstanding contributions. MDPI will continue to provide support and recognition to the academic community.
- Jasper Fuk-Woo Chan, Queen Mary Hospital, Hong Kong
- Mateusz Maciejczyk, Medical University of Bialystok, Poland
- Matteo Lambertini, University of Genova, Italy
- Helen Rogers, Newcastle University, UK
- Amir Karami, University of South Carolina, USA
- Andrea Palermo, Campus Bio-Medico University, Italy
Journal of Personalized Medicine:
- Simone Di Franco, University of Palermo, Italy
- Catriona Hippman, University of Calgary, Canada
- Veeru Kasivisvanathan, University College London, UK
- Andrea Cortegiani, University of Palermo, Italy; University Hospital Policlinico Paolo Giaccone, Italy
- Qi Zhou, Purdue University, USA
20 June 2022
MDPI’s 2021 Travel Awards in “Medicine & Pharmacology”—Winners Announced
We are proud to recognize the winners of MDPI’s 2021 Travel Awards in the “Medicine & Pharmacology” category for their outstanding presentations and to present them with the prize.
MDPI journals regularly offer travel awards to encourage talented junior scientists to present their latest research at academic conferences in specific fields, which helps to increase their influence.
The winners mentioned below were carefully selected by the journal editors based on an outline of their research and the work to be presented at an academic conference.
We would like to warmly congratulate the Travel Awards winners for the year 2021 and wish them the greatest success with their future research endeavors. MDPI will continue to enhance communication among scientists.
- Soheil Saeedi, University of Zurich, Switzerland
- Shawn Alexander Hallett, University of Michigan, USA
- Claire Albert, Yale University, USA
- Raquel Filipa da Costa Viveiros, NOVA University of Lisbon, Portugal
- Patrick Jim Küppers, University Hospital Bonn, Germany
20 June 2022
MDPI’s 2021 Outstanding Reviewer Awards in “Medicine & Pharmacology”—Winners Announced
In order to acknowledge our reviewers, who so generously dedicate their time to reviewing papers, and demonstrate diligence, professionalism, and timeliness when reviewing manuscripts, MDPI journals regularly offer outstanding reviewer awards to scholars who participate in the peer-review process.
We are proud to recognize winners for the year 2021 in the “Medicine & Pharmacology” category for their outstanding contributions among extensive competition by presenting them with an Outstanding Reviewer Award.
We would like to take this opportunity to congratulate all of the winners on their achievement. MDPI will continue to provide support and recognition to the academic community.
- Antonio G. Solimando, University of Bari Aldo Moro, Italy
- Chenghui Li, University of Arkansas for Medical Sciences, USA
- Joaquim Carreras, Tokai University, Japan
- Pierfrancesco Franco, University of Turin School of Medicine, Italy
- Laurentiu Pop, University of Texas Southwestern Medical Center, USA
- Margaret Fitch, University of Toronto, Canada
- Caroline Mariano, BC Cancer Agency, Canada; University of British Columbia, Canada
- Naser Alsharairi, Griffith University, Australia
- Peter W. Choate, Mount Royal University, Canada
- Qin Xiang Ng, National University of Singapore, Singapore
- Giulio Francesco, Sapienza University of Rome, Italy
- Sebastian Schnaubelt, Medical University of Vienna, Austria
- Olga Kislitsina, Northwestern University, Northwestern Memorial Hospital, USA
Journal of Personalized Medicine:
- Onofrio Laselva, University of Foggia, Italy
- Ping-Hsun Wu, Kaohsiung Medical University, Taiwan
- Vladimir Vladimirov, Virginia Commonwealth University, USA
- Mauro Giuffrè, University of Trieste, Italy
- Erika Palmieri, National Cancer Institute at Frederick, USA
- Anjul Khadria, California Institute of Technology, Pasadena, USA
20 June 2022
MDPI’s 2021 Best Paper Awards in “Medicine & Pharmacology”—Winners Announced
The purpose of our Best Paper Awards is to promote and recognize the most impactful contributions published within MDPI journals.
The editors of each journal carefully selected reviews and research papers through a rigorous judging process based on criteria such as the scientific merit, overall impact, and the quality of presentation of the papers published in the journal last year.
We are honored to present the winners in the “Medicine & Pharmacology” category, who were selected amongst extensive competition, and congratulate the authors for their outstanding scientific publications.
MDPI will continue to provide support and recognition to the academic community.
by Eunice Ego Mgbeahuruike, Milla Stålnacke, Heikki Vuorela and Yvonne Holm
Antibiotics 2019, 8(2), 55; doi:10.3390/antibiotics8020055
by Bernardo Ribeiro da Cunha, Luís P. Fonseca and Cecília R. C. Calado
Antibiotics 2019, 8(2), 45; doi:10.3390/antibiotics8020045
by Zvi Artzi, Shiran Sudri, Ori Platner and Avital Kozlovsky
Dent. J. 2019, 7(1), 29; doi:10.3390/dj7010029
by Philipp Sahrmann, Cyrill Bettschart, Daniel B. Wiedemeier, Ahmed Al-Majid, Thomas Attin and Patrick R. Schmidlin
Dent. J. 2019, 7(4), 115; doi:10.3390/dj7040115
by Chantal Huisman and Helianthe Kort
Healthcare 2019, 7(1), 31; doi:10.3390/healthcare7010031
by Vijay Kumar Chattu, Soosanna Kumary Chattu, Deepa Burman, David Warren Spence and Seithikurippu R. Pandi-Perumal
Healthcare 2019, 7(1), 37; doi:10.3390/healthcare7010037
by Eija Könönen, Mervi Gursoy and Ulvi Kahraman Gursoy
Clin. Med. 2019, 8(8), 1135; doi:10.3390/jcm8081135
by Yueyuan Zhou, Yusuke Yamamoto, Zhongdang Xiao and Takahiro Ochiya
Clin. Med. 2019, 8(7), 1025; doi:10.3390/jcm8071025
by Tara K. Sigdel, Felipe Acosta Archila, Tudor Constantin, Sarah A. Prins, Juliane Liberto, Izabella Damm, Parhom Towfighi, Samantha Navarro, Eser Kirkizlar, Zachary P. Demko, Allison Ryan, Styrmir Sigurjonsson, Reuben D. Sarwal, Szu-Chuan Hseish, Chitranon Chan-On, Bernhard Zimmermann, Paul R. Billings, Solomon Moshkevich and Minnie M. Sarwal
Clin. Med. 2019, 8(1), 19; doi:10.3390/jcm8010019
by Borros Arneth
Medicina 2020, 56(1), 15; doi: 10.3390/medicina56010015
by Márió Gajdács, Marianna Ábrók, Andrea Lázár, and Katalin Burián
Medicina 2019, 55(7), 356; doi: 10.3390/medicina55070356
by Atheer Awad, Fabrizio Fina, Sarah J. Trenfield, Pavanesh Patel, Alvaro Goyanes, Simon Gaisford and Abdul W. Basit.
Pharmaceutics 2019, 11(4), 148; doi:10.3390/pharmaceutics11040148
by Constantin Mircioiu, Victor Voicu, Valentina Anuta, Andra Tudose, Christian Celia, Donatella Paolino, Massimo Fresta, Roxana Sandulovici and Ion Mircioiu
Pharmaceutics 2019, 11(3), 140; doi:10.3390/pharmaceutics11030140
9 June 2022
2021 CiteScores - Released
The 2021 citation metrics have been officially released in Scopus!
We are pleased to announce that 182 MDPI journals are included, of which:
● 21 journals received their first CiteScore.
● 85% of journals increased their CiteScore from 2020.
● 155 journals (85%) ranked above average, in at least one category.
The following 65 MDPI journals (36%) ranked among the top 25% of journals, in at least one category:
Journal |
CiteScore |
Quartile |
Category |
10.1 |
Q1 |
Genetics |
|
10.0 |
Q1 |
Biomedical Engineering |
|
8.1 |
Q1 |
Pharmacology, Toxicology and Pharmaceutics (miscellaneous) |
|
7.9 |
Q1 |
Electrical and Electronic Engineering |
|
7.9 |
Q1 |
Nutrition and Dietetics |
|
7.4 |
Q1 |
General Earth and Planetary Sciences |
|
7.2 |
Q1 |
Computer Science Applications |
|
6.9 |
Q1 |
Inorganic Chemistry |
|
6.9 |
Q1 |
Computer Networks and Communications |
|
6.7 |
Q1 |
General Biochemistry, Genetics and Molecular Biology |
|
6.6 |
Q1 |
General Chemical Engineering |
|
6.6 |
Q1 |
Health, Toxicology and Mutagenesis |
|
6.6 |
Q1 |
Infectious Diseases |
|
6.5 |
Q1 |
Food Science |
|
6.5 |
Q1 |
Civil and Structural Engineering |
|
6.4 |
Q1 |
Nature and Landscape Conservation |
|
6.4 |
Q1 |
Instrumentation |
|
6.1 |
Q1 |
Management Information Systems |
|
5.9 |
Q1 |
Chemistry (miscellaneous) |
|
5.7 |
Q1 |
Polymers and Plastics |
|
5.6 |
Q1 |
Engineering (miscellaneous) |
|
5.5 |
Q1 |
General Environmental Science |
|
5.5 |
Q1 |
Urban Studies |
|
5.4 |
Q2 |
Computer Networks and Communications |
|
5.3 |
Q1 |
Food Science |
|
5.3 |
Q1 |
Plant Science |
|
5.2 |
Q1 |
Ecology, Evolution, Behavior and Systematics |
|
5.2 |
Q1 |
General Engineering |
|
Journal of Open Innovation: Technology, Market, and Complexity |
5.1 |
Q1 |
Development |
5.0 |
Q1 |
Chemistry (miscellaneous) |
|
5.0 |
Q1 |
Control and Optimization |
|
5.0 |
Q1 |
Geography, Planning and Development |
|
5.0 |
Q1 |
Geography, Planning and Development |
|
4.9 |
Q1 |
Forestry |
|
4.9 |
Q1 |
Control and Optimization |
|
4.9 |
Q1 |
Soil Science |
|
4.8 |
Q1 |
General Earth and Planetary Sciences |
|
4.8 |
Q1 |
Mechanical Engineering |
|
4.8 |
Q1 |
Public Health, Environmental and Occupational Health |
|
4.8 |
Q1 |
Geography, Planning and Development |
|
International Journal of Environmental Research and Public Health |
4.5 |
Q1 |
Public Health, Environmental and Occupational Health |
4.5 |
Q1 |
Physical Therapy, Sports Therapy and Rehabilitation |
|
4.4 |
Q1 |
Mathematical Physics |
|
4.4 |
Q1 |
General Medicine |
|
4.3 |
Q1 |
General Mathematics |
|
4.2 |
Q1 |
Surgery |
|
4.1 |
Q1 |
Health Professions (miscellaneous) |
|
4.1 |
Q1 |
Plant Science |
|
4.0 |
Q1 |
General Engineering |
|
4.0 |
Q1 |
Forestry |
|
4.0 |
Q1 |
Education |
|
3.9 |
Q1 |
General Pharmacology, Toxicology and Pharmaceutics |
|
3.9 |
Q1 |
Applied Mathematics |
|
3.8 |
Q1 |
Development |
|
3.8 |
Q1 |
Architecture |
|
3.8 |
Q1 |
Metals and Alloys |
|
3.5 |
Q1 |
Communication |
|
3.4 |
Q1 |
General Social Sciences |
|
2.9 |
Q1 |
General Mathematics |
|
2.8 |
Q1 |
Analysis |
|
2.7 |
Q1 |
General Veterinary |
|
2.6 |
Q1 |
Algebra and Number Theory |
|
1.8 |
Q1 |
Conservation |
|
1.0 |
Q1 |
Religious Studies |
|
0.9 |
Q1 |
Philosophy |
Source: 2021 CiteScores™ (Elsevier)
8 June 2022
Journal of Personalized Medicine | Webinar on Radiation Response Biomarkers for Individualised Cancer Treatments, 15 June 2022
Date: 15 June 2022
Time: 14:30 (CEST)
Webinar ID: 871 1746 2760
Register here: https://jpm-1.sciforum.net/
Participation fee: None
Language: English
Webinar keywords: radiation, radiotherapy, sensitivity, radiation oncology, biomarkers, cancer, X-rays
Link to related Special Issue: https://www.mdpi.com/journal/jpm/special_issues/radiation_cancer
Webinar Chair and Speakers:
Chair:
- Dr. Christophe Badie, Cancer Mechanisms and Biomarkers Group, UK Health Security Agency, Harwell Campus, UK
Speakers:
- Dr. Elisa Placidi, UOC Radioterapia Oncologica, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli, Italy
- Prof. Dr. Susan M. Bailey, Department of Environmental & Radiological Health Sciences, Cancer Biology & Comparative Oncology University Program of Research and Scholarly Excellence, Colorado State University, USA
If you have any questions about this webinar, please contact [email protected].
We look forward to your participation in this event.
JPM Editorial Office
16 March 2022
Welcoming New Editorial Board Members of Journal of Personalized Medicine
We are excited to welcome the following recognized researchers, who recently joined the Editorial Board of the Journal of Personalized Medicine (JPM, ISSN: 2075-4426):
Name: Dr. Cristian Ripoli
Affiliation: Department of Neuroscience, Faculty of Medicine and Surgery, Università Cattolica del Sacro Cuore, 00168 Rome, Italy
Name: Dr. Jeonghyun Ahn
Affiliation: Department of Cell Biology, Leonard M. Miller School of Medicine, University of Miami, Miami, FL, USA
Name: Dr. Sheng Ho
Affiliation: Department of Radiation Oncology, Chi Mei Medical Center, Graduate Institute of Medical Science, Chang Jung Christian University, Tainan 710, Taiwan
Name: Dr. Ming-Chao Tsai
Affiliation: 1. Division of Hepato-Gastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan
2. Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan 83301, Taiwan
Name: Dr. Erik Wilms
Affiliation: Hospital Pharmacy, The Hague Hospitals, 2545 AB The Hague, The Netherlands
Name: Dr. Sara Bravaccini
Affiliation: IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, via Maroncelli 40, 47014 Meldola, Italy
Name: Prof. Dr. Giovanni Squadrito
Affiliation: Department of Clinical and Experimental Medicine, University of Messina, 98100 Messina, Italy
Name: Prof. Dr. Alfredo Berruti
Affiliation: Dipartimento di Specialità Medico-Chirurgiche, Scienze Radiologiche e Sanità Pubblica, Brescia, Italy
Name: Prof. Dr. Cheng-Hsien Lu
Affiliation: 1. Department of Neurology, Chang Gung Memorial Hospital-Kaohsiung and Chang Gung University 123, Ta-Pei Road, Niao Sung district, Kaohsiung City 83304, Taiwan
2. Department of Biological Science, National Sun Yat-sen University, Kaohsiung City 80424, Taiwan
Name: Dr. Ceres Fernandez Rozadilla
Affiliation: 1. Grupo de Medicina Xenómica, Universidade de Santiago de Compostela (USC), 15706 Santiago de Compostela, Spain
2. Instituto de Investigación Sanitaria de Santiago (IDIS), 15706 Santiago de Compostela, Spain
Name: Dr. Francesca Stillitano
Affiliation: Cardiovascular Department, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands
Name: Dr. Hui-Hua Hsiao
Affiliation: Division of Hematology-Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
Name: Prof. Dr. Juan J. Salazar Corral
Affiliation: Instituto de Investigaciones Oftalmológicas Ramón Castroviejo, Departamento Oftalmología y ORL, Universidad Complutense de Madrid, Madrid, Spain
Name: Dr. Margarida Maria Fernandes Baptista e Silva
Affiliation: Department of Biochemistry and Human Biology, Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal
Name: Dr. Sara Llufriu
Affiliation: Center of Neuroimmunology, Laboratory of Advanced Imaging in Neuroimmunological Diseases, Hospital Clinic Barcelona, Institut d’Investigacions Biomediques August Pi i Sunyer (IDIBAPS) and Universitat de Barcelona, 08036 Barcelona, Spain
Name: Prof. Dr. Won Hyuk Chang
Affiliation: Department of Physical & Rehabilitation Medicine, Center for Prevention and Rehabilitation, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea
Name: Dr. Mircea Tampa
Affiliation: Department of Dermatology, “Carol Davila” University of Medicine and Pharmacy, 020021 Bucharest, Romania
We wish them every success both in their research and in the development of the journal.
Further details about the Editorial Board can be found at: https://www.mdpi.com/journal/jpm/editors.
JPM Editorial Office
17 January 2022
Journal of Personalized Medicine | Top 10 Cited Papers
We are pleased to announce the list of the Top 10 Cited Papers published in 2020 and 2021 in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426):
1. “Wise Management of Ovarian Cancer: On the Cutting Edge”
by Stergios Boussios, Christos Mikropoulos, Eleftherios Samartzis, Peeter Karihtala, Michele Moschetta, Matin Sheriff, Afroditi Karathanasi, Agne Sadauskaite, Elie Rassy and Nicholas Pavlidis
2. “XGBoost Improves Classification of MGMT Promoter Methylation Status in IDH1 Wildtype Glioblastoma”
by Nguyen Quoc Khanh Le, Duyen Thi Do, Fang-Ying Chiu, Edward Kien Yee Yapp, Hui-Yuan Yeh and Cheng-Yu Chen
3. “Applications of Machine Learning Predictive Models in the Chronic Disease Diagnosis”
by Gopi Battineni, Getu Gamo Sagaro, Nalini Chinatalapudi and Francesco Amenta
4. “Molecular and Cellular Mechanisms Affected in ALS”
by Laura Le Gall, Ekene Anakor, Owen Connolly, Udaya Geetha Vijayakumar, William J. Duddy and Stephanie Duguez
5. “A Rare Case of Cerebral Venous Thrombosis and Disseminated Intravascular Coagulation Temporally Associated to the COVID-19 Vaccine Administration”
by Vincenzo D’Agostino, Ferdinando Caranci, Alberto Negro, Valeria Piscitelli, Bernardino Tuccillo, Fabrizio Fasano, Giovanni Sirabella, Ines Marano, Vincenza Granata, Roberta Grassi, Davide Pupo and Roberto Grassi
6. “Gallstone Disease, Obesity and the Firmicutes/Bacteroidetes Ratio as a Possible Biomarker of Gut Dysbiosis”
by Irina N. Grigor’eva
7. “A Research on the Classification and Applicability of the Mobile Health Applications”
by Ivan Miguel Pires, Gonçalo Marques, Nuno M. Garcia, Francisco Flórez-Revuelta, Vasco Ponciano and Salome Oniani
8. “The 35th Anniversary of the Discovery of EPR Effect: A New Wave of Nanomedicines for Tumor-Targeted Drug Delivery—Personal Remarks and Future Prospects”
by Hiroshi Maeda
9. “Returning Results in the Genomic Era: Initial Experiences of the eMERGE Network”
by Georgia L. Wiesner, Alanna Kulchak Rahm, Paul Appelbaum, Sharon Aufox, Sarah T. Bland, Carrie L. Blout, Kurt D. Christensen, Wendy K. Chung, Ellen Wright Clayton, Robert C. Green, Margaret H. Harr, Nora Henrikson, Christin Hoell, Ingrid A. Holm, Gail P. Jarvik, Iftikhar J. Kullo, Philip E. Lammers, Eric B. Larson, Noralane M. Lindor, Maddalena Marasa, Melanie F. Myers, Josh F. Peterson, Cynthia A. Prows, James D. Ralston, Hila Milo Rasouly, Richard R. Sharp, Maureen E. Smith, Sara L. Van Driest, Janet L. Williams, Marc S. Williams, Julia Wynn and Kathleen A. Leppig
10. “Biomarkers for Alzheimer’s Disease Early Diagnosis”
by Eva Ausó, Violeta Gómez-Vicente and Gema Esquiva
Further details about the Top 10 Cited Papers can be found at the following link:
https://www.mdpi.com/journal/jpm/stats.
JPM Editorial Office
15 December 2021
Welcoming New Editorial Board Members of Journal of Personalized Medicine
We are excited to welcome the following recognized researchers, who recently joined the Editorial Board of Journal of Personalized Medicine (ISSN: 2075-4426):
Name: Prof. Dr. Ping-Ho Chen
Affiliation: School of Dentistry, College of Dental Medicine, Kaohsiung Medical University, No. 100 Shih-Chuan 1st Road, Kaohsiung 807, Taiwan
Name: Dr. Waqar Rashid
Affiliation: Medical School, University of Sussex, Brighton, UK
Name: Prof. Dr. Richard Rokyta
Affiliation: Department of Cardiology, University Hospital and Faculty of Medicine in Pilsen, Charles University, 304 60 Pilsen, Czech Republic
Name: Prof. Dr. Marco Aiello
Affiliation: Institute for Architecture of Application Systems Service Computing
Name: Prof. Dr. Xiaomei Cong
Affiliation: School of Nursing, University of Connecticut, Storrs, CT, USA
Name: Prof. Dr. Hong-Sheng Wang
Affiliation: College of Medicine, University of Cincinnati, Cincinnati, OH, USA
Name: Dr. Sigve Nakken
Affiliation: Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway
Name: Prof. Dr. Jochen Schneider
Affiliation: Department of Medical Translational Research, University of Luxembourg, Esch-sur-Alzette, Luxembourg
Name: Prof. Dr. Paraskevi Katsaounou
Affiliations: 1. Pulmonary Dept of First ICU Clinic, Evangelismos Hospital, 10676 Athens, Greece
2. School of Medicine, National and Kapodistrian University of Athens, 10561 Athens, Greece
Name: Dr. Ivo Bokoski
Affiliation: Digestive Endoscopy Unit, Fondazione Policlinico Universitario agostino Gemelli IRCCS, Largo A. Gemelli, 00168 Roma, Italy
Name: Prof. Dr. Carmen Burtea
Affiliation: Department of General, Organic and Biomedical Chemistry, NMR and Molecular Imaging Laboratory, Faculty of Medicine and Pharmacy, University of Mons, Avenue Maistriau 19, Mendeleev Building, B-7000 Mons, Belgium
Name: Dr. Domenico Di Raimondo
Affiliation: Division of Internal Medicine and Stroke Care, Department of Promoting Health, Maternal-Infant, Excellence and Internal and Specialized Medicine (Promise) G. D'Alessandro, University of Palermo, Palermo, Italy
Name: Dr. Norio Yamamoto
Affiliations: 1. Department of Orthopedic Surgery, Miyamoto Orthopedic Hospital, Okayama, Japan
2. Department of Epidemiology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan
Name: Dr. Lea Bentur
Affiliation: Pediatric Pulmonary Institute, Ruth Children Hospital, Rambam Health Care Center, Haifa, Israel
We wish them every success both in their research and in the development of the journal.
Further details about the Editorial Board can be found at: https://www.mdpi.com/journal/jpm/editors.
JPM Editorial Office
10 December 2021
Welcoming New Section Editors-in-Chief of Journal of Personalized Medicine
We are pleased to announce that Prof. Dr. Kenneth P.H. Pritzker has been appointed Section Editor-in-Chief of “Clinical Medicine, Cell, and Organism Physiology”, Prof. Dr. K. Ray Chaudhuri has been appointed Section Editor-in-Chief of “Methodology, Drug and Device Discovery”, and Prof. Dr. Enrico Mini has been appointed Section Editor-in-Chief of “Pharmacogenetics” in the Journal of Personalized Medicine (JPM; ISSN 2075-4426). We look forward to their contribution to the continued success of the journal.
Name: Prof. Dr. Kenneth P.H. Pritzker
Affiliation: Professor Emeritus, Department of Laboratory Medicine and Pathobiology, Department of Surgery, University of Toronto, 6 Queens Pk Crescent W, F, Toronto, ON M5S 3H2, Canada
Interests: biomineralization: normal and pathological; pathogenesis of degenerative joint diseases, osteoarthritis; pathogenesis of crystal deposits in tissues; connective tissues as biomaterials; novel biomaterials; biomedical applications of fullerenes; connective tissue neoplasia; ribosomal RNA and its pathology; neoplasia risk assessment using novel biomarkers and histo-/cytomorphometry; ultrasound enabled histologic and cytologic technologies; novel biomarkers for spondylitis and other chronic inflammatory diseases; abiotic stress
Name: Prof. Dr. K. Ray Chaudhuri
Affiliation: Department of Basic and Clinical Neuroscience, The Maurice Wohl Clinical Neuroscience Institute, King's College London, Cutcombe Road, London SE5 9RT, UK
Interests: Parkinson's disease; movement disorders
Name: Prof. Dr. Enrico Mini
Affiliation: Department of Health Sciences, Universita degli Studi di Firenze, Florence, Italy
Interests: gastrointestinal cancers; tumor drug resistance; biomarkers; pharmacogenetics; pharmacogenomics; translational studies
JPM Editorial Office
8 December 2021
Journal of Personalized Medicine | Introducing Editor's Choice Articles
On behalf of the Journal of Personalized Medicine (JPM, ISSN: 2075-4426), we would like to introduce a new feature, "Editor's choice articles", to highlight outstanding papers published in the journal. The Editor’s choice articles will be selected by the editors, and will include original articles that contain important and impactful findings, as well as review articles that are excellently written. With the introduction of this feature, readers can expect timely and useful highlights of recent articles in the journal, and deserving authors will receive more attention for their excellent contributions. We hope that this feature will enhance your reading pleasure and experience with JPM.
JPM Editorial Office
1 December 2021
JPM Editorial Board Members Receive "2021 Highly Cited Researchers" Distinction
It is our great honor to congratulate the Editorial Board Members of JPM (ISSN: 2075-4426) who have been distinguished as Highly Cited Researchers in 2021 by Clarivate, according to the Web of Science data. We would like to express our gratitude for the immense impact the named researchers continue to have on scientific progress and our journal’s development.
Clarivate's annual list of Highly Cited ResearchersTM identifies the most highly cited scientists in the past decade. The impactful papers of these researchers are among the top 1% in the citation distribution of 22 fields analyzed in the "Essential Science Indicators", distinguishing them as hugely influential among their peers.
Name: Prof. Dr. Adam J. Guastella
Affiliation: Brain and Mind Centre, The University of Sydney, Camperdown, NSW 2050, Australia
Name: Prof. Dr. Matthias Schwab
Affiliation: Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart and Department of Clinical Pharmacology, Institute of Experimental and Clinical Pharmacology and Toxicology and Interfaculty Center for Pharmacogenomics and Drug Research (ICEPHA), University Hospital, Tuebingen Auerbachstrasse 112, 70376 Stuttgart, Germany
Name: Dr. Stuart A. Scott
Affiliation: Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
The full list of Highly Cited Researchers for 2021 can be accessed at the following webpage in the Web of Science: https://recognition.webofscience.com/awards/highly-cited/2021/.
We would like to extend our sincerest congratulations to these individuals. In addition, we would like to acknowledge the professional support and valuable publications from all of our academic editors.
JPM Editorial Office
22 November 2021
722 MDPI Editorial Board Members Receiving "2021 Highly Cited Researchers" Distinction
It is our great honor to congratulate the Editorial Board Members and Editors in MDPI's journals who have been distinguished as 2021 Highly Cited Researchers by Clarivate, according to Web of Science data. We herewith express our gratitude for the immense impact the named researchers continue to make on scientific progress and on our journals' development.
Clarivate's annual list of Highly Cited ResearchersTM identifies the most highly cited scientists for the past decade. Their impactful papers are among the top 1 per cent in the citation distribution of one or more of 22 fields analyzed in the "Essential Science Indicators", distinguishing them as hugely influential among their peers.
Abate, Antonio Abatzoglou, John T. Abbaszadeh, Mostafa Acharya, U. Rajendra Acharya, Viral V. Agarwal, Ravi P. Ahn, Myung-Ju Airoldi, Laura Ali, Imran Allakhverdiev, Suleyman I. Aluko, Rotimi E. Anasori, Babak Andersson, Dan I. Andes, David Anker, Stefan D. Apergis, Nicholas Ariga, Katsuhiko Arqub, Omar Abu Aschner, Michael Assaraf, Yehuda G. Astruc, Didier Atala, Anthony Atanasov, Atanas G. Atangana, Abdon Bahram, Mohammad Bakris, George L. Balandin, Alexander A. Baleanu, Dumitru Balsamo, Gianpaolo Bando, Yoshio Banks, William A. Bansal-Travers, Maansi Barba, Francisco J. Barros, Lillian Basit, Abdul W. Baskonus, Haci Mehmet Bassetti, Matteo Battino, Maurizio Bell, Jordana T. Bellomo, Nicola Benediktsson, Jon Atli Benelli, Giovanni Benjakul, Soottawat Bhatnagar, Amit Biddle, Stuart J. H. Biondi, Antonio Biondi-Zoccai, Giuseppe Bjarnsholt, Thomas Blaabjerg, Frede Blaschke, Thomas Blay, Jean-Yves Blumwald, Eduardo Blunt, John W. Boffetta, Paolo Bogers, Marcel Bonomo, Robert A. Bowman, David M.J.S. Boyer, Cyrille Brestic, Marian Brevik, Eric C. Buhalis, Dimitrios Burdick, Jason A. Byrd, John C. Cabeza, Luisa F. Cai, Xingjuan Cai, Jianchao Calhoun, Vince D. Calin, George Cao, Jinde Cao, Guozhong Carvalho, Andre F. Castellanos-Gomez, Andres Cerqueira, Miguel Ângelo Parente Ribeiro Chang, Jo-Shu Chang, Chih-Hao Chastin, Sebastien Chau, Kwok-wing Chemat, Farid Chen, Xiaobo Chen, YangQuan Chen, Jianmin Chen, Chaoji Chen, Min Chen, Qi Chen, Jun Chen, Xi Chen, Peng Chen, Yulin Chen, Bo Chen, Chen Chen, Zhi-Gang Chen, Wei-Hsin Chen, Gang Chen, Yongsheng Chen, Xiang Chen, Yimin Chen, Runsheng Chen, Lidong Chen, Shaowei Chen, Qian Chen, Yu Chen, Shuangming Chiclana, Francisco Cho, Sun Young Choi, Wonyong Chowdhary, Anuradha Choyke, Peter L. Cichocki, Andrzej Corella, Dolores Corma, Avelino Cortes, Javier Cortes, Jorge Costanza, Robert Crommie, Michael F. Cui, Yi Cui, Haiying Cui, Qinghua Cummings, Kenneth Michael Dai, Shifeng Dai, Sheng Daiber, Andreas Davis, Steven J. Dawson, Ted M. de la Fuente-Nunez, Cesar Decker, Eric Andrew Dekel, Avishai Demaria, Marco Deng, Yong Deng, Xiangzheng DePinho, Ronald A. Desneux, Nicolas Dimopoulos, Meletios-Athanasios Ding, Aijun Dionysiou, Dionysios D. Dokmeci, Mehmet Remzi Dolgui, Alexandre Dong, Fan Dou, Shi Xue Dou, Letian Du, Qian Du, Bo Dube, Shanta Rishi Dufresne, Alain Dummer, Reinhard Dupont, Didier Edwards, David Elaissari, Abdelhamid Elhoseny, Mohamed Ellahi, Rahmat Ellis, Erle C. ElMasry, Gamal Esteller, Manel Estévez, Mario Fabbro, Doriano Facchetti, Antonio Fan, Zhanxi Fang, Chuanglin Fasano, Alessio Fečkan, Michal Felser, Claudia Feng, Liangzhu Fensholt, Rasmus Ferdinandy, Péter Fernandez-Lafuente, Roberto Ferreira, Isabel C. F. R. Filippi, Massimo Fisher, Helen Fortino, Giancarlo Fosso Wamba, Samuel Franceschi, Claudio Fujita, Hamido Fujita, Masayuki Gai, Francesco Gaisford, Simon Galanakis, Charis M. Galluzzi, Lorenzo Galvano, Fabio Gan, Ren-You Gan, Lihua Gandomi, Amir H. Gao, Bin Gao, Feng Gao, Minrui Gao, Huijun Gao, Wei Gao, Huile Garbe, Claus Garcia, Hermenegildo Gasbarrini, Antonio Gasco, Laura Gautret, Philippe Geng, Yong Gerdts, Gunnar Geschwind, Daniel H. Ghadimi, Noradin Ghaffari, Roozbeh Ghamisi, Pedram Giampieri, Francesca Glick, Bernard R. Gnant, Michael Goel, Ajay Gogotsi, Yury Goldewijk, Kees Klein Gong, Jinlong Gong, Yongji Govindan, Kannan Granato, Daniel Grancini, Giulia Green, Douglas R. Grosso, Giuseppe Gu, Ke Guan, Cao Guastella, Adam J. Guerrero, Josep M. Gui, Guan Guizani, Mohsen Guo, Zaiping Gupta, Rangan Gutzmer, Ralf Haase, Dagmar Habibi-Yangjeh, Aziz Hagemann, Stefan Hagger, Martin Hamblin, Michael R. Hammoudeh, Shawkat Han, Heesup Hanes, Justin Harrison, Roy M. Hartung, Hans-Peter Hasanuzzaman, Mirza He, Jr-Hau He, Hongwen He, Jiaqing He, Debiao Henseler, Jörg Herrera, Francisco Herrera-Viedma, Enrique Hetz, Claudio Ho Kim, Jung Holmes, Elaine Hossain, Ekram Hsueh, Po-Ren Hu, Xiaosong Hu, Wenbin Huang, Jianping Huang, Hongwei Huang, Yu Huang, Jianying Huang, Peng Huang, Baibiao Huang, Shaoming Hubacek, Klaus |
Iqbal, Hafiz M. N. |
Saad, Fred |
The full list of 2021 Highly Cited Researchers can be accessed at the following webpage in the Web of ScienceTM https://recognition.webofscience.com/awards/highly-cited/2021/.
--- Highly Cited Researchers (HCR) is a Clarivate product.
16 November 2021
Topical Advisory Panel Established to Support Editorial Board
Academic editors play a crucial role in leading our journals and ensuring that each article undergoes a robust and timely peer-review. With the launch of Topics this year and addition of Topic Editors to our family of academic editors, we decided it would be a good time to restructure our academic boards, thus providing more clarity and support for each role. MDPI is pleased to announce the launch of a new position—Topical Advisory Panel Member, that will replace the previous position of Topics Board Member. The Topical Advisory Panel will be comprised of early career researchers eager to gain experience in editorial work.
The main responsibility of the new members of the Topical Advisory Panel is to regularly provide support to Guest Editors, Topic Editors, and Section Board Members. The responsibilities of the Topical Advisory Panel are available here: https://www.mdpi.com/editors.
Each year, the members’ performances are evaluated, and outstanding members are promoted to the Editorial Board by the Editor-in-Chief.
To qualify as a Topical Advisory Panel Member, applicants must:
- Have expertise and experience in the field related to the journal;
- Have received a Ph.D. in the last 10 years, approximately;
- Have at least 6-8 published papers in the last 5 years as first author or corresponding author;
- Currently hold an independent research position in academia or a government institute.
If you are interested in this role, please contact the editorial office by email.
We look forward to hearing from you soon.
25 October 2021
Open Access Week 2021 | It Matters How We Open Knowledge: Building Structural Equity, 25–31 October
Founded in 1996, MDPI was one of the first fully Open Access publisher. Over 25 years MDPI has grown to become the largest Open Access publisher globally, publishing over 160,000 articles across more than 350 journals in 2020. At the core, MDPI was founded in response to a pressing need of fast publication and inclusion. The scholar was set at the centre of the publication process for the first time. Acting as a service provider, rather than a product provider, MDPI exists to help scientists achive their objective to disseminate research results. At MDPI, we believe scientists deserve a better service from the publishing world.
The International Open Access Week (Open Access Week), founded by the SPARC (the Scholarly Publishing and Academic Resources Coalition) Alliance and student partners in 2008, has been successfully running for 13 years. As an advocate and pioneer of open access publishing, MDPI actively responds to the call of International Open Access Week. This year’s theme of “It Matters How We Open Knowledge: Building Structural Equity” highlights the Recommendation’s call for equitable participation from all authors and readers.
For the last 25 years, MDPI has been committed to disseminating open research. Here is a video showing MDPI’s Commitment to Equity, Inclusion and Diversity for More than 25 Years.
International Open Access Week is an important opportunity to catalyze new conversations, create connections across and between communities that can facilitate this co-design, and advance progress in the building of more equitable foundations for opening knowledge—discussions and actions that need to be continued, year in and year out. MDPI has always aimed to provide professional and efficient publishing services to scholars around the world.
Our mission is to make scientific research accessible to everyone; this year, we interview and hold discussions with open science ambassadors on how to build an equal and inclusive environment for open science. Academic editors help us collaborate with more institutions to advocate for open access ideas.
Besides this, our scientific community is a key driver of our success and MDPI’s remarkable growth. Despite the pandemic, we have prepared online conferences and workshops to gather scholars from different communities.
The Basel Sustainable Publishing online forum provides an equal opportunity for stakeholders and researchers from multi-cultural environments to exchange ideas and eliminate barriers to participation.
Conference date: 25 October 2021, online
Conference website: https://bspf2021.sciforum.net/
Main topics: MDPI discusses the current dilemma of open access science from various perspectives such as governments, libraries, and publishers, and related measures on how to change the status quo of discrimination from a global perspective.
We aim to support equality, inclusion, diversity, and accessibility in scholarly communications. We collaborate with universities and key laboratories and have scholarly communications with researchers, teachers, and students on open access workshops.
- 25 October 2021
Energies journal and Institute of Mechanics, Chinese Academy of Sciences
- 28 October 2021
Machines journal and State Key Laboratory of Traction Power, Southwest Jiaotong University
- 29 October 2021
Processes journal and Beijing Institute of Technology
- 29 October 2021
Coatings journal and Wuhan University of Technology
MDPI is committed to providing open access and high-quality publishing services for scholars and promoting rapid dissemination of academic achievements. We hope to promote the practices and policies of open access publishing and diversify the dissemination of academic achievements.
23 September 2021
2020 MDPI Top Reviewer Award—Winners Announced
Rigorous peer-review is the cornerstone of high-quality academic publishing. Over 369,916 scholars served as reviewers for MDPI journals in 2020. We are extremely appreciative of all those who made a contribution to the editorial process in this capacity. At the beginning of every year, journal editorial offices publish a list of all reviewers’ names to express our gratitude. In addition, this year, the MDPI Top Reviewer Award was announced, to recognize the very best reviewers for their expertise and dedication, and their high-quality, and timely review reports. We are pleased to announce the following winners of the 2020 MDPI Top Reviewer Award:
- Adriana Burlea-Schiopoiu;
- Alban Kuriqi;
- Álvaro González-Vila;
- Alessandro Alaimo;
- Alexey Beskopylny;
- Alexander Yu Churyumov;
- Alberto Fernández-Isabel;
- Andrea Mastinu;
- Antonios N. Papadopoulos;
- Anton Rassõlkin;
- Antonio Humberto Hamad Minervino;
- Arkadiusz Matwijczuk;
- Artur Słomka;
- Baojie He;
- Bartłomiej Potaniec;
- Bojan Đurin;
- Camilo Arturo Rodriguez Diaz;
- Carmelo Maria Musarella;
- Chiachung Chen;
- Chiman Kwan;
- Cristian Busu;
- Danil Pimenov;
- Dan-Cristian Dabija;
- Delfín Ortega-Sánchez;
- Demetrio Antonio Zema;
- Denis Butusov;
- Elena Lucchi;
- Gaurab Dutta;
- Livia Anastasiu;
- M. R. Safaei.
For more information about how to become a reviewer of MDPI journals, please see: www.mdpi.com/reviewers.
22 September 2021
MDPI Joins SDG Publishers Compact
UN's 17 Sustainable Development Goals (SDGs) are the blueprint to achieve a better and more sustainable future for all. In 2020 the SDG Publishers Compact was launched, aimed to inspire publishers and accelerate progress to achieve the 17 goals by 2030. Members of the programme are committed to support the publication of materials that will promote and inspire actions towards SDGs.
MDPI is an eager advocate of SDGs and has already been supporting the programme by creating Special Issues and publishing a series of books on SDGs prior to joining the Compact in 2021. MDPI's Sustainability Foundation initiated the World Sustainability Awards in 2016. We fully support UN's goals to promote sustainable actions that make the world a better place for all and, as part of its commitment, we will focus our actions on SDG10: Reduced Inequalities whilst promoting all 17 SDGs. For more details, please visit the programme’s website: https://www.un.org/sustainabledevelopment/sdg-publishers-compact/.
Joining this initiative was a unanimous decision. MDPI has in its core values the dissemination of science for all, breaking the wall between research access and under-represented members of the scientific community and the general population. To support this initiative further and continue to support under-represented scientists, MDPI will take a series of actions that will be announced once ready.
The first action MDPI takes is to nominate Dr. Liliane Auwerter as the coordinator of the programme. Dr. Auwerter studied Environmental Process Technology (UTFPR, Brazil), obtained her MSc degree in Water and Environmental Engineering (University of Surrey, UK) and in 2020 completed her PhD in self-healing low-friction materials for water transport (Imperial College London, UK), always focusing on diverse scientific projects that would potentially bring sustainability to industrial processes. As a student in Brazil, she engaged in volunteering activities focused on environmental education and took part in the Millennial Development Goals meetings held at the university.
For more information, please contact:
Dr. Liliane Auwerter
Scientific Officer
[email protected]
17 September 2021
Journal of Personalized Medicine | Compiled Book from Harvard Medical School Authors
We are happy to announce that we have compiled the Harvard papers we published between 2019 and 2020 into a book , since authors from Harvard Medical School published the greatest number of papers in JPM (ISSN: 2075-4426), and because these papers brought numerous good references to the attention of our readers. We invite you to read this book and encourage you to share it with your colleagues.
The book is available at
https://drive.google.com/file/d/1cW9NzC_QmAM7TcQKGovkZpWiO8UlsGny/view?usp=sharing.
15 September 2021
Welcoming New Editorial Board Members of Journal of Personalized Medicine
We are excited to welcome the following recognized researchers, who recently joined the Editorial Board of Journal of Personalized Medicine:
Prof. Dr. Tsuyoshi Sugiura | Dr. Edward J. Modestino |
Dr. Kuan-Hao Tsui | Dr. Christophe Badie |
Dr. Weiliang Qiu | Dr. Afsane Riazi |
Prof. Dr. Maximilian Rudert | Dr. Rajendra D Badgaiyan |
Prof. Dr. Lu Qi | Prof. Dr. Igor Elman |
Prof. Dr. Jules Alexandre Desmeules | Dr. Gustavo Glusman |
Dr. Eric R. Braverman | Prof. Dr. Shang-Ming Zhou |
Dr. Emilio González-Jiménez | Prof. Dr. Robert Passier |
Prof. Dr. Piotr Galecki | Dr. Miguel Angel Ortega |
Dr. Florence T. Bourgeois | Prof. Dr. Jung-Wook Kim |
Prof. Dr. Panayotis Thanos | Prof. Dr. Andreas Schmutzler |
3 August 2021
Announcement on Japanese Consumption Tax (JCT)
This serves to announce to our valued authors based in Japan that value-added tax, or consumption tax will now be imposed on article processing fees and other service fees for all papers submitted, or resubmitted (assigned new paper IDs), effective from 15 August 2021. The change is in accordance with the Japanese "Act for Partial Revision of the Income Tax Act and Other Acts" (Act No. 9 of 2015), which includes a revision of consumption taxation on cross-border supplies of services such as digital content distribution.
For additional information from the National Tax Agency please see here ("Cross-border supplies of electronic services").
Contact: Setsuko Nishihara, MDPI Tokyo
9 July 2021
Prof. Dr. David Alan Rizzieri Appointed Editor-in-Chief of Journal of Personalized Medicine
We are pleased to announce that Prof. Dr. David Alan Rizzieri has been appointed Editor-in-Chief of Journal of Personalized Medicine (ISSN 2075-4426).
Prof. Dr. Rizzieri, MD, is a medical oncologist at the Duck Cancer Institute in Durham, NC, USA, and has over 30 years of experience in the medical field. He graduated from the University of Rochester School of Medicine in 1991. He is affiliated with Duke University Hospital.
He has been a member of the Combined International Bone Marrow Transplant Registry Lymphoma Writing Committee and is a member of the ALLIANCE (formerly CALGB) Leukemia Core Committee. He has served as chair or co-chair of multiple ALLIANCE lymphoma/ leukemia trials. He has led a team’s novel approaches for the care of patients using non-myeloablative allogeneic therapy to optimize a less toxic regimen for the transplant of patients with hematologic malignancies using haplo-identical, as well as matched donors. Furthermore, he has served on various NIH/NHLBI grant review committees and the ASH sub-committee on government affairs. He oversees the development and conduct of all clinical trials in adults with hematologic malignancies conducted in the Duke Cancer Institute. In recognition of his leadership and success in clinical research efforts, he was fortunate to receive the NIH “Clinical Investigator Team Leadership Award” in 2010 and was awarded the “Wendell Rosse Teaching Award” by the fellows in 2009.
He has published 457 peer-reviewed scientific papers with more than 10,000 citations. His research interests focus on the care of patients with hematologic malignancies, both with and without the use of bone marrow or stem cell transplantation. He focuses his research efforts on new approaches to manipulate minimal residual disease.
He will work closely with over 200 editorial board members from across the globe.
We warmly welcome Prof. Dr. David Alan Rizzieri in his role as Editor-in-Chief, and we look forward to him leading JPM to achieve more milestones.
30 June 2021
2020 Impact Factors - Released
The 2020 citation metrics have been officially released in the Journal Citation Reports (JCR)!
We are pleased to announce that 85 MDPI journals are included, of which:
- 10 journals received their first impact factor
- 96% of journals increased their impact factor from 2019
- 32 journals (38%) ranked among the top 25% of journals, in at least one category
Journal | Impact Factor | Rank | Category |
Cancers | 6.639 | Q1 | • Oncology |
Cells | 6.600 | Q2 | • Cell Biology |
Pharmaceutics | 6.321 | Q1 | • Pharmacology & Pharmacy |
Antioxidants | 6.313 | Q1 | • Food Science & Technology |
• Biochemistry & Molecular Biology | |||
• Chemistry, Medicinal | |||
Biomedicines | 6.081 | Q1 | • Medicine, Research & Experimental |
• Pharmacology & Pharmacy | |||
• Biochemistry & Molecular Biology | |||
International Journal of Molecular Sciences | 5.924 | Q1 | • Biochemistry & Molecular Biology |
Q2 | • Chemistry, Multidisciplinary | ||
Pharmaceuticals | 5.863 | Q1 | • Pharmacology & Pharmacy |
• Chemistry, Medicinal | |||
Journal of Fungi | 5.816 | Q1 | • Mycology |
• Microbiology | |||
Nutrients | 5.719 | Q1 | • Nutrition & Dietetics |
Biosensors | 5.519 | Q1 | • Chemistry, Analytical |
• Instruments & Instrumentation | |||
Q2 | • Nanoscience & Nanotechnology | ||
Marine Drugs | 5.118 | Q1 | • Chemistry, Medicinal |
• Pharmacology & Pharmacy | |||
Biology | 5.079 | Q1 | • Biology |
Nanomaterials | 5.076 | Q1 | • Physics, Applied |
Q2 | • Chemistry, Multidisciplinary | ||
• Materials Science, Multidisciplinary | |||
• Nanoscience & Nanotechnology | |||
Viruses | 5.048 | Q2 | • Virology |
Journal of Personalized Medicine | 4.945 | Q1 | • Medicine, General & Internal |
• Health Care Sciences & Services | |||
Metabolites | 4.932 | Q2 | • Biochemistry & Molecular Biology |
Biomolecules | 4.879 | Q2 | • Biochemistry & Molecular Biology |
Remote Sensing | 4.848 | Q1 | • Geosciences, Multidisciplinary |
Q2 | • Remote Sensing | ||
• Imaging Science & Photographic Technology | |||
• Environmental Sciences | |||
Gels * | 4.702 | Q1 | • Polymer Science |
Antibiotics | 4.639 | Q2 | • Infectious Diseases |
• Pharmacology & Pharmacy | |||
Toxins | 4.546 | Q1 | • Toxicology |
• Food Science & Technology | |||
Vaccines | 4.422 | Q2 | • Immunology |
• Medicine, Research & Experimental | |||
Molecules | 4.412 | Q2 | • Chemistry, Multidisciplinary |
• Biochemistry & Molecular Biology | |||
Foods | 4.350 | Q2 | • Food Science & Technology |
Polymers | 4.329 | Q1 | • Polymer Science |
Journal of Clinical Medicine | 4.242 | Q1 | • Medicine, General & Internal |
Toxics | 4.146 | Q2 | • Toxicology |
• Environmental Sciences | |||
Catalysts | 4.146 | Q2 | • Chemistry, Physical |
Microorganisms | 4.128 | Q2 | • Microbiology |
Membranes | 4.106 | Q1 | • Polymer Science |
Q2 | • Engineering, Chemical | ||
• Materials Science, Multidisciplinary | |||
• Chemistry, Physical | |||
Genes | 4.096 | Q2 | • Genetics & Heredity |
Fermentation * | 3.975 | Q2 | • Biotechnology & Applied Microbiology |
Journal of Cardiovascular Development and Disease * | 3.948 | Q2 | • Cardiac & Cardiovascular Systems |
Plants | 3.935 | Q1 | • Plant Sciences |
Life | 3.817 | Q2 | • Biology |
Diagnostics | 3.706 | Q2 | • Medicine, General & Internal |
Current Oncology | 3.677 | Q3 | • Oncology |
Materials | 3.623 | Q1 | • Metallurgy & Metallurgical Engineering |
Q2 | • Materials Science, Multidisciplinary | ||
• Chemistry, Physical | |||
• Physics, Applied | |||
• Physics, Condensed Matter | |||
Sensors | 3.576 | Q1 | • Instruments & Instrumentation |
Q2 | • Chemistry, Analytical | ||
• Engineering, Electrical & Electronic | |||
Pathogens | 3.492 | Q2 | • Microbiology |
Agronomy | 3.417 | Q1 | • Agronomy |
• Plant Sciences | |||
Chemosensors | 3.398 | Q2 | • Instruments & Instrumentation |
• Chemistry, Analytical | |||
Q3 | • Electrochemistry | ||
Land | 3.398 | Q2 | • Environmental Studies |
Brain Sciences | 3.394 | Q3 | • Neurosciences |
International Journal of Environmental Research and Public Health | 3.390 | Q1 | • Public, Environmental & Occupational Health (SSCI) |
Q2 | • Public, Environmental & Occupational Health (SCIE) | ||
• Environmental Sciences (SCIE) | |||
Tomography | 3.358 | Q2 | • Radiology, Nuclear Medicine & Medical Imaging |
Fractal and Fractional * | 3.313 | Q1 | • Mathematics, Interdisciplinary Applications |
Sustainability | 3.251 | Q2 | • Environmental Sciences (SCIE) |
• Environmental Studies (SSCI) | |||
Q3 | • Green & Sustainable Science & Technology (SCIE) | ||
• Green & Sustainable Science & Technology (SSCI) | |||
Water | 3.103 | Q2 | • Water Resources |
• Environmental Sciences | |||
Journal of Theoretical and Applied Electronic Commerce Research | 3.049 | Q3 | • Business |
Energies | 3.004 | Q3 | • Energy & Fuels |
Agriculture | 2.925 | Q1 | • Agronomy |
ISPRS International Journal of Geo-Information | 2.899 | Q2 | • Geography, Physical |
• Computer Science, Information Systems | |||
Q3 | • Remote Sensing | ||
Micromachines | 2.891 | Q2 | • Instruments & Instrumentation |
• Physics, Applied | |||
Q3 | • Chemistry, Analytical | ||
• Nanoscience & Nanotechnology | |||
Coatings | 2.881 | Q2 | • Materials Science, Coatings & Films |
• Physics, Applied | |||
Q3 | • Materials Science, Multidisciplinary | ||
Children | 2.863 | Q2 | • Pediatrics |
Processes | 2.847 | Q3 | • Engineering, Chemical |
Separations | 2.777 | Q3 | • Chemistry, Analytical |
Insects | 2.769 | Q1 | • Entomology |
Animals | 2.752 | Q1 | • Agriculture, Dairy & Animal Science |
• Veterinary Sciences | |||
Symmetry | 2.713 | Q2 | • Multidisciplinary Sciences |
Atmosphere | 2.686 | Q3 | • Meteorology & Atmospheric Sciences |
• Environmental Sciences | |||
Applied Sciences | 2.679 | Q2 | • Engineering, Multidisciplinary |
• Physics, Applied | |||
Q3 | • Chemistry, Multidisciplinary | ||
• Materials Science, Multidisciplinary | |||
Photonics | 2.676 | Q2 | • Optics |
Buildings * | 2.648 | Q2 | • Construction & Building Technology |
• Engineering, Civil | |||
Healthcare | 2.645 | Q2 | • Health Policy & Services (SSCI) |
Q3 | • Health Care Sciences & Services (SCIE) | ||
Minerals | 2.644 | Q2 | • Mining & Mineral Processing |
• Mineralogy | |||
• Geochemistry & Geophysics | |||
Forests | 2.634 | Q1 | • Forestry |
Crystals | 2.589 | Q2 | • Crystallography |
Q3 | • Materials Science, Multidisciplinary | ||
Entropy | 2.524 | Q2 | • Physics, Multidisciplinary |
Diversity | 2.465 | Q2 | • Biodiversity Conservation |
Q3 | • Ecology | ||
Journal of Marine Science and Engineering | 2.458 | Q2 | • Oceanography |
• Engineering, Marine | |||
• Engineering, Ocean | |||
Medicina | 2.430 | Q2 | • Medicine, General & Internal |
Machines * | 2.428 | Q2 | • Engineering, Mechanical |
Q3 | • Engineering, Electrical & Electronic | ||
Electronics | 2.397 | Q3 | • Engineering, Electrical & Electronic |
• Computer Science, Information Systems | |||
• Physics, Applied | |||
Fishes * | 2.385 | Q2 | • Fisheries |
• Marine & Freshwater Biology | |||
Metals | 2.351 | Q2 | • Metallurgy & Metallurgical Engineering |
Q3 | • Materials Science, Multidisciplinary | ||
Horticulturae * | 2.331 | Q1 | • Horticulture |
Veterinary Sciences * | 2.304 | Q1 | • Veterinary Sciences |
Universe | 2.278 | Q3 | • Physics, Particles & Fields |
• Astronomy & Astrophysics | |||
Mathematics | 2.258 | Q1 | • Mathematics |
Magnetochemistry | 2.193 | Q3 | • Chemistry, Inorganic & Nuclear |
• Chemistry, Physical | |||
• Materials Science, Multidisciplinary | |||
Current Issues in Molecular Biology | 2.081 | Q4 | • Biochemistry & Molecular Biology |
Actuators | 1.994 | Q3 | • Instruments & Instrumentation |
• Engineering, Mechanical | |||
Aerospace * | 1.659 | Q2 | • Engineering, Aerospace |
* Journals given their first Impact Factor in 2021
Source: 2020 Journal Impact Factors, Journal Citation Reports ® (Clarivate, 2021)
24 June 2021
Welcoming New Editorial Board Members of Journal of Personalized Medicine
We are excited to welcome the following recognized researchers, who recently joined the Editorial Board of Journal of Personalized Medicine:
Prof. Dr. Salvatore Scacco |
Dr. Roberto Díaz Peña |
Prof. Dr. Luigi Tritapepe |
Prof. Dr. José Braganca |
Prof. Dr. José Carmelo Adsuar Sala |
Dr. Gianluca Ingrosso |
Prof. Dr. Margaret DeAngelis |
Dr. Matthew B. Lanktree |
Dr. Jun Fang |
Dr. Luigi Minafra |
Prof. Dr. Chun-Jen Huang |
Dr. Ruslan Dorfman |
Dr. Raffaele Palmirotta |
Dr. Carlo M. Petrini |
Prof. Dr. Weikuan Gu |
Dr. Sara M. Falzarano |
Prof. Dr. Julia Bujan |
Dr. Alessandro Gozzetti |
Prof. Dr. H. Miles Prince |
Prof. Dr. Johannes Mosbacher |
Dr. Niels Bergsland |
Prof. Dr. Wei Wang |
Dr. Seungil Ro |
Prof. Dr. Walter Kolch |
Dr. Didier Ducloux |
Dr. Laura B. Scheinfeldt |
Prof. Dr. Marijn Speeckaert |
Dr. Giorgio Malpeli |
Prof. Dr. David Edvardsson |
Prof. Dr. Peter Polverini |
Prof. Dr. Giorgio Walter Canonica |
Dr. Cristina L. Ronchi |
Prof. Dr. Sabina Tangaro |
Dr. Elizabeth Vafiadaki |
Dr. Minna Stolt |
Prof. Dr. Jochen Walter |
Prof. Dr. Riitta Suhonen |
Prof. Dr. Klaus Bønnelykke |
Prof. Dr. Valentina Bessi |
Prof. Stephen Opat |
Dr. Farah R. Zahir |
Dr. Christos Damaskos |
Dr. Colleen A. Campbell |
Prof. Roberta Granese |
Prof. Dr. Tarec Christoffer El-Galaly |
Dr. Amir Sherif |
Prof. Dr. Roberto Grassi |
Prof. Dr. Volker J. Schmidt |
Prof. Chiara Bellia |
Prof. Dr. Cynthia Aristei |
Dr. Carla Minoia |
28 April 2021
Book Builder—Compile a Customized E-Book from Your Favorite MDPI Open Access Content
MDPI Books recently released Book Builder, a new online tool to conveniently arrange, design and produce an eBook from any content published in MDPI journals. Book Builder offers two functions: on the one hand (1) Selections, available to every registered user of MDPI; on the other hand (2) Special Issue Reprints, which can be used exclusively by Guest Editors of Special Issues.
Selections
In just a matter of a few clicks, all users are now able to assemble books from MDPI articles and receive instantaneous feedback in the form of a fully produced and compiled book (PDF), which can be downloaded or ordered as print copy. Selections can include any paper published with MDPI, picking and combining content from different journals and special issues.
This way, the user may for example choose to compile an ebook focusing around a particular topic, or assemble articles from a group of others.
We invite you to make yourself familiar with the new tool! The Book Builder can be found here: https://www.mdpi.com/books/book_builder.
Special Issue Reprints
The Book Builder allows Guest Editors of MDPI journals to create a reprint from a successfully completed Special Issue or Topical Collection in book format. If you are a Guest Editor for an MDPI journal, you can use the new tool to create an PDF document which includes all articles published in the Special Issue as well as a book cover and table of contents.
For Special Issues containing a minimum of 5 articles, the Guest Editor can request its publication on the MDPI Book platform. Published reprints are assigned an ISBN and DOI.
In addition to the PDF copy of the Reprint Book, as a token of our gratitude, MDPI offers every Guest Editor one (1) complimentary print copy (via print-on-demand). All contributors benefit from a discount on orders of any additional print copies, to share with colleagues or libraries or others.
In line with our organization's values, MDPI Books publishes all content in open access, promoting the exchange of ideas and knowledge in a globalized world. MDPI Books encompasses all the benefits of open access—high availability and visibility, as well as wide and rapid dissemination. MDPI Books are distributed under the terms and conditions of the Creative Commons Attribution License, meaning as an author you retain the copyright for your work. In addition, with MDPI Books you can complement the digital version of your work with a high-quality printed counterpart.
If you are interested in editing a book volume or series, or have a monograph manuscript to be considered for publication, please submit your proposal online and look at our Information for Authors.
Contact: Laura Wagner, MDPI Books Manager (email)
15 April 2021
MDPI Celebrates Company Milestone With 25th Anniversary Page
"We exist to help scientists achieve their own objectives"
In June of this year, MDPI will celebrate the 25th anniversary of its foundation. To mark this significant milestone, we have created a 25th Anniversary page on our website that evokes the development of our company over the past quarter-century.
MDPI has been a pioneer of Open Access publishing ever since the concept was first created.
In a wide-ranging interview, our CEO Delia Mihaila reflects on the company’s 25th anniversary and its contribution to the world of scientific publishing.
Delia considers how MDPI has evolved since starting life in 1996 as a visionary ‘project’ run out of an apartment in Basel, Switzerland, by Dr. Shu-Kun Lin. A chemist who was passionate about the long-term preservation of rare chemical sample, Dr. Lin was determined to help scholars publish their findings as quickly as possible and make their research results available to as wide a readership as possible worldwide. That determination remains unchanged 25 years later.
Today, MDPI is an international organization with over 4,000 employees based on three continents and in ten countries, and ranks among the world's top four academic publishers.
MDPI's mission is to accelerate access to new scientific research, delivering insight faster for researchers worldwide. Read more here about the company's remarkable success story and what the Open Access publishing model can offer the global scientific community.
19 March 2021
JPM | Welcoming New Editorial Board Members
We are excited to welcome the following recognized researchers, who recently joined the Editorial Board of JPM:
Dr. Yoshihiro Noda |
Prof. Dr. Roger E. Thomas |
10 March 2021
Journal Selector: Helping to Find the Right MDPI Journal for Your Article
At MDPI, we strive to make your online publication process seamless and efficient. To achieve this, our team is continuously developing tools and features to make the user experience useful and convenient.
As the number of academic papers continues to grow, so does the need to analyze and work with them on a large scale. This prompted us to design a new feature aimed at helping researchers find journals that are relevant to their publication by matching their abstract topic. In this regard, we designed a similarity model that automatically identifies the most suitable academic journals for your paper.
We are pleased to introduce Journal Selector, a new feature that measures similarity in academic contexts. By simply entering the title and/or abstract into our Journal Selector, the author will see a list of the most related scientific journals published by MDPI. This method helps authors select the correct journals for their papers, highlighting the time of publication and citability.
The methodology is known as representation learning, where words are represented as vectors in hyperspace. Representation helps us differentiate between different concepts within articles, and in turn, helps us identify similarities between them.
We used an advanced machine learning model to better capture the semantic meanings of words. This helps the algorithm make better predictions by leveraging scientific text representation. In turn, this ensures high precision, helping authors decide which journal they should submit their paper to.
The goal is to support authors to publish their work in the most suitable journal for their research, as fast as possible, accelerating their career progress.
Contact: Andrea Perlato, Head of Data Analytics, MDPI (email)
9 February 2021
The First International Electronic Conference on Clinical Medicine
We are pleased to announce that the first International Electronic Conference on Clinical Medicine (ECCM), chaired by Prof. Dr. Emmanuel Andrès, from the University Hospital of Strasbourg, France, and Prof. Dr. Michael G. Hennerici, from the University of Heidelberg, Germany, will be held on 15–30 September 2021 at Sciforum (https://sciforum.net/conference/ECCM).
The conference will cover all the multidisciplinary aspects of clinical medicine. The topics of interest include, but are not limited to, the following:
Cardiology
COVID-19
Gastroenterology and Hepatopancreatobiliary Medicine
Oncology
Infectious Diseases
Pulmonology
Hematology
Neurology and Stroke Neurology
Stomatology
Clinical Psychology
Psychiatry
Obstetrics and Gynecology
Endocrinology and Metabolism
Nephrology and Urology
Epidemiology and Public Health
Orthopedics
Dermatology
Ophthalmology
Otolaryngology
Nuclear Medicine and Radiology
Pharmacology
Anesthesiology
Emergency Medicine
The conference will be completely free of charge, both to attend and, for scholars, to upload and present their latest work on the conference platform. Accepted abstract submissions will be published in the proceedings of the conference, and authors are invited to develop their abstracts into full manuscripts, which will be considered for publication in JCM, with a 10% discount on the APC. JCM is an open access journal, published semimonthly by MDPI, in the field of clinical medicine. The journal is indexed in the Science Citation Index Expanded (SCIE IF = 3.303) and other databases. Full texts are archived in PubMed Central (PMC).
Important Dates
- Abstract Submission: 31 May 2021
- Acceptance Notification: 14 June 2021
- Full Paper Submission: 12 July 2021
- Conference Open: 15–30 September 2021
For more information on ECCM, please visit the conference website (https://sciforum.net/conference/ECCM) or contact us by email ([email protected]).
4 February 2021
JPM 2020 10th Anniversary Outstanding Reviewer Awards—Winners Announced
We are pleased to announce the winners of the JPM 2020 10th Anniversary Outstanding Reviewer Awards. The JPM Editorial Board and Editorial Team would like to express their gratitude for the time and energy dedicated by reviewers in checking the manuscripts submitted to JPM. It is due to their efforts that the high quality of the journal and quick turnaround have been maintained.
Each of them will receive a chance to publish one paper in JPM free of charge before 1 August 2021, 500 Swiss Francs, and a certificate to recognize their outstanding work. Please join us in congratulating the following winners:
Dr. Alain R. Thierry
Cancer Research Institute of Montpellier, INSERM, Montpellier, France
Research Interest: circulating DNA; clinical diagnostic and cancer; DNA auto-organization: synthetic biology, nanotechnology and gene therapy
Prof. Dr. Dirk Henrich
Department for Trauma, Hand and Reconstructive Surgery, Goethe University Frankfurt, Frankfurt, Germany
Research Interest: cell culture; gene expression; flow cytometry; primary cell culture; inflammation; resuscitation; sepsis; tissue engineering; diabetes; immunology; innate immunity; stem cell biology
Dr. Francesca Mancuso
Department of Experimental Medicine, University of Perugia, Perugia, Italy
Research Interest: diabetes; transplant immunology; microencapsulation; pancreatic islets
Dr. Jacob J. Michaelson
Department of Psychiatry, University of Iowa, Iowa City, IA, USA
Research Interest: gene expression; genomics; gene regulation; regulation of gene expression; mutation; computational biology; genome sequencing; gene expression and chromatin biology; methylation; computational genomics
For more information about JPM awards, please see the following link: https://www.mdpi.com/journal/jpm/awards
24 December 2020
JPM Has Become a Monthly Publication
We are pleased to announce that JPM became a monthly publication on 1 January, 2021. A monthly publication allows papers to be indexed in Web of Science and other indexing databases on a monthly basis rather than every 3 months, and they become searchable and are cited earlier. We also acknowledge the many valuable publications from our authors and the important contribution of our dedicated reviewers.
22 December 2020
JPM | Welcoming New Editorial Board Members
We are excited to welcome the following recognized researchers, who recently joined the Editorial Board of JPM:
Prof. Susan Bailey |
Prof. Dr. Shahina Pardhan |
Prof. Dr. Ramesh Narayanan |
Prof. Dr. Joanna Saluk-Bijak |
Prof. Dr. Simon Kasif |
Dr. Stephanie Duguez |
Prof. Dr. Henrik Galbo |
Dr. Colleen Campbell |
Dr. Justin M. Watts |
Dr. Justin M. Watts |
Prof. Kyung-Han Lee |
Dr. Jin-Rong Zhou |
Prof. Victor E. Ortega |
|
22 December 2020
Get Involved with JPM’s Reviewer and Topics Boards
JPM is currently establishing its Reviewer Board and Topics Board. If you are interested in a position on the Reviewer Board or have potential candidates to recommend, please contact the JPM Editorial Office ([email protected]). We are looking forward to your support.
15 December 2020
MDPI adopts C4DISC principles to improve diversity and inclusion in scholarly communications
MDPI is proud to adopt the principles of the Coalition for Diversity & Inclusion in Scholarly Communications (C4DISC) to support building equity, inclusion, diversity, and accessibility in scholarly communications.
The C4DISC represents organizations and individuals working in scholarly communications and is focused on addressing issues of diversity and inclusion within the publishing industry.
MDPI’s Managing Editors encourage the Editors-in-Chief and Associate Editors to appoint diverse expert Editorial Boards. This is also reflective in our multi-national and inclusive workplace. We are proud to create equal opportunities without regard to gender, ethnicity, geographic location, sexual orientation, age, disability, political beliefs, religion, or socio-economic status. There is no place for discrimination in our workplace and editors of MDPI journals are to uphold these principles in high regard.
Representatives from C4DISC meet monthly, and have started to implement initiatives to shed light and improve on the lack of diversity in scholarly communications. Some of the initiatives include developing a joint statement of principles; conducting market research; providing training resources, best practices, toolkits, and documentation for our collective memberships; and establishing outreach programs, curricula, events, and publications.
The Coalition is committed to:
- eliminating barriers to participation, extending equitable opportunities across all stakeholders, and ensuring that our practices and policies promote equitable treatment and do not allow, condone, or result in discrimination;
- creating and maintaining an environment that respects diverse traditions, heritages, and experiences;
- promoting diversity in all staff, volunteers, and audiences, including full participation in programs, policy formulation, and decision-making;
- raising awareness about career opportunities in our industries to groups who are currently underrepresented in the workforce;
- supporting our members in achieving diversity and inclusion within their organizations.
14 December 2020
Article Layout and Templates Revised for Future Volumes
At MDPI we have slightly revised the layout for articles to be published in the 2021 Volume, starting at the end of December 2020. As of today, the article templates available for download on ‘Instructions for Authors’ pages have been updated.
The most noticeable change can be found on the first page of the article, where a left-hand column has been created to include the following front matter elements: (i) the recommended citation style for the article, (ii) the publishing history, (iii) as well as the Creative Commons Attribution license used (iv) a standard note regarding affiliations. At the same time, the extra spacing on the left means the authors’ affiliations are now more clearly set apart than before. Other front matter key elements such as journal logo, article type, article title, authors, abstract and keywords remain unchanged.
The blank column on the left runs through all pages in an article; as a result, the main text is slightly more condensed, which improve reader friendliness for smaller screens. Small figures/tables are aligned on the left with standard indenture, while large figures/tables are centered and covering the full width of the page. The revised layout was applied in the article pictured below, to serve as an example:
1) Information is displayed in the left information bar.
2) In the main text, there is a blank column on the left.
3) Small tables/figures are aligned on the left, large tables/figures are centered.
11 December 2020
2020 "Highly Cited Researchers" on MDPI Journal's Editorial Boards
We are pleased to acknowledge that many academic editors who have made an impact on MDPI journals as editorial board members, editors-in-chief, or section editors, are recognized as 2020 Highly Cited Researchers by Clarivate.
Highly Cited Researchers highlights the top 1% of researchers, by citations, in one or more of the 22 fields used in Clarivate Analytics Essential Science Indicators. We offer our congratulations to 279 academic editors of MDPI journals who were recognized as the most influential scholars in their fields in 2020.
Adams, Dave Agarwal, Ravi P. Ahn, Choon Ki Ahn, Myung-Ju Albrecht, Randy A. Andersson, Dan I. Anker, Stefan D. Apergis, Nicholas Ariga, Katsuhiko Artaxo, Paulo Balsamo, Gianpaolo Barba, Francisco J. Benediktsson, Jon Atli Benelli, Giovanni Bhatnagar, Amit Bialystok, Ellen Blaabjerg, Frede Blay, Jean-Yves Bogers, Marcel Bolton, Declan J. Boyer, Cyrille Brocca, Luca Bruix, Jordi Buhalis, Dimitrios Burdick, Jason A. Byrd, John C. Cabeza, Luisa F. Cabrerizo-Lorite, Francisco Javier Cai, Jianchao Calhoun, Vince D. Cantu, Robert C. Cerqueira, Miguel Chang, Jo-Shu Chau, Kwok-wing Chemat, Farid Chen, Jianmin Chen, Jun Chen, Min Chen, Shaowei Chen, Wei Chen, Wei-Hsin Chen, Xiaofeng Chen, Yangkang Chen, Zhi-Gang Chiclana, Francisco Corella, Dolores Cortes, Javier Cortes, Jorge Cummings, Kenneth Michael Dai, Shifeng Decker, Eric A. DePinho, Ronald A. Dimopoulos, Meletios-Athanasios Dincer, Ibrahim Du, Yihong Dupont, Didier Edwards, David Ellahi, Rahmat Ellis, Erle C. ElMasry, Gamal Esteller, Manel Estruch, Ramón Fang, Chuanglin Fasano, Alessio Fernandez-Lafuente, Roberto Ferreira, Isabel Fortino, Giancarlo Galluzzi, Lorenzo Galvano, Fabio Gandomi, Amir H. Gandomi, Amir H. Gao, Bin Gao, Feng Gao, Wei Garbe, Claus García, Hermenegildo Geschwind, Daniel H. Giampieri, Francesca Giralt, Sergio A. Glanz, Karen Goldewijk, Kees Klein Gössling, Stefan Govindan, Kannan Granato, Daniel Grosso, Giuseppe Grosso, Giuseppe Guerrero, Josep M. Haase, Dagmar Hagger, Martin S. Hamblin, Michael R. Han, Heesup Jankovic, Joseph Janotti, Anderson |
Jiang, Hai-Long Kalaji, Hazem M. Kalantar-Zadeh, Kourosh Kaner, Richard B. Karimi, Hamid Reza Kataoka, Kazunori Keesstra, Saskia Kepp, Oliver Kerminen, Veli-Matti Keyzers, Robert A. Khademhosseini, Ali Khan, Nafees A. Kim, Ki-Hyun Klemeš, Jiří Jaromír Klenk, Hans-Peter Konopleva, Marina Y. Krammer, Florian Krebs, Frederik C. Kroemer, Guido Kudo, Masatoshi Kurths, Juergen Kurzrock, Razelle Kuznetsov, Nikolay V. Kyrpides, Nikos C. La Vecchia, Carlo Lai, Yuekun Lam, James Lancellotti, Patrizio Lee, Sangmoon Leung, Victor C. M. Li, Jinghong Li, Yurui Lindahl, José M. Merigó Lip, Gregory Y. H. Loh, Xian Jun Long, Hualou Lund, Henrik Luo, Jingshan Luque, Rafael Lyons, Timothy W. Ma, Jun Ma, Wen-Xiu Ma, Yanming Maeda, Keisuke Makarova, Kira Mantovani, Alberto Martín-Belloso, Olga Martinoia, Enrico Marzband, Mousa Masclaux-Daubresse, Celine Masson, Patrick Mateos, María Victoria Mathiesen, Brian Vad Matyjaszewski, Krzysztof McArthur, Grant A. McCauley, Darren Medlock, Jolyon M. Melero, Ignacio Mezzetti, Bruno Miroshnichenko, Andrey E. Moran, Daniel Mueller, Lukas A. Mueller-Roeber, Bernd Naushad, Mu Nemeroff, Charles B. Nieto, Juan J. O'Donnell, Colm Ogino, Shuji Olabi, Abdul-Ghani O'Regan, Donal Orsini, Nicola Oswald, Isabelle P. Ozcan, Aydogan Pahl-Wostl, Claudia Pang, Huan Payne, James E. Peng, Shushi Perc, Matjaz Perez-Alvarez, Jose Angel Piquero, Alex R. Ploss, Alexander Postolache, Mihai Pradhan, Biswajeet Prinsep, Michele R. Qian, Dong Qu, Xiaogang Reiter, Russel J. Riahi, Keywan Richter, Andreas Rignot, Eric Robert, Caroline Ros, Emilio Rosell, Rafael |
Rosen, Marc A. |
The full list of 2020 Highly Cited Researchers can be accessed on https://recognition.webofsciencegroup.com/awards/highly-cited/2020/
--- Highly Cited Researchers (HCR) is a Clarivate product.
10 July 2020
Meet Us at the Society for Neurosciences’ 50th Annual Meeting (Neuroscience 2020), Washington, USA, 24–28 October 2020
MDPI will be attending the conference Neuroscience 2020, which will be hosted in Washington, USA, 24–28 October 2020.
SfN’s 50th annual meeting is the premier venue for the presentation of emerging science in the field of neurosciences, where one can learn from experts, forge collaborations with peers, explore new tools and technologies, and advance their career.
The following MDPI journals will be represented:
- Brain Sciences (leading journal)
- JCM
- Medicina
- Genes
- Children
- Cancers
- Behavioral Sciences
- Cells
- IJERPH
- Disease
- Biomedicines
- JPM
- Pathogens
- Healthcare
- IJMS
- Psych
- Pharmaceuticals
- Clocks&Sleep
- Jounal of Intelligence
- Pharmaceutics
If you are attending this conference, please feel free to stop by our booth (Booth #208). Our delegates look forward to meeting you in person, to answer any questions you may have. For more information about the conference, please visit:
9 July 2020
Open Access Agreement Between Jisc Collections and MDPI
We are delighted to announce the establishment of our Open Access agreement with Jisc Collections, which will allow UK institutions to benefit from access to article processing charge (APC) discounts and streamlined payment workflows.
All institutions participating in the agreement will also gain access to the MDPI online submission system where they can find full article metadata and pricing information for easy identification and additional transparency.
Eligible authors affiliated with the participating institutions are prompted to choose the corresponding Institutional Open Access Program (IOAP) when they submit an article via our online submission system.
About Jisc
Jisc's vision is for the UK to be the most digitally advanced education and research nation in the world. At its heart is the super-fast national research and education network, Janet, with built-in cyber security protection. Jisc also provides technology solutions for its members (colleges, universities and research centres) and customers (public sector bodies), helps members save time and money by negotiating sector-wide deals and provides advice and practical assistance on digital technology. Jisc is funded by the UK higher and further education and research funding bodies and member institutions.
For more information, contact [email protected].
About MDPI
MDPI is a publisher of fully peer-reviewed, Open Access journals with a focus on thorough and rapid editorial processing. Its aim is to ensure that high-quality research is verified and made available to the research community as quickly as possible. MDPI stands at the forefront of the Open Access movement, having launched its first online journal Molecules in 1996. Today, MDPI is a leader in Open Access publishing with over 250 journals across all research disciplines, and all content published under a Creative Commons Attribution License (CC BY).
For any questions about this agreement, please contact the MDPI IOAP team at [email protected].
2 July 2020
EBMs of JPM recognized as Highly Cited Researchers for 2019
Professor Dr. Grant McArthu and Professor Dr. Ewout W. Steyerberg, Editorial Board Members of JPM, have recently been recognized as Clarivate Analytics Highly Cited Researchers for 2019. This corresponds to the top 1% of the most cited researchers in the field of clinical medicine for that publication year.
Professor Dr. Grant McArthu |
Professor Dr. Ewout W. Steyerberg |
29 June 2020
Updated Impact Factors Released in the Journal Citation Reports (Clarivate)
The updated citation metrics have been released in the Journal Citation Reports (JCR), published by Clarivate. The recent release of the JCR includes seventy-one MDPI titles. Out of these, 18 titles are newcomers, receiving a first Journal Impact Factor which is based on citation activity in 2019: Actuators, Agriculture, Biology, Biomedicines, Biosensors, Chemosensors, Children, Healthcare, Journal of Fungi, Journal of Personalized Medicine (JPM), Land, Life, Magnetochemistry, Membranes, Pharmaceuticals, Photonics, Separations and Toxics.
- Out of the previously listed journals, a total of 72 percent boast an increased Impact Factor.
- 25 journals are ranked among the top 25% of journals in at least one of the categories they are ranked for.
- Articles published in 2019 in MDPI journals account for approximately 17 percent of of articles published in gold Open Access journals covered in the Science Citation Index Expanded (SCIE) and Social Sciences Citation Index (SSCI).
First Impact Factors
Journal | Impact Factor | Rank | Category | Details |
Actuators | 1.957 | 31/64 (Q2) | • Instruments & Instrumentation | Link |
Agriculture | 2.072 | 25/91 (Q2) | • Agronomy | Link |
Biology | 3.796 | 19/93 (Q1) | • Biology | Link |
Biomedicines | 4.717 | 30/138 (Q1) 36/270 (Q1) |
• Medicine, Research & Experimental • Pharmacology & Pharmacy |
Link |
Biosensors | 3.240 | 24/86 (Q2) | • Chemistry, Analytical | Link |
Chemosensors | 3.108 | 16/64 (Q1) 27/86 (Q2) 13/27 (Q2) |
• Instruments & Instrumentation • Chemistry, Analytical • Electrochemistry |
Link |
Children | 2.078 | 50/128 (Q2) | • Pediatrics | Link |
Healthcare | 1.916 | 62/102 (Q3) 45/87 (Q3) |
• Health Care Sciences & Services (SCIE) • Health Policy & Services (SSCI) |
Link |
Journal of Fungi | 4.621 | 5/29 (Q1) 31/135 (Q1) |
• Mycology • Microbiology |
Link |
Journal of Personalized Medicine | 4.433 | 24/165 (Q1) 10/102 (Q1) |
• Medicine, General & Internal • Health Care Sciences & Services |
Link |
Land | 2.429 | 58/123 (Q2) | • Environmental Studies (SSCI) | Link |
Life | 2.991 | 26/93 (Q2) 109/267 (Q2) |
• Biology • Microbiology |
Link |
Magnetochemistry | 1.947 | 22/45 (Q2) 109/159 (Q3) 201/314 (Q3) |
• Chemistry, Inorganic & Nuclear • Chemistry, Physical • Materials Science, Multidisciplinary |
Link |
Membranes | 3.094 | 53/143 (Q2) 129/314 (Q2) 23/89 (Q2) |
• Engineering, Chemical • Materials Science, Multidisciplinary • Polymer Science |
Link |
Pharmaceuticals | 4.286 | 49/270 (Q1) | • Pharmacology & Pharmacy | Link |
Photonics | 2.140 | 48/97 (Q2) | • Optics | Link |
Separations | 1.900 | 53/86 (Q3) | • Chemistry, Analytical | Link |
Toxics | 3.271 | 32/92 (Q2) 92/265 (Q2) |
• Toxicology • Environmental Sciences |
Link |
Updated Impact Factors
Journal | Impact Factor | Rank | Category | Details |
Agronomy | 2.603 | 18/91 (Q1) 65/234 (Q2) |
• Agronomy • Plant Sciences |
Link |
Animals | 2.323 | 10/63 (Q1) 14/142 (Q1) |
• Agriculture, Dairy & Animal Science • Veterinary Sciences |
Link |
Antibiotics | 3.893 | 23/93 (Q1) 64/270 (Q1) |
• Infectious Diseases • Pharmacology & Pharmacy |
Link |
Antioxidants | 5.014 | 10/139 (Q1) 56/297 (Q1) 7/61 (Q1) |
• Food Science & Technology • Biochemistry & Molecular Biology • Chemistry, Medicinal |
Link |
Applied Sciences | 2.474 | 161/314 (Q3) 32/91 (Q2) 88/177 (Q2) 62/154 (Q2) |
• Materials Science, Multidisciplinary • Engineering, Multidisciplinary • Chemistry, Multidisciplinary • Physics, Applied |
Link |
Atmosphere | 2.397 | 48/93 (Q3) | • Meteorology & Atmospheric Sciences | Link |
Biomolecules | 4.082 | 98/297 (Q2) | • Biochemistry & Molecular Biology | Link |
Brain Sciences | 3.332 | 113/271 (Q2) | • Neurosciences | Link |
Cancers | 6.126 | 37/244 (Q1) | • Oncology | Link |
Catalysts | 3.520 | 65/159 (Q2) | • Chemistry, Physical | Link |
Cells | 4.366 | 70/195 (Q2) | • Cell Biology | Link |
Coatings | 2.436 | 10/21 (Q2) | • Materials Science, Coatings & Films | Link |
Crystals | 2.404 | 10/26 (Q2) 165/314 (Q3) |
• Crystallography • Materials Science, Multidisciplinary |
Link |
Diagnostics | 3.110 | 39/165 (Q1) | • Medicine, General & Internal | Link |
Diversity | 1.402 | 119/168 (Q3) | • Ecology | Link |
Electronics | 2.412 | 125/266 (Q2) | • Engineering, Electrical & Electronic | Link |
Energies | 2.702 | 63/112 (Q3) | • Energy & Fuels | Link |
Entropy | 2.494 | 33/85 (Q2) | • Physics, Multidisciplinary | Link |
Foods | 4.092 | 27/139 (Q1) | • Food Science & Technology | Link |
Forests | 2.221 | 17/68 (Q1) | • Forestry | Link |
Genes | 3.759 | 53/177 (Q2) | • Genetics & Heredity | Link |
Insects | 2.220 | 18/101 (Q1) | • Entomology | Link |
International Journal of Environmental Research and Public Health (IJERPH) | 2.849 | 58/193 (Q2) 32/170 (Q1) 105/265 (Q2) |
• Public, Environmental & Occupational Health (SCIE) • Public, Environmental & Occupational Health (SSCI) • Environmental Sciences (SCIE) |
Link |
International Journal of Molecular Sciences (IJMS) | 4.556 | 74/297 (Q1) 48/177 (Q2) |
• Biochemistry & Molecular Biology • Chemistry, Multidisciplinary |
Link |
ISPRS International Journal of Geo-Information (IJGI) | 2.239 | 31/50 (Q3) 18/30 (Q3) |
• Geography, Physical • Remote Sensing |
Link |
Journal of Clinical Medicine | 3.303 | 36/165 (Q1) | • Medicine, General & Internal | Link |
Journal of Marine Science and Engineering | 2.033 | 31/66 (Q2) | • Oceanography | Link |
Marine Drugs | 4.073 | 16/61 (Q2) | • Chemistry, Medicinal | Link |
Materials | 3.057 | 132/314 (Q2) | • Materials Science, Multidisciplinary | Link |
Mathematics | 1.747 | 28/324 (Q1) | • Mathematics | Link |
Medicina | 1.205 | 107/165 (Q3) | • Medicine, General & Internal | Link |
Metabolites | 4.097 | 95/297 (Q2) | • Biochemistry & Molecular Biology | Link |
Metals | 2.117 | 18/79 (Q1) 185/314 (Q3) |
• Metallurgy & Metallurgical Engineering • Materials Science, Multidisciplinary |
Link |
Micromachines | 2.523 | 56/92 (Q3) 23/64 (Q2) |
• Nanoscience & Nanotechnology • Instruments & Instrumentation |
Link |
Microorganisms | 4.152 | 37/135 (Q2) | • Microbiology | Link |
Minerals | 2.380 | 6/21 (Q2) 11/30 (Q2) |
• Mining & Mineral Processing • Mineralogy |
Link |
Molecules | 3.267 | 70/177 (Q2) 141/297 (Q2) |
• Chemistry, Multidisciplinary • Biochemistry & Molecular Biology |
Link |
Nanomaterials | 4.324 | 89/314 (Q2) 42/103 (Q2) |
• Materials Science, Multidisciplinary • Nanoscience & Nanotechnology |
Link |
Nutrients | 4.546 | 17/89 (Q1) | • Nutrition & Dietetics | Link |
Pathogens | 3.018 | 65/135 (Q2) | • Microbiology | Link |
Pharmaceutics | 4.421 | 44/270 (Q1) | • Pharmacology & Pharmacy | Link |
Plants | 2.762 | 58/234 (Q1) | • Plant Sciences | Link |
Polymers | 3.426 | 16/89 (Q1) | • Polymer Science | Link |
Processes | 2.753 | 59/143 (Q2) | • Engineering, Chemical | Link |
Remote Sensing | 4.509 | 9/30 (Q2) | • Remote Sensing | Link |
Sensors | 3.275 | 22/86 (Q2) 77/266 (Q2) 15/64 (Q1) |
• Chemistry, Analytical • Engineering, Electrical & Electronic • Instruments & Instrumentation |
Link |
Sustainability | 2.576 | 120/265 (Q2) 26/41 (Q3) 53/123 (Q2) 6/8 (Q3) |
• Environmental Sciences (SCIE) • Green & Sustainable Science & Technology (SCIE) • Environmental Studies (SSCI) • Green & Sustainable Science & Technology (SSCI) |
Link |
Symmetry | 2.645 | 29/71 (Q2) | • Multidisciplinary Sciences | Link |
Toxins | 3.531 | 21/92 (Q1) 34/139 (Q1) |
• Toxicology • Food Science & Technology |
Link |
Universe | 1.752 | 18/29 (Q3) 42/68 (Q3) |
• Physics, Particles & Fields • Astronomy & Astrophysics |
Link |
Vaccines | 4.086 | 57/158 (Q2) 50/138 (Q2) |
• Immunology • Medicine, Research & Experimental |
Link |
Viruses | 3.816 | 12/37 (Q2) | • Virology | Link |
Water | 2.544 | 31/94 (Q2) | • Water Resources | Link |
Source: Clarivate 2020, InCites Journal Citation Reports®.
29 June 2020
Journal of Personalized Medicine Receives First Journal Impact Factor of 4.433
The editors are pleased to inform that Journal of Personalized Medicine has received a first Impact Factor of 4.433, as published in the 2019 Edition of the Journal Citation Reports® (Clarivate), released just now. Journal of Personalized Medicine ranks 24th out of 165 (Q1) titles in the 'Medicine, General & Internal', as well as 10th out of 102 (Q1) tiles in the 'Health Care Sciences & Services' category.
Thank you to the authors, editorial board members and reviewers for their contribution in achieving this milestone for Journal of Personalized Medicine.
13 May 2020
COVID-19 Academic Resources Center
Since 1996, MDPI has been committed to supporting the research community by providing the latest research freely available and making relevant and useful research available as quickly as possible. The world is current experiencing a pandemic of COVID-19, and researchers are working extremely hard to understand it and find a cure.
The values MDPI holds strongly are particularly important at the moment, and we will continue to publish relevant, peer-reviewed research as quickly as possible in open access format. This means that it will immediately be available for researchers, health professionals, and the general public to read, distribute, and reuse. We believe that scientific advancements will be crucial to overcoming this pandemic, and will do everything we can to support researchers working looking for solutions.
COVID-19 Academic Resources Center contains a variety of information related to COVID-19 available from MDPI, including journal articles, special issues, and preprints, among others.
For more information, please visit: https://www.mdpi.com/covid-19
30 April 2020
Meet Us at the European Society of Cardiology Congress 2020(ESC Congress 2020) in Amsterdam, The Netherlands, 29 Aug–2 Sep 2020
MDPI will be attending the European Society of Cardiology Congress 2020(ESC Congress 2020) in Amsterdam, The Netherlands, 29 Aug–2 Sep 2020.
ESC Congress 2020 will build on the solid foundations of a congress which attracts worldwide cardiology leaders to present and exchange on their knowledge and most important research results. It will focus on the best and latest science but will also emphasize the importance of innovation, introducing topics at the frontiers of cardiovascular medicine and science to the attendees.
The following MDPI journals will be represented:
If you are also attending this conference, please feel free to stop by our booth (Booth N600). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit here.
9 April 2020
Free Open Platforms to Support Academics During the COVID-19 Pandemic
As a leading Open Access publisher, MDPI is committed to fostering open scientific exchange in all forms across all disciplines. Due to the outbreak of COVID-19, many researchers have to stay at home and many academic conferences have been cancelled or postponed. In light of these changes, MDPI has adopted numerous initiatives that may help accelerate scientific exchange and provide support to the academics during this period.
Scholarly Community—Encyclopedia
Encyclopedia is an online reference created and curated by active scholars. It aims to highlight the latest research results as well as providing benchmark information for researchers and the general public interested in accurate and advanced knowledge on specific topics.
Comprehensive and Free Literature Database—Scilit
Scilit is a comprehensive, free database for scientists that uses a new method to collate data and index scientific material. Our crawlers extract the latest data from CrossRef and PubMed on a daily basis. This means that newly published articles are immediately added to Scilit.
Display Academic Achievements—SciProfiles
SciProfiles is an innovative social network for researchers and scholars that is developed by MDPI. In line with our broad mission, the purpose of SciProfiles is to accelerate discovery and innovation by facilitating immediate access to research results and providing opportunities for academic networking.
Organize and Participate in Conferences Online—Sciforum
Sciforum is an event planning platform that supports open science by offering the opportunity to host and participate in academic conferences. It provides an environment for scholarly exchange, discussion of topics of current interest, building of networks, and establishing collaborations.
Post Early Versions of Research Outputs—Preprints
Preprints is a platform dedicated to making early versions of research outputs permanently available and citable. We post original research articles and comprehensive reviews, and papers can be updated by authors at any time. Content on Preprints is not peer-reviewed, and feedback can be received from readers.
***
MDPI remains committed to open science and open data and has signed a statement, along with more than thirty scholarly publishers, showing our intention to facilitate sharing of new research findings as early on as possible. The initiative sees publishers collectively removing barriers to new research, in the face of a global healthcare crisis.
25 March 2020
MDPI Comment on the COVID-19 Virus
The world is currently suffering from a global pandemic of the corona virus COVID-19. MDPI expresses its sympathies for all of those affected by the virus and stands in solidarity with medical staff and researchers treating patients and searching for scientific solutions.
MDPI has previously published papers covering corona viruses in addition to new papers on the current outbreak, see all papers here. In particular, Viruses has published a number of Special Issues and papers on the topic (see here, here, and here) as well as a forthcoming Special Issue.
Alongside journal articles, MDPI has been a strong supporter of preprints, which are increasingly being used to rapidly disseminate the latest research, and we run the preprint server Preprints.org. Our database of research articles, Scilit, is free to use and covers all publishers including preprint servers. New papers are often in search results within hours of publication and users can set up alerts for new papers.
Our main priority during this period has been the health and safety of staff, and we continue to allow staff to work at home and closely monitor the situation in all locations in which we work. Despite the restrictions, we continue to provide a full publication service and, by close collaboration with our editorial boards and making use our in-house teams, ensure that there are no unnecessary delays in publishing vital research. Fast and open publication has always been at the core of MDPI values and is now more important than ever.
We hope that a solution to the current situation will emerge soon. In the meantime, we will do our best to continue communicating vital research in all fields.
20 March 2020
MDPI Backs Open Pharma Statement on Open Access
MDPI has endorsed Open Pharma’s Position Statement in support of open access publishing with the aim of advancing medical science and ultimately, improving patient care. Open pharma is a group of research funders, healthcare professionals, publishers, academics, and other healthcare stakeholders.
Since its inception in 1996, MDPI’s efforts have aligned with Open Pharma’s vision of more effective and transparent publishing, collaborating internationally with experts to deliver peer-reviewed online research journals to the scientific community and the general public. MDPI publishes 56 journals in the field of Medicine and Pharmacology and is planning to hold the World Pharma Forum in Basel in 2021.
Published under a Creative Commons License, MDPI’s articles can be freely shared and their content re-used, upon proper attribution. In support of the statement, MDPI will continue to uphold its open access policy and provide fast editorial services to ensure that new medical evidence can be read by everyone, without paywall restrictions.
18 March 2020
MDPI Co-Signed Position Statement on Transformative Agreements
The advantages of the open access model of scientific publishing are being increasingly recognized in the scientific community. It allows new scientific evidence to be accessed from the moment of publication for free by anyone around the globe, boosting the impact of new research. In response, many funders, libraries and universities have been adopting new principles to accelerate the transition to open access.
Recently, “transformative agreements” have been negotiated between traditional publishers and various institutions. While increasing the number of open access papers, these agreements lack binding commitments to a full transition to open access, their conditions vary across different regions, and access is still limited for many users.
MDPI is a co-signatory of the recent position statement raising concerns about potential downsides of transformative agreements and how they may delay a full transition to open access. The statement highlights that these models “risk perpetuating current limitations on access, transparency and market competitiveness, while simultaneously facilitating excessive charges on the public purse”.
As a pioneering open access journal publisher, MDPI is the first to promote the importance of science being made available to everyone. Our peer-reviewed journals, covering diverse academic disciplines, are fully accessible to the public free of charge under a Creative Commons Attribution License (CC BY). This is why, along with other open access publishers, MDPI is a proud signatory of the position paper and is committed to contributing to the replacement of weak transitional agreements with “agreements with publishers that are already fully committed to open science and who offer full, immediate and transparent Open Access”.
Read the position paper here
17 March 2020
Catching Up with Journal of Personalized Medicine Editors at PMWC 2020
The Precision Medicine World Conference 2020 was held in Silicon Valley, CA, USA during 21-24 Jan 2020. As an exhibitor, we had the chance to meet Editorial Board Member Professor Dr. Kathryn A. Phillips, Guest Editor Professor Dr. Sergey Suchkov and many other experts in the filed. We appreciate their inputs for developing the journal.
16 March 2020
Encyclopedia Outstanding Contributor Awards 2020 - Open for Application
We are pleased to announce that Encyclopedia will be awarding five Outstanding Contributor Awards for researchers in 2020. The nominations and applications will be assessed by an Evaluation Committee consisting of senior scholars from the Encyclopedia Editorial Board.
Prize for Winners
- An official certificate;
- A cash award of 500 CHF or an MDPI discount voucher of 800 CHF.
Application Deadline
31 December, 2020 (Please send your application email with a list of all entries you contributed to our office before the deadline: [email protected])
Candidate Requirements
- Have a Ph.D. degree;
- Have more than three qualified entries published in Encyclopedia in 2020.
Evaluation Standards
- Number of entries published in Encyclopedia in 2020;
- Quality of entries online (including length, figure quality, and novelty);
- Impact of entries (including the number of likes, discussion contents, views, and downloads).
If you are a researcher and have not yet contribute entries to Encyclopedia, please do not miss this chance to highlight your research results.
19 February 2020
Meet Us at American Thoracic Society (ATS) 2020 Congress in Philadelphia, PA, USA, 15–20 May 2020
MDPI will be attending the American Thoracic Society (ATS) 2020 Congress in Philadelphia, PA, USA, 15–20 May 2020.
The ATS International Conference is the home of pulmonary, critical care, and sleep professionals, from those in the earliest stages of their careers to those whose research or strides in clinical care has gained them international recognition. Each year, nearly 14,000 of these professionals choose to attend, present, and learn about the latest advances, meet with colleagues from around the world, and strike new collaborations. It is truly where today’s science meets tomorrow’s care.
This international conference is also multidisciplinary. Clinicians and researchers in many other fields attend the conference, thereby enriching conversations that lead to insights that ultimately improve patient care.
The following MDPI journals will be represented:
If you are also attending this conference, please feel free to stop by our booth (Booth 1101). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit: https://conference.thoracic.org.
11 December 2019
Meet Us at Precision Medicine World Conference 2020 in Silicon Valley, CA, USA, 21-24 January, 2020
MDPI will be attending Precision Medicine World Conference 2020 in Silicon Valley, CA, USA, 21-24 January, 2020.
PMWC, the “Precision Medicine World Conference” is the largest & original annual conference dedicated to precision medicine. PMWC’s mission is to bring together recognized leaders, top global researchers and medical professionals, and innovators across healthcare and biotechnology sectors to showcase practical content that helps close the knowledge gap between different sectors, thereby catalyzing cross-functional fertilization & collaboration in an effort to accelerate the development and spread of precision medicine.
The following MDPI journals will be represented:
- Journal of Personalized Medicine
- Journal of Clinical Medicine
- Medicial Sciences
- Cancers
- Healthcare
- Medicines
- Genes
- Diagnostics
If you are also attending this conference, please feel free to stop by our booth (Booth C1823). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit: https://www.pmwcintl.com/
11 October 2019
Introducing SciProfiles, an Academic Social Network
MDPI is pleased to announce the release of SciProfiles, its social network platform for researchers and scholars.
The purpose of SciProfiles is aligned with MDPI’s broad mission to accelerate discovery and innovation by facilitating immediate access to research results and to serve scholars and communities by providing opportunities for academic networking.
SciProfiles also ambitions to serve as a sustainable, transparent and community-driven research evaluation system aligned with the DORA principles (https://sfdora.org/). Through their scientific profiles, academics can highlight their contribution to research communities, and measure their impact on their field, beyond publication numbers and impact factors. SciProfiles is currently a beta version and will enrich to give researchers the possibility to highlight all of their contributions to science and their scientific communities as authors, reviewers, editors, conference organizers, conference panelists, conference keynote speakers, or even as lecturers or student mentors at their University.
The classic components of popular community social networks, including follower/following, classical metrics, endorsements and recommendations (https://www.mdpi.com/about/announcements/1690), comments (https://www.mdpi.com/about/announcements/1397) are or will be very soon highlighted in SciProfiles as open science contributions.
To help increase the impact and visibility of articles and their authors to an appropriate audience, the platform offers a NewsFeed that includes recommendations of relevant content based on interests, publication history, saved searches or colleagues’ recommendations.
SciProfiles’ avatars are now being integrated on several MDPI platforms, meaning that you will directly access researchers’ profiles from any of the MDPI platforms:
MDPI's journal publishing website: www.mdpi.com
MDPI's conference hosting and management website: www.sciforum.net
MDPI's pre-print website : www.preprints.org
MDPI's knowledge sharing website : www.encyclopedia.pub
MDPI's books store: www.mdpi.com/books
MDPI's literature database : www.scilit.net
SciProfiles aims to serve scientific communities at large. It can be embedded into third-party websites and also welcomes integration of data from third-parties.
Dr. Shu-Kun Lin: https://sciprofiles.com/profile/2
Dr. Franck Vazquez: https://sciprofiles.com/profile/FranckVazquez
Dr. Martyn Rittman: https://sciprofiles.com/profile/martynrittman
2 October 2019
Winners of the 2019 MDPI Writing Prize
We are delighted to announce the winners of the 2019 MDPI Writing Prize. Entrants were asked to write on the theme "Judging research: How should research and researchers be evaluated and rewarded?" We received a large number of excellent essays from PhD students and postdocs, and the process of shortlisting and choosing winners was not an easy one. The winners demonstrated excellent writing skills alongside interesting and thought-provoking ideas.
As last year, we will begin the process of collating all entries into a book that will be available in open access format. Alongside promoting good writing skills, we see the prize as a way to promote the voices of early career researchers within broader debates and policy discussions.
Congratulations to all of the participants and especially the winners. The winners are:
1st Prize (500 CHF):
Albin Nilsson (National Centre for Nuclear Research, Warsaw, Poland)
[Read here]
2nd Prize (250 CHF):
Qi Zhang (Shandong University, Jinan, China)
[Read here]
Igor Ogashawara (Indiana University, Indianapolis, US)
[Read here]
3rd Prize (100 CHF):
Margaret Sivapragasam (Universiti Teknologi Petronas, Perak, Malaysia)
[Read here]
Arvind Sharma (The University of Queensland, Gatton, Australia)
[Read here]
Jose Flores-Guerrero (University Medical Center Groningen, Groningen, The Netherlands)
[Read here]
The MDPI Writing Prize is an annual award supported by MDPI Author Services, which provides services including language editing, reformatting, plagiarism checks, and image editing.
20 September 2019
MDPI Now Gives Scholars the Possibility to Endorse and Recommend Articles
MDPI is pleased to announce the release of a new functionality giving the possibility for researchers and scholars to endorse, and formally recommend articles to their colleagues.
MDPI was an early signatory of the San Francisco Declaration on Research Assessment (https://sfdora.org/read/) which calls for improvement in how quality and impact of scholarly research outputs are evaluated, especially in moving beyond journal-based citation metrics (journal Impact Factor, Scopus Citescore, etc.).
MDPI supports the establishment of article-level impact metrics, including citations, views, downloads, and Altmetric scores. These measures serve as an impact indicator for research articles on a case–by-case basis, assessing paper on its own merit. However, these metrics are also subjective and can give a biased picture of the article impact: they do not directly reflect the quality or the intrinsic scientific value of the article.
In our view, community engagement with publications based on community-driven metrics can help to overcome this limitation. We have therefore launched an option for scholars to endorse articles, indicating their own assessment of its content and making a recommendation to their community. This follows our implementation of the open source Hypothesis commenting tool, which has been available for all articles published by MDPI for over a year (https://www.mdpi.com/about/announcements/1397). Both endorsement and commenting are available for all previously published and forthcoming MDPI articles.
In addition to potentially serving as a sustainable solution to article assessment, endorsements will help scientific communities to identify the most relevant articles, independently of the journal in which it was published.
The code for the endorsing functionality, which relies on DOIs and ORCIDs, will be made available on GitHub with an open source license.
Dr. Shu-Kun Lin, President and Founder
Dr. Franck Vazquez, Chief Scientific Officer
Dr. Martyn Rittman, Publishing Director
11 September 2019
Create an Entry in Encyclopedia to Get a 100 CHF Voucher in Publishing in MDPI Journals
Encyclopedia is a free online reference created and curated by active scholars. It aims to highlight the latest research results as well as provide a comprehensive record of scientific development. If you have any suggestions or questions, please feel free to contact us via [email protected].
22 August 2019
Journal of Fungi, Journal of Personalized Medicine and Separations Accepted into the SCIE in the Web of Science
We are happy to announce the inclusion of three more journals into the Science Citation Index Expanded (SCIE) in the Web of ScienceTM. Journal of Fungi (JoF), Journal of Personalized Medicine (JPM) and Separations are due to receive 2019 journal metrics in the 2020 release of the Journal Citation ReportsTM (Clarivate Analytics).
Thank you to all authors, reviewers and editors who contributed to the journals and enabled these achievements!
Journal |
Current Volume |
Scope |
pathogenic and parasitic fungi; medical mycology; fungal biology | more | submit article |
||
pharmacogenomics/proteomics; genetic-based therapeutics; biomarker identification and application | more | submit article |
||
Vol. 6 (2019) | articles |
chromatography; separation methods and technology | more | submit article |
6 August 2019
Preprints Reaches 10,000 Posted Articles Milestone
We are pleased to announce that Preprints has passed the milestone of 10,000 posted preprints. We are delighted to have reached this after just over three years of operation. Our congratulations and thanks go to our authors and advisory board who have supported growth of the platform and been crucial to its operation.
You can find further details at https://www.preprints.org/announcement/show/37.
2 August 2019
DeepGreen Partnering with Publishers and Universities in Distributing Open Access Content to Institutional Repositories
Last week, the DeepGreen initiative in Germany started into an advanced test phase with the publishing partners S. Karger AG, SAGE Publishing, MDPI, Frontiers and De Gruyter, as well as 27 universities from all over Germany, from Hamburg University of Applied Sciences to University of Konstanz.
DeepGreen aims at lowering the barriers for open access publishing by automatically delivering metadata and full text publications from participating publishers to authorized repositories at German universities.
In preparation for a later live operation, the advanced test phase serves to gain experience with extensive data deliveries from publishers and also handling different repository software (including OPUS4, DSpace, EPrints, MyCoRe). DeepGreen thereby acts as a sophisticated platform, receiving articles published by authors affiliated with German universities and depositing these articles to respective university repositories, based on the affiliation metadata. For more information about DeepGreen: https://deepgreen.kobv.de
Karger AG has been a close cooperation partner of the DeepGreen consortium since 2016. S. Karger has more than 80 subscription-based and around 20 open access journals covering a wide spectrum in health science. DeepGreen will assign S. Karger articles to authorized institutions on the legal basis of German alliance and national licenses.
SAGE Publishing was founded by Sara Miller McCune in 1965 to support the dissemination of usable knowledge and educate a global community. SAGE publishes more than 1,000 journals and over 600 new books each year, spanning a wide range of subject areas. Our growing selection of library products includes archives, data, case studies and video. SAGE remains majority owned by our founder and after her lifetime will become owned by a charitable trust that secures the company’s continued independence. Principal offices are located in Los Angeles, London, New Delhi, Singapore, Washington DC and Melbourne. SAGE Publishing has been a close cooperation partner of DeepGreen since 2016.
MDPI is a scientific open access publisher and has been a partner of DeepGreen since 2017. MDPI comprises 205 peer-reviewed journals of various disciplines. All articles are published under a CC-BY license and are freely available without embargo period.
Frontiers is a scientific open access publisher with 61 journals of over 600 academic disciplines. All articles are peer-reviewed and published freely available under CC-BY license.
De Gruyter is an academic publisher with more than 700 subscription-based and open access journals of 29 disciplines. Articles provided by De Gruyter will be assigned to institutions with German alliance and national licenses.
There is promising communication with other publishers.
DeepGreen is funded by the German Research Foundation (DFG) and the consortium comprises six institutions: the Cooperative Library Network Berlin-Brandenburg, Bavarian State Library, Bavarian Library Network, University Library of the Technische Universität Berlin, University Library of Erlangen-Nuremberg and the Helmholtz Open Science Coordination Office at the GFZ German Research Centre for Geosciences.
If you would like to know in more detail which institutions take part in the advanced test phase of DeepGreen, you can find more information here.
30 July 2019
Meet Us at the 2019 APHA Annual Meeting and Expo
We will be attending the 2019 APHA Annual Meeting and Expo in Philadelphia, PA, USA from 2–6 November 2019. APHA's Annual Meeting and Expo is the largest and most influential annual gathering of public health professionals. Nearly 13,000 attendees join the conference each year to present, learn, and find inspiration. This year, the theme of the conference is “Creating the Healthiest Nation: For science. For action. For health”. Representatives of the following open access journals will attend:
If you are also attending this conference, please feel free to stop by our booth (Booth #1144). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit https://www.apha.org/events-and-meetings/annual.
25 July 2019
Meet Us at the 12th European Public Health Conference
We will be attending the 12th European Public Health Conference. From 20–23 November 2019, Marseille is hosting the 12th European Public Health (EPH) Conference, where you can reach over 1500 international delegates attending a fully packed programme over four days. Marseille 2019 offers you exceptional opportunities to network, raise your profile in the public health community, and gain valuable access to influential opinion-leaders, policy-makers, and researchers. The theme of the Congress is: Building bridges for solidarity and public health. Representatives of the following open access journals will attend:
IJERPH
Cancers
Toxics
Healthcare
JPM
17 July 2019
First Basel Sustainable Publishing Forum
The University of Basel and the MDPI Sustainability Foundation are organizing the First Basel Sustainable Publishing Forum on 9th September 2019.
The aim of this event is to provide background and perspectives on Plan S to Learned Societies, which have to make well-informed decisions to transition their journals to Open Access (OA).
The BSPF will bring together several representatives of Learned societies, Plan S architects as well as representatives from various publishers and publishing platforms. After getting the big picture from cOAlition S, panel discussions will allow to better understand the diverse challenges that Learned societies are facing to transition their journals to OA as well as to identify sustainable, implementable and scalable solutions for successful Open Access transition.
For program details and registration, please follow the link below:
https://sciforum.net/conference/SustainableSolutionsToOpenAccess
19 June 2019
Meet Us at Neuroscience 2019 in Chicago, IL, USA, 19–23 October 2019
MDPI will be attending Neuroscience 2019, to be held at McCormick Place in Chicago, IL, USA, 19–23 October 2019.
Join 30,000 colleagues from more than 70 countries at the world’s largest marketplace of ideas and tools for global neuroscience.
The following MDPI journals will be represented:
- Brain Sciences
- Journal of Clinical Medicine
- Genes
- Cancers
- Diagnostics
- Pathogens
- Medicines
- International Journal of Molecular Sciences
- Healthcare
- Journal of Personalized Medicine
- Psych
- Cells
- Children
- Biomedicines
If you are also attending this conference, please feel free to stop by our booth (Booth #405). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit: https://www.sfn.org/Meetings/Neuroscience-2019.
6 June 2019
Meet Us at European Society of Cardiology Congress 2019 in Paris, France, 31 August – 4 September 2019
MDPI will be attending the European Society of Cardiology Congress 2019 in Paris, France, 31 August – 4 September 2019.
The ESC Congress is the world’s largest conference in cardiovascular medicine. ESC Congress 2019 will take place in one of the world’s most alluring cities, Paris, and will be organised in conjunction with the World Heart Federation emphasizing the global reach of the event.
ESC Congress 2019 will build on the solid foundations of a congress that attracts worldwide cardiology leaders to present and exchange on their knowledge and most important research results. It will focus on the best and latest science but will also emphasize the importance of innovation, introducing topics at the frontiers of cardiovascular medicine and science to the attendees.
The following MDPI journals will be represented:
- Journal of Clinical Medicine
- Diagnostics
- Cancers
- Pathogens
- Cells
- Children
- Medicina
- Healthcare
- Journal of Personalized Medicine
- Journal of Cardiovascular Development and Disease
- Biomedicines
If you are also attending this conference, please feel free to stop by our booth (Booth C590). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit the following link: http://www.escexhibition.org/ESC2019/default.aspx.
20 May 2019
Meet Us at the European Human Genetics Conference in Gothenburg, Sweden, 15–18 June 2019
MDPI will be attending the ESHG 2019, to be held in Gothenburg, Sweden, 15th-18th June 2019.
ESHG 2019 - The 53rd European Human Genetics Conference is everything you need in human genetics, whatever your professional background. The Scientific Program Committee (SPC) has worked hard to invite the best speakers from various sectors of human genetics, and to select the best abstracts for platform presentations.
The following MDPI journals will be represented:
- Genes
- Journal of Clinical Medicine
- Cancers
- International Journal of Molecular Sciences
- Cells
- Diagnostics
- Healthcare
- Journal of Personalized Medicine
- Genealogy
- Biomedicines
If you are also attending this conference, please feel free to stop by our booth (Booth #492). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit: https://2019.eshg.org/
8 May 2019
Meet Us at the ESMO Congress 2019
Barcelona, Spain
27 September–1 October 2019
We will be attending the ESMO Congress 2019 in Barcelona, Spain from 27 September to 1 October 2019. The European Society for Medical Oncology (ESMO) is the leading European professional organization for medical oncology. Comprised of 17,000 oncology professionals from over 130 countries, they are the society of reference for oncology education and information. The annual ESMO Congress, which is held every year, is attended by 25,000 participants. The Congress presents the latest scientific developments in basic, translational and clinical cancer research and contextualizes new findings for practical implementation in everyday patient care. Representatives of the following MDPI open access journals will attend:
Cancers (https://www.mdpi.com/journal/cancers)
Diagnostics (https://www.mdpi.com/journal/diagnostics)
Genes (https://www.mdpi.com/journal/genes)
Healthcare (https://www.mdpi.com/journal/healthcare)
IJERPH (https://www.mdpi.com/journal/ijerph)
Journal of Clinical Medicine (https://www.mdpi.com/journal/jcm)
Journal of Personalized Medicine (https://www.mdpi.com/journal/jpm)
Medicina (https://www.mdpi.com/journal/medicina)
Medicines (https://www.mdpi.com/journal/medicines)
Vaccines (https://www.mdpi.com/journal/vaccines)
If you will attend this conference, please stop by our booth (Booth # P433). Our delegates look forward to meeting you in person and to answering any questions you may have concerning open access publishing and our journals.
For more information about the conference, please visit
https://www.esmo.org/Conferences/ESMO-Congress-2019
11 April 2019
Meet Us at the 46th Controlled Release Society Annual Meeting & Exposition
We will be attending the 46th Controlled Release Society Annual Meeting & Exposition. It is one of the biggest events in pharmaceutical field. Representatives of the following open access journals will attend:
Pharmaceutics
JCM
Biomolecules
Materials
IJMS
Molecules
Nanomaterials
Pharmaceuticals
Scientia Pharmaceutica
Vaccines
JPM
Genes
JFB
IJERPH
Biomedicines
Healthcare
If you are also attending this conference, please feel free to stop by our booth (Booth #303). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit: https://2019.controlledreleasesociety.org/
20 March 2019
Fostering Open Access Publishing Worldwide: New IOAP Participants in February and March 2019
We are pleased to welcome more universities from Poland, Italy, Germany, Brazil and other parts of the world to MDPI's Institutional Open Access Program (IOAP). A warm welcome to the institutions listed below, who have joined the Program in February and March this year.
Authors affiliated with these institutions can now enjoy a discount on the APC for papers accepted for publication in any MDPI journal. If you would like to learn more about our program, please visit: https://www.mdpi.com/about/ioap or email us at [email protected].
5 March 2019
MDPI Joins Jisc’s Publications Router Service
We are delighted to announce our participation in Jisc’s Publication Router project, as of March 2019.
Publications Router is a Jisc service that automatically sends notifications about research articles to institutions' systems such as their repositories or CRISs, since May 2015. Through this agreement, MDPI will provide Jisc with daily feeds and information regarding published articles, which will be gathered by their system and delivered to institutions also registered to this service. Nearly all of our articles are published within 15 days of acceptance, so institutions will receive them quite promptly.
The feed will include the full text of the published version of record, with no embargo, so the articles can be exposed immediately for public view. They are accompanied by rich metadata, including confirmation of the immediate CC BY licence, minimising the need for any manual intervention or checking.
For more information about Publications Router, you may contact Jisc’s central helpdesk at [email protected]. For any queries about MDPI’s institutional agreements and collaborations, you may get in touch with MDPI’s Institutional Engagement team at [email protected], which would be very happy to hear from further UK institutions.
1 February 2019
2018 MDPI Top Reviewer Award—Winners Announced
Rigorous peer-review is the cornerstone of high quality academic publishing. Over 97,000 scholars served as reviewers for MDPI journals in 2018. We are extremely appreciative of all those who made a contribution to the editorial process in this capacity. At the beginning of every year, journal editorial offices publish a list all reviewers’ names to express our gratitude. In addition, this year the “MDPI Top Reviewer Awards” are announced, to recognize the very best reviewers for their expertise, dedication, high quality, and timely review reports. We are pleased to announce the following winners of the 2018 MDPI Top Reviewer Awards:
- Ali Behnood
- Andrea Pezzuolo
- Angela Gorgoglione
- Anna D'Auria
- Antonio D'Andrea
- Azhar Abbas
- Bogdan Zagajewski
- Chunhui Chen
- Dominika Głąbska
- Dominika Guzek
- Dragan Pamucar
- Francisco J. G. Silva
- Frank Li
- Gianluca Serafini
- Gyorgy Szekely
- Haozhi Pan
- Helvi Heinonen-Tanski
- José Manuel Gómez-Soberón
- Kathy Lewis
- Klara Kosova
- Luis N. López De Lacalle
- M. Z. Naser
- Malwina Tytła
- Masoume Amirkhani
- Matteo Ghidelli
- Moretti Laura
- Petra Schneider
- Roberto Cerchione
- Spyros Papaefthymiou
- Ştefan Cristian Gherghina
24 January 2019
JAMS Journals: A Low-Cost Publishing Platform
Since 2010, MDPI has run its own online submission system. More recently, we have made the software, with accompanying publishing services, available to other publishers as JAMS (Journal and Article Management System). We are now delighted to announce the launch of JAMS Journals, a standardized platform for operating open access journals at low cost.
JAMS Journals provides a comprehensive service, including a shared submission website, journal websites hosted at a URL provided by the publisher, and a full production service. There is a small setup fee and the cost for each published paper is just a few hundred Swiss francs.
The platform demonstrates that running an open access journal can be straightforward and affordable. The JAMS Journals platform is suitable for
- small publishers or groups of scholars looking to launch their own journal;
- existing publishers or societies seeking to explore open access options;
- publishers looking to convert an existing subscription journal to open access.
JAMS journals launches with two journals from Canadian-based publisher Etcetera Publications:
- Canadian Journal of Pesticides & Pest Management (http://www.cjppm.ca)
- Nanotechnology in Agriculture, Food & Environment (http://www.nanoafe.ca)
Dr AJ Al-Rajab (President of Etcetera Publications) comments:
“In the past few months, we were working on our project to launch new open access scientific journals in the field of agricultural and environmental sciences. We decided to go with JAMS for this venture because of the high quality of their services, reasonable prices, professionalism and easy communication. Our portfolio is expected to grow rapidly during 2019 to include more titles covering different areas in agriculture and environment. MDPI earned already our complete satisfaction and we are looking for a long term cooperation.”
Alongside the new platform, we continue to provide flexible, tailored journal management solutions for existing publishers. For any questions or to request a quotation, contact Dr. Constanze Schelhorn ([email protected]).
24 January 2019
Popularity of Preprints Continues to Grow
2018 was a great year for preprints, with increasing numbers of authors looking to make their papers available online before peer review. Along with other preprint servers, our platform Preprints.org saw an increase in the uptake from authors, and more than double the number of announced papers compared to 2017. In fact, we recently passed two important milestones: 8000 preprints online and 30,000 authors.
We believe that the whole research community has the opportunity to benefit from work being available online as early as possible. We thank and congratulate our authors for supporting us to make this goal a reality.
In 2019, we will be looking carefully at how to provide better value for authors, maintain efficiency while growing in size, and make sure we remain well-connected with the research community.
If you want to participate, you can consider screening preprints or joining our advisory board. And, of course, posting your own work.
9 January 2019
Open Access Agreement between the Austrian Academic Library Consortium (KEMÖ), the Austrian Science Fund (FWF), and MDPI
We are delighted to announce the establishment of our national Open Access agreement with the Austrian Academic Library Consortium (KEMÖ) and the Austrian Science Fund (FWF). Through this national agreement, the Austrian institutions listed below as well as FWF will cover the Article Processing Charges (APC) of manuscripts published by eligible corresponding or funded authors in MDPI journals as long as central funds are available.
All participating institutions have gained access to the MDPI online submission system where they can find full article metadata and pricing information as well as Funder and Grant ID details for easy identification and additional transparency. At the same time eligible authors are benefited from an APC discount which comes at no cost for the institutions.
Eligible corresponding authors affiliated with the participating institutions are prompted to choose the corresponding Institutional Open Access Program (IOAP) when they submit an article via our online submission system. The program will be selected automatically if authors submit their papers using their institutional email address. To claim their discount, FWF funded authors should choose the particular funder and add their Grant ID upon online submission of their manuscript. The institutions will then crosscheck the information and confirm the APC funding.
Eligible authors that have their APC covered by their institution or funder are advised to include the following sentence in their acknowledgments: "Open Access Funding by the [name of the institution/funder]".
The full text of the agreement is openly available online at: http://doi.org/10.5281/zenodo.2536007
For any questions about the agreement, please contact the KEMÖ Consortium at [email protected], FWF at [email protected], or the MDPI IOAP team at [email protected].
The Austrian institutions participating in this agreement are:
- Austrian Science Fund (FWF)
- University for Continuing Education Krems
- University of Applied Sciences BFI Vienna
- University of Applied Sciences Upper Austria
- University of Applied Sciences Technikum Wien
- Vorarlberg University of Applied Sciences
- International Institute for Applied Systems Analysis (IIASA)
- Institute of Science and Technology Austria
- MCI Management Center Innsbruck
- University of Graz
- University of Linz
- University of Salzburg
- Graz University of Technology
- TU Wien
- University of Veterinary Medicine Vienna
- University of Vienna
This is our first collective agreement with a national library consortium, while the individual institutions around the world participating in our IOAP are now more than 500 - see details here: https://www.mdpi.com/about/ioap. We would be mostly interested in discussing about possible collaborations with other consortia, funders, and institutions in our mutual efforts to accelerate Open Access.
2 January 2019
Encyclopedia—the Scholarly Community Encyclopedia
We are pleased to announce the new platform Encyclopedia, which is an online reference created and curated by active scholars. It aims to highlight the latest research results as well as providing benchmark information for researchers and the general public interested in accurate and advanced knowledge on specific topics.
We encourage authors of review articles to quote and adapt the content of their published papers to create Encyclopedia entries. You can create completely new entries on topics in which you have knowledge and expertise. There is no limit on the topics or research fields. All of science and the humanities are included. Each entry will be published directly after submission.
We also have prepared a DOI application function in Encyclopedia. Once a DOI application is approved, the entry website will announce the DOI number and a pdf version with DOI information will be automatically created.
We look forward to your contributions and hope you will make use of this service. Find more about the service at: https://encyclopedia.pub/
30 October 2018
Institutional Open Access Agreement between Bill and Melinda Gates Foundation and MDPI
We are delighted to announce that the Bill and Melinda Gates Foundation (BMGF) is now a participant of our Institutional Open Access Program (IOAP). Authors funded by the BMGF can enjoy discounts on the APC, while the funder covers the costs of eligible articles centrally. BMGF also has access to the MDPI online submission system where they can find full article metadata and pricing information as well as Grant ID details for easy identification and additional transparency.
We hope that funded authors find the programme beneficial and we are happy to offer our IOAP to other funders that need a streamlined workflow of compliance checking and APC coverage.
To claim their discount, BMGF funded authors should choose the particular funder and add their Grant ID upon online submission of their manuscript.
For any questions about the BMGF agreement, please contact the funder at [email protected] or the MDPI IOAP team at [email protected].
11 October 2018
Meet Us at the NanoBio&Med2018 conference in Barcelona, Spain, 20–22 November 2018
MDPI will be attending NanoBio&Med2018, to be held in Barcelona, Spain, 20–22 November 2018.
This conference presents the most recent international developments in the field of Nanobiotechnology and Nanomedicine. Emerging and future trends of the converging fields of Nanotechnology, Biotechnology and Medicine will be discussed among industry, academic, governmental and non-governmental institutions and the conference will provide a platform for multidisciplinary communication.
The following MDPI journals will be represented:
If you are also attending this conference, please feel free to stop by our booth. Our delegates look forward to meeting you in person to answer any question you may have. For more information about the conference, please visit: http://www.nanobiomedconf.com/NBM18/index.php
2 October 2018
MDPI Welcomes Plan S
Recently, it was announced that a group of European funders supported 10 principles that will help to expand open access, known as Plan S. MDPI warmly welcomes this move as a step towards achieving more open and accessible communication of research across all disciplines. Some aspects remain to be clarified, however the details given so far match the aims and values that MDPI has held over the past two decades.
We believe that open access publishers should be active participants in discussions around Plan S, particularly regarding potential new business models and practical aspects of implementation. MDPI supports APCs as a transparent unit of payment for article publishing, however we are committed to exploring other measures and recently signed the Jussieu Call. Sustainability is a key value for MDPI, and future funding models should have at their heart the sustainability of knowledge and research dissemination. Plan S provides an opportunity for funders and publishers to directly discuss funding of open access journals in ways that are beneficial to all parties involved.
30 August 2018
MDPI establishes Open Access agreement with Qatar National Library
We are happy to announce the establishment of an Open Access (OA) agreement with Qatar National Library (QNL). QNL is committed to supporting and helping Qatar authors publish OA at no cost. Through this national agreement, QNL will cover the Article Processing Charges (APC) of manuscripts published by Qatar-based corresponding authors in MDPI journals.
Eligible corresponding authors affiliated with Qatar research centers and universities are prompted to choose QNL as part of our Institutional Open Access Program (IOAP) when they submit an article via our online submission system. The program will be selected automatically if authors submit their papers using their institutional email and/or a computer registered with the institution’s IP range. QNL will then crosscheck the information and confirm the APC funding.
Qatar authors that have their APC covered by QNL are advised to include the following sentence in their acknowledgments: "The publication of this article was funded by Qatar National Library".
For more information, please visit Open Access at QNL or email the QNL Open Access team at [email protected].
3 July 2018
Meet Us at the ESMO 2018 Congress (19–23 October 2018) in Munich, Germany
We will be attending the ESMO 2018 Congress in Munich, Germany from 19th to 23rd October 2018. The European Society for Medical Oncology (ESMO) is the leading European professional organization for medical oncology. Comprising 18,000 oncology professionals from over 150 countries, they are the society of reference for oncology education and information. The ESMO 2018 Congress will provide a scientific and educational program able to directly impact the daily clinical practice of oncologists. This year, the program also features a dedicated nursing track through a collaboration with the European Oncology Nursing Society (EONS). Representatives of the following MDPI open access journals will attend:
Cancers (https://www.mdpi.com/journal/cancers)
Antibodies (https://www.mdpi.com/journal/antibodies)
Epigenomes (https://www.mdpi.com/journal/epigenomes)
Healthcare (https://www.mdpi.com/journal/healthcare)
High-Throughput (https://www.mdpi.com/journal/high-throughput)
Journal of Clinical Medicine (https://www.mdpi.com/journal/jcm)
Journal of Personalized Medicine (https://www.mdpi.com/journal/jpm)
Medical Sciences (https://www.mdpi.com/journal/medsci)
Medicina (https://www.mdpi.com/journal/medicina)
Medicines (https://www.mdpi.com/journal/medicines)
Vaccines (https://www.mdpi.com/journal/vaccines)
If you are attending this conference, please stop by our booth (Booth # P106). Our delegates look forward to meeting you in person and answering any questions you may have concerning open access publishing and our journals.
For more information about the conference, please visit:
http://www.esmo.org/Conferences/ESMO-2018-Congress
1 June 2018
Journal of Personalized Medicine 2017 CiteScore™ Announced - 2.61
We are pleased to report the Journal of Personalized Medicine (JPM) received a CiteScore of 2.61 for 2017. The metric reflects citation activity in 2017 in Scopus for papers published in the period 2014‒2016.
For the full details in the current CiteScore release, please see the journal's Source profile. To check the full list of MDPI journals receiving CiteScores, please see here.
31 May 2018
2017 CiteScore™ Metrics Released
The 2017 CiteScore™ data is available now, based on citation data in the Scopus® database. The current CiteScore reflects citation activity in 2017 for articles published in 2014‒2016. Please note that the list below includes journals assigned a CiteScore in this year’s release. For a full list of journals indexed in Scopus, please see our journal list.
Thirteen of our journals received a CiteScore which is in the top 10% of the distribution in at least one of the categories (marked with * in the table below), while a further 32 journals exhibit scores that are in the first quartile of the respective categories.
To access the full data for MDPI journals, please see here. More data can also be found in SJR Scimago Journal & Country Rank.
Unlike CiteScores and the widely used Journal Impact Factors, the Source Normalized Impact per Paper (SNIP) metrics are normalized in order to correct for differences in citation practices between scientific fields. Therefore, the SNIP allows direct comparison between journals specialized in different fields.
According to 2017 data, MDPI publishes six journals with an average citation impact, or SNIP, in excess of 1.500. These journals are Biomolecules, Cancers, Journal of Clinical Medicine (JCM), Marine Drugs, Remote Sensing and Sensors (see the last column in the table below).
CiteScore Data for MDPI Journals
Journal | Rank (Quartile) |
Category | Link | CiteScore 2017 | 2016 |
2015 |
SNIP 2017 |
Aerospace | 43/116 (Q2) | • Aerospace Engineering | Link | 1.23 | - | - | 1.152 |
Agriculture | 69/309 (Q1) 91/398 (Q1) 78/255 (Q2) |
• Agronomy and Crop Science • Plant Science • Food Science |
Link | 1.93 | - | - | 1.133 |
Agronomy | 46/309 (Q1) | • Agronomy and Crop Science | Link | 2.38 | - | - | 1.115 |
Algorithms | 22/46 (Q2) 61/125 (Q2) 60/107 (Q3) 64/114 (Q3) |
• Numerical Analysis • Computational Mathematics • Computational Theory and Mathematics • Theoretical Computer Science |
Link | 1.03 | 1.15 | 1.07 | 0.749 |
Animals | 12/154 (Q1) * 48/367 (Q1) |
• General Veterinary • Animal Science and Zoology |
Link | 2.02 | 1.46 | 1.66 | 1.099 |
Antibiotics | 6/68 (Q1) * 62/263 (Q1) 55/230 (Q1) 31/108 (Q2) 47/134 (Q2) 139/398 (Q2) |
• General Pharmacology, Toxicology and Pharmaceutics • Infectious Diseases • Pharmacology (medical) • Microbiology (medical) • Microbiology • Biochemistry |
Link | 2.85 | 1.65 | - | 0.975 |
Antibodies | 43/143 (Q2) 61/164 (Q2) 85/189 (Q2) |
• Drug Discovery • Immunology and Allergy • Immunology |
Link | 2.85 | - | - | 0.844 |
Antioxidants | 23/119 (Q1) 35/169 (Q2) 100/398 (Q2) 119/367 (Q2) 102/264 (Q2) |
• Clinical Biochemistry • Physiology • Biochemistry • Molecular Biology • Cell Biology |
Link | 3.42 | - | - | 1.361 |
Applied Sciences | 48/270 (Q1) 15/66 (Q1) 31/116 (Q2) 18/53 (Q2) 151/434 (Q2) 186/535 (Q2) |
• General Engineering • Fluid Flow and Transfer Processes • Instrumentation • Process Chemistry and Technology • General Materials Science • Computer Science Applications |
Link | 1.90 | - | - | 0.801 |
Biology | 12/177 (Q1)* 32/186 (Q1) 10/40 (Q1) |
• General Agricultural and Biological Sciences • General Biochemistry, Genetics and Molecular Biology • General Immunology and Microbiology |
Link | 3.48 | 3.02 | 2.78 | 0.961 |
Biomolecules | 31/398 (Q1) * 41/367 (Q1) |
• Biochemistry • Molecular Biology |
Link | 5.72 | 1.67 | 3.08 | 1.542 |
Biosensors | 20/119 (Q1) | • Clinical Biochemistry | Link | 3.59 | 2.83 | 2.37 | 1.122 |
Brain Sciences | 47/111 (Q2) | • General Neuroscience | Link | 2.56 | - | - | 0.695 |
Cancers | 26/323 (Q1) * 23/191 (Q1) |
• Oncology • Cancer Research |
Link | 5.82 | 5.02 | 4.07 | 1.567 |
Catalysts | 32/151 (Q1) 21/46 (Q2) |
• Physical and Theoretical Chemistry • Catalysis |
Link | 3.23 | 3.44 | 3.45 | 0.954 |
Crystals | 76/272 (Q2) 140/434 (Q2) 127/398 (Q2) 26/64 (Q2) |
• General Chemical Engineering • General Materials Science • Condensed Matter Physics • Inorganic Chemistry |
Link | 1.97 | 1.89 | 1.47 | 0.745 |
Diagnostics | 49/119 (Q2) | • Clinical Biochemistry | Link | 2.43 | - | - | 0.788 |
Diversity | 30/124 (Q1) 14/52 (Q2) 83/306 (Q2) 11/29 (Q2) |
• Nature and Landscape Conservation • Agricultural and Biological Sciences (miscellaneous) • Ecology • Ecological Modelling |
Link | 2.15 | 2.03 | 1.96 | 1.300 |
Electronics | 109/644 (Q1) 26/148 (Q1) 42/224 (Q1) 50/259 (Q1) 23/96 (Q1) |
• Electrical and Electronic Engineering • Hardware and Architecture • Control and Systems Engineering • Computer Networks and Communications • Signal Processing |
Link | 2.97 | - | - | 1.227 |
Energies | 6/73 (Q1) * 31/192 (Q1) 103/644 (Q1) 4/16 (Q1) 47/140 (Q2) |
• Control and Optimization • Energy Engineering and Power Technology • Electrical and Electronic Engineering • Energy (miscellaneous) • Renewable Energy, Sustainability and the Environment |
Link | 3.11 | 2.50 | 2.87 | 1.340 |
Entropy | 35/202 (Q1) | • General Physics and Astronomy | Link | 2.41 | 1.87 | 1.99 | 1.189 |
Forests | 17/129 (Q1) | • Forestry | Link | 2.31 | 2.06 | 1.76 | 0.990 |
Future Internet | 132/259 (Q3) | • Computer Networks and Communications | Link | 1.25 | - | - | - |
Games | 132/187 (Q3) 78/110 (Q3) 305/418 (Q3) |
• Statistics and Probability • Statistics, Probability and Uncertainty • Applied Mathematics |
Link | 0.61 | 0.87 | 0.57 | 1.038 |
Genes | 21/91 (Q1) 74/311 (Q1) |
• Genetics (clinical) • Genetics |
Link | 3.49 | 3.62 | 3.18 | 0.374 |
Geosciences | 32/182 (Q1) |
• General Earth and Planetary Sciences | Link | 1.97 | 1.67 | 1.29 | 0.856 |
Information | 143/251 (Q3) | • Information Systems | Link | 1.16 | 0.78 | 0.94 | 1.146 |
Insects | 27/135 (Q1) | • Insect Science | Link | 1.85 | 1.81 | 1.38 | 0.719 |
International Journal of Environmental Research and Public Health (IJERPH) | 80/478 (Q1) 34/106 (Q2) |
• Public Health, Environmental and Occupational Health • Health, Toxicology and Mutagenesis |
Link | 2.41 | 2.38 | 2.42 | 0.931 |
International Journal of Molecular Sciences (IJMS) | 7/69 (Q1) * 61/535 (Q1) 20/163 (Q1) 9/64 (Q1) 26/151 (Q1) 89/367 (Q2) 17/46 (Q2) |
• Spectroscopy • Computer Science Applications • Organic Chemistry • Inorganic Chemistry • Physical and Theoretical Chemistry • Molecular Biology • Catalysis |
Link | 3.86 | 3.73 | 3.37 | 0.998 |
ISPRS International Journal of Geo-Information (IJGI) | 79/605 (Q1) 22/82 (Q2) 13/36 (Q2) |
• Geography, Planning and Development • Earth and Planetary Sciences (miscellaneous) • Computers in Earth Sciences |
Link | 2.10 | 1.62 | 1.52 | 1.062 |
Journal of Clinical Medicine (JCM) | 10/841 (Q1) * | • General Medicine | Link | 7.07 | - | - | 1.535 |
Journal of Functional Biomaterials (JFB) | 43/199 (Q1) 23/77 (Q2) |
• Biomedical Engineering • Biomaterials |
Link | 3.47 | - | - | 1.344 |
Journal of Low Po- wer Electronics and Applications (JLPEA) |
301/644 (Q2) | • Electrical and Electronic Engineering | Link | 1.12 | 0.98 | 0.83 | 0.367 |
Journal of Personalized Medicine (JPM) | 54/189 (Q2) | • Medicine (miscellaneous) | Link | 2.61 | - | - | 0.944 |
Land | 50/124 (Q2) 129/306 (Q2) 36/65 (Q3) |
• Nature and Landscape Conservation • Ecology • Global and Planetary Change |
Link | 1.44 | - | - | 0.658 |
Life | 4/94 (Q1) * 70/561 (Q1) 40/186 (Q1) 20/80 (Q2) |
• Palaeontology • Ecology, Evolution, Behavior and Systematics • General Biochemistry, Genetics and Molecular Biology • Space and Planetary Science |
Link | 3.16 | 2.95 | 1.68 | 0.935 |
Marine Drugs | 17/146 (Q1) | • Drug Discovery | Link | 4.58 | 3.83 | 3.66 | 1.537 |
Materials | 83/434 (Q1) | • General Materials Science | Link | 3.02 | 3.26 | 3.11 | 1.285 |
Membranes | 5/18 (Q2) 15/53 (Q2) 4/10 (Q2) |
• Chemical Engineering (miscellaneous) • Process Chemistry and Technology • Filtration and Separation |
Link | 2.69 | 2.19 | 2.95 | 0.880 |
Metabolites | 47/209 (Q1) 103/398 (Q2) 127/367 (Q2) |
• Endocrinology, Diabetes and Metabolism • Biochemistry • Molecular Biology |
Link | 3.35 | - | - | 0.925 |
Metals | 155/434 (Q2) | • General Materials Science | Link | 1.87 | - | - | 0.955 |
Micromachines | 105/554 (Q1) 154/644 (Q1) 64/224 (Q2) |
• Mechanical Engineering • Electrical and Electronic Engineering • Control and Systems Engineering |
Link | 2.31 | 1.83 | 1.78 | 0.987 |
Minerals | 33/175 (Q1) 45/208 (Q1) |
• Geotechnical Engineering and Engineering Geology • Geology |
Link | 2.21 | 2.13 | 1.77 | 1.149 |
Molecules | 4/25 (Q1) 25/172 (Q1) 18/104 (Q1) 31/163 (Q1) 30/151 (Q1) 31/146 (Q1) 55/160 (Q2) |
• Chemistry (miscellaneous) • Pharmaceutical Science • Analytical Chemistry • Organic Chemistry • Physical and Theoretical Chemistry • Drug Discovery • Molecular Medicine |
Link | 3.27 | 3.09 | 2.65 | 1.146 |
Nutrients | 11/255 (Q1) * 9/112 (Q1) * |
• Food Science • Nutrition and Dietetics |
Link | 4.35 | 4.29 | 4.07 | 1.403 |
Pathogens | 38/263 (Q1) 20/108 (Q1) 9/40 (Q1) 40/164 (Q1) 110/367 (Q2) |
• Infectious Diseases • Microbiology (medical) • General Immunology and Microbiology • Immunology and Allergy • Molecular Biology |
Link | 3.52 | - | - | 1.166 |
Pharmaceuticals | 14/172 (Q1) * 33/160 (Q1) |
• Pharmaceutical Science • Molecular Medicine |
Link | 4.12 | 4.90 | 3.64 | 1.370 |
Pharmaceutics | 21/172 (Q1) | • Pharmaceutical Science | Link | 3.68 | 3.83 | 2.68 | 1.092 |
Photonics | 30/116 (Q1) 80/270 (Q2) 53/160 (Q2) |
• Instrumentation • Radiology Nuclear Medicine and Imaging • Atomic and Molecular Physics, and Optics |
Link | 1.96 | - | - | 0.817 |
Plants | 73/561 (Q1) 48/389 (Q1) 44/306 (Q1) |
• Ecology, Evolution, Behavior and Systematics • Plant Science • Ecology |
Link | 3.13 | - | - | 0.969 |
Polymers | 17/142 (Q1) 63/359 (Q1) |
• Polymers and Plastics • General Chemistry |
Link | 3.30 | 3.74 | 3.37 | 1.213 |
Religions | 26/389 (Q1) * | • Religious Studies | Link | 0.56 | - | - | 0.676 |
Remote Sensing | 13/182 (Q1) * | • General Earth and Planetary Sciences | Link | 4.03 | 3.56 | 3.76 | 1.559 |
Resources | 19/142 (Q1) 39/261 (Q1) |
• Nature and Landscape Conservation • Management, Monitoring, Policy and Law |
Link | 2.69 | - | - | 1.387 |
Scientia Pharmaceutica | 92/172 (Q3) | • Pharmaceutical Science | Link | 0.86 | - | - | 0.513 |
Sensors | 9/116 (Q1) * 25/160 (Q1) 100/644 (Q1) 19/104 (Q1) 113/398 (Q2) |
• Instrumentation • Atomic and Molecular Physics, and Optics • Electrical and Electronic Engineering • Analytical Chemistry • Biochemistry |
Link | 3.23 | 2.78 | 2.21 | 1.550 |
Social Sciences | 81/213 (Q2) | • General Social Sciences | Link | 0.60 | - | - | 0.445 |
Sustainability | 61/605 (Q1) * 55/261 (Q1) 60/140 (Q2) |
• Geography, Planning and Development • Management, Monitoring, Policy and Law • Renewable Energy, Sustainability and the Environment |
Link | 2.37 | 1.96 | 1.78 | 1.030 |
Symmetry | 44/327 (Q1) 17/45 (Q2) 16/40 (Q2) 14/25 (Q2) |
• General Mathematics • Computer Science (miscellaneous) • Physics and Astronomy (miscellaneous) • Chemistry (miscellaneous) |
Link | 1.32 | 1.12 | 0.95 | 0.802 |
Toxins | 18/106 (Q1) 21/111 (Q1) |
• Health, Toxicology and Mutagenesis • Toxicology |
Link | 3.32 | 3.34 | 3.76 | 1.136 |
Vaccines | 5/230 (Q1) * 13/263 (Q1) * 18/302 (Q1) * 11/146 (Q1) * 32/189 (Q1) |
• Pharmacology (medical) • Infectious Diseases • Pharmacology • Drug Discovery • Immunology |
Link | 4.88 | 1.23 | 3.76 | 1.255 |
Viruses | 29/263 (Q1) 16/68 (Q1) |
• Virology • Infectious Diseases |
Link | 3.88 | 3.60 | 3.74 | 1.130 |
Water | 66/605 (Q1) 37/191 (Q1) 43/199 (Q1) 193/398 (Q2) |
• Geography, Planning and Development • Water Science and Technology • Aquatic Science • Biochemistry |
Link | 2.29 | 2.05 | 1.96 | 1.007 |
30 April 2018
Winners of the First MDPI Writing Prize
We are pleased to announce the results of the first MDPI Writing Prize. We received a large number of entries from across the globe on the theme of “The Global Benefits of Open Research”. It was a pleasure to read so many original, well-researched and well-presented ideas, and the final choice was not an easy one. We are pleased to announce that the winners are as follows:
1st prize (500 CHF, Swiss knife and certificate)
Edmond Sanganyado, Shantou University, China
2nd prizes (250 CHF, Swiss knife and certificate)
Kamala T. Rajahgopal, Asia e University, Malaysia
Yin Zhixuan, Qingdao University of Technology, China
3rd prizes (100 CHF, Swiss knife and certificate)
Alexandra Ticea, Carol Davila University of Medicine and Pharmacy, Romania
Ankur Sarker, University of Virginia, USA
Daniel Attoye, United Arab Emirates University, UAE
Congratulations to all of them! The winning entries can be downloaded by clicking on the names above. A compilation of all entries will soon be available as an open access book.
The writing prize is sponsored by the MDPI English editing service.
23 March 2018
Check for Updates: A New Function in the Article PDF Version
At MDPI, we always want to keep you up to date. Even for already published articles, some corrections or minor changes may occur. To prevent you from missing any updates, from now on you will be able to access the latest version of any manuscript by clicking on the “check for updates” logo that you can find in the PDF file, even if you have saved the file on your computer.
13 March 2018
MDPI Becoming a Member of UKSG
We are proud to announce that MDPI is now a member of UKSG, the UK´s largest scholarly communications community. Through UKSG, different stakeholders share their knowledge and experience in order to improve the knowledge and information environment for researchers. UKSG´s members include universities, publishers, content providers, intermediaries, and other similar organisations. Members participate in discussions and events on issues around scholarly communications.
The UKSG Annual Conference and Exhibition is a flagship initiative from the UKSG and one of the most stimulating events in the scholarly communications calendar. It is held annually and attracts a large number of delegates. More information is available at https://www.uksg.org/events/annualconference
MDPI is delighted to be a part of this active community and we look forward to making our own contribution. We will continue to support organisations and initiatives that boost collaboration and vision within scholarly communication.
More information about UKSG can be found at https://www.uksg.org/. The full membership list is available at: https://www.uksg.org/members.
1 February 2018
MDPI Signed the San Francisco Declaration on Research Assessment (DORA)
The DORA initiative addresses the need for advanced approaches in the evaluation and measurement of the quality of scientific research outputs. It is a worldwide initiative covering all scholarly disciplines. MDPI proudly joins a list of more than 400 organizations around the world which support DORA’s recommendations for improving the way the quality of research results is evaluated.
More info can be found at http://www.ascb.org/dora/
21 December 2017
Meet Us at the AACR Annual Meeting 2018 in Chicago, IL, USA
We will be attending the AACR Annual Meeting 2018, to be held in Chicago, IL, USA, 14-18 April 2018. The American Association for Cancer Research (AACR) is the world's oldest and largest professional association related to cancer research. The AACR gives the opportunity to gain visibility for your organization among more than 21,000 scientists and other cancer professionals who are projected to attend from around the world. Representatives of the following MDPI open access journals will attend:
Antibodies (https://www.mdpi.com/journal/antibodies)
Biomedicines (https://www.mdpi.com/journal/biomedicines)
Cancers (https://www.mdpi.com/journal/cancers)
Cells (https://www.mdpi.com/journal/cells)
Children (https://www.mdpi.com/journal/children)
Diagnostics (https://www.mdpi.com/journal/diagnostics)
Epigenomes (https://www.mdpi.com/journal/epigenomes)
Genes (https://www.mdpi.com/journal/genes)
Healthcare (https://www.mdpi.com/journal/healthcare)
High-Throughput (https://www.mdpi.com/journal/high-throughput)
IJERPH (https://www.mdpi.com/journal/ijerph)
JCM (https://www.mdpi.com/journal/jcm)
IJMS (https://www.mdpi.com/journal/ijms)
JPM (https://www.mdpi.com/journal/jpm)
Medical Sciences (https://www.mdpi.com/journal/medsci)
Medicines (https://www.mdpi.com/journal/medicines)
Metabolites (https://www.mdpi.com/journal/metabolites)
ncRNA (https://www.mdpi.com/journal/ncrna)
Pharmaceuticals (https://www.mdpi.com/journal/pharmaceuticals)
Pharmaceutics (https://www.mdpi.com/journal/pharmaceutics)
Scientia Pharmaceutica (https://www.mdpi.com/journal/scipharm)
Vaccines (https://www.mdpi.com/journal/vaccines)
Please come along to our stand, No.1339, to have a chat with our delegates about the journals, and information on online publishing as well as our editorial procedures. You may also learn more about the various awards offered by the journals, including the Best Paper Awards, the Young Investigator Awards, Travel Awards, etc. Some useful handouts are also available. We look forward to meeting you in person to answer any questions you may have.
Conference address:
AACR Annual Meeting 2018
McCormick Place North/South
Chicago, IL, USA
Conference date:
14-18 April 2018
For more information on the conference, please visit:
http://www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=136
19 December 2017
Announcing the MDPI English Writing Prize
The competition is still open until end of March! Please check out the banner for more details: https://mdpi-res.com/data/english-prize.pdf
15 December 2017
UCL Press Adopts the MDPI Editorial Platform JAMS
We are delighted to announce that UCL Press has adopted MDPI's Journal Article & Management System, JAMS, including production services. JAMS is a modular, integrated editorial platform for academic publishers. It offers flexibility, ease-of-use, and is a fully integrated solution for the end-to-end management of scholarly journals. JAMS is based on the software used to publish MDPI’s portfolio of journals.
Ian Caswell, UCL Press Journals Manager, says he is "excited to see UCL Press and MDPI partner together to implement the JAMS submission system for all UCL Press journals. The system offered a flexible, efficient and straightforward solution for our processes from author submission to ready for publication. I am grateful for the valuable experience and support MDPI have offered and look forward to developing our programme with an effective submission system in place.” Dr Martyn Rittman, MDPI’s Publishing Services Manager, adds, “We are proud to support one of the UK’s premier university presses in their publishing operation. This is an excellent way for us at MDPI to share our experience and knowledge, and benefit the research community beyond our own journals.”
JAMS combines services that are kept separate for many publishers. The entire editorial process, production and invoicing (e.g. for open access article processing charges) are fully integrated into a single platform. This allows for efficient, fast manuscript processing. For further information about JAMS, see https://www.mdpi.com/publishing_services.
23 November 2017
New Participants in the Institutional Open Access Program (IOAP)
We are pleased to welcome new participants to MDPI's Institutional Open Access Program (IOAP), designed to help institutions manage the transition to the Open Access publishing model. Researchers affiliated with participating universites benefit from a 10% discount on the Article Processing Charges (APC) for any paper published in an MDPI journal, while the participating library or university incurs no basic fee for participating in the program.
The IOAP set of free services, provided by MDPI to institutions that sign up, include:- No fee for participants and no obligation to prolong after the initial 12 months. The participants may withdraw from the programme at any time, and we will also keep it free for the library for as long as they continue in the programme.
- Authors affiliated with the university will receive a 10% discount on the APC.
- The institution is granted free access to the MDPI submission system and can receive free alerts of new submissions to our journals.
- By default, authors from the institution will continue to be invoiced directly unless the institution opts for central billing.
- Auto-archiving of papers into the institutions´ repository as long as it supports SWORD 1.3.
More details about the programme and a list of our current participant institutions can be found at: https://www.mdpi.com/about/ioap
Institutions which are interested to participate may do so online at: https://www.mdpi.com/ioap-form
The following North American universities have signed up to the IOAP program recently:
Connecticut College, USA
Emory University, USA
Florida International University, USA
Johns Hopkins University, USA
Mississippi State University, USA
Northeastern University, USA
Rice University, USA
University of Ontario Institute of Technology, Canada
University of Rhode Island, USA
University of Texas Southwestern Medical Center, USA
University of Toronto, Canada
University of Windsor, Canada
University of Wisconsin–Madison, USA
Wellesley College, USA
West Virginia University, USA
Many prestigious institutions from Europe and Asia have joined as well:
Asia Pacific University of Technology & Innovation, Malaysia
Czech Technical University in Prague, Czech Republic
Gdansk University of Technology, Poland
Martin-Luther-Universität Halle-Wittenberg, Germany
National Chung Hsing University, Taiwan
Newcastle University, UK
Northumbria University, UK
Southwest University, China
Technical University of Crete, Greece
University Malaya, Malaysia
University of Antwerp, Belgium
University of Cyprus, Cyprus
University of Manchester, UK
University of Reading, UK
University of Sussex, UK
University of Warwick, UK
West Pomeranian University of Technology Szczecin, Poland
We offer a warm welcome to the new participants!
10 November 2017
Available Journal Awards at MDPI
In order to reward the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields, for example, Young Investigator Awards, Travel Awards, Best Paper Awards, and Best Poster Awards, etc. The awardees range from PhD students to junior scientists.
Currently, the following 44 awards given by MDPI journals are accepting applications. Please click on the award title below to check whether you are eligible for it and start the application process.
Subject |
Journal |
Award |
Intended Awardee |
Biology & Life Sciences |
Animals |
PhD students or postdoctoral researchers |
|
Antioxidants |
Postdoctoral researchers or PhD students |
||
Biology |
PhD or postdoctoral fellows |
||
Forests |
Postdocs or PhD students |
||
International Journal of Molecular Sciences (IJMS) |
Ground-breaking contribution in the fields of Molecular Biology, and Molecular Pathology |
||
Journal of Fungi (JoF) |
Travel Awards 2018 |
PhD graduate students, and postdoctoral fellows |
|
Life |
Travel Award 2018 |
PhD students or postdoctoral fellows |
|
Metabolites |
PhD students |
||
Pharmaceuticals |
PhD students |
||
Toxins |
Postdoctoral fellows |
||
Viruses |
Viruses 2018 participants |
||
Viruses |
Viruses 2018 participants |
||
Water |
2018 Young Investigator Award |
Young investigators |
|
Chemistry & Materials Science |
Biomimetics
|
Graduate Student or Postdoctoral Trainee / Research Associate |
|
Catalysts |
PhD students |
||
Chemosensors |
PhD or postdoctoral fellows |
||
Entropy |
Young investigators |
||
Fibers |
2018 Travel award |
Postdocs or PhD students |
|
Magnetochemistry |
Postdocs |
||
Materials |
PhD or postdoctoral fellows |
||
Metals |
PhD or postdoctoral fellows |
||
Minerals |
PhD or postdoctoral fellows |
||
Sensors |
Travel Award 2018 |
PhD or postdoctoral fellows |
|
Sensors |
Sensors' reviewers in 2017 |
||
Sensors |
Young investigators |
||
Technologies |
PhD students |
||
Computer Science & Mathematics |
Multimodal Technologies and Interaction (MTI) |
Postdoctoral researchers or PhD students |
|
ISPRS International Journal of Geo-Information(IJGI) |
Postdocs |
||
Journal of Sensor and Actuator Networks (JSAN) |
Postdoctoral fellows and PhD students |
||
Journal of Imaging |
Postdoctoral fellows and PhD students |
||
Engineering |
Actuators |
PhD or postdoctoral fellows |
|
Remote Sensing |
Authors |
||
Machines |
PhD or postdoctoral fellows |
||
Micromachines |
PhD or postdoctoral fellows |
||
Fluids |
Postdoctoral fellows and PhD students |
||
ChemEngineering |
Postdoctoral researchers and PhD students |
||
Environmental & Earth Sciences |
Diversity |
Travel Awards 2018 |
Postdoctoral fellows |
International Journal of Environmental Research and Public Health (IJERPH) |
Authors who submit from 1 Nov 2017 to 31 Oct 2018 |
||
Resources |
Postdocs or PhD students |
||
Geosciences |
Postdoctoral fellows and PhD students |
||
Physical Sciences & Astronomy |
Galaxies |
Ph.D. students, postdoctoral fellows, or lecturers in cosmology or galaxies physics |
|
Applied Science |
Postdocs |
||
Medicine & Pharmacology; Public Health & Healthcare |
Journal of Clinical Medicine (JCM) |
PhD or postdoctoral fellows |
|
Medicines |
Postdocs |
7 November 2017
MDPI has signed the Jussieu Call for Open Science and Bibliodiversity
The Jussieu Call aims to develop and implement alternative models to meet the aims of open science while promoting bibliodiversity. In particular it wishes to promote new business models for funding open access publication. It was drafted on the Jussieu campus in Paris by a group of French researchers and scientific publishing professionals.
MDPI supports scholarly communities and initiatives that innovate and further promote Open Access publishing. There is a need to explore different frameworks to fund open access in ways that ensure that excessive funds are not diverted from research towards publishing. Many fair funding models already exist, and they can be further developed and extended. These include institutional support, library contributions or subsidies, premium services, participatory funding, etc. For this reason, MDPI has signed up to the Jussieu call and welcomes its aims.
More information can be found at http://jussieucall.org/ (archived here)
6 October 2017
Dr. Franck Vazquez, MDPI CEO, Interviewed by Scholarly Kitchen
The Society for Scholarly Publishing’s popular blog about topics in academic publishing, Scholarly Kitchen, recently interviewed MDPI’s CEO, Dr. Franck Vazquez. He shared some thoughts and information on the past and future of MDPI and open access publishing in general:
“In the long run, we aim to anchor MDPI in research communities. We recently developed and launched the preprint platform Preprints, revamped our free-to-use conference hosting platform Sciforum, and are working on other projects, such as Scilit, our bibliographic database.”
Read the full interview here.
2 October 2017
Meet Us at the ASHG 2017 Conference in Orlando
We will attend the American Society of Human Genetics (ASHG 2017) Conference that will be held in Orlando, FL, USA 17–21 October 2017, representing our open access journals at the interface of nanotechnology, medicine and biology:
Biomolecules
Genes
Journal of Personalized Medicine
High-Throughput
Please stop by booth 534 to chat with our delegates about the journals. They will answer any questions about open access publishing and our journals. We look forward to meeting you in Orlando!
For more information on the conference, please visit:
http://www.ashg.org/2017meeting/
25 September 2017
Meet Us at the ICONAN 2017 Conference in Barcelona
We will attend the International Conference On Nanomedicine And Nanobiotechnology (ICONAN 2017) that will be held in Barcelona, Spain, 25–27 September 2017, representing our open access journals at the interface of nanotechnology, medicine and biology:
Bioengineering
Biomedicines
Biomimetics
Biomolecules
Journal of Functional Biomaterials
Journal of Personalized Medicine
High-Throughput
Medical Sciences
Scientia Pharmaceutica
Please stop by our booth to chat with our delegates about our journals. They will answer any questions about open access publishing and our journals. We look forward to meeting you in Barcelona!
For more information on the conference, please visit:
http://premc.org/conferences/iconan-nanomedicine-nanobiotechnology/
19 September 2017
A Warm Welcome to the New IOAP Participants
We are delighted to have welcomed 24 new participants to our Institutional Open Access Programme (IOAP) since the beginning of September this year. These are University libraries and Research Institutions located around the world; from the USA and Canada to the UK, and from Norway and Spain to Greece. Well respected Universities, such as the University of Denver, the University of Colorado Boulder, and the University of Arizona in the US, have signed up, while their researchers can now benefit from a 10% discount on the Article Processing Charges (APC) for any papers they publish in MDPI journals, at no cost for the library or the University.
We are more than happy to see the Open Access movement growing stronger and wider every day and we appreciate the vital role which librarians, repository managers, and other scholarly communications professionals play in the field. Our communication with and service to this community is, therefore, one of our principal priorities. The IOAP is our way to support academic and scientific Institutions as well as their scholars in managing, administrating, and publishing research in an Open Access world.
The IOAP set of free services, provided by MDPI to institutions that sign up, include:
- No fee for participants and no obligation to prolong after the initial 12 months. The participants may withdraw from the programme at any time, and we will also keep it free for the library for as long as they continue in the programme.
- Authors affiliated with the university will receive a discount on the article processing charge (APC).
- The institution is granted free access to the MDPI submission system and can receive free alerts of new submissions to our journals.
- By default, authors from the institution will continue to be invoiced directly unless the institution opts for central billing.
- Auto-archiving of papers into the institutions´ repository as long as it supports SWORD 1.3.
More details about the programme and a list of our current participant institutions can be found at: https://www.mdpi.com/about/ioap
Institutions which are interested to participate may do so online at: https://www.mdpi.com/ioap-form
The full list of the Institutions that signed up in September is as follows:
- University of Denver, USA
- University of Colorado Boulder, USA
- University of Arizona, USA
- Institute of Metrology of Bosnia and Herzegovina, Bosnia and Herzegovina
- Middlebury College, USA
- Touro College, USA
- University of New Orleans, USA
- University of Leicester, UK
- Indiana University-Purdue University Indianapolis, USA
- University of Strathclyde, UK
- Cranfield University, UK
- Hope College, USA
- Oregon State University, USA
- Drew University, USA
- Swansea University, UK
- University of South Florida, USA
- University of Georgia, USA
- Arizona State University, USA
- University of Southern Mississippi, USA
- Université du Québec à Chicoutimi, Canada
- Grinnell College, USA
- Norwegian University of Science and Technology, Norway
- University of Patras, Greece
- Public University of Navarre, Spain
23 June 2017
Congratulations for Publishing the 100,000th Peer-Reviewed Article
Congratulations to the authors Javier Monroy and Javier Gonzalez-Jimenez from Universidad de Malaga, Spain, Victor Hernandez-Bennets, Han Fan and Achim Lilienthal from Örebro University, Sweden for publishing the 100,000th peer-reviewed article.
The article is published in the Chemical Sensors section of Sensors.
GADEN: A 3D Gas Dispersion Simulator for Mobile Robot Olfaction in Realistic Environments
Evermore pressing environmental concerns have led global actors and decision-makers to search for stricter emission monitoring approaches. As part of novel monitoring systems, robots with gas and environmental sensors are a promising solution. However, validation of such robotic inspectors is expensive, time consuming, and plagued by repeatability issues. In this article, we present GADEN (the short form for Gas Dispersion Simulator for Mobile Robot Olfaction in Realistic Environments), which combines gas dispersion and robotics simulation in a common framework. Developed under the widely used Robot Operating System (ROS), GADEN enables validation of sensing strategies with gas dispersion being simulated using computational fluid dynamics and filament dispersion theory. GADEN allows simulating complex, realistic, 3D environments for reproducible testing of robotic gas sensing algorithms. Through qualitative and quantitative evaluations, we show that GADEN is a versatile and user-friendly evaluation tool and emphasize its enormous potential for the mobile robot olfaction community.
Read the full article here: https://www.mdpi.com/1424-8220/17/7/1479/htm
6 June 2017
CiteScore™ Metrics Released for Scopus Journals
The CiteScore, the new citation metric for journals covered in the Scopus® database, was released on 1 June 2017, reflecting the citation activity in 2016 for articles published during the three previous years. Please note that the list below does not contain all MDPI journals covered in Scopus. For the CiteScore to serve as a reliable metric at least three volumes of articles need to be indexed in Scopus; journals which have not met this criterion have been omitted here.
Ten MDPI journals received a CiteScore which is in the Top 10% of scores in at least one of the categories, while a further 21 journals exhibit scores that are in the first quartile of the respective categories.
CiteScore Data for MDPI Journals
Journal | Rank | Category | Link | CiteScore 2016 | 2015 |
2014 |
Algorithms | 44/112 (Q2) 49/111 (Q2) 19/42 (Q2) 52/113 (Q2) |
• Numerical Analysis • Computational Mathematics • Computational Theory and Mathematics • Theoretical Computer Science |
Link | 1.15 | 1.07 | 1.06 |
Animals | 69/343 (Q1) 21/146 (Q1) |
• Animal Science and Zoology • General Veterinary |
Link | 1.46 | 1.66 | 0.74 |
Biology | 13/92 (Q1) 34/81 (Q1) 10/75 (Q1) |
• General Agricultural and Biological Sciences • General Biochemistry, Gene- tics and Molecular Biology • General Immunology and Microbiology |
Link | 3.02 | 2.78 | 1.74 |
Biomolecules | 234/382 (Q3) 260/353 (Q3) |
• Biochemistry • Molecular Biology |
Link | 1.67 | 3.08 | 1.00 |
Biosensors | 36/118 (Q2) 209/2156 (Q1) |
• Clinical Biochemistry • General Medicine |
Link | 2.83 | 2.37 | 2.04 |
Cancers | 29/196 (Q1) 27/321 (Q1) |
• Cancer Research • Oncology |
Link | 5.02 | 4.07 | 2.31 |
Catalysts | 18/44 (Q2) 27/144 (Q1) |
• Catalysis • Physical and Theoretical Chemistry |
Link | 3.44 | 3.45 | 2.17 |
Crystals | 70/270 (Q2) 25/64 (Q2) 118/398 (Q2) 131/424 (Q2) |
• General Chemical Engineering • Inorganic Chemistry • Condensed Matter Physics • General Materials Science |
Link | 1.89 | 1.47 | 1.03 |
Diversity | 10/41 (Q1) 9/25 (Q2) 76/291 (Q2) 24/109 (Q1) |
• Agricultural and Biological Sciences (miscellaneous) • Ecological Modelling • Ecology • Nature and Landscape Conservation |
Link | 2.03 | 1.96 | 1.82 |
Energies | - | - | Link | 2.50 | 2.87 | 2.66 |
Entropy | 51/198 (Q2) | • General Physics and Astronomy | Link | 1.87 | 1.99 | 1.69 |
Forests | 17/127 (Q1) | • Forestry | Link | 2.06 | 1.76 | 1.84 |
Games | 204/398 (Q3) 83/181 (Q2) 48/105 (Q2) |
• Applied Mathematics • Statistics and Probability • Statistics, Probability and Uncertainty |
Link | 0.87 | 0.57 | 0.64 |
Genes | 62/300 (Q1) 18/90 (Q1) |
• Genetics • Genetics (clinical) |
Link | 3.62 | 3.18 | 1.33 |
Geosciences | 36/169 (Q1) |
• General Earth and Planetary Sciences | Link | 1.67 | 1.29 | 1.13 |
Information | 156/237 (Q3) | • Information Systems | Link | 0.78 | 0.94 | 0.74 |
Insects | 28/131 (Q1) | • Insect Science | Link | 1.81 | 1.38 | 1.23 |
International Journal of Environmental Research and Public Health (IJERPH) | 67/446 (Q1) 31/102 (Q2) |
• Public Health, Environmental and Occupational Health • Health, Toxicology and Mutagenesis |
Link | 2.38 | 2.42 | 2.47 |
International Journal of Molecular Sciences (IJMS) | 23/157 (Q1) 8/64 (Q1) 90/353 (Q1) 22/144 (Q1) 16/44 (Q1) 8/62 (Q1) |
• Organic Chemistry • Inorganic Chemistry • Molecular Biology • Physical and Theoretical Chemistry • Catalysis • Spectroscopy |
Link | 3.73 | 3.37 | 3.06 |
ISPRS International Journal of Geo-Information | 12/29 (Q2) 28/79 (Q2) 96/587 (Q1) |
• Computers in Earth Sciences • Earth and Planetary Sciences (miscellaneous) • Geography, Planning and Development |
Link | 1.62 | 1.52 | - |
Journal of Low Power Electronic Applications (JLPEA) | 301/645 (Q2) | • Electrical and Electronic Engineering | Link | 0.98 | 0.83 | 0.83 |
Life | 65/525 (Q1) 36/186 (Q1) 5/92 (Q1) 20/80 (Q2) |
• Ecology, Evolution, Behavior and Systematics • General Biochemistry, Gene- tics and Molecular Biology • Palaeontology • Space and Planetary Science |
Link | 2.95 | 1.68 | 1.20 |
Marine Drugs | 18/145 (Q1) | • Drug Discovery | Link | 3.83 | 3.66 | 3.59 |
Materials | 63/424 (Q1) | • General Materials Science | Link | 3.26 | 3.11 | 2.69 |
Membranes | 103/424 (Q1) | • Materials Science | Link | 2.19 | 2.95 | 2.42 |
Micromachines | 173/645 (Q2) 69/211 (Q2) 113/526 (Q1) |
• Electrical and Electronic Engineering • Control and Systems Engineering • Mechanical Engineering |
Link | 1.83 | 1.78 | 2.10 |
Minerals | 45/206 (Q1) 29/167 (Q1) |
• Geology • Geotechnical Engineering and Engineering Geology |
Link | 2.13 | 1.77 | - |
Molecules | 32/157 (Q1) | • Organic Chemistry | Link | 3.09 | 2.65 | 2.62 |
Nutrients | 12/247 (Q1) | • Food Science | Link | 4.29 | 4.07 | 3.78 |
Pharmaceuticals | 8/168 (Q1) 21/158 (Q1) |
• Pharmaceutical Science • Molecular Medicine |
Link | 4.90 | 3.64 | 1.92 |
Pharmaceutics | 19/168 (Q1) | • Pharmaceutical Science | Link | 3.83 | 2.68 | 2.46 |
Polymers | 13/138 (Q1) 44/354 (Q1) |
• Polymers and Plastics • General Chemistry |
Link | 3.74 | 3.37 | 4.10 |
Remote Sensing | 13/169 (Q1) | • General Earth and Planetary Sciences | Link | 3.56 | 3.76 | 3.23 |
Sensors | 25/96 (Q2) 25/159 (Q1) 124/382 (Q2) 103/645 (Q1) |
• Analytical Chemistry • Atomic and Molecular Physics, and Optics • Biochemistry • Electrical and Electronic Engineering |
Link | 2.78 | 2.21 | 2.40 |
Sustainability | 49/129 (Q2) 68/587 (Q1) 56/236 (Q1) |
• Renewable Energy, Sustai-nability and the Environment • Geography, Planning and Development • Management, Monitoring, Policy and Law |
Link | 1.96 | 1.78 | 1.52 |
Symmetry | 17/42 (Q2) 49/111 (Q2) |
• Numerical Analysis • Computational Mathematics |
Link | 1.12 | 0.95 | 1.02 |
Toxins | 16/102 (Q1) 16/108 (Q1) |
• Health, Toxicology and Mutagenesis • Toxicology |
Link | 3.34 | 3.76 | 2.85 |
Vaccines | 146/184 (Q4) 151/250 (Q3) 93/145 (Q3) 186/299 (Q3) 130/232 (Q3) |
• Immunology • Infectious Diseases • Drug Discovery • Pharmacology • Pharmacology (medical) |
Link | 1.23 | 3.76 | 2.85 |
Viruses | 15/68 (Q1) 34/250 (Q1) |
• Virology • Infectious Diseases |
Link | 3.60 | 3.74 | 3.80 |
Water | 33/184 (Q1) 48/195 (Q1) 62/587 (Q1) 198/382 (Q3) |
• Water Science and Technology • Aquatic Science • Geography, Planning and Development • Biochemistry |
Link | 2.05 | 1.96 | 1.45 |
24 May 2017
Stanford Researchers Study the Reliability of Smart Watches in JPM Article
17 May 2017
Three New Institutional Memberships Established
We are pleased to announce that the Goethe University of Frankfurt, the Technical University of Hamburg (TU Hamburg-Harburg), as well as the Humboldt University of Berlin, in Germany, have joined MDPI's institutional membership program: Primary authors from these instititions will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
4 May 2017
MDPI Supports the Initiative for Open Citations (I4OC)
As an open access publisher, we are keen to support openness and transparency in the research process. Citation data is very important for assessing the value of individual papers and the contribution of researchers. As such, we support the recently launched Initiative for Open Citations (I4OC). The initiative recognizes that citations should be freely available and machine-readable. By doing so, authors gain the maximum benefit from having their work cited.
MDPI now uploads citation data with metadata uploaded to Crossref when registering digital object identifiers (DOIs) for published papers. We are delighted to take this step to support a truly open research environment.
2 May 2017
Publons Peer Review Academy Goes Live
Getting high quality review reports is critical for any journal’s editorial process. At MDPI we have put in place several measures to motivate reviewers and reward them for their work. We are proud of the quality of reviewer reports we receive and grateful for the hours put in by active researchers from across the globe.
Reviewers of MDPI’s largest journals can get recognition via Publons, a website dedicated to rewarding peer reviewers. They have now taken this one step further and launched the Publons Reviewer Academy to help train reviewers to provide useful feedback. Through the academy, researchers can be trained and tutored in various aspects of how to provide structured feedback that will be of genuine help to editors and authors. We support this initiative and recommend it to potential MDPI reviewers, especially early career researchers. See the Publons announcement for further information.
More information on reviewing for MDPI, including how to volunteer as a reviewer, can be found here.
24 April 2017
Two New Institutional Memberships Established
We are pleased to announce that the following universities have joined MDPI's institutional membership program: Trinity University, San Antonio, Texas, USA and the University of New South Wales (UNSW), Sydney, Australia. Primary authors from these instititions will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
30 March 2017
Credit for Preprints Comments via Publons
Preprints.org is a platform run by MDPI that allows authors to make early versions of manuscripts available before peer review has been completed.
One of the major benefits of putting a preprint online is to get feedback before journal submission. Until now, however, the feedback has been on a voluntary basis. Preprints is delighted to be the first preprint server to collaborate with Publons to acknowledge substantial comments as reviews and give commentators the opportunity to receive credit for their efforts.
When you add a comment to any article, there is a check box to click for it to appear on Publons. If you have already linked your account it will be passed on automatically. If you don't already have a Publons account, you will be contacted soon afterwards with instructions on how to create one.
We appreciate the enthusiasm and cooperation of Publons in this project and expect it to be of great benefit to authors and commenters alike.
20 March 2017
MDPI 2016 Annual Report Released
We are pleased to announce that our annual report for the year 2016 has now been published.
It contains information regarding company and journal performance, conferences and other publishing services that we provided throughout 2016.
To read the report in full or download a copy, please click here.
15 March 2017
Our 100,000th Article Could be Yours!
After the 20th anniversary of MDPI in 2016, we will reach another milestone this year and will publish the 100,000th peer-reviewed article in one of our 170+ open access journals.
We would like you to be part of this great achievement and so are offering to publish the 100,000th accepted paper free of charge.
To be in with a chance, select a journal in one of our 10 scientific subject areas and submit your paper.
Access the live tracker on published articles here.
3 March 2017
1000 Preprints Online
We are delighted that Preprints now has 1000 papers online since its launch on 3 May 2016.
For more information, see the editorial here.
9 February 2017
Minister and State Secretaries Visit MDPI Office at STP, Belgrade, Serbia
Earlier this week the Science Technology Park in Belgrade, Serbia was visited by Swiss Secretary of State Dr. Mauro Dell’Ambrogio, as well as Serbian Minister of Public Administration and Local Self-Government Ana Brnabic, State Secretary Dr. Vladimir Popovic and Mayor of Belgrade Mr. Siniša Mali.
During the visit to the STP they had a short presentation from MDPI’s CEO Dr. Franck Vazquez and IT Manager Mr. Miloš Čučulović, and further discussed important issues such as Open Access and Open education. Dr. Dell'Ambrogio said he was impressed with the potential for development and ideas for business.
For more information please see:
http://bit.ly/2kpIu7k and http://bit.ly/2kpUQfz
7 February 2017
The 6th World Sustainability Forum: Final Press Release
Basel, 29 January 2017
The 6th World Sustainability Forum #WSF2017SA: African universities critical to achieving the Sustainable Development Goals
Jeffrey and Sonia Sachs win first World Sustainability Award.
Universities need to take the lead in solving the greatest challenges the world faces today, particularly in Africa. They need to do this not only through education – teaching the next generation to think critically and creatively to find sustainable solutions – but also through research that cuts across a range of disciplines. To ensure these solutions are implemented, they need to partner with the private sector and with government.
This was the key message from the 6th World Sustainability Forum (WSF2017), which took place in Cape Town on 27 and 28 January 2017. Sponsored by MDPI and the journal Sustainability under the patronage of the Universities of the Western Cape (UWC), Cape Town (UCT), University of Basel and the National Research Foundation (NRF) of South Africa, the conference was attended by key national and international speakers, including world-leading economist Professor Jeffrey D. Sachs, senior United Nations (UN) advisor and director of the Earth Institute at Columbia University.
The WSF is an annual sustainability conference which addresses research in a range of areas related to sustainable development and sustainability globally. This was the first WSF to take place on the African continent. Discussions at the 2017 conference were driven by the 17 sustainable development goals (SDGs) adopted as part of the 2030 Agenda for Sustainable Development by the UN in September 2015.
Achieving the SDGs “is the moonshot for our generation,” said Sachs. “Like the moonshot [moon landing] of the 1960s, these are tough, bold and achievable objectives.”
“This is a nasty, tough world we live in, and our world agrees on very little. So when 193 governments agree on something, that is important. And when they agree on something as important as sustainable development, that is really something for us to grab hold of – that is a lifeline.”
There was agreement at the WSF that the SDGs are particularly important for Africa, and that African universities in particular have a role to play in achieving them.
Said Professor Tyrone Pretorius, vice-chancellor of UWC: “The quest for sustainable development can only be met through education. Universities today are the oil that fuels the knowledge economy.”
As part of the drive to develop academic capacity to provide the knowledge needed to meet the SDGs, WSF2017 was preceded by the 1st Postgraduate Forum on Sustainability. “A series of workshops for postgraduate education linked to WSF are important, in order to equip postgraduates with the skills necessary to promote sustainability,” said Professor Thandi Mgwebi, director for research at UWC. A second postgraduate forum will take place alongside the WSF2018 in Beijing.
This capacity development is particularly critical to Africa. Said Sachs: “African universities need to do research to find solutions to Africa’s development challenges, because no other university will.”
The UN set a target of achieving the SDGs by 2030: “I regard this as the breakthrough period to end extreme poverty on the continent,” said Sachs, “and for Africa to become one of the most dynamic centres of the world economy.”
It is a critical time for South African universities, said Professor Mamokgethi Phakeng, deputy vice-chancellor for research and internationalisation at UCT: “Higher education is at a crossroads, and there is much polarisation. We need to think carefully about how this sustainable development agenda is owned by all so that it is inclusionary.”
There was also strong emphasis on public–private partnerships – for universities, business and government to work together to achieve the goals.
Said Professor Francis Petersen, deputy vice-chancellor at UCT and vice-chancellor designate at the University of the Free State: “Business sustainability has become critical, because there is increasing demand and complexity of demand on business from the natural, social and economic environment. Sustainability cannot be a standalone issue, divorced from business as usual. Sustainability needs to be embedded into business.”
Environmental crises and climate change was also high on the WSF agenda. In his keynote address, Sachs noted the irreversibility of the climate- and environmental-related challenges.
“If we don’t get our act together, we lose the chance of safety,” he said.
Said Professor Mark New, pro vice-chancellor and director of the African Climate and Development Initiative at UCT: “We have a fundamental challenge in responding to climate change, and we must go further than just putting a plaster on a wound. We need to address the deep structural issues, to move from our current model of development into climate-compatible development.”
“This requires researchers to find the evidence for the correct development pathways to take, and then support the ability of policymakers at all levels to enable the shift to climate-compatible development planning.”
Said Dr. Aldo Stroebel, executive director of international relations and cooperation at the NRF, in closing: “We have seen over the past two days an urgency towards the next step of thinking, that critical type of framework that we all must engage with, not only from an academic perspective, but further up into the policy environment and into rural-based environments where one can clearly see the links and effectiveness of the work.”
World Sustainability Awards
The first World Sustainability Award and the first Emerging Sustainability Leader Awards were presented by Prof. Thandi Mgwebi, Director of Research at UWC, and Dr. Franck Vazquez, CEO of MDPI, during the ceremony on 27 January 2017 as part of the gala dinner of the 6th World Sustainability Forum in South Africa.after day one of proceedings of the 2017 World Sustainability Forum South Africa.
Professor Jeffrey D. Sachs and Dr. Sonia Ehrlich Sachs are the joint recipients of the first World Sustainability Award. Jeffrey Sachs is a world-renowned economist and senior United Nations (UN) advisor and director of the Earth Institute at Columbia University. Sonia Sachs is a paediatrician and public health specialist, and director of the Health Centre at the Centre for Sustainable Development, also at Columbia University.
The joint recipients of the first Emerging Sustainability Leader Award are Dr. Esther Ngumbi and Dr. Xiaosong Hu. Esther Ngumbi is a postdoctoral researcher at Auburn University in Alabama USA and serves as a 2015 Clinton Global University Mentor for agriculture. Xiaosong Hu is a professor at the Chongqing University in China and specialises in automotive control systems and mechanical engineering.
The World Sustainability Award and the Emerging Sustainability Leader Awards are funded to encourage new initiatives and developments in sustainability with the ultimate aim of fostering the transition to sustainable practices and societies.
The World Sustainability Award is funded by the MDPI Sustainability Foundation, and included a monetary prize of USD 100,000 to Jeffrey and Sonia Sachs. The Emerging Sustainability Leader Award is funded by the journal Sustainability, awarded to researchers under 40, and included a monetary prize of USD10,000.
Issued jointly by: UCT Global Strategy and Visibility, Research Office, UWC Communications & Media and MDPI AG
Conference photos are free available at: https://sciforum.net/conference/wsf-6/page/175 Photo credit: Matthias Burkhalter
Carla Bernardo |
Luthando Tyhalibongo |
Matthias Burkhalter |
31 January 2017
Three New Institutional Memberships Established
We are pleased to announce that the Chalmers University of Technology, Sweden, the University of Manitoba, Canada and the Technical University of Cartagena, Spain, have joined MDPI's institutional membership program: Primary authors from these institutions will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
27 January 2017
6th World Sustainability Forum under way in South Africa
The 6th World Sustainability Forum is currently being held at the Cape Sun Hotel until 28 January 2017.
The Forum will showcase the work of internationally renowned researchers and include more than 150 presentations. During the conference dinner, the World Sustainability Award, associated with a US$ 100,000 prize, will be announced, as well as the Emerging Sustainability Leader Award, associated with a US$ 10,000 prize. The prizes are sponsored by the MDPI Sustainability Foundation and Sustainability, an academic open access journal by MDPI.
Here are some pictures from the forum so far:
To see the full WSF2017 program and schedule, please see here: https://sciforum.net/conference/wsf-6/page/schedule
19 January 2017
Cape Town to Host the 6th World Sustainability Forum
Cape Town will host the 6th World Sustainability Forum at the Cape Sun Hotel on 27 and 28 January 2017. This prominent event, held for the first time in Africa, will include many illustrious South African and international experts, such as Her Excellency Graça Machel (Sustainable Development Advocate for the United Nations, Mozambique), Joyene Isaacs (HoD Agriculture Western Cape Government), Jeffrey Sachs (Columbia University, USA), Max Bergman (SRaM, University of Basel), Mark New (Pro Vice-Chancellor, University of Cape Town), Frans Swanepoel (FutureAfrica, University of Pretoria) and Francis Petersen (Vice-Chancellor-designate, University of the Free State). The Forum will provide a stage for national and international debates on sustainability in South Africa, the African continent, and about international perspectives on sustainability. It brings together researchers and representatives from government and the business sector to discuss a wide-ranging set of issues associated with sustainability, including food security, water and energy scarcity, mining, poverty reduction, climate change, and urbanisation.
The next few decades will be marked by profound changes in the relationships between global economics, national societies, and the environment. We have entered what some call the Anthropocene, an age in which human activity dominates the climate and the environment. These changes will have numerous consequences on societies around the globe. South Africa and Africa will play a central role, for better or worse, in creating opportunities and risks during these changing times as Africa is profoundly influencing and being influenced by global developments.
The adoption of the 17 United Nations Sustainable Development Goals and the 2030 Agenda for Sustainable Development in September 2015 was accompanied by what insiders considered an optimism they have not experienced in relation to UN resolutions before. The relative efficiency in the drafting, the lack of trenches between East and West, or between North and South, and the unanimity of support of the 193 countries speak volumes. In stark contrast, sustainability seems to go against a changing economic and political tide, where waves of nationalism and protectionism from some of the most powerful countries risk the wellbeing of the rest of the world. The 6th World Sustainability Forum will enable fruitful exchanges, which sensitise South African and international communities to the global urgency and specifics of sustainability.
The Forum will showcase the work of internationally renowned researchers and include more than 150 presentations. During the conference dinner, the World Sustainability Award, associated with a US$ 100 000 prize, will be announced, as well as the Emerging Sustainability Leader Award, associated with a US$ 10 000 prize. The prizes are sponsored by the MDPI Sustainability Foundation and Sustainability, an academic open access journal by MDPI. The World Sustainability Forum is preceded by the Postgraduate Forum on Sustainability, which will introduce more than 100 young scholars from South Africa and the African continent to sustainability research. Both events are organized and sponsored by the University of Cape Town, the University of the Western Cape, the University of Basel, MDPI, and by the National Research Foundation of South Africa.
Contacts:
Scientific Matters: Prof Manfred Max Bergman, Social Research and Methodology Group (SRaM), University of Basel, Switzerland; Email: [email protected]
Press Accreditation and General Enquiries: Mr Matthias Burkhalter, MDPI AG, Basel, Switzerland; Email: [email protected]; Tel. +41 61 683 77 34
Follow us on Twitter
#WSF2017SA
6 January 2017
MDPI Supports the OA2020 Initiative
MDPI is now a proud supporter of the OA2020 Initiative.
Open Access 2020 is an international initiative that aims to induce the swift, smooth and scholarly-oriented transformation of today’s scholarly journals from subscription to open access publishing.
MDPI is participating in the upcoming Berlin13 conference in March 2017, where we are contributing to the initiative by aiding in the design of the roadmap which will make OA the default publishing model.
For more information please see here.
5 January 2017
Three New Institutional Memberships Established
We are pleased to announce that the University of Texas at Arlington, USA, the Harbin Institute of Technology, China and TU Darmstadt, Germany, have joined MDPI's institutional membership program: Primary authors from these institutions will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
22 December 2016
Two New Institutional Memberships Established
We are pleased to announce that the Otto-von-Guericke-Universität Magdeburg, Germany and the University of California, Berkeley, USA, have joined MDPI's institutional membership program: Primary authors from these instititions will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
19 December 2016
MDPI and Wellcome Trust Compliance
The Wellcome Trust has, for a number of years, required that the results of its funded projects are published in open access format. Recently it announced criteria that publishers must fulfil for publication fees to be paid by the Trust. MDPI is pleased to have been added to the list of compliant publishers.
Only publishers who have confirmed their compliance by 16 December 2016 will be eligible to receive payment of APCs by the Wellcome Trust as of 1 April 2017. For more information on the criteria and a full list of publishers that meet them, see here.
13 December 2016
Meet MDPI at the 2016 AGU Fall Meeting
MDPI is currently attending the 2016 AGU Fall Meeting (12–16 December, 2016)
If you are also attending the conference, please feel free to stop by our booth (Booth #1147) and meet the representative editors.
Conference details:
2016 AGU Fall Meeting
12–16 December 2016
Moscone Center
747 Howard St
San Francisco, CA 94103, USA
8 December 2016
Three New Institutional Memberships Established
We are pleased to announce that Purdue University, USA, the Universitat Politécnica de Valencia, Spain and the Queensland University of Technology, Australia, have joined MDPI's institutional membership program: Primary authors from these instititions will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
16 November 2016
World Sustainability Award - Final Extension
The deadline for the World Sustainability Award has been extended for one last time! You now have one more month to nominate an individual researcher, group or project! The final deadline for nominations will be December 15, 2016.
For full details, please visit here.
11 November 2016
Three New Institutional Memberships Established
We are pleased to announce that the University of Minnesota, USA, the Universidad Politécnica de Madrid, Spain and Shanghai Jiao Tong University, China, have joined MDPI's institutional membership program: Primary authors from these instititions will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
4 November 2016
MDPI Joins the United Nations Global Compact
MDPI has become a member of the United Nations Global Compact to support corporate sustainability and have committed ourselves to the ten principles associated with the Compact.
Sustainability has always been at the core of MDPI’s values, starting with the collection and preservation of rare chemical samples that started in 1996 and led to the first journal, Molecules. Sustainability has become one of our flagship journals and we have supported and organized several conferences and events based on Sustainability, including the upcoming 6th World Sustainability Forum. As a global enterprise, we see it as our duty to promote responsible practices that will ensure a bright future for our planet. Given this, the choice to join the Global Compact was an easy one and we will do our utmost to fully implement it.
3 November 2016
MDPI Now a Member of SPARC Europe
We are delighted to announce that MDPI has become a member of SPARC Europe, an organization that works for open scholarship in Europe, including support of open access publication.
As one of the few publishers to join SPARC Europe to date, MDPI looks forward to making a contribution that puts open scholarship on a positive and sustainable path. We fully support the goals of open scholarship that allow the largest number of people possible to benefit from work of researchers in all disciplines. We hope that our membership will enable us to work with other stakeholders to find the best possible solution.
2 November 2016
World Sustainability Award Deadline Extension
The deadline for the World Sustainability Award has been extended! You now have until November 15, 2016 to nominate an individual researcher, group or project!
For full details, please visit here.
26 October 2016
Four New Institutional Memberships Established
We are pleased to announce that the Wuppertal Institut, Germany, the University of Girona, Spain and Central South University and Huazhong University of Science and Technology, China, have joined MDPI's institutional membership program: Primary authors from these instititions will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
24 October 2016
International Open Access Week 2016
Meet us during International Open Access Week 2016! We will be presenting at various locations in Europe and China.
To get involved and for full details see the complete list of events organised by MDPI here.
18 October 2016
Institutional Membership established with Universitat Pompeu Fabra, Spain and Aalto University, Finland
We are pleased to announce that the Universitat Pompeu Fabra, Spain and Aalto University, Finland, have joined MDPI's institutional membership program: Primary authors from these universities will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
12 October 2016
Institutional Membership Established with Iowa State University and the University of North Texas, USA
We are pleased to announce that the Iowa State University and the University of North Texas, USA, have joined MDPI's institutional membership program: Primary authors from these universities will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
7 October 2016
MDPI at Open Access Days in Munich, 10-11 October 2016
Meet MDPI during the Open Access Days held from 10-11 October 2016 at Ludwig Maximilian University of Munich, Germany.
The two-day event will feature experts from the open access sector, scientists from all disciplines, publishing representatives and supporters of scientific research and communication from libraries as well as research institutes and funding institutions. Join us!
For more information about the event and to see the program, visit the event webpage.
7 October 2016
Institutional Membership Established with the University of Sevilla and the University of Alicante, Spain
We are pleased to announce that the University of Sevilla and the University of Alicante, Spain have joined MDPI's institutional membership program: Primary authors from these universities will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
29 September 2016
Institutional Membership Established with the University of Delaware
We are pleased to announce that the University of Delaware, USA, has joined MDPI's institutional membership program: Primary authors from this university will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
19 September 2016
Peer Review Week 2016
As an open access publisher indebted to the work of our peer reviewers, we are proud to support Peer Review Week 2016. As part of the week's activities and to celebrate this year's theme "Recognition for Review", MDPI will host two webinars that anyone can join.
These webinars will explore the role and value of reviewers and the recognition they receive from a publishers perspective, with examples from MDPI's experience in publishing nearly 80,000 peer reviewed papers, along with evidence from reviewer surveys. It will also touch upon potential changes in how review is carried out and tips for early career researchers who want to be involved in the review process.
Details and links to join can be found below:
Wednesday September 21, 08:00 (CEST)
Friday September 23, 16:00 (CEST)
For more information about all the activites taking place, please visit the Peer Review Week website.
6 September 2016
Institutional Membership established with Kansas State University and Northwestern University, USA
We are pleased to announce that Kansas State University and Northwestern Universty, USE, have joined MDPI's institutional membership program: Primary authors from these universities will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
5 September 2016
Institutional Membership Established with University College Cork
We are pleased to announce that University College Cork, Ireland, has joined MDPI's institutional membership program: Primary authors from this university will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
22 August 2016
MDPI New Office Location
We are pleased to announce that MDPI has now moved to a new permanent address:
MDPI AG
St. Alban Anlage 66
CH-4052 Basel
Postfach, CH-4020 Basel
Switzerland
Telephone and fax numbers remain unchanged.
10 August 2016
Institutional Membership established with the University of Texas at Austin, USA, the Wroclaw University of Science and Technology, Poland and the University of Granada and the Compultense University of Madrid, Spain
We are pleased to announce that the following institutions have joined MDPI's institutional membership program in August 2016:
- University of Texas at Austin, USA
- Wroclaw University of Science and Technology, Poland
- University of Granada, Spain
- Compultense University of Madrid, Spain
Authors affiliated with these institutions will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
18 July 2016
Institutional Membership established with Louisiana State University and Florida State University, USA, Royal College of Surgeons, Ireland, University of Rostock, Germany, AGH University of Science and Technology, Poland and Southeast University, China
We are pleased to announce that the following institutions have joined MDPI's institutional membership program in July 2016:
- Louisiana State University, USA
- Florida State University, USA
- Royal College of Surgeons, Ireland
- University of Rostock, Germany
- AGH University of Science and Technology, Poland
- Southeast University, China
Authors affiliated with these institutions will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
12 July 2016
MDPI Moving to New Office Location in Basel (Switzerland) in August 2016
As of 20 August 2016, MDPI's new address in Basel will be:
MDPI AG
St. Alban-Anlage 66
CH-4052 Basel
Switzerland
Telephone and fax numbers remain unchanged.
St. Alban-Anlage 66 was built from 1947 to 1948 and initially the home of the "Bühler AG", a book printing business.
For more information about this building, see: https://www.mdpi.com/about/headquarters
21 June 2016
"Behind the Scenes of Academic Publishing—A Publisher's Perspective" - MDPI's Lecture at the University of Basel
From the 15-16 September, 2016, MDPI will run a course on Academic Publishing at the University of Basel.
In this two day workshop, MDPI will look in detail at the role performed by academic journal publishers and how they interact with academics. Ethical dimensions, what happens when problems occur and how the publisher coordinates all aspects of the submission process will also be covered.
For more detailed information about the program, trainers and registration please visit the course webpage.
14 June 2016
2015 Impact Factors Released
We are pleased to report the 2015 Journal Impact Factors in the latest Journal Citation Reports® Science Edition, published by Thomson Reuters in June 2016. Twenty out of 25 journals have seen an increase in their Impact Factor and two journals (Crystals and IJGI) received a first Impact Factor. Coatings was recently added to SCIE and will receive its first Impact Factor in next year’s JCR.
Updated Impact Factors for Journals in the Science Citation Index Expanded (SCIE)
Journal | 2015 Impact Factor | Details | Category Rank |
Applied Sciences | 1.726 | Link | 83/163 (Q3) in ‘Chemistry, Multidisciplinary’; 129/271 (Q2) in ‘Materials Science, Multidisciplinary’; 64/145 (Q2) in ‘Physics, Applied’ |
Atmosphere | 1.221 | Link | 66/84 (Q4) in ‘Meteorology & Atmospheric Sciences’ |
Catalysts | 2.964 | Link | 53/144 (Q2) in ‘Chemistry, Physical’ |
Energies | 2.077 | Link | 43/88 (Q2) in ‘Energy & Fuels’ |
Entropy | 1.743 | Link | 25/79 (Q2) in ‘Physics, Multidisciplinary’ |
Forests | 1.583 | Link | 19/66 (Q2) in ‘Forestry’ |
Genes | 3.242 | Link | 60/165 (Q2) in ‘Genetics & Heredity’ |
International Journal of Environmental Research and Public Health (IJERPH) | 2.035 | Link | 101/225 (Q2) in ‘Environmental Sciences’ |
International Journal of Molecular Sciences (IJMS) | 3.257 | Link | 110/289 (Q2) in ‘Biochemistry & Molecular Biology’; 51/163 (Q2) in ‘Chemistry, Multidisciplinary’ |
Marine Drugs | 3.345 | Link | 13/59 (Q1) in ‘Chemistry, Medicinal’ |
Materials | 2.728 | Link | 63/271 (Q1) in ‘Materials Science, Multidisciplinary’ |
Metals | 1.574 | Link | 18/73 (Q1) in ‘Metallurgy & Metallurgical Engineering’; 145/271 (Q3) in ‘Materials Science, Multidisciplinary’ |
Micromachines | 1.295 | Link | 30/56 (Q3) in ‘Instruments & Instrumentation’ 63/83 (Q4) in ‘Nanoscience & Nanotechnology’ |
Minerals | 1.468 | Link | 9/21 (Q2) in ‘Mining & Mineral Processing; 14/29 (Q2) in ‘Mineralogy’ |
Molecules | 2.465 | Link | 24/59 (Q2) in ‘Chemistry, Organic’ |
Nanomaterials | 2.690 | Link | 64/271 (Q1) in ‘Materials Science, Multidisciplinary’; 36/83 (Q2) in ‘Nanoscience & Nanotechnology’ |
Nutrients | 3.759 | Link | 16/78 (Q1) in ‘Nutrition & Dietetics’ |
Polymers | 2.944 | Link | 20/85 (Q1) in ‘Polymer Science’ |
Remote Sensing | 3.036 | Link | 5/28 (Q1) in ‘Remote Sensing’ |
Sensors | 2.033 | Link | 36/75 (Q2) in ‘Chemistry, Analytical’; 16/27 (Q3) in ‘Electrochemistry’; 12/56 (Q1) in ‘Instruments & Instrumentation’ |
Sustainability | 1.343 | Link | 146/225 (Q3) in ‘Environmental Sciences’; 22/29 (Q4) in ‘Green & Sustainable Science & Technology’ |
Symmetry | 0.841 | Link | 31/63 (Q2) in ‘Multidisciplinary Sciences’ |
Toxins | 3.571 | Link | 16/89 (Q1) in ‘Toxicology’ |
Viruses | 3.042 | Link | 14/33 (Q2) in ‘Virology’ |
Water | 1.687 | Link | 33/85 (Q2) in ‘Water Resources’ |
Journals with First Impact Factors
Journal | 2015 Impact Factor | Details | Category Rank |
Crystals | 2.075 | Link | 13/26 (Q2) in ‘Crystallography’ |
ISPRS International Journal of Geo-Information | 0.651 | Link | 45/49 (Q4) in ‘Geography, Physical’; 26/28 (Q4) in ‘Remote Sensing’. |
26 May 2016
Institutional Membership established with University of Bremen, Germany, Koç University, Turkey, IIASA, Austria and Jilin University and Kunming Institute of Botany, CAS, China
We are pleased to announce that the following institutions have joined MDPI's institutional membership program in May 2016:
- Unversity of Bremen, Germany
- Koç University, Turkey
- International Institute for Applied Systems Analysis (IIASA), Austria
- Jilin University, China
- Kunming Institute of Botany, Chinese Academy of Sciences, China
Authors affiliated with these institutions will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
23 May 2016
Institutional Membership Established with the KTH Royal Institute of Technology, Sweden and the South China University of Technology, Beijing University of Technology and Southern Medical University, China
We are pleased to announce that the following institutions have joined MDPI's institutional membership program in April and May 2016:
- KTH Royal Institute of Technology, Sweden
- South China University of Technology, China
- Beijing University of Technology, China
- Southern Medical University, China
Authors affiliated with these institutions will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
26 April 2016
New Section on www.mdpi.com - Latest Books
You may have noticed a new section that is now visible on our home page. This section is called "Latest Books" and showcases recent publications from MDPI Books, our book publishing service.
By clicking on the hyperlink "More Books" you will be taken to the MDPI Books Home Page. There you will find more information about the service, as well as the "Recent Publications" list.
Clicking on any of the book images in this list will take you to detailed information about that book (shown below). Here you can also download a PDF version of the book, or order a hardcover printed copy.
For further information about the MDPI Books service, please visit the webpage or contact [email protected].
31 March 2016
Axioms, Behavioral Sciences, Photonics, Separations and Toxics added to the Emerging Sources Citation Index in Web of Science
We are pleased to announce that the journals Axioms, Behavioral Sciences, Photonics, Separations and Toxics were recently accepted for inclusion in the newly launched Emerging Sources Citation Index (ESCI) in Web of Science.
ESCI serves to highlight promising journals which are still under consideration for the Science Citation Index Expanded (SCIE) or the Social Sciences Citation Index (SSCI).
The Emerging Sources Citation Index (ESCI), Science Citation Index Expanded (SCIE), Social Sciences Citation Index
(SSCI), and Web of Science™ (WoS) are Thomson Reuters products.
30 March 2016
Institutional Membership established with the University of Winchester, UK, Silesian University of Technology, Poland and Beijing Jiaotong University and Zhejiang University, China
We are pleased to announce that the University of Winchester, UK, the Silesian University of Technology, Poland and Beijing Jiaotong University and Zhejiang University, China, have joined our Institutional Membership program. Primary authors from these universities will benefit from a 10% discount on article processing charges.
Additional details can be found on our institutional membership page.
24 March 2016
New Editorial Office in Barcelona, Spain
We are excited to announce the opening of our new editorial office in Barcelona, Spain. The launch team is led by a Senior Editor and comprises further staff holding doctoral degrees with several years of research experience. The new editorial team will help us to get closer to European research communities and progress Sciforum, the platform to support the scientific community via conference hosting and other functions. They will also help spread the word about Open Access and meet academics at scientific events.
We are in the process of hiring more doctoral and masters graduates to join the editorial team and welcome applications via [email protected]. For contact details about the office, see our contact page.
22 February 2016
Membership Established with the Max Planck Society
We are pleased to announce that the Max Planck Digital Library (MPDL) has signed an agreement with MDPI to support authors associated with the Max Planck Society (Max-Planck-Gesellschaft). As of 22 February 2016, corresponding authors will receive full funding from the MPDL for articles published in MDPI journals, with a 10% discount applied to the Article Processing Charges. Additional details can be found at our institutional membership page.
Founded in 1948, The Max Planck Society is one of Germany’s leading research organizations, and is currently made up of 83 institutes conducting basic research in natural sciences, life sciences, social sciences and humanities. 18 Nobel laureates have emerged from its ranks of scientists and the society has more than 15,000 publications in scientific journals each year.
5 February 2016
Institutional Membership Extension: Wageningen University, CSIC, University of Zürich, ETH Zürich, University of Tübingen and Osnabrück University
We are pleased to announce that Wageningen University, the Netherlands, the Spanish National Research Council (CSIC), Spain, the University of Zürich and ETH Zürich, Switzerland, and the University of Tübingen and Osnabrück University, Germany, have not only renewed their institutional memberships with MDPI after two years of successful cooperation, but have also increased the reduction of the article processing charges (APCs) for affiliated authors to 25%.
Additional details can be found on our institutional membership page.
5 February 2016
Institutional Membership established with Brock University, Canada and the University of Pisa, Italy
We are pleased to announce that Brock University, Cananda, and the University of Pisa, Italy, have joined MDPI's institutional membership program: Primary authors from these universities will benefit from a 10% discount on the article processing charges as of 01 February 2016.
Additional details can be found on our institutional membership page.
25 January 2016
MDPI Sponsors diss:kurs with the University of Basel
MDPI is pleased to announce its newly established sponsorship of diss:kurs, an event coordinated by the University of Basel to support their doctorate program. For more information about the event and how to register, please visit the diss:kurs webpage.
7 January 2016
New Institutional Memberships Established with Tsinghua University, the Chinese Society of Micro-Nano Technology, Ruhr University Bochum and the University of Ulm
We are pleased to announce that the following institutions have joined MDPI's institutional membership program as of 1 January 2016:
- Tsinghua University, China
- Chinese Society of Micro-Nano Technology (CSMNT)
- Ruhr University Bochum, Germany
- University of Ulm, Germany
Authors affiliated with these institutions will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
5 January 2016
Safety, Fermentation, C-Journal of Carbon Research, Magnetochemistry, Batteries and Horticulturae Released Their First Issue in December 2015
We are pleased to announce that MDPI's open access journals Safety, Journal of Imaging, Fermentation, C-Journal of Carbon Research, Magnetochemistry, Batteries and Horticulturae released their first issue at the end of December 2015.
17 December 2015
Institutional Membership Extension: University of Bern, Switzerland
We are pleased to announce that the University of Bern, Switzerland has not only renewed their institutional membership with MDPI after two years of successful cooperation, but also increased the reduction of the article processing charges (APCs) for affiliated authors to 25%.
17 December 2015
Institutional Membership with the University of Ulm and Helmholtz Zentrum Munich
We are pleased to announce that University of Ulm, Germany and Helmholtz Zentrum Munich, Germany has joined MDPI's institutional membership program:
Primary authors from the University of Ulm and Helmholtz Zentrum Munich will benefit from a 10% discount on the article processing charges as of 1 January 2016. Additional details can be found on our institutional membership page.
9 December 2015
Membership Established with the Virginia Polytechnic Institute and State University (Virginia Tech)
We are pleased to announce that Virginia Tech has joined MDPI's institutional membership program. Authors from Virginia Tech will benefit from a 10% discount on the article processing charges as of 1 December 2015. Additional details can be found on our institutional membership page.
1 December 2015
Membership Established with the Technical University of Denmark and the University of North Florida
We are pleased to announce that the following universities have joined MDPI's institutional membership program:
- Technical University of Denmark (as of 1 November 2015)
- University of North Florida, USA (as of 15 November 2015)
Primary authors from the Technical University of Denmark and the University of North Florida will benefit from a 10% discount on the article processing charges.
Additional details can be found on our institutional membership page.
2 October 2015
Membership Established with the University of Freiburg and the University of Regensburg
We are pleased to announce that the following universities have joined MDPI's institutional membership program:
University of Freiburg, Germany
University of Regensburg, Germany
Primary authors from the University of Freiburg and the University of Regensburg will benefit from a 10% discount on the article processing charges as of 1 October 2015 and 1 November 2015.
Additional details can be found on our institutional membership page.